rearrangement	amino_acid	frame_type	rearrangement_type	templates	reads	frequency	productive_frequency	cdr3_length	v_family	v_gene	v_allele	d_family	d_gene	d_allele	j_family	j_gene	j_allele	v_deletions	d5_deletions	d3_deletions	j_deletions	n2_insertions	n1_insertions	v_index	n1_index	n2_index	d_index	j_index	v_family_ties	v_gene_ties	v_allele_ties	d_family_ties	d_gene_ties	d_allele_ties	j_family_ties	j_gene_ties	j_allele_ties	sequence_tags	v_shm_count	v_shm_indexes	antibody	bio_identity	v_resolved	d_resolved	j_resolved	sample_name	species	locus	product_subtype	kit_pool	sku	test_name	sample_catalog_tags	sample_rich_tags	sample_rich_tags_json	kit_control	total_templates	productive_templates	outofframe_templates	stop_templates	dj_templates	total_rearrangements	productive_rearrangements	outofframe_rearrangements	stop_rearrangements	dj_rearrangements	total_reads	total_productive_reads	total_outofframe_reads	total_stop_reads	total_dj_reads	productive_clonality	productive_entropy	sample_clonality	sample_entropy	sample_amount_ng	sample_cells_mass_estimate	fraction_productive_of_cells_mass_estimate	sample_cells	fraction_productive_of_cells	max_productive_frequency	max_frequency	counting_method	primer_set	sequence_result_status	release_date	upload_date	sample_tags	fraction_productive	order_name	kit_id	total_t_cells	total_templates_agg
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTAGACCCCGCGGGGGCGATTGGCTACACCTTCGGTTCG	CASSVDPAGAIGYTF	In	VDJ	1	11	8.134951449130669E-5	9.538757706882647E-5	45	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-02	01	0	7	2	7	5	4	23	39	51	44	55			01,02										Vb 1	CASSVDPAGAIGYTF+TCRBV09-01+TCRBJ01-02	TCRBV09-01	TCRBD02-01*01	TCRBJ01-02*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCTACCGTTCGGATGAAGCTTTCTTTGGACAA	CASSYRSDEAFF	In	VDJ	1	11	8.134951449130669E-5	9.538757706882647E-5	36	TCRBV09	TCRBV09-01					TCRBJ01	TCRBJ01-01	01	4	1	8	7	8	0	23	35	-1	43	46			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 1	CASSYRSDEAFF+TCRBV09-01+TCRBJ01-01	TCRBV09-01		TCRBJ01-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTAGATTTTCTCTCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	12	8.87449248996073E-5		41	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	0	4	10	3	5	2	23	39	46	44	48			01,02			01,02							Vb 1	X+TCRBV09-01+TCRBJ02-07	TCRBV09-01	TCRBD02-01	TCRBJ02-07*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCACCGGGACAGGGAGGACTGAAGCTTTCTTTGGACAA	CASTGTGRTEAFF	In	VDJ	1	14	1.0353574571620853E-4	1.2140237081487006E-4	39	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	0	3	5	2	3	23	33	44	35	47			01,02										Vb 1	CASTGTGRTEAFF+TCRBV09-01+TCRBJ01-01	TCRBV09-01	TCRBD01-01*01	TCRBJ01-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCTGGAAACCTGGGTTCACTGAAGCTTTCTTTGGACAA	CASSWKPGFTEAFF	In	VDJ	1	14	1.0353574571620853E-4	1.2140237081487006E-4	42	TCRBV09	TCRBV09-01					TCRBJ01	TCRBJ01-01	01	4	0	9	4	9	2	23	35	47	44	49			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 1	CASSWKPGFTEAFF+TCRBV09-01+TCRBJ01-01	TCRBV09-01		TCRBJ01-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGTCGTTTAGGACAGGGGGCCAGGAATGAGCAGTTCTTCGGGCCA	CASSRLGQGARNEQFF	In	VDJ	1	15	1.1093115612450913E-4	1.3007396873021792E-4	48	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	1	0	7	7	4	23	34	52	41	56			01,02										Vb 1	CASSRLGQGARNEQFF+TCRBV09-01+TCRBJ02-01	TCRBV09-01	TCRBD01-01*01	TCRBJ02-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTACAGCCCCGGGGACGAGCTTTCTTTGGACAA	CASSVQPRGRAFF	In	VDJ	1	16	1.1832656653280974E-4	1.3874556664556577E-4	39	TCRBV09	TCRBV09-01					TCRBJ01	TCRBJ01-01	01	1	0	7	10	8	1	23	38	51	46	52			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 1	CASSVQPRGRAFF+TCRBV09-01+TCRBJ01-01	TCRBV09-01		TCRBJ01-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGTCCCGGCGACGACACTGAAGCTTTCTTTGGACAA	CASSPGDDTEAFF	In	VDJ	1	16	1.1832656653280974E-4	1.3874556664556577E-4	39	TCRBV09	TCRBV09-01					TCRBJ01	TCRBJ01-01	01	5	2	7	3	7	1	23	34	44	41	45			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 1	CASSPGDDTEAFF+TCRBV09-01+TCRBJ01-01	TCRBV09-01		TCRBJ01-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCCCCCCGGGGGAGACTAGCTCCAATGAGCAGTTCTTCGGGCCA	CASSPPGETSSNEQFF	In	VDJ	1	20	1.4790820816601219E-4	1.734319583069572E-4	48	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	4	2	7	6	11	2	23	35	53	46	55			01,02			01,02							Vb 1	CASSPPGETSSNEQFF+TCRBV09-01+TCRBJ02-01	TCRBV09-01	TCRBD02-01	TCRBJ02-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTCGACAGGGCGGGGGAGCAGTACTTCGGGCCG	CASSVDRAGEQYF	In	VDJ	1	21	1.5530361857431278E-4	1.821035562223051E-4	39	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	2	2	3	7	1	5	23	37	45	38	50			01,02										Vb 1	CASSVDRAGEQYF+TCRBV09-01+TCRBJ02-07	TCRBV09-01	TCRBD01-01*01	TCRBJ02-07*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTAGAAGCGACTAGTCCCTACGAGCAGTACTTCGGGCCG	CASSVEATSPYEQYF	In	VDJ	1	24	1.774898497992146E-4	2.0811834996834865E-4	45	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	0	2	8	2	4	2	23	39	49	43	51			01,02			01,02							Vb 1	CASSVEATSPYEQYF+TCRBV09-01+TCRBJ02-07	TCRBV09-01	TCRBD02-01	TCRBJ02-07*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTAGGACCGGACACCTGAATCTGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	24	1.774898497992146E-4		53	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	0	1	6	0	4	8	23	39	48	43	56			01,02										Vb 1	X+TCRBV09-01+TCRBJ01-01	TCRBV09-01	TCRBD01-01*01	TCRBJ01-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCACGGAGGGGTTGAACACTGAAGCTTTCTTTGGACAA	CASSTEGLNTEAFF	In	VDJ	1	25	1.848852602075152E-4	2.1678994788369653E-4	42	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	4	10	0	0	2	2	23	35	43	37	45			01,02										Vb 1	CASSTEGLNTEAFF+TCRBV09-01+TCRBJ01-01	TCRBV09-01	TCRBD02-01*02	TCRBJ01-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCGCCCGGCAGGGGCAAGAGACCCAGTACTTCGGGCCA	CASARQGQETQYF	In	VDJ	1	25	1.848852602075152E-4	2.1678994788369653E-4	39	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	7	4	2	2	6	0	23	32	-1	38	44			01,02										Vb 1	CASARQGQETQYF+TCRBV09-01+TCRBJ02-05	TCRBV09-01	TCRBD01-01*01	TCRBJ02-05*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTAGGGACAGGGGTCCAAGAGACCCAGTACTTCGGGCCA	CASSVGTGVQETQYF	In	VDJ	1	26	1.9228067061581583E-4	2.254615457990444E-4	45	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	0	1	2	1	0	1	23	-1	48	39	49			01,02										Vb 1	CASSVGTGVQETQYF+TCRBV09-01+TCRBJ02-05	TCRBV09-01	TCRBD01-01*01	TCRBJ02-05*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCCCGGGACAGGTGCCAGGCAATGAGCAGTTCTTCGGGCCA	CASSPGQVPGNEQFF	In	VDJ	1	27	1.9967608102411643E-4	2.3413314371439225E-4	45	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	4	0	4	6	2	7	23	35	45	37	52			01,02										Vb 1	CASSPGQVPGNEQFF+TCRBV09-01+TCRBJ02-01	TCRBV09-01	TCRBD01-01*01	TCRBJ02-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGCATACGGGACAGAGGCAGATACGCAGTATTTTGGCCCA	CASSAYGTEADTQYF	In	VDJ	1	27	1.9967608102411643E-4	2.3413314371439225E-4	45	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	3	0	5	4	5	3	23	36	48	41	51			01,02										Vb 1	CASSAYGTEADTQYF+TCRBV09-01+TCRBJ02-03	TCRBV09-01	TCRBD01-01*01	TCRBJ02-03*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGAGCCCCTACAGGGCCCGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSEPLQGPNTGELFF	In	VDJ	1	33	2.4404854347392007E-4	2.8616273120647944E-4	51	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	3	3	3	0	7	2	23	36	49	43	51			01,02										Vb 1	CASSEPLQGPNTGELFF+TCRBV09-01+TCRBJ02-02	TCRBV09-01	TCRBD01-01*01	TCRBJ02-02*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTAGGCGGGACAGGGAACTATGGCTACACCTTCGGTTCG	CASSVGGTGNYGYTF	In	VDJ	1	37	2.736301851071225E-4	3.208491228678709E-4	45	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	0	3	2	2	0	23	39	-1	41	50			01,02										Vb 1	CASSVGGTGNYGYTF+TCRBV09-01+TCRBJ01-02	TCRBV09-01	TCRBD01-01*01	TCRBJ01-02*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGGGACAGTATCCTACGAGCAGTACTTCGGGCCG	CASSGTVSYEQYF	In	VDJ	1	47	3.475842891901286E-4	4.0756510202134946E-4	39	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	1	5	1	0	2	23	-1	42	36	44			01,02										Vb 1	CASSGTVSYEQYF+TCRBV09-01+TCRBJ02-07	TCRBV09-01	TCRBD01-01*01	TCRBJ02-07*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTTCTTCAGGGGTCGCACTATGGCTACACCTTCGGTTCG	CASSVLQGSHYGYTF	In	VDJ	1	49	3.623751100067298E-4	4.249082978520452E-4	45	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	2	4	2	3	4	4	23	37	47	41	51			01,02										Vb 1	CASSVLQGSHYGYTF+TCRBV09-01+TCRBJ01-02	TCRBV09-01	TCRBD01-01*01	TCRBJ01-02*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCACCGGGACTAGCGGGAGAAGGGTTAGGCCTAGGAATGAGCAGTTCTTCGGGCCA	CASTGTSGRRVRPRNEQFF	In	VDJ	1	51	3.7716593082333106E-4	4.422514936827409E-4	57	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	6	0	2	7	2	16	23	33	49	35	65			01,02										Vb 1	CASTGTSGRRVRPRNEQFF+TCRBV09-01+TCRBJ02-01	TCRBV09-01	TCRBD02-01*02	TCRBJ02-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTAGGGGGGACCCGGACCGGGGAGCTGTTTTTTGGAGAA	CASSVGGTRTGELFF	In	VDJ	2	59	4.363292140897359E-4	5.116242770055238E-4	45	TCRBV09	TCRBV09-01					TCRBJ02	TCRBJ02-02	01	0	0	7	5	2	4	23	39	46	41	50			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 1	CASSVGGTRTGELFF+TCRBV09-01+TCRBJ02-02	TCRBV09-01		TCRBJ02-02*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCCGATTTTCCGGGACAAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSRFSGTSSYNEQFF	In	VDJ	2	68	5.028879077644413E-4	5.896686582436546E-4	51	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	4	0	6	0	9	2	23	35	50	44	52			01,02										Vb 1	CASSRFSGTSSYNEQFF+TCRBV09-01+TCRBJ02-01	TCRBV09-01	TCRBD01-01*01	TCRBJ02-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGATAGGACAGGAGTGAACACTGAAGCTTTCTTTGGACAA	CASSDRTGVNTEAFF	In	VDJ	3	104	7.691226824632633E-4	9.018461831961776E-4	45	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	1	4	0	3	2	23	36	46	39	48			01,02										Vb 1	CASSDRTGVNTEAFF+TCRBV09-01+TCRBJ01-01	TCRBV09-01	TCRBD01-01*01	TCRBJ01-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGGCCAGGAACCCTTGGGCCCGGGGAGCTGTTTTTTGGAGAA	CASRPGTLGPGELFF	In	VDJ	5	165	0.0012202427173696004	0.001430813656032397	45	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	5	4	4	6	2	11	23	34	40	36	51			01,02										Vb 1	CASRPGTLGPGELFF+TCRBV09-01+TCRBJ02-02	TCRBV09-01	TCRBD01-01*01	TCRBJ02-02*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTGGGAGGCAGACCTGGAAACACCATATATTTTGGAGAG	CASSVGGRPGNTIYF	In	VDJ	5	170	0.0012572197694111034	0.0014741716456091365	45	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-03	01	2	9	1	2	0	5	23	-1	43	37	48			01,02										Vb 1	CASSVGGRPGNTIYF+TCRBV09-01+TCRBJ01-03	TCRBV09-01	TCRBD02-01*02	TCRBJ01-03*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCCCTCTCGCTAGCCCAAGCACAGATACGCAGTATTTTGGCCCA	CASSPLASPSTDTQYF	In	VDJ	6	194	0.0014347096192103182	0.001682289995577485	48	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	4	4	7	0	7	3	23	35	47	42	50			01,02			01,02							Vb 1	CASSPLASPSTDTQYF+TCRBV09-01+TCRBJ02-03	TCRBV09-01	TCRBD02-01	TCRBJ02-03*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTACTAGCGGGAAACTACGAGCAGTACTTCGGGCCG	CASSVLAGNYEQYF	In	VDJ	9	307	0.002270390995348287	0.0026621805600117936	42	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	1	4	3	3	0	2	23	-1	47	38	49			01,02										Vb 1	CASSVLAGNYEQYF+TCRBV09-01+TCRBJ02-07	TCRBV09-01	TCRBD02-01*02	TCRBJ02-07*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAAGACTAGCGGGAGGGCCAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	10	345	0.00255141659086371		44	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	6	2	0	1	1	0	23	33	-1	34	48			01,02										Vb 1	X+TCRBV09-01+TCRBJ02-05	TCRBV09-01	TCRBD02-01*02	TCRBJ02-05*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTAGGACAGGGTTGGGCCTACGAGCAGTACTTCGGGCCG	CASSVGQGWAYEQYF	In	VDJ	15	513	0.003793845539458212	0.004448529730573453	45	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	0	2	3	2	0	5	23	-1	46	39	51			01,02										Vb 1	CASSVGQGWAYEQYF+TCRBV09-01+TCRBJ02-07	TCRBV09-01	TCRBD01-01*01	TCRBJ02-07*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCCTGAGGCCCGGGAACACTGAAGCTTTCTTTGGACAA	CASSLRPGNTEAFF	In	VDJ	24	832	0.006152981459706107	0.007214769465569421	42	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	4	11	1	1	2	5	23	35	41	37	46			01,02										Vb 1	CASSLRPGNTEAFF+TCRBV09-01+TCRBJ01-01	TCRBV09-01	TCRBD02-01*02	TCRBJ01-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GGACTCGGCCATGTATCTCTGTGCCAGCAGCGCCGACAGGGGAAAGGGTCAGCCCCAGCATTTTGGTGAT	CASSADRGKGQPQHF	In	VDJ	1	14	1.0353574571620853E-4	1.2140237081487006E-4	45	TCRBV11	TCRBV11-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	5	2	2	6	3	6	19	31	42	34	48														CASSADRGKGQPQHF+TCRBV11-01+TCRBJ01-05	TCRBV11-01*01	TCRBD01-01*01	TCRBJ01-05*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GGACTCGGCCATGTATCTCTGTGCCAGCAGCTGGGCAGGGGACACCGGGGAGCTGTTTTTTGGAGAA	CASSWAGDTGELFF	In	VDJ	1	16	1.1832656653280974E-4	1.3874556664556577E-4	42	TCRBV11	TCRBV11-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	4	4	2	3	3	0	19	32	-1	35	41														CASSWAGDTGELFF+TCRBV11-01+TCRBJ02-02	TCRBV11-01*01	TCRBD01-01*01	TCRBJ02-02*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GGACTCGGCCATGTATCTCTGTGCCAGCAGCTTAGTAGCGGGAGGGCCTTACAATGAGCAGTTCTTCGGGCCA	CASSLVAGGPYNEQFF	In	VDJ	1	20	1.4790820816601219E-4	1.734319583069572E-4	48	TCRBV11	TCRBV11-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	1	5	0	4	0	3	19	-1	46	35	49														CASSLVAGGPYNEQFF+TCRBV11-01+TCRBJ02-01	TCRBV11-01*01	TCRBD02-01*02	TCRBJ02-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GGACTCGGCCATGTATCTCTGTGCCAGCAGCTTCCGGGACAGGCTACAGCCCCAGCATTTTGGTGAT	CASSFRDRLQPQHF	In	VDJ	1	22	1.6269902898261338E-4	1.9077515413765293E-4	42	TCRBV11	TCRBV11-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	3	0	4	7	2	3	19	33	43	35	46														CASSFRDRLQPQHF+TCRBV11-01+TCRBJ01-05	TCRBV11-01*01	TCRBD01-01*01	TCRBJ01-05*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GGACTCGGCCATGTATCTCTGTGCCAGCAGCTTGGAAGAGGGTCTCTCTGGAAACACCATATATTTTGGAGAG	CASSLEEGLSGNTIYF	In	VDJ	1	27	1.9967608102411643E-4	2.3413314371439225E-4	48	TCRBV11	TCRBV11-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-03	01	3	11	0	0	4	3	19	33	42	37	45														CASSLEEGLSGNTIYF+TCRBV11-01+TCRBJ01-03	TCRBV11-01*01	TCRBD02-01*02	TCRBJ01-03*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGACTACTGGGACAGGGGACGCCGAAACACTGAAGCTTTCTTTGGACAA	CASSQDYWDRGRRNTEAFF	In	VDJ	1	16	1.1832656653280974E-4	1.3874556664556577E-4	57	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	0	0	2	2	5	7	18	35	50	40	57													Vb 16	CASSQDYWDRGRRNTEAFF+TCRBV14-01+TCRBJ01-01	TCRBV14-01*01	TCRBD01-01*01	TCRBJ01-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAATGATCTCAGGAAAACACCGGGGAGCTGTTTTTTGGAGAA	CASSQ*SQENTGELFF	Stop	VDJ	1	18	1.3311738734941096E-4		48	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	2	4	4	2	6	2	29	44	54	50	56													Vb 16	CASSQ*SQENTGELFF+TCRBV14-01+TCRBJ02-02	TCRBV14-01*01	TCRBD01-01*01	TCRBJ02-02*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGAATATAACACTGAAGCTTTCTTTGGACAA	CASSQEYNTEAFF	In	VDJ	1	20	1.4790820816601219E-4	1.734319583069572E-4	39	TCRBV14	TCRBV14-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	0	5	9	2	1	1	29	46	49	47	50						01,02							Vb 16	CASSQEYNTEAFF+TCRBV14-01+TCRBJ01-01	TCRBV14-01*01	TCRBD02-01	TCRBJ01-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAATACATTGGGACGATGGGTGGCTACACCTTCGGTTCG	CASSQYIGTMGGYTF	In	VDJ	1	22	1.6269902898261338E-4	1.9077515413765293E-4	45	TCRBV14	TCRBV14-01	01				TCRBJ01	TCRBJ01-02	01	2	0	7	7	6	6	29	44	55	50	61				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 16	CASSQYIGTMGGYTF+TCRBV14-01+TCRBJ01-02	TCRBV14-01*01		TCRBJ01-02*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAATTTGGGTTTGAGACAATGAGCAGTTCTTCGGGCCA	CASSQIWV*DNEQFF	Stop	VDJ	1	25	1.848852602075152E-4		45	TCRBV14	TCRBV14-01	01				TCRBJ02	TCRBJ02-01	01	2	0	9	5	4	6	29	44	51	48	57				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 16	CASSQIWV*DNEQFF+TCRBV14-01+TCRBJ02-01	TCRBV14-01*01		TCRBJ02-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCTAGAGCAGGGATGGGAGACCCAGTACTTCGGGCCA	CASSLEQGWETQYF	In	VDJ	1	34	2.5144395388222067E-4	2.948343291218273E-4	42	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	0	4	3	5	1	4	29	46	52	47	56													Vb 16	CASSLEQGWETQYF+TCRBV14-01+TCRBJ02-05	TCRBV14-01*01	TCRBD01-01*01	TCRBJ02-05*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAACAAGCGGGAGGCGGAAACATTCAGTACTTCGGCGCC	CASSQQAGGGNIQYF	In	VDJ	2	54	3.9935216204823286E-4	4.682662874287845E-4	45	TCRBV14	TCRBV14-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-04	01	2	6	1	6	2	3	29	44	55	46	58													Vb 16	CASSQQAGGGNIQYF+TCRBV14-01+TCRBJ02-04	TCRBV14-01*01	TCRBD02-01*02	TCRBJ02-04*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
AACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCTCTTGTAGGTATCTGACAAAGTCGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	2	55	4.0674757245653346E-4		55	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	5	2	6	5	14	5	26	38	56	52	61													Vb 16	X+TCRBV14-01+TCRBJ02-06	TCRBV14-01*01	TCRBD01-01*01	TCRBJ02-06*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCATGGGCTGAACACTGAAGCTTTCTTTGGACAA	CASSHGLNTEAFF	In	VDJ	2	58	4.289338036814353E-4	5.02952679090176E-4	39	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	8	0	0	1	0	29	43	-1	44	48													Vb 16	CASSHGLNTEAFF+TCRBV14-01+TCRBJ01-01	TCRBV14-01*01	TCRBD01-01*01	TCRBJ01-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCATATCGGGAGGTCGGGCAGATACGCAGTATTTTGGCCCA	CASSISGGRADTQYF	In	VDJ	2	59	4.363292140897359E-4	5.116242770055238E-4	45	TCRBV14	TCRBV14-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	5	8	1	4	4	5	29	41	52	45	57													Vb 16	CASSISGGRADTQYF+TCRBV14-01+TCRBJ02-03	TCRBV14-01*01	TCRBD02-01*02	TCRBJ02-03*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCGTCCGGGACAGTCAGCCCCAGCATTTTGGTGAT	CASSVRDSQPQHF	In	VDJ	2	62	4.5851544531463775E-4	5.376390707515674E-4	39	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	5	0	5	6	4	0	29	41	-1	45	52													Vb 16	CASSVRDSQPQHF+TCRBV14-01+TCRBJ01-05	TCRBV14-01*01	TCRBD01-01*01	TCRBJ01-05*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGATGAGGGCAGGGGGAGACCCAGTACTTCGGGCCA		Out	VDJ	2	69	5.10283318172742E-4		44	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	0	4	2	5	6	0	29	46	-1	52	58													Vb 16	X+TCRBV14-01+TCRBJ02-05	TCRBV14-01*01	TCRBD01-01*01	TCRBJ02-05*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCACTATGGACAGTACACCGGGGAGCTGTTTTTTGGAGAA	CASSHYGQYTGELFF	In	VDJ	2	73	5.398649598059444E-4	6.330266478203939E-4	45	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	3	1	5	3	4	1	29	43	53	47	54													Vb 16	CASSHYGQYTGELFF+TCRBV14-01+TCRBJ02-02	TCRBV14-01*01	TCRBD01-01*01	TCRBJ02-02*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
TGTGCCAGCAGCCAGATCGGAGACAGGCGCCTTTTTGAATGTAAAAACTGGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	2	73	5.398649598059444E-4		70	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	3	2	4	2	7	20	0	14	27	21	47													Vb 16	X+TCRBV14-01+TCRBJ02-06	TCRBV14-01*01	TCRBD01-01*01	TCRBJ02-06*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCTATCTGACCGGGACCTTGGAGACCCAGTACTTCGGGCCA	CASSYLTGTLETQYF	In	VDJ	2	75	5.546557806225457E-4	6.503698436510896E-4	45	TCRBV14	TCRBV14-01	01				TCRBJ02	TCRBJ02-05	01	5	0	7	5	9	4	29	41	55	50	59				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 16	CASSYLTGTLETQYF+TCRBV14-01+TCRBJ02-05	TCRBV14-01*01		TCRBJ02-05*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCCTAGCGGAGCCTACGAGCAGTACTTCGGGCCG	CASSPSGAYEQYF	In	VDJ	2	77	5.694466014391469E-4	6.677130394817853E-4	39	TCRBV14	TCRBV14-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	4	4	5	2	0	2	29	-1	49	42	51						01,02							Vb 16	CASSPSGAYEQYF+TCRBV14-01+TCRBJ02-07	TCRBV14-01*01	TCRBD02-01	TCRBJ02-07*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGATAGTCCAGGGGAGCTCCTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	2	78	5.768420118474474E-4		52	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	0	4	2	0	5	2	29	46	57	51	59													Vb 16	X+TCRBV14-01+TCRBJ02-01	TCRBV14-01*01	TCRBD01-01*01	TCRBJ02-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCTAGAGACAGGGGAGCTCTGGAAACACCATATATTTTGGAGAG		Out	VDJ	2	80	5.916328326640487E-4		49	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	0	2	2	0	0	2	29	-1	54	46	56													Vb 16	X+TCRBV14-01+TCRBJ01-03	TCRBV14-01*01	TCRBD01-01*01	TCRBJ01-03*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGGTTATGGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	2	82	6.064236534806499E-4		37	TCRBV14	TCRBV14-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	1	5	9	8	2	2	29	45	49	47	51						01,02							Vb 16	X+TCRBV14-01+TCRBJ02-02	TCRBV14-01*01	TCRBD02-01	TCRBJ02-02*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGACAGGGGGCGCGAGATGGCTACACCTTCGGTTCG		Out	VDJ	3	106	7.839135032798645E-4		44	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	4	0	6	0	5	29	-1	54	46	59													Vb 16	X+TCRBV14-01+TCRBJ01-02	TCRBV14-01*01	TCRBD01-01*01	TCRBJ01-02*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGATGTGGCCCCACACTGAAGCTTTCTTTGGACAA		Out	VDJ	4	137	0.0010131712259371835		43	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	0	9	0	3	3	3	29	46	52	49	55													Vb 16	X+TCRBV14-01+TCRBJ01-01	TCRBV14-01*01	TCRBD01-01*01	TCRBJ01-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCTAGCGGGAGGGGACGCCGGGGAGCTGTTTTTTGGAGAA	CASSLAGGDAGELFF	In	VDJ	4	153	0.001131497792469993	0.0013267544810482228	45	TCRBV14	TCRBV14-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	4	5	0	6	0	4	29	-1	53	42	57													Vb 16	CASSLAGGDAGELFF+TCRBV14-01+TCRBJ02-02	TCRBV14-01*01	TCRBD02-01*02	TCRBJ02-02*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAAAACCACTCTAGCGGGGGAGCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	5	165	0.0012202427173696004		49	TCRBV14	TCRBV14-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	7	4	2	0	8	0	29	39	-1	47	57													Vb 16	X+TCRBV14-01+TCRBJ02-03	TCRBV14-01*01	TCRBD02-01*01	TCRBJ02-03*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCCAGCGGGAACCACAGATACGCAGTATTTTGGCCCA	CASSPAGTTDTQYF	In	VDJ	5	177	0.0013089876422692078	0.0015348728310165714	42	TCRBV14	TCRBV14-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	4	6	3	2	1	2	29	42	50	43	52													Vb 16	CASSPAGTTDTQYF+TCRBV14-01+TCRBJ02-03	TCRBV14-01*01	TCRBD02-01*02	TCRBJ02-03*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGCCTTCGAAAGGCGGGGATACTACGAGCAGTACTTCGGGCCG	CASSQAFERRGYYEQYF	In	VDJ	14	496	0.003668123562517102	0.004301112566012539	51	TCRBV14	TCRBV14-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	1	7	3	3	10	3	29	45	61	55	64													Vb 16	CASSQAFERRGYYEQYF+TCRBV14-01+TCRBJ02-07	TCRBV14-01*01	TCRBD02-01*01	TCRBJ02-07*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGGGGCTCTAGCGCCCAATGAGCAGTTCTTCGGGCCA	CASSQGALAPNEQFF	In	VDJ	19	647	0.004784830534170494	0.0056105238512300665	45	TCRBV14	TCRBV14-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	1	4	6	6	5	2	29	45	56	50	58						01,02							Vb 16	CASSQGALAPNEQFF+TCRBV14-01+TCRBJ02-01	TCRBV14-01*01	TCRBD02-01	TCRBJ02-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGATAATCACCTCCCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	22	773	0.00571665224561637		47	TCRBV14	TCRBV14-01	01				TCRBJ02	TCRBJ02-03	01	0	3	7	2	5	4	29	46	53	51	57				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 16	X+TCRBV14-01+TCRBJ02-03	TCRBV14-01*01		TCRBJ02-03*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCCCTAGCGGGACGTCCTACAATGAGCAGTTCTTCGGGCCA	CASSPSGTSYNEQFF	In	VDJ	1	11	8.134951449130669E-5	9.538757706882647E-5	45	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	5	4	3	1	1	2	24	36	46	37	48														CASSPSGTSYNEQFF+TCRBV21-or09_02+TCRBJ02-01	TCRBV21-or09_02*01	TCRBD02-01*02	TCRBJ02-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGTATCCGGCATTACAGATACGCAGTATTTTGGCCCA	CASSVSGITDTQYF	In	VDJ	1	11	8.134951449130669E-5	9.538757706882647E-5	42	TCRBV21	TCRBV21-or09_02	01				TCRBJ02	TCRBJ02-03	01	5	9	0	3	6	3	24	36	45	42	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSVSGITDTQYF+TCRBV21-or09_02+TCRBJ02-03	TCRBV21-or09_02*01		TCRBJ02-03*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGTAGTCCCCCTCAAGGGGCAGAACACTGAAGCTTTCTTTGGACAA	CASSVVPLKGQNTEAFF	In	VDJ	1	13	9.614033530790792E-5	1.127307728995222E-4	51	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	5	2	1	13	2	24	36	54	49	56														CASSVVPLKGQNTEAFF+TCRBV21-or09_02+TCRBJ01-01	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ01-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCTTAGACAGCCCCACAGATACGCAGTATTTTGGCCCA	CASSLDSPTDTQYF	In	VDJ	1	13	9.614033530790792E-5	1.127307728995222E-4	42	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	5	2	5	2	3	3	24	36	44	39	47														CASSLDSPTDTQYF+TCRBV21-or09_02+TCRBJ02-03	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ02-03*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCAAAGGGACTAGCGGGAGGCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	15	1.1093115612450913E-4		49	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	1	1	2	1	0	0	24	-1	-1	40	53														X+TCRBV21-or09_02+TCRBJ02-03	TCRBV21-or09_02*01	TCRBD02-01*02	TCRBJ02-03*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCAAGAGACAGGGCACAACTAATGAAAAACTGTTTTTTGGCAGT	CASSKRQGTTNEKLFF	In	VDJ	1	22	1.6269902898261338E-4	1.9077515413765293E-4	48	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	3	2	3	0	2	2	24	38	47	40	49														CASSKRQGTTNEKLFF+TCRBV21-or09_02+TCRBJ01-04	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ01-04*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCCAAAGCCTTTCCGGGACAGGGGGCGCTTAGAGGGCTACACCTTCGGTTCG		Out	VDJ	1	24	1.774898497992146E-4		53	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	10	0	0	8	14	8	24	31	57	45	65														X+TCRBV21-or09_02+TCRBJ01-02	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ01-02*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCCCTAGCGGGAGCACCTACAATGAGCAGTTCTTCGGGCCA	CASSPSGSTYNEQFF	In	VDJ	1	25	1.848852602075152E-4	2.1678994788369653E-4	45	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	5	4	2	2	1	2	24	36	47	37	49														CASSPSGSTYNEQFF+TCRBV21-or09_02+TCRBJ02-01	TCRBV21-or09_02*01	TCRBD02-01*02	TCRBJ02-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAACACGGGAGAAGGGGCCTACAATGAGCAGTTCTTCGGGCCA	CASNTGEGAYNEQFF	In	VDJ	1	32	2.3665313306561948E-4	2.7749113329113154E-4	45	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	10	8	2	2	6	6	24	31	43	37	49														CASNTGEGAYNEQFF+TCRBV21-or09_02+TCRBJ02-01	TCRBV21-or09_02*01	TCRBD02-01*02	TCRBJ02-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGTGTTAGTCGGGCCCTAGGCGGCTATGGCTACACCTTCGGTTCG	CASSVSRALGGYGYTF	In	VDJ	1	36	2.662347746988219E-4	3.12177524952523E-4	48	TCRBV21	TCRBV21-or09_02	01				TCRBJ01	TCRBJ01-02	01	6	8	0	4	8	9	24	35	47	43	56				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSVSRALGGYGYTF+TCRBV21-or09_02+TCRBJ01-02	TCRBV21-or09_02*01		TCRBJ01-02*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGTAGATGGGACTACCCCTTATACGCAGTATTTTGGCCCA	CASSVDGTTPYTQYF	In	VDJ	3	114	8.430767865462694E-4	9.885621623496562E-4	45	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	5	0	9	7	6	6	24	36	49	42	55						01,02								CASSVDGTTPYTQYF+TCRBV21-or09_02+TCRBJ02-03	TCRBV21-or09_02*01	TCRBD02-01	TCRBJ02-03*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGACAGAGCTAGCGGGAAGGATCCTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	5	171	0.0012646151798194041		53	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	5	4	3	1	7	4	24	36	52	43	56														X+TCRBV21-or09_02+TCRBJ02-01	TCRBV21-or09_02*01	TCRBD02-01*02	TCRBJ02-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GACTCGGCCATGTATCGCTGTGCCAGCAGCTTGGCTTTAAGGGACTAGCGGGAGTCCCCCAAAAACATTCAGTACTTCGGCGCC	CASSLALRD*RESPKNIQYF	Stop	VDJ	1	11	8.134951449130669E-5		60	TCRBV07	TCRBV07-06	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-04	01	3	0	2	2	8	4	18	32	54	40	58														CASSLALRD*RESPKNIQYF+TCRBV07-06+TCRBJ02-04	TCRBV07-06*01	TCRBD02-01*02	TCRBJ02-04*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GACTCGGCCATGTATCGCTGTGCCAGCAGCTCGGGCTTCTCGGGGGATACGCAGTATTTTGGCCCA	CASSSGFSGDTQYF	In	VDJ	1	12	8.87449248996073E-5	1.0405917498417433E-4	42	TCRBV07	TCRBV07-06	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	4	8	3	6	9	0	18	31	-1	40	45														CASSSGFSGDTQYF+TCRBV07-06+TCRBJ02-03	TCRBV07-06*01	TCRBD02-01*01	TCRBJ02-03*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GACTCGGCCATGTATCGCTGTGCCAGCAGCCAGATCCCGAATTACGTTGAAAAACTGTTTTTTGGCAGT	CASSQIPNYVEKLFF	In	VDJ	1	13	9.614033530790792E-5	1.127307728995222E-4	45	TCRBV07	TCRBV07-06	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	5	4	5	7	0	14	18	-1	33	30	47														CASSQIPNYVEKLFF+TCRBV07-06+TCRBJ01-04	TCRBV07-06*01	TCRBD01-01*01	TCRBJ01-04*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GACTCGGCCATGTATCGCTGTGCCAGCAGCTTATCGGCTGGGAAGGGTACGCAGTATTTTGGCCCA	CASSLSAGKGTQYF	In	VDJ	1	13	9.614033530790792E-5	1.127307728995222E-4	42	TCRBV07	TCRBV07-06	01				TCRBJ02	TCRBJ02-03	01	2	0	8	8	6	4	18	33	43	39	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLSAGKGTQYF+TCRBV07-06+TCRBJ02-03	TCRBV07-06*01		TCRBJ02-03*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GACTCGGCCATGTATCGCTGTGCTAGCAGCCTGAGACTAGCGGGAGCTGGTGAGACCCAGTACTTCGGGCCA	CASSLRLAGAGETQYF	In	VDJ	1	13	9.614033530790792E-5	1.127307728995222E-4	48	TCRBV07	TCRBV07-06	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	5	2	2	5	4	5	18	30	46	34	51														CASSLRLAGAGETQYF+TCRBV07-06+TCRBJ02-05	TCRBV07-06*01	TCRBD02-01*02	TCRBJ02-05*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GACTCGGCCATGTATCGCTGTGCCAGCAGCCGAACGGGGGGGTAGGACTAATGAAAAACTGTTTTTTGGCAGT		Out	VDJ	1	14	1.0353574571620853E-4		49	TCRBV07	TCRBV07-06	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-04	01	5	8	0	2	4	4	18	30	42	34	46														X+TCRBV07-06+TCRBJ01-04	TCRBV07-06*01	TCRBD02-01*01	TCRBJ01-04*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GACTCGGCCATGTATCGCTGTGCCAGCAGCTTTGAAGACTAGCGGGAGGTAGCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	16	1.1832656653280974E-4		53	TCRBV07	TCRBV07-06	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	3	2	1	0	4	1	18	32	49	36	50														X+TCRBV07-06+TCRBJ02-03	TCRBV07-06*01	TCRBD02-01*02	TCRBJ02-03*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GACTCGGCCATGTATCGCTGTGCCAGCACCCTGACAGGGAGCAATCAGCCCCAGCATTTTGGTGAT	CASTLTGSNQPQHF	In	VDJ	1	17	1.2572197694111034E-4	1.4741716456091364E-4	42	TCRBV07	TCRBV07-06	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	7	2	3	1	4	0	18	28	-1	32	39														CASTLTGSNQPQHF+TCRBV07-06+TCRBJ01-05	TCRBV07-06*01	TCRBD01-01*01	TCRBJ01-05*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GACTCGGCCATGTATCGCTGTGCCAGCAGCGTTATCGGGACAGCCCTGGAAGCTTTCTTTGGACAA	CASSVIGTALEAFF	In	VDJ	1	17	1.2572197694111034E-4	1.4741716456091364E-4	42	TCRBV07	TCRBV07-06	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	0	5	8	6	5	18	30	43	36	48														CASSVIGTALEAFF+TCRBV07-06+TCRBJ01-01	TCRBV07-06*01	TCRBD01-01*01	TCRBJ01-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GACTCGGCCATGTATCGCTGTGCCAGCAGCCAAGGGGTGGGACCGAGACCCTATGGCTACACCTTCGGTTCG	CASSQGVGPRPYGYTF	In	VDJ	1	18	1.3311738734941096E-4	1.560887624762615E-4	48	TCRBV07	TCRBV07-06	01				TCRBJ01	TCRBJ01-02	01	5	0	7	4	8	7	18	30	43	38	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQGVGPRPYGYTF+TCRBV07-06+TCRBJ01-02	TCRBV07-06*01		TCRBJ01-02*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GACTCGGCCATGTATCGCTGTGCCAGCAGCTTAAGCCAGGGGGCTAGGAGCAGTACTTCGGGCCG		Out	VDJ	1	23	1.70094439390914E-4		41	TCRBV07	TCRBV07-06	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	2	4	0	7	3	3	18	33	44	36	47														X+TCRBV07-06+TCRBJ02-07	TCRBV07-06*01	TCRBD01-01*01	TCRBJ02-07*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GACTCGGCCATGTATCGCTGTGCCAGCAGCATTTTTCGCATCTCGGAAAGACCTATGGCTACACCTTCGGTTCG		Out	VDJ	1	25	1.848852602075152E-4		50	TCRBV07	TCRBV07-06	01				TCRBJ01	TCRBJ01-02	01	5	1	8	4	14	5	18	30	47	44	52				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV07-06+TCRBJ01-02	TCRBV07-06*01		TCRBJ01-02*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GACTCGGCCATGTATCGCTGTGCCAGCAGCCACATCTCCGACCGGGGGTATGGCTACACCTTCGGTTCG	CASSHISDRGYGYTF	In	VDJ	1	25	1.848852602075152E-4	2.1678994788369653E-4	45	TCRBV07	TCRBV07-06	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-02	01	5	8	2	5	12	0	18	30	-1	42	48														CASSHISDRGYGYTF+TCRBV07-06+TCRBJ01-02	TCRBV07-06*01	TCRBD02-01*01	TCRBJ01-02*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GACTCGGCCATGTATCGCTGTGCCAGCAGCCCAGCCCAGGGGCCGTACGAGCAGTACTTCGGGCCG	CASSPAQGPYEQYF	In	VDJ	1	25	1.848852602075152E-4	2.1678994788369653E-4	42	TCRBV07	TCRBV07-06	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	4	2	4	6	3	18	30	42	36	45														CASSPAQGPYEQYF+TCRBV07-06+TCRBJ02-07	TCRBV07-06*01	TCRBD01-01*01	TCRBJ02-07*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GACTCGGCCATGTATCGCTGTGCCAGCAGCCTTCGGGGCGGCGCAGGGCCCCAGCATTTTGGTGAT	CASSLRGGAGPQHF	In	VDJ	1	27	1.9967608102411643E-4	2.3413314371439225E-4	42	TCRBV07	TCRBV07-06	01				TCRBJ01	TCRBJ01-05	01	5	7	0	9	4	8	18	30	39	34	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLRGGAGPQHF+TCRBV07-06+TCRBJ01-05	TCRBV07-06*01		TCRBJ01-05*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GACTCGGCCATGTATCGCTGTGCCAGCAGCCCCGCAAGGGTTCGGGAAGATACGCAGTATTTTGGCCCA	CASSPARVREDTQYF	In	VDJ	1	48	3.549796995984292E-4	4.162366999366973E-4	45	TCRBV07	TCRBV07-06	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	5	8	3	5	12	0	18	30	-1	42	47														CASSPARVREDTQYF+TCRBV07-06+TCRBJ02-03	TCRBV07-06*01	TCRBD02-01*02	TCRBJ02-03*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GACTCGGCCATGTATCGCTGTGCCAGCAGCTTAAGACCTGGGGGGCCAAAAACATTCAGTACTTCGGCGCC		Out	VDJ	2	75	5.546557806225457E-4		47	TCRBV07	TCRBV07-06	01				TCRBJ02	TCRBJ02-04	01	2	6	1	1	6	0	18	33	-1	39	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV07-06+TCRBJ02-04	TCRBV07-06*01		TCRBJ02-04*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CGACTCGGCTGTGTATCTCTGTGCCAGCAGCTGAAGAGCGTAGGTCTACGAGCAGTACTTCGGGCCG	CASS*RA*VYEQYF	Stop	VDJ	1	11	8.134951449130669E-5		42	TCRBV07	TCRBV07-05	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	3	6	6	3	4	5	19	32	40	36	45						01,02								CASS*RA*VYEQYF+TCRBV07-05+TCRBJ02-07	TCRBV07-05*01	TCRBD02-01	TCRBJ02-07*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CGACTCGGCTGTGTATCTCTGTGCCAGCAGCCTCTATCCGGGCAAAAATATTCAGTACTTCGGCGCC	CASSLYPGKNIQYF	In	VDJ	1	12	8.87449248996073E-5	1.0405917498417433E-4	42	TCRBV07	TCRBV07-05	01				TCRBJ02	TCRBJ02-04	01	4	8	0	10	8	6	19	31	43	39	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLYPGKNIQYF+TCRBV07-05+TCRBJ02-04	TCRBV07-05*01		TCRBJ02-04*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CGACTCGGCTGTGTATCTCTGTGCCAGCAGCTTAGGAAGGACCGCTGAAAACACCATATATTTTGGAGAG	CASSLGRTAENTIYF	In	VDJ	1	13	9.614033530790792E-5	1.127307728995222E-4	45	TCRBV07	TCRBV07-05	01				TCRBJ01	TCRBJ01-03	01	0	1	7	6	3	6	19	35	42	38	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLGRTAENTIYF+TCRBV07-05+TCRBJ01-03	TCRBV07-05*01		TCRBJ01-03*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CGACTCGGCTGTGTATCTCTGTGCCAGCAGCTTGGCCCCTAGCGGCCCCTACGAGCAGTACTTCGGGCCG	CASSLAPSGPYEQYF	In	VDJ	1	18	1.3311738734941096E-4	1.560887624762615E-4	45	TCRBV07	TCRBV07-05	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	2	4	5	2	5	2	19	33	45	38	47						01,02								CASSLAPSGPYEQYF+TCRBV07-05+TCRBJ02-07	TCRBV07-05*01	TCRBD02-01	TCRBJ02-07*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CGACTCGGCTGTGTATCTCTGTGCCAGCAGCCAATTACTAAGGGAACAAGATACGCAGTATTTTGGCCCA	CASSQLLREQDTQYF	In	VDJ	1	20	1.4790820816601219E-4	1.734319583069572E-4	45	TCRBV07	TCRBV07-05	01				TCRBJ02	TCRBJ02-03	01	4	0	8	5	10	3	19	31	45	41	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQLLREQDTQYF+TCRBV07-05+TCRBJ02-03	TCRBV07-05*01		TCRBJ02-03*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CGACTCGGCTGTGTATCTCTGTGCCAGCAGCGGAACGGGAGGATCCTACAATGAGCAGTTCTTCGGGCCA	CASSGTGGSYNEQFF	In	VDJ	1	23	1.70094439390914E-4	1.994467520530008E-4	45	TCRBV07	TCRBV07-05	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	4	8	1	1	4	1	19	31	42	35	43														CASSGTGGSYNEQFF+TCRBV07-05+TCRBJ02-01	TCRBV07-05*01	TCRBD02-01*02	TCRBJ02-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CGACTCGGCTGTGTATCTCTGTGCCAGCAGCCCCGCCCGAGGGGGTCGGGAGACCCAGTACTTCGGGCCA	CASSPARGGRETQYF	In	VDJ	1	43	3.1800264755692617E-4	3.72878710359958E-4	45	TCRBV07	TCRBV07-05	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	4	5	1	5	8	4	19	31	45	39	49														CASSPARGGRETQYF+TCRBV07-05+TCRBJ02-05	TCRBV07-05*01	TCRBD01-01*01	TCRBJ02-05*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CGACTCGGCTGTGTATCTCTGTGCCAGCAGCTTAGAAGGGACGTCAGGGACGGGGCAGTTCTTCGGGCCA	CASSLEGTSGTGQFF	In	VDJ	1	50	3.697705204150304E-4	4.3357989576739306E-4	45	TCRBV07	TCRBV07-05	01				TCRBJ02	TCRBJ02-01	01	0	0	7	12	2	12	19	35	42	37	54				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLEGTSGTGQFF+TCRBV07-05+TCRBJ02-01	TCRBV07-05*01		TCRBJ02-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CGACTCGGCTGTGTATCTCTGTGCCAGCAGCTTAGGGKGGCAGGGAGCCTACAATGAGCAGTTCTTCGGGCCA	CASSLGXQGAYNEQFF	In	VDJ	1	52	3.8456134123163166E-4	4.509230915980888E-4	48	TCRBV07	TCRBV07-05	01	unresolved			TCRBJ02	TCRBJ02-01	01	0	6	0	2	0	6	19	-1	41	35	47				TCRBD01,TCRBD02										CASSLGXQGAYNEQFF+TCRBV07-05+TCRBJ02-01	TCRBV07-05*01	unresolved	TCRBJ02-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CGACTCGGCTGTGTATCTCTGTGCCAGCAGTCTCGGAGGGGGCCAAGGGGAGACCCAGTACTTCGGGCCA	CASSLGGGQGETQYF	In	VDJ	3	100	7.395410408300608E-4	8.671597915347861E-4	45	TCRBV07	TCRBV07-05	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	8	5	0	5	9	6	19	27	43	36	49														CASSLGGGQGETQYF+TCRBV07-05+TCRBJ02-05	TCRBV07-05*01	TCRBD01-01*01	TCRBJ02-05*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCAGTGAAGTCCCAACCTACGAGCAGTACTTCGGGCCG	CASSEVPTYEQYF	In	VDJ	2	62	4.5851544531463775E-4	5.376390707515674E-4	39	TCRBV06	TCRBV06-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	1	4	6	2	3	1	23	39	44	42	45														CASSEVPTYEQYF+TCRBV06-01+TCRBJ02-07	TCRBV06-01*01	TCRBD01-01*01	TCRBJ02-07*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GGGGGACTCAGCTGTGTATCTCTGTGCCAGCAGCTTAGGATCGGACAAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	11	8.134951449130669E-5		40	TCRBV07	TCRBV07-04	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	1	1	6	7	4	0	22	38	-1	42	47														X+TCRBV07-04+TCRBJ02-01	TCRBV07-04*01	TCRBD01-01*01	TCRBJ02-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GGGGGACTCAGCTGTGTATCTCTGTGCCAGCAGCCCCCAATCGGACAGCGGGAGGCAGTATTTTGGCCCA	CASSPQSDSGRQYF	In	VDJ	1	19	1.4051279775771156E-4	1.6476036039160937E-4	42	TCRBV07	TCRBV07-04	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	5	6	2	11	12	0	22	34	-1	46	54														CASSPQSDSGRQYF+TCRBV07-04+TCRBJ02-03	TCRBV07-04*01	TCRBD02-01*02	TCRBJ02-03*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GGGGGACTCAGCTGTGTATCTCTGTGCCAGCAGCTCGACTAGCGGGAGGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSSTSGRNTGELFF	In	VDJ	1	23	1.70094439390914E-4	1.994467520530008E-4	48	TCRBV07	TCRBV07-04	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	4	2	2	1	1	0	22	35	-1	36	48														CASSSTSGRNTGELFF+TCRBV07-04+TCRBJ02-02	TCRBV07-04*01	TCRBD02-01*02	TCRBJ02-02*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GGGGGACTCAGCTGTGTATCTCTGTGCCATTATCCGGGACGGATCCTACGAGCAGTACTTCGGGCCG	CAIIRDGSYEQYF	In	VDJ	1	38	2.810255955154231E-4	3.2952072078321873E-4	39	TCRBV07	TCRBV07-04	01				TCRBJ02	TCRBJ02-07	01	10	0	7	1	6	3	22	29	40	35	43				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CAIIRDGSYEQYF+TCRBV07-04+TCRBJ02-07	TCRBV07-04*01		TCRBJ02-07*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGTCTCAGGGATACGAGGAGCTGTTTTTTGGAGAA	CAWSQGYEELFF	In	VDJ	1	11	8.134951449130669E-5	9.538757706882647E-5	36	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	5	4	3	10	3	6	26	35	43	38	49			unresolved										Vb 20	CAWSQGYEELFF+TCRBV30-01+TCRBJ02-02	TCRBV30-01*01	TCRBD01-01*01	TCRBJ02-02*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
TCCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGACTTGGCGGGGCGCGGGTCACTGAAGCTTTCTTTGGACAA	CAWRLGGARVTEAFF	In	VDJ	1	12	8.87449248996073E-5	1.0405917498417433E-4	45	TCRBV30	TCRBV30-01	02	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	3	7	3	4	5	7	26	37	48	42	55													Vb 20	CAWRLGGARVTEAFF+TCRBV30-01+TCRBJ01-01	TCRBV30-01*02	TCRBD02-01*01	TCRBJ01-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTAGTTCGCCGGGAGATACGCAGTATTTTGGCCCA	CAWSSSPGDTQYF	In	VDJ	1	13	9.614033530790792E-5	1.127307728995222E-4	39	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	2	8	4	5	7	0	26	38	-1	45	49						01,02							Vb 20	CAWSSSPGDTQYF+TCRBV30-01+TCRBJ02-03	TCRBV30-01*01	TCRBD02-01	TCRBJ02-03*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTACGTGGGGACGGTCATCAGCCCCAGCATTTTGGTGAT	CAWSVRGDGHQPQHF	In	VDJ	1	13	9.614033530790792E-5	1.127307728995222E-4	45	TCRBV30	TCRBV30-01	01				TCRBJ01	TCRBJ01-05	01	0	0	7	5	5	4	26	40	50	45	54			unresolved	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWSVRGDGHQPQHF+TCRBV30-01+TCRBJ01-05	TCRBV30-01*01		TCRBJ01-05*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTCCCGGTGGGCCTCTCCAATGAGCAGTTCTTCGGGCCA	CAWSVPVGLSNEQFF	In	VDJ	1	14	1.0353574571620853E-4	1.2140237081487006E-4	45	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	0	8	0	6	6	5	26	40	50	46	55			unresolved										Vb 20	CAWSVPVGLSNEQFF+TCRBV30-01+TCRBJ02-01	TCRBV30-01*01	TCRBD01-01*01	TCRBJ02-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAAACGGATGAACACTGAAGCTTTCTTTGGACAA	CAWKRMNTEAFF	In	VDJ	1	16	1.1832656653280974E-4	1.3874556664556577E-4	36	TCRBV30	TCRBV30-01	01				TCRBJ01	TCRBJ01-01	01	4	1	8	0	3	0	26	36	-1	39	42				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWKRMNTEAFF+TCRBV30-01+TCRBJ01-01	TCRBV30-01*01		TCRBJ01-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTACCCCCTAGCACCGGGGAGCTGTTTTTTGGAGAA	CAWSVPPSTGELFF	In	VDJ	1	17	1.2572197694111034E-4	1.4741716456091364E-4	42	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	0	4	8	4	5	0	26	40	-1	45	49						01,02							Vb 20	CAWSVPPSTGELFF+TCRBV30-01+TCRBJ02-02	TCRBV30-01*01	TCRBD02-01	TCRBJ02-02*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTATAACCGGCGGGAGTCGCGGCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	17	1.2572197694111034E-4		50	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	0	7	2	3	7	6	26	40	54	47	60													Vb 20	X+TCRBV30-01+TCRBJ02-07	TCRBV30-01*01	TCRBD02-01*02	TCRBJ02-07*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
TCCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGACAAGACAGGGTCTCTTCCAGCCCCAGCATTTTGGTGAT	CAWTRQGLFQPQHF	In	VDJ	1	18	1.3311738734941096E-4	1.560887624762615E-4	42	TCRBV30	TCRBV30-01	02	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	4	2	3	7	3	7	26	36	46	39	53													Vb 20	CAWTRQGLFQPQHF+TCRBV30-01+TCRBJ01-05	TCRBV30-01*02	TCRBD01-01*01	TCRBJ01-05*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGCCTCCATAACTAATGAAAAACTGTTTTTTGGCAGT	CAWSASITNEKLFF	In	VDJ	1	18	1.3311738734941096E-4	1.560887624762615E-4	42	TCRBV30	TCRBV30-01	01				TCRBJ01	TCRBJ01-04	01	1	4	6	1	4	1	26	39	45	43	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWSASITNEKLFF+TCRBV30-01+TCRBJ01-04	TCRBV30-01*01		TCRBJ01-04*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTTTATTCGGACTAGCGGGCATCAACGAGCAGTACTTCGGGCCG	CAWSLFGLAGINEQYF	In	VDJ	1	18	1.3311738734941096E-4	1.560887624762615E-4	48	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	2	1	4	5	6	5	26	38	55	44	60						01,02							Vb 20	CAWSLFGLAGINEQYF+TCRBV30-01+TCRBJ02-07	TCRBV30-01*01	TCRBD02-01	TCRBJ02-07*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTATCACAGGGGAGGGGCACCGGGGAGCTGTTTTTTGGAGAA	CAWSVSQGRGTGELFF	In	VDJ	1	19	1.4051279775771156E-4	1.6476036039160937E-4	48	TCRBV30	TCRBV30-01	01				TCRBJ02	TCRBJ02-02	01	0	3	2	4	3	5	26	40	50	43	55				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWSVSQGRGTGELFF+TCRBV30-01+TCRBJ02-02	TCRBV30-01*01		TCRBJ02-02*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTAAGCAGGGTATATAGCAATCAGCCCCAGCATTTTGGTGAT	CAWSVSRVYSNQPQHF	In	VDJ	1	20	1.4790820816601219E-4	1.734319583069572E-4	48	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	0	4	3	0	3	4	26	40	48	43	52													Vb 20	CAWSVSRVYSNQPQHF+TCRBV30-01+TCRBJ01-05	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-05*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
TCCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTACAGGGGGGGGCAGCCAACTATGGCTACACCTTCGGTTCG	CAWSVQGGAANYGYTF	In	VDJ	1	24	1.774898497992146E-4	2.0811834996834865E-4	48	TCRBV30	TCRBV30-01	02	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	3	1	2	0	8	26	-1	48	40	56													Vb 20	CAWSVQGGAANYGYTF+TCRBV30-01+TCRBJ01-02	TCRBV30-01*02	TCRBD01-01*01	TCRBJ01-02*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
TCCTCAGTGACTCTGGCTTCTATCTCTGTGCCCGGGCTAGCGGAGGGTACAATGAGCAGTTCTTCGGGCCA	CARASGGYNEQFF	In	VDJ	1	26	1.9228067061581583E-4	2.254615457990444E-4	39	TCRBV30	TCRBV30-01	02	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	8	4	5	4	4	4	26	32	43	36	47						01,02							Vb 20	CARASGGYNEQFF+TCRBV30-01+TCRBJ02-01	TCRBV30-01*02	TCRBD02-01	TCRBJ02-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGACCAGGACTGGCTACAATGAGCAGTTCTTCGGGCCA	CAWTRTGYNEQFF	In	VDJ	1	26	1.9228067061581583E-4	2.254615457990444E-4	39	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	4	1	10	3	3	2	26	36	44	39	46			unresolved			01,02							Vb 20	CAWTRTGYNEQFF+TCRBV30-01+TCRBJ02-01	TCRBV30-01*01	TCRBD02-01	TCRBJ02-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGGGGAGGGGGCCCTGTTTTTTGGCAGT	CAWSGEGALFF	In	VDJ	1	30	2.2186231224901825E-4	2.6014793746043585E-4	33	TCRBV30	TCRBV30-01	01				TCRBJ01	TCRBJ01-04	01	1	5	0	14	3	1	26	39	49	42	50			unresolved	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWSGEGALFF+TCRBV30-01+TCRBJ01-04	TCRBV30-01*01		TCRBJ01-04*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGATTGGTCGGCGTGAACACTGAAGCTTTCTTTGGACAA	CAWRLVGVNTEAFF	In	VDJ	1	35	2.588393642905213E-4	3.0350592703717514E-4	42	TCRBV30	TCRBV30-01	02				TCRBJ01	TCRBJ01-01	01	3	9	0	0	7	1	26	37	47	44	48			unresolved	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWRLVGVNTEAFF+TCRBV30-01+TCRBJ01-01	TCRBV30-01*02		TCRBJ01-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTTTCGCGGGAGTACAATGAGCAGTTCTTCGGGCCA	CAWSVSREYNEQFF	In	VDJ	1	37	2.736301851071225E-4	3.208491228678709E-4	42	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	0	7	2	4	3	0	26	40	-1	43	50			unresolved										Vb 20	CAWSVSREYNEQFF+TCRBV30-01+TCRBJ02-01	TCRBV30-01*01	TCRBD02-01*02	TCRBJ02-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGTGGAGGTAGGGGGCGAGGCACAGATACGCAGTATTTTGGCCCA	CACGGRGRGTDTQYF	In	VDJ	1	38	2.810255955154231E-4	3.2952072078321873E-4	45	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	6	5	0	1	7	3	26	34	48	41	51													Vb 20	CACGGRGRGTDTQYF+TCRBV30-01+TCRBJ02-03	TCRBV30-01*01	TCRBD01-01*01	TCRBJ02-03*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTTCGACAGGGAACTATGGCTACACCTTCGGTTCG	CAWSSTGNYGYTF	In	VDJ	1	43	3.1800264755692617E-4	3.72878710359958E-4	39	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	2	2	3	2	2	0	26	38	-1	40	47													Vb 20	CAWSSTGNYGYTF+TCRBV30-01+TCRBJ01-02	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-02*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGCATTAAGACTAGCGGACCACAGATACGCAGTATTTTGGCCCA	CAWH*D*RTTDTQYF	Stop	VDJ	1	44	3.2539805796522677E-4		45	TCRBV30	TCRBV30-01	02	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	5	2	5	2	6	2	26	35	50	41	52			unresolved			01,02							Vb 20	CAWH*D*RTTDTQYF+TCRBV30-01+TCRBJ02-03	TCRBV30-01*02	TCRBD02-01	TCRBJ02-03*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTGAAGGGAACAGGCACCCCCTTGAGGGCTTTCTTTGGACAA	CAWSVKGTGTPLRAFF	In	VDJ	1	44	3.2539805796522677E-4	3.8155030827530587E-4	48	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	0	3	4	11	7	13	26	40	52	47	65			unresolved										Vb 20	CAWSVKGTGTPLRAFF+TCRBV30-01+TCRBJ01-01	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
TCCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGACCGGGACAGGGGTAGGCGAGCAGTACTTCGGGCCG	CAWTGTGVGEQYF	In	VDJ	1	46	3.40188878781828E-4	3.988935041060016E-4	39	TCRBV30	TCRBV30-01	02	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	0	2	6	2	4	26	36	48	38	52													Vb 20	CAWTGTGVGEQYF+TCRBV30-01+TCRBJ02-07	TCRBV30-01*02	TCRBD01-01*01	TCRBJ02-07*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGGATAGCACAGATACGCAGTATTTTGGCCCA	CAWDSTDTQYF	In	VDJ	1	50	3.697705204150304E-4	4.3357989576739306E-4	33	TCRBV30	TCRBV30-01	01				TCRBJ02	TCRBJ02-03	01	5	2	8	0	0	1	26	-1	37	35	38			unresolved	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWDSTDTQYF+TCRBV30-01+TCRBJ02-03	TCRBV30-01*01		TCRBJ02-03*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGGGTCCCCGGCCTATGGCTACACCTTCGGTTCG	CAWSGSPAYGYTF	In	VDJ	1	51	3.7716593082333106E-4	4.422514936827409E-4	39	TCRBV30	TCRBV30-01	01				TCRBJ01	TCRBJ01-02	01	1	9	0	4	7	0	26	39	-1	46	49			unresolved	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWSGSPAYGYTF+TCRBV30-01+TCRBJ01-02	TCRBV30-01*01		TCRBJ01-02*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
TCCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGTCGAATCAGGGGGCGACTAATGAAAAACTGTTTTTTGGCAGT	CAWSNQGATNEKLFF	In	VDJ	2	53	3.9195675163993226E-4	4.5959468951343665E-4	45	TCRBV30	TCRBV30-01	02	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	5	4	0	2	6	1	26	35	49	41	50													Vb 20	CAWSNQGATNEKLFF+TCRBV30-01+TCRBJ01-04	TCRBV30-01*02	TCRBD01-01*01	TCRBJ01-04*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGGCTAGCGGGAGGGGTAGAGACCCAGTACTTCGGGCCA	CAWRLAGGVETQYF	In	VDJ	2	57	4.215383932731347E-4	4.942810811748281E-4	42	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	3	4	0	4	1	2	26	37	50	38	52			unresolved										Vb 20	CAWRLAGGVETQYF+TCRBV30-01+TCRBJ02-05	TCRBV30-01*01	TCRBD02-01*02	TCRBJ02-05*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTAGTGGCCGGGGAGCTGTTTTTTGGAGAA	CAWSVVAGELFF	In	VDJ	2	67	4.954924973561408E-4	5.809970603283067E-4	36	TCRBV30	TCRBV30-01	02				TCRBJ02	TCRBJ02-02	01	0	0	10	6	3	0	26	40	-1	43	45			unresolved	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWSVVAGELFF+TCRBV30-01+TCRBJ02-02	TCRBV30-01*02		TCRBJ02-02*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAAGGGTTCAGGCAGCTTCTCTGGAAACACCATATATTTTGGAGAG	CAWKGSGSFSGNTIYF	In	VDJ	2	85	6.286098847055517E-4	7.370858228045682E-4	48	TCRBV30	TCRBV30-01	01				TCRBJ01	TCRBJ01-03	01	4	4	4	0	6	6	26	36	46	42	52				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWKGSGSFSGNTIYF+TCRBV30-01+TCRBJ01-03	TCRBV30-01*01		TCRBJ01-03*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTCTTACAGGGTCTGGAAACACCATATATTTTGGAGAG	CAWSLTGSGNTIYF	In	VDJ	3	105	7.765180928715639E-4	9.105177811115254E-4	42	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	2	3	3	1	3	0	26	38	-1	41	47													Vb 20	CAWSLTGSGNTIYF+TCRBV30-01+TCRBJ01-03	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-03*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
TCCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTCCAAGGTACCAAGAGACCCAGTACTTCGGGCCA	CAWSPRYQETQYF	In	VDJ	3	110	8.134951449130669E-4	9.538757706882647E-4	39	TCRBV30	TCRBV30-01	02				TCRBJ02	TCRBJ02-05	01	2	5	4	0	3	1	26	38	44	41	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWSPRYQETQYF+TCRBV30-01+TCRBJ02-05	TCRBV30-01*02		TCRBJ02-05*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTTCTGGGCTCGGGGAAAAACTGTTTTTTGGCAGT	CAWSSGLGEKLFF	In	VDJ	3	111	8.208905553213676E-4	9.625473686036126E-4	39	TCRBV30	TCRBV30-01	01				TCRBJ01	TCRBJ01-04	01	2	8	0	8	3	5	26	38	45	41	50			unresolved	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWSSGLGEKLFF+TCRBV30-01+TCRBJ01-04	TCRBV30-01*01		TCRBJ01-04*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGCGTCGGGAGTTTTGCAGATACGCAGTATTTTGGCCCA	CAWSVGSFADTQYF	In	VDJ	4	131	9.687987634873798E-4	0.0011359793269105699	42	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	3	8	2	4	3	5	26	37	46	40	51													Vb 20	CAWSVGSFADTQYF+TCRBV30-01+TCRBJ02-03	TCRBV30-01*01	TCRBD02-01*02	TCRBJ02-03*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
TCTGGCTTCTATCTCTGTGCCTGGAGTGTTCATAGGCGGGGGYGAGGCTAGTAACGGAATGAAAAACTGTTTTTTGGCAGT	CAWSVHRRGXG**RNEKLFF	Stop	VDJ	4	150	0.0011093115612450914		60	TCRBV30	TCRBV30-01		TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-04	01	0	7	2	5	6	15	15	29	42	35	57			01,02										Vb 20	CAWSVHRRGXG**RNEKLFF+TCRBV30-01+TCRBJ01-04	TCRBV30-01	TCRBD02-01*01	TCRBJ01-04*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTAATAGGGGGACTCTGGAAACACCATATATTTTGGAGAG		Out	VDJ	19	655	0.004843993817436899		46	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	0	5	1	0	3	1	26	40	49	43	50			unresolved										Vb 20	X+TCRBV30-01+TCRBJ01-03	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-03*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCGAGAGGAGACCGCCGACTATGGCTACACCTTCGGTTCG	CASSREETADYGYTF	In	VDJ	1	11	8.134951449130669E-5	9.538757706882647E-5	45	TCRBV01	TCRBV01-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	0	10	2	3	0	7	23	-1	44	40	51														CASSREETADYGYTF+TCRBV01-01+TCRBJ01-02	TCRBV01-01*01	TCRBD02-01*02	TCRBJ01-02*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCTACGAGGGACAGGTAGCTCCTACGAGCAGTACTTCGGGCCG	CASSLRGTGSSYEQYF	In	VDJ	1	11	8.134951449130669E-5	9.538757706882647E-5	48	TCRBV01	TCRBV01-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	0	4	0	5	3	23	36	49	41	52														CASSLRGTGSSYEQYF+TCRBV01-01+TCRBJ02-07	TCRBV01-01*01	TCRBD01-01*01	TCRBJ02-07*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCTTACCGGGGCTAGCGGGTACCTTCGATCCTACGAGCAGTACTTCGGGCCG	CASSLTGASGYLRSYEQYF	In	VDJ	1	11	8.134951449130669E-5	9.538757706882647E-5	57	TCRBV01	TCRBV01-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	4	4	4	1	9	9	23	36	53	45	62						01,02								CASSLTGASGYLRSYEQYF+TCRBV01-01+TCRBJ02-07	TCRBV01-01*01	TCRBD02-01	TCRBJ02-07*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCTACAGGGTTCTGGGCGAGCAGTACTTCGGGCCG	CASSYRVLGEQYF	In	VDJ	1	11	8.134951449130669E-5	9.538757706882647E-5	39	TCRBV01	TCRBV01-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	3	3	6	1	7	23	35	42	36	49														CASSYRVLGEQYF+TCRBV01-01+TCRBJ02-07	TCRBV01-01*01	TCRBD01-01*01	TCRBJ02-07*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCTATGCCGGGACAGCCAATGGCTACACCTTCGGTTCG	CASSYAGTANGYTF	In	VDJ	1	11	8.134951449130669E-5	9.538757706882647E-5	42	TCRBV01	TCRBV01-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	0	5	6	6	3	23	35	48	41	51														CASSYAGTANGYTF+TCRBV01-01+TCRBJ01-02	TCRBV01-01*01	TCRBD01-01*01	TCRBJ01-02*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAAGGGCGAGGACGGGAGGGCCGGGAGCAGTTCTTCGGGCCA	CASSQGRGREGREQFF	In	VDJ	1	15	1.1093115612450913E-4	1.3007396873021792E-4	48	TCRBV01	TCRBV01-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	1	8	0	10	8	4	23	39	55	47	59														CASSQGRGREGREQFF+TCRBV01-01+TCRBJ02-01	TCRBV01-01*01	TCRBD02-01*02	TCRBJ02-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAGGGGACAGCTTACACCGGGGAGCTGTTTTTTGGAGAA	CASSQGTAYTGELFF	In	VDJ	1	20	1.4790820816601219E-4	1.734319583069572E-4	45	TCRBV01	TCRBV01-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	3	0	5	3	1	3	23	37	45	38	48														CASSQGTAYTGELFF+TCRBV01-01+TCRBJ02-02	TCRBV01-01*01	TCRBD01-01*01	TCRBJ02-02*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCGTCTTACTAGCGGCAACCCCTACGAGCAGTACTTCGGGCCG	CASSRLTSGNPYEQYF	In	VDJ	1	20	1.4790820816601219E-4	1.734319583069572E-4	48	TCRBV01	TCRBV01-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	4	3	5	2	5	5	23	36	49	41	54						01,02								CASSRLTSGNPYEQYF+TCRBV01-01+TCRBJ02-07	TCRBV01-01*01	TCRBD02-01	TCRBJ02-07*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAGGAGGTAACTAGCGTCTACGAACAGTACTTCGGGCCG	CASSQEVTSVYEQYF	In	VDJ	1	22	1.6269902898261338E-4	1.9077515413765293E-4	45	TCRBV01	TCRBV01-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	3	3	6	10	7	8	23	37	51	44	59						01,02								CASSQEVTSVYEQYF+TCRBV01-01+TCRBJ02-07	TCRBV01-01*01	TCRBD02-01	TCRBJ02-07*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAAAGTCCAGGGGGCAATGAGCAGTTCTTCGGGCCA	CASSQSPGGNEQFF	In	VDJ	1	23	1.70094439390914E-4	1.994467520530008E-4	42	TCRBV01	TCRBV01-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	2	4	1	6	4	0	23	38	-1	42	49														CASSQSPGGNEQFF+TCRBV01-01+TCRBJ02-01	TCRBV01-01*01	TCRBD01-01*01	TCRBJ02-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAAGAAAGGACAGGGGTCGAGCAGTACTTCGGGCCG	CASSQERTGVEQYF	In	VDJ	1	23	1.70094439390914E-4	1.994467520530008E-4	42	TCRBV01	TCRBV01-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	0	1	2	6	2	1	23	40	51	42	52														CASSQERTGVEQYF+TCRBV01-01+TCRBJ02-07	TCRBV01-01*01	TCRBD01-01*01	TCRBJ02-07*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAAGAAATAAAGGGGGGACAGGGAAATGGCTACACCTTCGGTTCG	CASSQEIKGGQGNGYTF	In	VDJ	1	25	1.848852602075152E-4	2.1678994788369653E-4	51	TCRBV01	TCRBV01-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	0	3	6	9	2	23	40	58	49	60														CASSQEIKGGQGNGYTF+TCRBV01-01+TCRBJ01-02	TCRBV01-01*01	TCRBD01-01*01	TCRBJ01-02*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAATTCGCGATAGACATGAACACTGAAGCTTTCTTTGGACAA	CASSQFAIDMNTEAFF	In	VDJ	1	25	1.848852602075152E-4	2.1678994788369653E-4	48	TCRBV01	TCRBV01-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	2	6	0	9	0	23	38	-1	47	51														CASSQFAIDMNTEAFF+TCRBV01-01+TCRBJ01-01	TCRBV01-01*01	TCRBD01-01*01	TCRBJ01-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAAGGGAGGGGGGAAATCTGGAATCAGCCCCAGCATTTTGGTGAT	CASSQGRGEIWNQPQHF	In	VDJ	1	26	1.9228067061581583E-4	2.254615457990444E-4	51	TCRBV01	TCRBV01-01	01				TCRBJ01	TCRBJ01-05	01	1	5	1	4	2	9	23	39	47	41	56				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQGRGEIWNQPQHF+TCRBV01-01+TCRBJ01-05	TCRBV01-01*01		TCRBJ01-05*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAAGGGCTCGGGGGAGGGCGCAATGAGTAGTTCTTCGGGCCA	CASSQGLGGGRNE*FF	Stop	VDJ	1	26	1.9228067061581583E-4		48	TCRBV01	TCRBV01-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	1	9	0	14	7	10	23	39	53	46	63														CASSQGLGGGRNE*FF+TCRBV01-01+TCRBJ02-01	TCRBV01-01*01	TCRBD02-01*02	TCRBJ02-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCTTATAACTGGAAACACCATATATTTTGGAGAG	CASSLITGNTIYF	In	VDJ	1	26	1.9228067061581583E-4	2.254615457990444E-4	39	TCRBV01	TCRBV01-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-03	01	4	5	9	2	1	3	23	36	39	37	42						01,02								CASSLITGNTIYF+TCRBV01-01+TCRBJ01-03	TCRBV01-01*01	TCRBD02-01	TCRBJ01-03*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAAACAGGGGCGGTCGGTGGCTACACCTTCGGTTCG	CASSQTGAVGGYTF	In	VDJ	1	30	2.2186231224901825E-4	2.6014793746043585E-4	42	TCRBV01	TCRBV01-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	2	3	2	7	0	7	23	-1	45	38	52														CASSQTGAVGGYTF+TCRBV01-01+TCRBJ01-02	TCRBV01-01*01	TCRBD01-01*01	TCRBJ01-02*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCCCGAAAAACACGGGACTCCTACTTCTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	30	2.2186231224901825E-4		56	TCRBV01	TCRBV01-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	4	0	10	3	11	7	23	36	53	47	60						01,02								X+TCRBV01-01+TCRBJ02-01	TCRBV01-01*01	TCRBD02-01	TCRBJ02-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCCATTCAGGGGGGCCTACAATGAGCAGTTCTTCGGGCCA	CASSPFRGAYNEQFF	In	VDJ	1	34	2.5144395388222067E-4	2.948343291218273E-4	45	TCRBV01	TCRBV01-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	4	4	1	2	4	1	23	36	47	40	48														CASSPFRGAYNEQFF+TCRBV01-01+TCRBJ02-01	TCRBV01-01*01	TCRBD01-01*01	TCRBJ02-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAAGATGGAAACTACAGGGTGGGGGTCCAGTACTTCGGGCCA	CASSQDGNYRVGVQYF	In	VDJ	1	35	2.588393642905213E-4	3.0350592703717514E-4	48	TCRBV01	TCRBV01-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	0	3	3	10	8	7	23	40	54	48	61														CASSQDGNYRVGVQYF+TCRBV01-01+TCRBJ02-05	TCRBV01-01*01	TCRBD01-01*01	TCRBJ02-05*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCCTCGGGGGTATAACCTCTACAATGAGCAGTTCTTCGGGCCA	CASSPRGYNLYNEQFF	In	VDJ	1	43	3.1800264755692617E-4	3.72878710359958E-4	48	TCRBV01	TCRBV01-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	4	8	2	3	2	8	23	36	44	38	52														CASSPRGYNLYNEQFF+TCRBV01-01+TCRBJ02-01	TCRBV01-01*01	TCRBD02-01*01	TCRBJ02-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCCAGGGAGGGTTTCCTCCACTGAAGCTTTCTTTGGACAA	CASSPGRVSSTEAFF	In	VDJ	1	47	3.475842891901286E-4	4.0756510202134946E-4	45	TCRBV01	TCRBV01-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	4	9	0	4	2	7	23	36	45	38	52														CASSPGRVSSTEAFF+TCRBV01-01+TCRBJ01-01	TCRBV01-01*01	TCRBD02-01*02	TCRBJ01-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAAGCGGGAGGGAGCACAGATACGCAGTATTTTGGCCCA	CASSQAGGSTDTQYF	In	VDJ	1	49	3.623751100067298E-4	4.249082978520452E-4	45	TCRBV01	TCRBV01-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	1	8	0	0	0	0	23	-1	-1	39	47														CASSQAGGSTDTQYF+TCRBV01-01+TCRBJ02-03	TCRBV01-01*01	TCRBD02-01*02	TCRBJ02-03*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
AAGAAGACTCAGCTGCGTATCTCTGCACCAGCAGCCCTTTACCGGGACAGGGAGCGGTAGGCACTGAAGCTTTCTTTGGACAA	CTSSPLPGQGAVGTEAFF	In	VDJ	2	84	6.212144742972511E-4	7.284142248892203E-4	54	TCRBV01	TCRBV01-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	0	3	4	7	9	23	36	52	43	61														CTSSPLPGQGAVGTEAFF+TCRBV01-01+TCRBJ01-01	TCRBV01-01*01	TCRBD01-01*01	TCRBJ01-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCACGGGACGAACACTGAAGCTTTCTTTGGACAA	CASSHGTNTEAFF	In	VDJ	4	141	0.0010427528675703858	0.0012226953060640484	39	TCRBV01	TCRBV01-01	01				TCRBJ01	TCRBJ01-01	01	3	0	7	1	1	0	23	37	-1	38	43				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSHGTNTEAFF+TCRBV01-01+TCRBJ01-01	TCRBV01-01*01		TCRBJ01-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCCCCGGACAGGGGCCTACGAGCAGTACTTCGGGCCG	CASSPRTGAYEQYF	In	VDJ	4	151	0.001116706971653392	0.001309411285217527	42	TCRBV01	TCRBV01-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	1	2	2	3	0	23	36	-1	39	48														CASSPRTGAYEQYF+TCRBV01-01+TCRBJ02-07	TCRBV01-01*01	TCRBD01-01*01	TCRBJ02-07*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
AAGAAGACTCAGCTGCGTATCTCTGCACCAGCAGCCAAGATCGGCTAGCGGGGGCCGCTAGCCAAAAACATTCAGTACTTCGGCGCC		Out	VDJ	6	216	0.0015974086481929314		58	TCRBV01	TCRBV01-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-04	01	0	4	2	0	4	5	23	40	54	44	59														X+TCRBV01-01+TCRBJ02-04	TCRBV01-01*01	TCRBD02-01*01	TCRBJ02-04*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAAGATCCGGGTTTTTACGAGCAGTACTTCGGGCCG	CASSQDPGFYEQYF	In	VDJ	8	275	0.0020337378622826674	0.002384689426720662	42	TCRBV01	TCRBV01-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	0	8	4	4	2	4	23	40	46	42	50						01,02								CASSQDPGFYEQYF+TCRBV01-01+TCRBJ02-07	TCRBV01-01*01	TCRBD02-01	TCRBJ02-07*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAAGAGAGGGCATCTGGAAACACCATATATTTTGGAGAG	CASSQERASGNTIYF	In	VDJ	9	306	0.002262995584939986	0.0026535089620964456	45	TCRBV01	TCRBV01-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-03	01	0	11	0	1	0	2	23	-1	45	40	47														CASSQERASGNTIYF+TCRBV01-01+TCRBJ01-03	TCRBV01-01*01	TCRBD02-01*02	TCRBJ01-03*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
AAGAAGACTCAGCTGCGTATCTCTGCACCAGCAGCCCGCCTTGAGCGGTTTGGGATACGAGCAGTACTTCGGGCCG		Out	VDJ	9	323	0.0023887175618810966		47	TCRBV01	TCRBV01-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	4	6	5	4	7	7	23	36	48	43	55						01,02								X+TCRBV01-01+TCRBJ02-07	TCRBV01-01*01	TCRBD02-01	TCRBJ02-07*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCACCAGCACGGTAGCGGGGATGTACAATGAGCAGTTCTTCGGGCCA	CATSTVAGMYNEQFF	In	VDJ	18	637	0.0047108764300874875	0.0055238078720765875	45	TCRBV01	TCRBV01-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	5	5	3	4	4	3	23	35	47	39	50														CATSTVAGMYNEQFF+TCRBV01-01+TCRBJ02-01	TCRBV01-01*01	TCRBD02-01*01	TCRBJ02-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCCCGGAGGGGCTGCGTGAAAAACTGTTTTTTGGCAGT	CASSPEGLREKLFF	In	VDJ	1	11	8.134951449130669E-5	9.538757706882647E-5	42	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-04	01	4	10	0	7	2	6	19	31	39	33	45													Vb 5.1	CASSPEGLREKLFF+TCRBV05-01+TCRBJ01-04	TCRBV05-01*01	TCRBD02-01*02	TCRBJ01-04*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGGGGTCTCAGGGACAACTCTACGAGCAGTACTTCGGGCCG	CASSLGSQGQLYEQYF	In	VDJ	1	11	8.134951449130669E-5	9.538757706882647E-5	48	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	0	0	6	3	7	3	19	35	48	42	51													Vb 5.1	CASSLGSQGQLYEQYF+TCRBV05-01+TCRBJ02-07	TCRBV05-01*01	TCRBD01-01*01	TCRBJ02-07*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTCGCTAGCGGGAGAAACAAATGAGCAGTTCTTCGGGCCA	CASSSLAGETNEQFF	In	VDJ	1	12	8.87449248996073E-5	1.0405917498417433E-4	45	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	3	4	2	7	2	5	19	32	44	34	49													Vb 5.1	CASSSLAGETNEQFF+TCRBV05-01+TCRBJ02-01	TCRBV05-01*01	TCRBD02-01*02	TCRBJ02-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTCAGGACAGATGGAAACACCATATATTTTGGAGAG	CASSFRTDGNTIYF	In	VDJ	1	12	8.87449248996073E-5	1.0405917498417433E-4	42	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	2	1	5	3	2	1	19	33	41	35	42													Vb 5.1	CASSFRTDGNTIYF+TCRBV05-01+TCRBJ01-03	TCRBV05-01*01	TCRBD01-01*01	TCRBJ01-03*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGATTGGGGGGAAGGTTAATCCCGGGGAGCTGTTTTTTGGAGAA	CASSLIGGKVNPGELFF	In	VDJ	1	12	8.87449248996073E-5	1.0405917498417433E-4	51	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	1	9	1	6	3	10	19	34	43	37	53													Vb 5.1	CASSLIGGKVNPGELFF+TCRBV05-01+TCRBJ02-02	TCRBV05-01*01	TCRBD02-01*01	TCRBJ02-02*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCGAGACAGGGCGAAATGAAAAACTGTTTTTTGGCAGT	CASSETGRNEKLFF	In	VDJ	1	13	9.614033530790792E-5	1.127307728995222E-4	42	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	4	2	3	5	2	3	19	31	40	33	43													Vb 5.1	CASSETGRNEKLFF+TCRBV05-01+TCRBJ01-04	TCRBV05-01*01	TCRBD01-01*01	TCRBJ01-04*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCGCGGGACGGAGTAATGAAAAACTGTTTTTTGGCAGT	CASSAGRSNEKLFF	In	VDJ	1	13	9.614033530790792E-5	1.127307728995222E-4	42	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-04	01	4	7	3	4	0	5	19	-1	37	31	42													Vb 5.1	CASSAGRSNEKLFF+TCRBV05-01+TCRBJ01-04	TCRBV05-01*01	TCRBD02-01*02	TCRBJ01-04*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGGGGGGGGGTAGCATCCCCCTTTTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	13	9.614033530790792E-5		55	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	0	9	0	4	0	14	19	-1	42	35	56													Vb 5.1	X+TCRBV05-01+TCRBJ02-01	TCRBV05-01*01	TCRBD02-01*01	TCRBJ02-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTTGGGGGTCCTGATTATGGCTACACCTTCGGTTCG	CASSFGGPDYGYTF	In	VDJ	1	13	9.614033530790792E-5	1.127307728995222E-4	42	TCRBV05	TCRBV05-01	01				TCRBJ01	TCRBJ01-02	01	2	6	1	5	1	7	19	33	39	34	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 5.1	CASSFGGPDYGYTF+TCRBV05-01+TCRBJ01-02	TCRBV05-01*01		TCRBJ01-02*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCCCAGGACTAGCTGTGGATACGCAGTATTTTGGCCCA	CASSPGLAVDTQYF	In	VDJ	1	14	1.0353574571620853E-4	1.2140237081487006E-4	42	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	4	1	7	6	3	4	19	31	42	34	46						01,02							Vb 5.1	CASSPGLAVDTQYF+TCRBV05-01+TCRBJ02-03	TCRBV05-01*01	TCRBD02-01	TCRBJ02-03*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGGTACTAGCGGGAGCCAATGAGCAGTTCTTCGGGCCA	CASSLVLAGANEQFF	In	VDJ	1	15	1.1093115612450913E-4	1.3007396873021792E-4	45	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	0	3	2	6	1	1	19	35	47	36	48													Vb 5.1	CASSLVLAGANEQFF+TCRBV05-01+TCRBJ02-01	TCRBV05-01*01	TCRBD02-01*02	TCRBJ02-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTACGTTTTCCGTAGGACAGGGGAAAACGAGCAGTACTTCGGGCCG		Out	VDJ	1	16	1.1832656653280974E-4		52	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	2	1	2	5	12	3	19	33	54	45	57													Vb 5.1	X+TCRBV05-01+TCRBJ02-07	TCRBV05-01*01	TCRBD01-01*01	TCRBJ02-07*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTCGACCCCCGGCCACTCCTACAATGAGCAGTTCTTCGGGCCA	CASSSTPGHSYNEQFF	In	VDJ	1	17	1.2572197694111034E-4	1.4741716456091364E-4	48	TCRBV05	TCRBV05-01	01				TCRBJ02	TCRBJ02-01	01	3	2	7	0	1	9	19	32	36	33	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 5.1	CASSSTPGHSYNEQFF+TCRBV05-01+TCRBJ02-01	TCRBV05-01*01		TCRBJ02-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGGCCGGAGCAAGGGCGATCGAAAACTGTTTTTTGGCAGT		Out	VDJ	1	17	1.2572197694111034E-4		47	TCRBV05	TCRBV05-01	01				TCRBJ01	TCRBJ01-04	01	0	5	3	10	8	6	19	35	47	43	53				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 5.1	X+TCRBV05-01+TCRBJ01-04	TCRBV05-01*01		TCRBJ01-04*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTGGACCAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSWTSSYNEQFF	In	VDJ	1	18	1.3311738734941096E-4	1.560887624762615E-4	42	TCRBV05	TCRBV05-01	01				TCRBJ02	TCRBJ02-01	01	3	1	7	0	0	3	19	-1	36	32	39				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 5.1	CASSWTSSYNEQFF+TCRBV05-01+TCRBJ02-01	TCRBV05-01*01		TCRBJ02-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGGCCGAGAGCGGGAGGATTACTGAGCAGTTCTTCGGGCCA	CASSLAESGRITEQFF	In	VDJ	1	18	1.3311738734941096E-4	1.560887624762615E-4	48	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	0	6	1	9	5	5	19	35	49	40	54													Vb 5.1	CASSLAESGRITEQFF+TCRBV05-01+TCRBJ02-01	TCRBV05-01*01	TCRBD02-01*02	TCRBJ02-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGGCCCCAAGCGGGAGATCCAATGAGCAGTTCTTCGGGCCA	CASSLAPSGRSNEQFF	In	VDJ	1	20	1.4790820816601219E-4	1.734319583069572E-4	48	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	0	6	2	6	5	3	19	35	48	40	51													Vb 5.1	CASSLAPSGRSNEQFF+TCRBV05-01+TCRBJ02-01	TCRBV05-01*01	TCRBD02-01*02	TCRBJ02-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGGAGGTCGTAGGGCCCATCGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	21	1.5530361857431278E-4		52	TCRBV05	TCRBV05-01	01				TCRBJ01	TCRBJ01-01	01	0	5	3	1	7	6	19	35	46	42	52				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 5.1	X+TCRBV05-01+TCRBJ01-01	TCRBV05-01*01		TCRBJ01-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGTGAGGGGCTAGACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	21	1.5530361857431278E-4		44	TCRBV05	TCRBV05-01	01				TCRBJ02	TCRBJ02-02	01	1	5	2	5	2	4	19	34	41	36	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 5.1	X+TCRBV05-01+TCRBJ02-02	TCRBV05-01*01		TCRBJ02-02*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTGGACCCCCAAAAGCCGGGACAGAGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	22	1.6269902898261338E-4		55	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	0	5	1	15	1	19	32	54	47	55													Vb 5.1	X+TCRBV05-01+TCRBJ01-01	TCRBV05-01*01	TCRBD01-01*01	TCRBJ01-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGGCCGTTTGGGACAGGGATGGCTACACCTTCGGTTCG	CASSLAVWDRDGYTF	In	VDJ	1	24	1.774898497992146E-4	2.0811834996834865E-4	45	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	0	3	6	6	0	19	35	-1	41	50													Vb 5.1	CASSLAVWDRDGYTF+TCRBV05-01+TCRBJ01-02	TCRBV05-01*01	TCRBD01-01*01	TCRBJ01-02*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGTACTGCTTCCATCCCCACAGATACGCAGTATTTTGGCCCA	CASSTASIPTDTQYF	In	VDJ	1	24	1.774898497992146E-4	2.0811834996834865E-4	45	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	5	3	10	2	1	11	19	30	34	31	45						01,02							Vb 5.1	CASSTASIPTDTQYF+TCRBV05-01+TCRBJ02-03	TCRBV05-01*01	TCRBD02-01	TCRBJ02-03*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GGACTCGGCCCTTTATCTTTGCGCCGAGGGGCTAGCGGGGGGTAGGTGGATGGACACAGATACGCAGTATTTTGGCCCA	CAEGLAGGRWMDTDTQYF	In	VDJ	1	24	1.774898497992146E-4	2.0811834996834865E-4	54	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	10	4	1	2	6	12	19	25	42	31	54													Vb 5.1	CAEGLAGGRWMDTDTQYF+TCRBV05-01+TCRBJ02-03	TCRBV05-01*01	TCRBD02-01*01	TCRBJ02-03*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCACCTCCTGGGGGGCGCGAGGCACTGAAGCTTTCTTTGGACAA	CASTSWGARGTEAFF	In	VDJ	1	26	1.9228067061581583E-4	2.254615457990444E-4	45	TCRBV05	TCRBV05-01	01				TCRBJ01	TCRBJ01-01	01	6	6	0	4	7	6	19	29	42	36	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 5.1	CASTSWGARGTEAFF+TCRBV05-01+TCRBJ01-01	TCRBV05-01*01		TCRBJ01-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCCTAGTAGCGGGACGCACAGATACGCAGTATTTTGGCCCA	CASSLVAGRTDTQYF	In	VDJ	1	39	2.884210059237237E-4	3.381923186985666E-4	45	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	4	5	3	1	4	1	19	31	43	35	44													Vb 5.1	CASSLVAGRTDTQYF+TCRBV05-01+TCRBJ02-03	TCRBV05-01*01	TCRBD02-01*02	TCRBJ02-03*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGTGGGGGTCGGGGCCGAACACTGAAGCTTTCTTTGGACAA	CASSLWGSGPNTEAFF	In	VDJ	1	44	3.2539805796522677E-4	3.8155030827530587E-4	48	TCRBV05	TCRBV05-01	01				TCRBJ01	TCRBJ01-01	01	1	6	1	1	1	8	19	34	40	35	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 5.1	CASSLWGSGPNTEAFF+TCRBV05-01+TCRBJ01-01	TCRBV05-01*01		TCRBJ01-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGGCAGGGGGACAGGGACAAACCGGGGAGCTGTTTTTTGGAGAA	CASSLAGGQGQTGELFF	In	VDJ	3	98	7.247502200134596E-4	8.498165957040904E-4	51	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	0	0	3	5	4	4	19	35	48	39	52													Vb 5.1	CASSLAGGQGQTGELFF+TCRBV05-01+TCRBJ02-02	TCRBV05-01*01	TCRBD01-01*01	TCRBJ02-02*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCTCAGCTTTTAGGGACAGGGCCTATGAAGCTTTCTTTGGACAA	CASSAFRDRAYEAFF	In	VDJ	3	111	8.208905553213676E-4	9.625473686036126E-4	45	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	7	0	3	7	10	4	19	28	47	38	51													Vb 5.1	CASSAFRDRAYEAFF+TCRBV05-01+TCRBJ01-01	TCRBV05-01*01	TCRBD01-01*01	TCRBJ01-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCACTGGGACTAGCGGGCTTTTGGAGCTGTTTTTTGGAGAA	CASSTGTSGLLELFF	In	VDJ	4	153	0.001131497792469993	0.0013267544810482228	45	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	4	0	4	10	3	5	19	31	46	34	51						01,02							Vb 5.1	CASSTGTSGLLELFF+TCRBV05-01+TCRBJ02-02	TCRBV05-01*01	TCRBD02-01	TCRBJ02-02*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGTACTCGCGGGCCCCAGGACGAGCAGTACTTCGGGCCG	CASSTRGPQDEQYF	In	VDJ	14	479	0.0035424015855759915	0.004153695401451625	42	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	5	7	4	5	5	7	19	30	40	35	47						01,02							Vb 5.1	CASSTRGPQDEQYF+TCRBV05-01+TCRBJ02-07	TCRBV05-01*01	TCRBD02-01	TCRBJ02-07*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GAGGGACTCAGCCGTGTATCTCTACAGTAGCGGGGGGACAGGGGCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	41	3.0321182674032497E-4		38	TCRBV17	TCRBV17-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	0	2	3	1	0	22	33	-1	34	44														X+TCRBV17-01+TCRBJ02-07	TCRBV17-01*01	TCRBD01-01*01	TCRBJ02-07*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GAGGGACTCAGCCGTGTATCTCTACAGTAGCCCTCGTCTTATTCTGGACAAAGCGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	2	85	6.286098847055517E-4		52	TCRBV17	TCRBV17-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	5	1	6	5	14	4	22	31	50	45	54														X+TCRBV17-01+TCRBJ02-06	TCRBV17-01*01	TCRBD01-01*01	TCRBJ02-06*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCACCTCCATGAAGGGGGCGCCGGGGCAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	12	8.87449248996073E-5		49	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	7	5	0	6	9	7	25	35	51	44	58													Vb 3	X+TCRBV28-01+TCRBJ02-01	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
TGGTGGCACCAACCAGACATTATGTACCTCTGTGCCAGCAGTCCTAGCGGGAGGGCCTCACGGAACAATGAGCAGTTCTTCGGGCCA	CASSPSGRASRNNEQFF	In	VDJ	1	12	8.87449248996073E-5	1.0405917498417433E-4	51	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	5	4	0	5	1	9	30	42	55	43	64													Vb 3	CASSPSGRASRNNEQFF+TCRBV28-01+TCRBJ02-01	TCRBV28-01*01	TCRBD02-01*02	TCRBJ02-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTCGCAGGGGGCAGAGGCGAGCAGTACTTCGGGCCG	CASSFAGGRGEQYF	In	VDJ	1	13	9.614033530790792E-5	1.127307728995222E-4	42	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	4	0	6	2	5	25	39	49	41	54													Vb 3	CASSFAGGRGEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-07*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGCCACGACAAGGGGGTTTTGAACACTGAAGCTTTCTTTGGACAA	CASSHDKGVLNTEAFF	In	VDJ	1	15	1.1093115612450913E-4	1.3007396873021792E-4	48	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	5	1	0	8	3	25	36	50	44	53													Vb 3	CASSHDKGVLNTEAFF+TCRBV28-01+TCRBJ01-01	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGGCGGACAGGGCTATTCTACGAGCAGTACTTCGGGCCG	CASRRTGLFYEQYF	In	VDJ	1	15	1.1093115612450913E-4	1.3007396873021792E-4	42	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	1	3	3	2	5	25	36	46	38	51													Vb 3	CASRRTGLFYEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-07*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGGCTCCTGAATAGCAATCAGCCCCAGCATTTTGGTGAT	CASRLLNSNQPQHF	In	VDJ	1	15	1.1093115612450913E-4	1.3007396873021792E-4	42	TCRBV28	TCRBV28-01	01				TCRBJ01	TCRBJ01-05	01	6	2	8	0	6	1	25	36	44	42	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASRLLNSNQPQHF+TCRBV28-01+TCRBJ01-05	TCRBV28-01*01		TCRBJ01-05*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTCCCGGGACAGCAAGAACCTACGAGCAGTACTTCGGGCCG	CASSPGTARTYEQYF	In	VDJ	1	16	1.1832656653280974E-4	1.3874556664556577E-4	45	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	0	5	2	3	6	25	37	47	40	53													Vb 3	CASSPGTARTYEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-07*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTACATTAATGCCATCTATGGCTACACCTTCGGTTCG	CASSYINAIYGYTF	In	VDJ	1	16	1.1832656653280974E-4	1.3874556664556577E-4	42	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	3	6	4	0	10	25	-1	41	38	51													Vb 3	CASSYINAIYGYTF+TCRBV28-01+TCRBJ01-02	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-02*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTCCGCGTCCCCCCGCCCCTACGAGCAGTACTTCGGGCCG	CASSSASPRPYEQYF	In	VDJ	1	16	1.1832656653280974E-4	1.3874556664556577E-4	45	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	4	7	6	2	2	10	25	38	43	40	53						01,02							Vb 3	CASSSASPRPYEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD02-01	TCRBJ02-07*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTAACCCAGAAGCAGGGTGAAGCTTTCTTTGGACAA	CASSLTQKQGEAFF	In	VDJ	1	16	1.1832656653280974E-4	1.3874556664556577E-4	42	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	4	3	7	9	0	25	40	-1	49	54													Vb 3	CASSLTQKQGEAFF+TCRBV28-01+TCRBJ01-01	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
TGGTGGCACCAACCAGMATCTATGTACCTCTGTGCCAGCAGTCCTAGCGGGAGGGCCTCACGGAACAATGAGCAGTTCTTCGGGCCA	CASSPSGRASRNNEQFF	In	VDJ	1	16	1.1832656653280974E-4	1.3874556664556577E-4	51	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	5	4	0	5	1	9	30	42	55	43	64													Vb 3	CASSPSGRASRNNEQFF+TCRBV28-01+TCRBJ02-01	TCRBV28-01*01	TCRBD02-01*02	TCRBJ02-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTCCAGGGACTAGCGCGACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	17	1.2572197694111034E-4		44	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	0	6	5	3	2	25	37	50	40	52						01,02							Vb 3	X+TCRBV28-01+TCRBJ02-01	TCRBV28-01*01	TCRBD02-01	TCRBJ02-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTGCGTCCGCAAGAGACCCAGTACTTCGGGCCA	CASSLRPQETQYF	In	VDJ	1	17	1.2572197694111034E-4	1.4741716456091364E-4	39	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	3	7	6	2	0	4	25	-1	42	39	46						01,02							Vb 3	CASSLRPQETQYF+TCRBV28-01+TCRBJ02-05	TCRBV28-01*01	TCRBD02-01	TCRBJ02-05*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
TGGTGGCACCACCAGACATCTATGTACCTCTGTGCCAGCAGTCCTAGCGGGAGGGCCTCACGGAACAATGAGCAGTTCTTCGGGCCA	CASSPSGRASRNNEQFF	In	VDJ	1	18	1.3311738734941096E-4	1.560887624762615E-4	51	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	5	4	0	5	1	9	30	42	55	43	64													Vb 3	CASSPSGRASRNNEQFF+TCRBV28-01+TCRBJ02-01	TCRBV28-01*01	TCRBD02-01*02	TCRBJ02-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTCGGGACAGGGGGCAGACTAAGAGCTGGCTACACCTTCGGTTCG	CASSFGTGGRLRAGYTF	In	VDJ	1	19	1.4051279775771156E-4	1.6476036039160937E-4	51	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	0	0	7	1	11	25	39	52	40	63													Vb 3	CASSFGTGGRLRAGYTF+TCRBV28-01+TCRBJ01-02	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-02*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTAGTTCAGGTCTCTGGAAACACCATATATTTTGGAGAG	CASSLVQVSGNTIYF	In	VDJ	1	20	1.4790820816601219E-4	1.734319583069572E-4	45	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	2	4	4	0	3	1	25	40	47	43	48													Vb 3	CASSLVQVSGNTIYF+TCRBV28-01+TCRBJ01-03	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-03*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
TGGTGGCACCAACCAGACATCTATGTACTCTGTGCCAGCAGTCCTAGCGGGAGGGCCTCACGGAACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	22	1.6269902898261338E-4		50	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	20	4	0	5	15	9	31	28	55	43	64													Vb 3	X+TCRBV28-01+TCRBJ02-01	TCRBV28-01*01	TCRBD02-01*02	TCRBJ02-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGCGCTACGGGGGTCAAGACCCAAGAGACCCAGTACTTCGGGCCA	CASSATGVKTQETQYF	In	VDJ	1	24	1.774898497992146E-4	2.0811834996834865E-4	48	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	6	8	2	1	5	7	25	36	47	41	54													Vb 3	CASSATGVKTQETQYF+TCRBV28-01+TCRBJ02-05	TCRBV28-01*01	TCRBD02-01*01	TCRBJ02-05*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CACCAACCAGACATCTATGTACCTCTGTGCTAGCAGTTTTGAGGGGAGGAGAGTCCACACTGAAGCTTTCTTTGGACAA	CASSFEGRRVHTEAFF	In	VDJ	1	24	1.774898497992146E-4	2.0811834996834865E-4	48	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	3	9	1	3	4	7	25	39	49	43	56													Vb 3	CASSFEGRRVHTEAFF+TCRBV28-01+TCRBJ01-01	TCRBV28-01*01	TCRBD02-01*02	TCRBJ01-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTCTTAGCGGGAGGGCCTCATGGAACAATGAGCAGTTCTTCGGGCCA	CASSLSGRASWNNEQFF	In	VDJ	1	25	1.848852602075152E-4	2.1678994788369653E-4	51	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	5	5	0	5	2	9	25	37	50	39	59													Vb 3	CASSLSGRASWNNEQFF+TCRBV28-01+TCRBJ02-01	TCRBV28-01*01	TCRBD02-01*02	TCRBJ02-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCCATTACAGGGGGAGATCTCTGGAAACACCATATATTTTGGAGAG		Out	VDJ	1	25	1.848852602075152E-4		47	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	8	3	1	0	4	4	25	34	46	38	50													Vb 3	X+TCRBV28-01+TCRBJ01-03	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-03*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTCCCGCACTAGCTTCCTACGAGCAGTACTTCGGGCCG	CASSPALASYEQYF	In	VDJ	1	27	1.9967608102411643E-4	2.3413314371439225E-4	42	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	5	3	7	1	5	1	25	37	48	42	49						01,02							Vb 3	CASSPALASYEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD02-01	TCRBJ02-07*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTCTAACAGAGGGCGGACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	27	1.9967608102411643E-4		43	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	5	11	0	3	6	3	25	37	48	43	51													Vb 3	X+TCRBV28-01+TCRBJ01-01	TCRBV28-01*01	TCRBD02-01*02	TCRBJ01-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTTGTGGCCGCGAACACTGAAGCTTTCTTTGGACAA	CASSFVAANTEAFF	In	VDJ	1	27	1.9967608102411643E-4	2.3413314371439225E-4	42	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	9	0	1	3	3	25	39	45	42	48													Vb 3	CASSFVAANTEAFF+TCRBV28-01+TCRBJ01-01	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTAGGTAGGGCGGAGACCCAGTACTTCGGGCCA	CASSLGRAETQYF	In	VDJ	1	28	2.0707149143241705E-4	2.4280474162974012E-4	39	TCRBV28	TCRBV28-01	01				TCRBJ02	TCRBJ02-05	01	2	5	3	5	3	2	25	40	47	43	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASSLGRAETQYF+TCRBV28-01+TCRBJ02-05	TCRBV28-01*01		TCRBJ02-05*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CACCAACCAGACATCTATGTACCTCTGTGCCATCCAAGTTAACACCGGGGAGCTGTTTTTTGGAGAA	CAIQVNTGELFF	In	VDJ	1	28	2.0707149143241705E-4	2.4280474162974012E-4	36	TCRBV28	TCRBV28-01	01				TCRBJ02	TCRBJ02-02	01	10	4	6	2	2	4	25	32	36	34	40				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CAIQVNTGELFF+TCRBV28-01+TCRBJ02-02	TCRBV28-01*01		TCRBJ02-02*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTCGGGACAGGGGTTGGTGAATGAGCAGTTCTTCGGGCCA	CASSSGQGLVNEQFF	In	VDJ	1	29	2.1446690184071765E-4	2.51476339545088E-4	45	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	4	0	2	7	1	6	25	38	49	39	55													Vb 3	CASSSGQGLVNEQFF+TCRBV28-01+TCRBJ02-01	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTAGAGGACAAAAAATAATGAAAAACTGTTTTTTGGCAGT		Out	VDJ	1	30	2.2186231224901825E-4		46	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	2	1	6	4	2	5	25	40	47	42	52													Vb 3	X+TCRBV28-01+TCRBJ01-04	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-04*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCGCCGAGGGGGGGCGCAATGAGCAGTTCTTCGGGCCA	CASAEGGRNEQFF	In	VDJ	1	32	2.3665313306561948E-4	2.7749113329113154E-4	39	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	8	9	0	6	5	2	25	34	46	39	48													Vb 3	CASAEGGRNEQFF+TCRBV28-01+TCRBJ02-01	TCRBV28-01*01	TCRBD02-01*01	TCRBJ02-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGCCGACAGGGGGCGAAAGCAGATACGCAGTATTTTGGCCCA	CASSRQGAKADTQYF	In	VDJ	1	36	2.662347746988219E-4	3.12177524952523E-4	45	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	6	2	0	4	2	5	25	36	48	38	53													Vb 3	CASSRQGAKADTQYF+TCRBV28-01+TCRBJ02-03	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-03*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
TGCCAGCGGCCTTCTTGGGACAGCTCCCCGAGCCGTCAGCGGGACCTCCATATGGAATGAGCAGTTCTTCGGGCCA	CASGLLGTAPRAVSGTSIWNEQFF	In	VDJ	1	36	2.662347746988219E-4	3.12177524952523E-4	72	TCRBV28	TCRBV28-01	01				TCRBJ02	TCRBJ02-01	01	8	0	5	7	9	32	-1	7	23	16	55				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASGLLGTAPRAVSGTSIWNEQFF+TCRBV28-01+TCRBJ02-01	TCRBV28-01*01		TCRBJ02-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGGACAGGAGCTAACTATGGCTACACCTTCGGTTCG	CASRTGANYGYTF	In	VDJ	1	37	2.736301851071225E-4	3.208491228678709E-4	39	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	2	4	0	0	2	25	-1	42	36	44													Vb 3	CASRTGANYGYTF+TCRBV28-01+TCRBJ01-02	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-02*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGGCCCACAGGGGGCTACGAGCAGTACTTCGGGCCG	CASRPTGGYEQYF	In	VDJ	1	39	2.884210059237237E-4	3.381923186985666E-4	39	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	3	1	3	4	0	25	36	-1	40	48													Vb 3	CASRPTGGYEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-07*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTGGGAGGACAGGGGGGGTTATATGGCTACACCTTCGGTTCG	CASSLGGQGGLYGYTF	In	VDJ	1	41	3.0321182674032497E-4	3.555355145292623E-4	48	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	1	1	5	4	5	25	39	53	43	58													Vb 3	CASSLGGQGGLYGYTF+TCRBV28-01+TCRBJ01-02	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-02*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTCGCAATAGCGGGAGGTCTCCAGATACGCAGTATTTTGGCCCA	CASSRNSGRSPDTQYF	In	VDJ	1	48	3.549796995984292E-4	4.162366999366973E-4	48	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	5	5	1	4	5	4	25	37	52	42	56													Vb 3	CASSRNSGRSPDTQYF+TCRBV28-01+TCRBJ02-03	TCRBV28-01*01	TCRBD02-01*02	TCRBJ02-03*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTTCCGACCGACAATGAGCAGTTCTTCGGGCCA	CASSFPTDNEQFF	In	VDJ	1	51	3.7716593082333106E-4	4.422514936827409E-4	39	TCRBV28	TCRBV28-01	01				TCRBJ02	TCRBJ02-01	01	3	2	7	5	3	2	25	39	45	42	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASSFPTDNEQFF+TCRBV28-01+TCRBJ02-01	TCRBV28-01*01		TCRBJ02-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTATGGGGGCCCCTACAGGGGGAGAACACTGAAGCTTTCTTTGGACAA	CASSLWGPLQGENTEAFF	In	VDJ	2	53	3.9195675163993226E-4	4.5959468951343665E-4	54	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	0	3	1	1	9	1	25	42	59	51	60													Vb 3	CASSLWGPLQGENTEAFF+TCRBV28-01+TCRBJ01-01	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGCCGACCCCACAGGGGGCTGGGCACTGAAGCTTTCTTTGGACAA	CASSRPHRGLGTEAFF	In	VDJ	2	55	4.0674757245653346E-4	4.7693788534413235E-4	48	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	3	0	4	8	4	25	36	53	44	57													Vb 3	CASSRPHRGLGTEAFF+TCRBV28-01+TCRBJ01-01	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTACAGTCGGGAAAACTGTTTTTTGGCAGT	CASSLQSGKLFF	In	VDJ	2	55	4.0674757245653346E-4	4.7693788534413235E-4	36	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-04	01	2	8	4	10	4	0	25	40	-1	44	48						01,02							Vb 3	CASSLQSGKLFF+TCRBV28-01+TCRBJ01-04	TCRBV28-01*01	TCRBD02-01	TCRBJ01-04*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTAACTAGCGCTGCCGGGGAGCTGTTTTTTGGAGAA	CASSLTSAAGELFF	In	VDJ	2	56	4.141429828648341E-4	4.8560948325948025E-4	42	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	2	3	6	6	0	3	25	-1	47	40	50						01,02							Vb 3	CASSLTSAAGELFF+TCRBV28-01+TCRBJ02-02	TCRBV28-01*01	TCRBD02-01	TCRBJ02-02*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTAACAACTAGCGGGACTCCCATCACAGATACGCAGTATTTTGGCCCA	CASSLTTSGTPITDTQYF	In	VDJ	2	61	4.511200349063371E-4	5.289674728362195E-4	54	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	2	3	3	2	3	7	25	40	53	43	60													Vb 3	CASSLTTSGTPITDTQYF+TCRBV28-01+TCRBJ02-03	TCRBV28-01*01	TCRBD02-01*02	TCRBJ02-03*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTATCAGGGGTTGGTGAAAAACTGTTTTTTGGCAGT	CASSLSGVGEKLFF	In	VDJ	2	62	4.5851544531463775E-4	5.376390707515674E-4	42	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	1	4	2	7	0	4	25	-1	47	41	51													Vb 3	CASSLSGVGEKLFF+TCRBV28-01+TCRBJ01-04	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-04*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCACGGGACAGGGGGCGGCTAATGAAAAACTGTTTTTTGGCAGT	CASTGQGAANEKLFF	In	VDJ	2	64	4.7330626613123895E-4	5.549822665822631E-4	45	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	7	0	0	3	1	2	25	35	48	36	50													Vb 3	CASTGQGAANEKLFF+TCRBV28-01+TCRBJ01-04	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-04*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCGGCGGGGCCGAGTCCACAGATACGCAGTATTTTGGCCCA	CASGGAESTDTQYF	In	VDJ	2	72	5.324695493976438E-4	6.24355049905046E-4	42	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	8	7	3	2	1	7	25	34	41	35	48													Vb 3	CASGGAESTDTQYF+TCRBV28-01+TCRBJ02-03	TCRBV28-01*01	TCRBD02-01*01	TCRBJ02-03*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGCAGTAGCGGGAGGTTGGGCAATGAGCAGTTCTTCGGGCCA	CASSSSGRLGNEQFF	In	VDJ	2	74	5.47260370214245E-4	6.416982457357418E-4	45	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	6	5	1	6	3	5	25	36	49	39	54													Vb 3	CASSSSGRLGNEQFF+TCRBV28-01+TCRBJ02-01	TCRBV28-01*01	TCRBD02-01*02	TCRBJ02-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTGGTACTCAACCCGGGGAGACCCAGTACTTCGGGCCA	CASSGTQPGETQYF	In	VDJ	2	82	6.064236534806499E-4	7.110710290585247E-4	42	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	5	8	4	5	11	0	25	37	-1	48	52						01,02							Vb 3	CASSGTQPGETQYF+TCRBV28-01+TCRBJ02-05	TCRBV28-01*01	TCRBD02-01	TCRBJ02-05*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTGGGGGGGACCAATCAGCCCCAGCATTTTGGTGAT	CASSLGGTNQPQHF	In	VDJ	3	96	7.099593991968584E-4	8.324733998733946E-4	42	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-05	01	3	9	0	3	0	2	25	-1	46	39	48													Vb 3	CASSLGGTNQPQHF+TCRBV28-01+TCRBJ01-05	TCRBV28-01*01	TCRBD02-01*01	TCRBJ01-05*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCGGCCTAGGAGACAGGGGAGGTCATCAGCCCCAGCATTTTGGTGAT	CASGLGDRGGHQPQHF	In	VDJ	3	97	7.173548096051591E-4	8.411449977887425E-4	48	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	8	2	2	5	9	5	25	34	51	43	56													Vb 3	CASGLGDRGGHQPQHF+TCRBV28-01+TCRBJ01-05	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-05*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCACCCCCTTTGTTAGGGGACGAAATAGCAATCAGCCCCAGCATTTTGGTGAT	CASTPFVRGRNSNQPQHF	In	VDJ	3	119	8.800538385877725E-4	0.0010319201519263955	54	TCRBV28	TCRBV28-01	01				TCRBJ01	TCRBJ01-05	01	7	0	7	0	13	4	25	35	53	48	57				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASTPFVRGRNSNQPQHF+TCRBV28-01+TCRBJ01-05	TCRBV28-01*01		TCRBJ01-05*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTGAGGGACAGGTTCTCCACAGATACGCAGTATTTTGGCCCA	CASSLRDRFSTDTQYF	In	VDJ	4	140	0.0010353574571620853	0.0012140237081487005	48	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	3	0	4	2	2	5	25	39	49	41	54													Vb 3	CASSLRDRFSTDTQYF+TCRBV28-01+TCRBJ02-03	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-03*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTTCAGAACATGAACACTGAAGCTTTCTTTGGACAA	CASSFQNMNTEAFF	In	VDJ	4	144	0.0010649390987952877	0.001248710099810092	42	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	3	6	0	5	0	25	39	-1	44	47													Vb 3	CASSFQNMNTEAFF+TCRBV28-01+TCRBJ01-01	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTCTTGGACTAGCGGATACGAGCAGTACTTCGGGCCG	CASSSWTSGYEQYF	In	VDJ	5	175	0.0012941968214526065	0.0015175296351858758	42	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	4	1	5	4	3	1	25	38	51	41	52						01,02							Vb 3	CASSSWTSGYEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD02-01	TCRBJ02-07*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTCACTACTAGCGGGAGATGAGACCCAGTACTTCGGGCCA	CASSSLLAGDETQYF	In	VDJ	6	205	0.0015160591337016248	0.0017776775726463115	45	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	4	3	2	5	4	2	25	38	53	42	55													Vb 3	CASSSLLAGDETQYF+TCRBV28-01+TCRBJ02-05	TCRBV28-01*01	TCRBD02-01*02	TCRBJ02-05*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTAATCGGGGAGGGCCGCCGGCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	6	215	0.0015900132377846309		52	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	2	9	0	1	4	6	25	40	51	44	57													Vb 3	X+TCRBV28-01+TCRBJ02-03	TCRBV28-01*01	TCRBD02-01*02	TCRBJ02-03*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGGCCTCCGGGGGGGGCTAATGAGCAGTTCTTCGGGCCA	CASRPPGGANEQFF	In	VDJ	6	223	0.0016491765210510357	0.001933766335122573	42	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	6	8	0	7	5	3	25	36	49	41	52													Vb 3	CASRPPGGANEQFF+TCRBV28-01+TCRBJ02-01	TCRBV28-01*01	TCRBD02-01*01	TCRBJ02-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTGGGAGGGGGATGGTATGGCTACACCTTCGGTTCG	CASSLGGGWYGYTF	In	VDJ	10	360	0.002662347746988219	0.00312177524952523	42	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	3	9	0	5	0	6	25	-1	46	39	52													Vb 3	CASSLGGGWYGYTF+TCRBV28-01+TCRBJ01-02	TCRBV28-01*01	TCRBD02-01*02	TCRBJ01-02*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGCTCGGGGACTAGCGGGGTCCAAGAGACCCAGTACTTCGGGCCA	CASSSGTSGVQETQYF	In	VDJ	12	407	0.0030099320361783475	0.0035293403515465793	48	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	6	0	3	1	4	1	25	36	53	40	54													Vb 3	CASSSGTSGVQETQYF+TCRBV28-01+TCRBJ02-05	TCRBV28-01*01	TCRBD02-01*01	TCRBJ02-05*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTCATGGACAGAAGCCTACGAGCAGTACTTCGGGCCG	CASSSWTEAYEQYF	In	VDJ	22	759	0.005613116499900162	0.006581742817749026	42	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	0	2	5	2	0	3	25	-1	47	42	50													Vb 3	CASSSWTEAYEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-07*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTCCTAGCGGGAGGGCCTCACGGAACAATGAGCAGTTCTTCGGGCCA	CASSPSGRASRNNEQFF	In	VDJ	238	8281	0.06124139359113734	0.07180950233699564	51	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	5	4	0	5	1	9	25	37	50	38	59													Vb 3	CASSPSGRASRNNEQFF+TCRBV28-01+TCRBJ02-01	TCRBV28-01*01	TCRBD02-01*02	TCRBJ02-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GACTCGGCCGTGTATGTCTGTGCAAGTCGCTTATACTTTCGGGGCTAGCGGGTACTAATACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	11	8.134951449130669E-5		58	TCRBV12	TCRBV12-02	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	2	4	4	4	11	6	18	33	52	44	58						01,02								X+TCRBV12-02+TCRBJ02-01	TCRBV12-02*01	TCRBD02-01	TCRBJ02-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GACTCGGCCGTGTATGTCTGTGCAAGTCGCTTAGGAATTGAGCGGGAGAATGAGACAGATACGCAGTATTTTGGCCCA	CASRLGIERENETDTQYF	In	VDJ	1	12	8.87449248996073E-5	1.0405917498417433E-4	54	TCRBV12	TCRBV12-02	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	1	6	2	3	6	6	18	34	48	40	54														CASRLGIERENETDTQYF+TCRBV12-02+TCRBJ02-03	TCRBV12-02*01	TCRBD02-01*02	TCRBJ02-03*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GACTCGGCCGTGTATGTCTGTGCAAGTCGCTCAGGGGACTAGCGGGGACTCGACCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	13	9.614033530790792E-5		53	TCRBV12	TCRBV12-02	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	4	0	3	2	3	7	18	31	47	34	54														X+TCRBV12-02+TCRBJ02-07	TCRBV12-02*01	TCRBD02-01*01	TCRBJ02-07*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GACTCGGCCGTGTATGTCTGTGCCTCTTTCCCCTTGGGCGGTCTCTATCCAGATGGCTACACCTTCGGTTCG	CASFPLGGLYPDGYTF	In	VDJ	3	95	7.025639887885578E-4	8.238018019580468E-4	48	TCRBV12	TCRBV12-02	01				TCRBJ01	TCRBJ01-02	01	12	8	0	6	12	13	18	23	39	35	52				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASFPLGGLYPDGYTF+TCRBV12-02+TCRBJ01-02	TCRBV12-02*01		TCRBJ01-02*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GACTCGGCCGTGTATGTCTGTGCCACCCGTCCGGGACTAGCGGGAGTGGGGGCCTACAATGAGCAGTTCTTCGGGCCA	CATRPGLAGVGAYNEQFF	In	VDJ	50	1740	0.01286801411044306	0.015088580372705279	54	TCRBV12	TCRBV12-02	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	12	0	2	2	9	6	18	23	46	32	52														CATRPGLAGVGAYNEQFF+TCRBV12-02+TCRBJ02-01	TCRBV12-02*01	TCRBD02-01*02	TCRBJ02-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCAACCAGACCTCTCTGTACTTCTGTGCCAGCAGGGGGGCACCCTATGGCTACACCTTCGGTTCG	CASRGAPYGYTF	In	VDJ	1	11	8.134951449130669E-5	9.538757706882647E-5	36	TCRBV27	TCRBV27-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	6	0	4	0	3	23	-1	40	34	43													Vb 14	CASRGAPYGYTF+TCRBV27-01+TCRBJ01-02	TCRBV27-01*01	TCRBD01-01*01	TCRBJ01-02*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCAACCAGACCTCTCTGTACTTCTGTGCCAGCAGTTTAAGGGGGGCCTACGAGCAGTACTTCGGGCCG	CASSLRGAYEQYF	In	VDJ	1	12	8.87449248996073E-5	1.0405917498417433E-4	39	TCRBV27	TCRBV27-01	01				TCRBJ02	TCRBJ02-07	01	2	5	1	2	0	1	23	-1	44	38	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 14	CASSLRGAYEQYF+TCRBV27-01+TCRBJ02-07	TCRBV27-01*01		TCRBJ02-07*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCAACCAGACCTCTCTGTACTTCTGTGCCAGCAGTTTAATGGACAAATCTGAAAAACTGTTTTTTGGCAGT	CASSLMDKSEKLFF	In	VDJ	1	21	1.5530361857431278E-4	1.821035562223051E-4	42	TCRBV27	TCRBV27-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	2	1	6	7	2	4	23	38	45	40	49													Vb 14	CASSLMDKSEKLFF+TCRBV27-01+TCRBJ01-04	TCRBV27-01*01	TCRBD01-01*01	TCRBJ01-04*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCAACCAGACCTCTCTGTACTTCTGTGCCAGCAGTTTATCACAGGGTTTTAATGAAAAACTGTTTTTTGGCAGT	CASSLSQGFNEKLFF	In	VDJ	1	26	1.9228067061581583E-4	2.254615457990444E-4	45	TCRBV27	TCRBV27-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	0	3	3	4	0	3	23	-1	46	40	49													Vb 14	CASSLSQGFNEKLFF+TCRBV27-01+TCRBJ01-04	TCRBV27-01*01	TCRBD01-01*01	TCRBJ01-04*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCAACCAGACCTCTCTGTACTTCTGTGCCAGCAGTTTTAGGGGACAATCCTACGAGCAGTACTTCGGGCCG	CASSFRGQSYEQYF	In	VDJ	1	27	1.9967608102411643E-4	2.3413314371439225E-4	42	TCRBV27	TCRBV27-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	0	6	1	3	1	23	37	46	40	47													Vb 14	CASSFRGQSYEQYF+TCRBV27-01+TCRBJ02-07	TCRBV27-01*01	TCRBD01-01*01	TCRBJ02-07*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGACAGTGCGAACACTGAAGCTTTCTTTGGACAA	CSVDSANTEAFF	In	VDJ	1	11	8.134951449130669E-5	9.538757706882647E-5	36	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	4	5	1	0	3	25	-1	39	36	42													Vb 4	CSVDSANTEAFF+TCRBV29-01+TCRBJ01-01	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGACCAGGGTCCTCCGGACGAGCAGTACTTCGGGCCG	CSVDQGPPDEQYF	In	VDJ	1	11	8.134951449130669E-5	9.538757706882647E-5	39	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	4	3	5	1	8	25	36	42	37	50													Vb 4	CSVDQGPPDEQYF+TCRBV29-01+TCRBJ02-07	TCRBV29-01*01	TCRBD01-01*01	TCRBJ02-07*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGATTTGATGATGACAGATACGCAGTATTTTGGCCCA	CSVDLMMTDTQYF	In	VDJ	1	12	8.87449248996073E-5	1.0405917498417433E-4	39	TCRBV29	TCRBV29-01	01				TCRBJ02	TCRBJ02-03	01	3	2	8	3	3	5	25	36	41	39	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	CSVDLMMTDTQYF+TCRBV29-01+TCRBJ02-03	TCRBV29-01*01		TCRBJ02-03*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAAGATGGGGGGGGAAACTACTACAATGAGCAGTTCTTCGGGCCA	CSVEDGGGNYYNEQFF	In	VDJ	1	14	1.0353574571620853E-4	1.2140237081487006E-4	48	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	0	9	0	3	1	7	25	39	47	40	54													Vb 4	CSVEDGGGNYYNEQFF+TCRBV29-01+TCRBJ02-01	TCRBV29-01*01	TCRBD02-01*01	TCRBJ02-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GCAAGCCACGTTTGGTGGCCCTGAAGACAGCAGCATTATCTCTGCAGCGTTGTGGTACGGGAGAGCACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	14	1.0353574571620853E-4		38	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	21	8	2	4	21	2	43	36	63	57	65													Vb 4	X+TCRBV29-01+TCRBJ01-01	TCRBV29-01*01	TCRBD02-01*02	TCRBJ01-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGCCCGACTAGCGGGAGGGAATGAGCAGTTCTTTGGGCCA	CSARLAGGNEQFF	In	VDJ	1	15	1.1093115612450913E-4	1.3007396873021792E-4	39	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02			7	2	0	22	3	15	25	32	49	35	64								TCRBJ02-01,TCRBJ02-05					Vb 4	CSARLAGGNEQFF+TCRBV29-01+TCRBJ02-X	TCRBV29-01*01	TCRBD02-01*02	TCRBJ02	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTGCCTAGCGGGAGAGGGCCCGCCTACGAGCAGTACTTCGGGCCG	CSVPSGRGPAYEQYF	In	VDJ	1	16	1.1832656653280974E-4	1.3874556664556577E-4	45	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	6	4	2	2	2	8	25	33	45	35	53													Vb 4	CSVPSGRGPAYEQYF+TCRBV29-01+TCRBJ02-07	TCRBV29-01*01	TCRBD02-01*02	TCRBJ02-07*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAAGTCAAGAGCGCGACCTACAATGAGCAGTTCTTCGGGCCA	CSVEVKSATYNEQFF	In	VDJ	1	17	1.2572197694111034E-4	1.4741716456091364E-4	45	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	1	6	6	2	5	3	25	38	47	43	50						01,02							Vb 4	CSVEVKSATYNEQFF+TCRBV29-01+TCRBJ02-01	TCRBV29-01*01	TCRBD02-01	TCRBJ02-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGATACTGGGACAGGGGAGGGCGAGCAGTACTTCGGGCCG	CSVDTGTGEGEQYF	In	VDJ	1	17	1.2572197694111034E-4	1.4741716456091364E-4	42	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	0	2	6	4	4	25	36	50	40	54													Vb 4	CSVDTGTGEGEQYF+TCRBV29-01+TCRBJ02-07	TCRBV29-01*01	TCRBD01-01*01	TCRBJ02-07*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGCCAACAAGGACAGGGTATTAGGCGAGCAGTACTTCGGGCCG	CSVANKDRVLGEQYF	In	VDJ	1	17	1.2572197694111034E-4	1.4741716456091364E-4	45	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	1	3	6	7	7	25	35	50	42	57													Vb 4	CSVANKDRVLGEQYF+TCRBV29-01+TCRBJ02-07	TCRBV29-01*01	TCRBD01-01*01	TCRBJ02-07*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTCAAGTTCGAGGACTAGCGGGAGGACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	18	1.3311738734941096E-4		49	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	1	1	1	5	5	0	25	38	-1	43	57													Vb 4	X+TCRBV29-01+TCRBJ02-01	TCRBV29-01*01	TCRBD02-01*02	TCRBJ02-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTCACGGGCGGGAGGGGGACACCGGGGAGCTGTTTTTTGGAGAA	CSVHGREGDTGELFF	In	VDJ	1	21	1.5530361857431278E-4	1.821035562223051E-4	45	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	5	7	0	3	5	2	25	34	48	39	50													Vb 4	CSVHGREGDTGELFF+TCRBV29-01+TCRBJ02-02	TCRBV29-01*01	TCRBD02-01*02	TCRBJ02-02*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGCCTCAGGGGCAGAGTATGGCTACACCTTCGGTTCG	CSASGAEYGYTF	In	VDJ	1	22	1.6269902898261338E-4	1.9077515413765293E-4	36	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	7	4	2	5	3	5	25	32	41	35	46													Vb 4	CSASGAEYGYTF+TCRBV29-01+TCRBJ01-02	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-02*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTCGCTTTGGTGGGGGGGAAGCAGATACGCAGTATTTTGGCCCA	CSVRFGGGEADTQYF	In	VDJ	1	27	1.9967608102411643E-4	2.3413314371439225E-4	45	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	5	9	0	4	9	3	25	34	50	43	53													Vb 4	CSVRFGGGEADTQYF+TCRBV29-01+TCRBJ02-03	TCRBV29-01*01	TCRBD02-01*01	TCRBJ02-03*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGGGGGACCCAATCAGCCCCAGCATTTTGGTGAT	CSVGGPNQPQHF	In	VDJ	1	27	1.9967608102411643E-4	2.3413314371439225E-4	36	TCRBV29	TCRBV29-01	01				TCRBJ01	TCRBJ01-05	01	4	0	7	3	1	1	25	35	41	36	42				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	CSVGGPNQPQHF+TCRBV29-01+TCRBJ01-05	TCRBV29-01*01		TCRBJ01-05*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTAAGGGGGGGCCCTACAATGAGCAGTTCTTCGGGCCA	CSVKGGPYNEQFF	In	VDJ	1	29	2.1446690184071765E-4	2.51476339545088E-4	39	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	5	9	0	2	2	1	25	34	43	36	44													Vb 4	CSVKGGPYNEQFF+TCRBV29-01+TCRBJ02-01	TCRBV29-01*01	TCRBD02-01*01	TCRBJ02-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAAGAAGGACAGCGTTCCTACGAGCAGTACTTCGGGCCG	CSVEEGQRSYEQYF	In	VDJ	1	29	2.1446690184071765E-4	2.51476339545088E-4	42	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	0	1	5	1	1	3	25	39	46	40	49													Vb 4	CSVEEGQRSYEQYF+TCRBV29-01+TCRBJ02-07	TCRBV29-01*01	TCRBD01-01*01	TCRBJ02-07*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGGGGGGGAGTACGACTATGGCTACACCTTCGGTTCG	CSVGGEYDYGYTF	In	VDJ	1	29	2.1446690184071765E-4	2.51476339545088E-4	39	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-02	01	4	9	1	3	0	6	25	-1	41	35	47													Vb 4	CSVGGEYDYGYTF+TCRBV29-01+TCRBJ01-02	TCRBV29-01*01	TCRBD02-01*01	TCRBJ01-02*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGCTGAAAGGCAGCTAAATGAGCAGTTCTTCGGGCCA	CSAERQLNEQFF	In	VDJ	1	30	2.2186231224901825E-4	2.6014793746043585E-4	36	TCRBV29	TCRBV29-01	01				TCRBJ02	TCRBJ02-01	01	2	4	5	7	3	3	25	37	43	40	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	CSAERQLNEQFF+TCRBV29-01+TCRBJ02-01	TCRBV29-01*01		TCRBJ02-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGGGGCCCTCTCCGGGACACCTAATGAAAAACTGTTTTTTGGCAGT	CSGALSGTPNEKLFF	In	VDJ	1	33	2.4404854347392007E-4	2.8616273120647944E-4	45	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	7	0	6	3	11	1	25	32	49	43	50													Vb 4	CSGALSGTPNEKLFF+TCRBV29-01+TCRBJ01-04	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-04*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGGTGGTGGGGTGCGGCAGAGCACAGATACGCAGTATTTTGGCCCA	CSVGGGVRQSTDTQYF	In	VDJ	1	34	2.5144395388222067E-4	2.948343291218273E-4	48	TCRBV29	TCRBV29-01	01				TCRBJ02	TCRBJ02-03	01	4	6	2	0	5	8	25	35	44	40	52				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	CSVGGGVRQSTDTQYF+TCRBV29-01+TCRBJ02-03	TCRBV29-01*01		TCRBJ02-03*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTAGGGACAGCAATCAGCCCCAGCATTTTGGTGAT	CSVRDSNQPQHF	In	VDJ	1	36	2.662347746988219E-4	3.12177524952523E-4	36	TCRBV29	TCRBV29-01	01				TCRBJ01	TCRBJ01-05	01	5	0	7	1	1	0	25	34	-1	35	40				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	CSVRDSNQPQHF+TCRBV29-01+TCRBJ01-05	TCRBV29-01*01		TCRBJ01-05*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTAGGGACAGGCAATCAGCCCCAGCATTTTGGTGAT	CSVGTGNQPQHF	In	VDJ	1	37	2.736301851071225E-4	3.208491228678709E-4	36	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	6	0	5	2	1	0	25	33	-1	34	41													Vb 4	CSVGTGNQPQHF+TCRBV29-01+TCRBJ01-05	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-05*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGATGAAGGGCCCGTTCTCTGGAAACACCATATATTTTGGAGAG		Out	VDJ	1	38	2.810255955154231E-4		43	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	1	9	0	0	0	5	25	-1	41	38	46													Vb 4	X+TCRBV29-01+TCRBJ01-03	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-03*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGCAATTAGAGGGAACACAGATACGCAGTATTTTGGCCCA	CSAIRGNTDTQYF	In	VDJ	1	39	2.884210059237237E-4	3.381923186985666E-4	39	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	7	11	0	2	6	2	25	32	43	38	45													Vb 4	CSAIRGNTDTQYF+TCRBV29-01+TCRBJ02-03	TCRBV29-01*01	TCRBD02-01*02	TCRBJ02-03*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTCCGGGACAGCAATCAGCCCCAGCATTTTGGTGAT	CSVRDSNQPQHF	In	VDJ	1	39	2.884210059237237E-4	3.381923186985666E-4	36	TCRBV29	TCRBV29-01	01				TCRBJ01	TCRBJ01-05	01	6	0	7	1	2	0	25	33	-1	35	40				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	CSVRDSNQPQHF+TCRBV29-01+TCRBJ01-05	TCRBV29-01*01		TCRBJ01-05*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTCCTACAGGGGGCATGGGTCACTGAAGCTTTCTTTGGACAA	CSVLQGAWVTEAFF	In	VDJ	1	42	3.1060723714862557E-4	3.642071124446102E-4	42	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	3	0	4	3	6	25	33	45	36	51													Vb 4	CSVLQGAWVTEAFF+TCRBV29-01+TCRBJ01-01	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTTGGATTTCGAACAGGCGTAATTTCGACGAGCAGTACTTCGGGCCG	CSVWISNRRNFDEQYF	In	VDJ	1	43	3.1800264755692617E-4	3.72878710359958E-4	48	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	3	4	5	10	10	25	34	49	44	59													Vb 4	CSVWISNRRNFDEQYF+TCRBV29-01+TCRBJ02-07	TCRBV29-01*01	TCRBD01-01*01	TCRBJ02-07*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTGACAGGGCGGTCCACAGATACGCAGTATTTTGGCCCA	CSVTGRSTDTQYF	In	VDJ	1	45	3.3279346837352736E-4	3.9022190619065377E-4	39	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	6	2	3	2	0	5	25	-1	40	33	45													Vb 4	CSVTGRSTDTQYF+TCRBV29-01+TCRBJ02-03	TCRBV29-01*01	TCRBD01-01*01	TCRBJ02-03*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTAGGGACAGGGGAGACACCGGGGAGCTGTTTTTTGGAGAA	CSVRDRGDTGELFF	In	VDJ	1	45	3.3279346837352736E-4	3.9022190619065377E-4	42	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	5	0	2	3	1	2	25	34	45	35	47													Vb 4	CSVRDRGDTGELFF+TCRBV29-01+TCRBJ02-02	TCRBV29-01*01	TCRBD01-01*01	TCRBJ02-02*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGCTGAAGCCATGGGCGGCACTGAAGCTTTCTTTGGACAA	CSAEAMGGTEAFF	In	VDJ	1	47	3.475842891901286E-4	4.0756510202134946E-4	39	TCRBV29	TCRBV29-01	01				TCRBJ01	TCRBJ01-01	01	1	8	0	4	4	2	25	38	46	42	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	CSAEAMGGTEAFF+TCRBV29-01+TCRBJ01-01	TCRBV29-01*01		TCRBJ01-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTATGGGGGGGGAAGGCACAGATACGCAGTATTTTGGCCCA	CSVMGGEGTDTQYF	In	VDJ	1	47	3.475842891901286E-4	4.0756510202134946E-4	42	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	5	9	0	1	2	4	25	34	43	36	47													Vb 4	CSVMGGEGTDTQYF+TCRBV29-01+TCRBJ02-03	TCRBV29-01*01	TCRBD02-01*01	TCRBJ02-03*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAATAGGCCGGGACAATAGCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	47	3.475842891901286E-4		44	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	2	0	6	3	6	4	25	37	49	43	53													Vb 4	X+TCRBV29-01+TCRBJ02-07	TCRBV29-01*01	TCRBD01-01*01	TCRBJ02-07*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGCCACGGGACAGGGGGGCACCGGGGAGCTGTTTTTTGGAGAA	CSATGQGGTGELFF	In	VDJ	1	49	3.623751100067298E-4	4.249082978520452E-4	42	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	7	0	1	4	4	1	25	32	47	36	48													Vb 4	CSATGQGGTGELFF+TCRBV29-01+TCRBJ02-02	TCRBV29-01*01	TCRBD01-01*01	TCRBJ02-02*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGTGTTCGTCAGTATTACCAAGAGACCCAGTACTTCGGGCCA	CSVRQYYQETQYF	In	VDJ	2	53	3.9195675163993226E-4	4.5959468951343665E-4	39	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	5	4	5	0	3	4	25	34	40	37	44													Vb 4	CSVRQYYQETQYF+TCRBV29-01+TCRBJ02-05	TCRBV29-01*01	TCRBD01-01*01	TCRBJ02-05*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGCTACCGGGACTATGCGAACACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	2	55	4.0674757245653346E-4		43	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	7	0	9	5	5	7	25	32	44	37	51						01,02							Vb 4	X+TCRBV29-01+TCRBJ02-01	TCRBV29-01*01	TCRBD02-01	TCRBJ02-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGTCTGGGTGGGCTACGAGCAGTACTTCGGGCCG	CSVVWVGYEQYF	In	VDJ	2	57	4.215383932731347E-4	4.942810811748281E-4	36	TCRBV29	TCRBV29-01	01				TCRBJ02	TCRBJ02-07	01	4	0	9	3	3	4	25	35	41	38	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	CSVVWVGYEQYF+TCRBV29-01+TCRBJ02-07	TCRBV29-01*01		TCRBJ02-07*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGCAACTAGTGGGAGTCGAGGAGGGGAAAAACTGTTTTTTGGCAGT	CSVATSGSRGGEKLFF	In	VDJ	2	58	4.289338036814353E-4	5.02952679090176E-4	48	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-04	01	4	10	0	8	17	0	25	35	-1	52	58													Vb 4	CSVATSGSRGGEKLFF+TCRBV29-01+TCRBJ01-04	TCRBV29-01*01	TCRBD02-01*02	TCRBJ01-04*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGGGGTGGAAGGCCAGGGCCAAGAGACCCAGTACTTCGGGCCA	CSGVEGQGQETQYF	In	VDJ	2	65	4.8070167653953955E-4	5.63653864497611E-4	42	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	7	4	3	1	11	0	25	32	-1	43	48													Vb 4	CSGVEGQGQETQYF+TCRBV29-01+TCRBJ02-05	TCRBV29-01*01	TCRBD01-01*01	TCRBJ02-05*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTCCGACTAGCGGGAGGGTTTCGAGCAGTACTTCGGGCCG		Out	VDJ	2	65	4.8070167653953955E-4		40	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	6	2	0	6	2	3	25	33	49	35	52													Vb 4	X+TCRBV29-01+TCRBJ02-07	TCRBV29-01*01	TCRBD02-01*02	TCRBJ02-07*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTCGGTGGGGGAGGACGAACTGAAGCTTTCTTTGGACAA	CSVGGGGRTEAFF	In	VDJ	2	73	5.398649598059444E-4	6.330266478203939E-4	39	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	6	9	1	5	6	4	25	33	45	39	49													Vb 4	CSVGGGGRTEAFF+TCRBV29-01+TCRBJ01-01	TCRBV29-01*01	TCRBD02-01*02	TCRBJ01-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTCTCGGAACGACAGTTTACCTACACCTTCGGTTCG	CSVSERQFTYTF	In	VDJ	2	73	5.398649598059444E-4	6.330266478203939E-4	36	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	2	5	10	8	5	25	33	46	41	51													Vb 4	CSVSERQFTYTF+TCRBV29-01+TCRBJ01-02	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-02*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGCTAGGGACGGGGGCAATCAGCCCCAGCATTTTGGTGAT	CSARDGGNQPQHF	In	VDJ	2	75	5.546557806225457E-4	6.503698436510896E-4	39	TCRBV29	TCRBV29-01	01				TCRBJ01	TCRBJ01-05	01	7	0	7	2	3	4	25	32	40	35	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	CSARDGGNQPQHF+TCRBV29-01+TCRBJ01-05	TCRBV29-01*01		TCRBJ01-05*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAGGAATTTAGGGGCCGCTGACTCCTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	2	75	5.546557806225457E-4		52	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	3	5	2	0	7	7	25	36	48	43	55													Vb 4	X+TCRBV29-01+TCRBJ02-01	TCRBV29-01*01	TCRBD01-01*01	TCRBJ02-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTGGGTTTCAGGGAGAACACTGAAGCTTTCTTTGGACAA	CSVGFRENTEAFF	In	VDJ	3	90	6.655869367470547E-4	7.804438123813075E-4	39	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	4	3	1	6	1	25	33	44	39	45													Vb 4	CSVGFRENTEAFF+TCRBV29-01+TCRBJ01-01	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAAGAGTTCAGCGGGAGGCCCGGGGACAATGAGCAGTTCTTCGGGCCA	CSVEEFSGRPGDNEQFF	In	VDJ	3	110	8.134951449130669E-4	9.538757706882647E-4	51	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	0	6	1	5	4	7	25	39	52	43	59													Vb 4	CSVEEFSGRPGDNEQFF+TCRBV29-01+TCRBJ02-01	TCRBV29-01*01	TCRBD02-01*02	TCRBJ02-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTCAGGGACAGGGGGTTTACCTACGAGCAGTACTTCGGGCCG	CSVRDRGFTYEQYF	In	VDJ	3	121	8.948446594043737E-4	0.0010492633477570913	42	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	0	1	2	2	4	25	33	46	35	50													Vb 4	CSVRDRGFTYEQYF+TCRBV29-01+TCRBJ02-07	TCRBV29-01*01	TCRBD01-01*01	TCRBJ02-07*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGCCCAGCGGGGGCCTAGCGGGATTTACGAGCAGTACTTCGGGCCG	CSAQRGPSGIYEQYF	In	VDJ	4	125	9.24426301037576E-4	0.0010839497394184827	45	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	7	4	3	4	12	2	25	32	53	44	55													Vb 4	CSAQRGPSGIYEQYF+TCRBV29-01+TCRBJ02-07	TCRBV29-01*01	TCRBD02-01*02	TCRBJ02-07*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTCGGACAGGGTCGAGCAATCAGCCCCAGCATTTTGGTGAT	CSVRTGSSNQPQHF	In	VDJ	4	126	9.318217114458767E-4	0.0010926213373338306	42	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	5	1	3	1	1	3	25	34	43	35	46													Vb 4	CSVRTGSSNQPQHF+TCRBV29-01+TCRBJ01-05	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-05*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAGTGGTGGCTGACAAGCTAACTATGGCTACACCTTCGGTTCG		Out	VDJ	6	210	0.0015530361857431277		46	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	2	6	0	9	2	25	36	49	45	51													Vb 4	X+TCRBV29-01+TCRBJ01-02	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-02*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGTGGTACGGGAGAGCACTGAAGCTTTCTTTGGACAA	CSVVVRESTEAFF	In	VDJ	18	616	0.004555572811513175	0.005341704315854282	39	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	4	8	2	4	5	2	25	35	46	40	48													Vb 4	CSVVVRESTEAFF+TCRBV29-01+TCRBJ01-01	TCRBV29-01*01	TCRBD02-01*02	TCRBJ01-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCAAGCCCCCAGGGCGACCCCCCTTAGGGAGCAGTTCTTCGGGCCA		Out	VDJ	26	894	0.006611496905020744		44	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	8	4	3	10	7	14	25	31	43	38	57													Vb 4	X+TCRBV29-01+TCRBJ02-01	TCRBV29-01*01	TCRBD01-01*01	TCRBJ02-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CACCAGCCAAACAGCTTTGTACTTCTGTGCCAGCAGTTTAGCCGGGAATAGCAATCAGCCCCAGCATTTTGGTGAT	CASSLAGNSNQPQHF	In	VDJ	1	21	1.5530361857431278E-4	1.821035562223051E-4	45	TCRBV22	TCRBV22-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-05	01	13	8	3	0	14	1	25	28	47	42	48														CASSLAGNSNQPQHF+TCRBV22-01+TCRBJ01-05	TCRBV22-01*01	TCRBD02-01*02	TCRBJ01-05*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCAGTTCTGGGGAGACGGACACCGGGGAGCTGTTTTTTGGAGAA	CASSSGETDTGELFF	In	VDJ	1	11	8.134951449130669E-5	9.538757706882647E-5	45	TCRBV06	unresolved		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	4	9	2	3	3	4	23	36	44	39	48		TCRBV06-05,TCRBV06-06,TCRBV06-08												CASSSGETDTGELFF+TCRBV06-X+TCRBJ02-02	unresolved	TCRBD02-01*02	TCRBJ02-02*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCTSCTCCCAGACATCTGTRTATTTCTGCGCCAGCAATGTCAGTGTGCGGAATTAACACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	11	8.134951449130669E-5		49	TCRBV10	unresolved		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	7	7	5	2	10	4	26	36	50	46	54		TCRBV10-01,TCRBV10-02				01,02								X+TCRBV10-X+TCRBJ02-02	unresolved	TCRBD02-01	TCRBJ02-02*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCTSCTCCCAGACATCTGTRTATTTCTGCGCCAGCACTAGCGGGCGGTTTCTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	11	8.134951449130669E-5		43	TCRBV10	unresolved		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	7	4	4	3	0	6	26	-1	44	36	50		TCRBV10-01,TCRBV10-02				01,02								X+TCRBV10-X+TCRBJ02-01	unresolved	TCRBD02-01	TCRBJ02-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GGACTCGGCCRTGTATSTCTGTGCCAGCATGTCTGGCTTATATGCATGAGTGAAAGACCTATGGCTACACCTTCGGTTCG		Out	VDJ	1	12	8.87449248996073E-5		55	TCRBV11	unresolved					TCRBJ01	TCRBJ01-02	01	7	2	7	4	26	0	18	28	-1	54	57		TCRBV11-01,TCRBV11-03		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV11-X+TCRBJ01-02	unresolved		TCRBJ01-02*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GGACTCGGCCCTSTATCTCTGTGCCAGCAGCCCAACCGGGACTAGCGACGAGCAGTACTTCGGGCCG	CASSPTGTSDEQYF	In	VDJ	1	12	8.87449248996073E-5	1.0405917498417433E-4	42	TCRBV05	unresolved		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	4	0	6	5	6	0	19	31	-1	37	47		TCRBV05-05,TCRBV05-06,TCRBV05-07				01,02								CASSPTGTSDEQYF+TCRBV05-X+TCRBJ02-07	unresolved	TCRBD02-01	TCRBJ02-07*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GGGGGACTYRGCTGTGTATCTCTGTGCCAGCAGCCCCCGACAGGGGGCAAACACTGAAGCTTTCTTTGGACAA	CASSPRQGANTEAFF	In	VDJ	1	12	8.87449248996073E-5	1.0405917498417433E-4	45	TCRBV07	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	2	0	2	4	1	22	34	48	38	49		TCRBV07-01,TCRBV07-04												CASSPRQGANTEAFF+TCRBV07-X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GGGSGACTYGGCTGTGTATCTCTGTGCCAGCAGCTTAAAAGGGTTGGGCGACGAGCAGTACTTCGGGCCG	CASSLKGLGDEQYF	In	VDJ	1	14	1.0353574571620853E-4	1.2140237081487006E-4	42	TCRBV07	unresolved					TCRBJ02	TCRBJ02-07	01	1	5	3	5	2	7	19	34	40	36	47		TCRBV07-01,TCRBV07-05		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLKGLGDEQYF+TCRBV07-X+TCRBJ02-07	unresolved		TCRBJ02-07*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GACTCGGCCRTGTATCKCTGTGCCAGCAGCCCGACAGGGTTGCACGGGGAGCTGTTTTTTGGAGAA	CASSPTGLHGELFF	In	VDJ	1	14	1.0353574571620853E-4	1.2140237081487006E-4	42	TCRBV07	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	5	2	3	7	2	5	18	30	39	32	44		TCRBV07-02,TCRBV07-06												CASSPTGLHGELFF+TCRBV07-X+TCRBJ02-02	unresolved	TCRBD01-01*01	TCRBJ02-02*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GGGGGACTYRGCTGTGTATCTCTGTGCCAGCAGCTTAGATTCCCACGGCTAACTATGGCTACACCTTCGGTTCG		Out	VDJ	1	14	1.0353574571620853E-4		46	TCRBV07	unresolved		TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	4	5	8	0	0	10	22	-1	38	35	48		TCRBV07-01,TCRBV07-04				01,02								X+TCRBV07-X+TCRBJ01-02	unresolved	TCRBD02-01	TCRBJ01-02*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CTCCCTCYCAGACWTCTGTWTACTTCTGTGCCAGCAGTTACTCCCGCAGGGGGGACACTGAAGCTTTCTTTGGACAA	CASSYSRRGDTEAFF	In	VDJ	1	15	1.1093115612450913E-4	1.3007396873021792E-4	45	TCRBV06	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	0	4	1	3	3	1	26	43	53	46	54		TCRBV06-05,TCRBV06-06,TCRBV06-07,TCRBV06-09												CASSYSRRGDTEAFF+TCRBV06-X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
AGGACTCSGCCGTGTATCTCTGTGCCAGCAGCCTCGGACATGGAAACACCATATATTTTGGAGAG	CASSLGHGNTIYF	In	VDJ	1	15	1.1093115612450913E-4	1.3007396873021792E-4	39	TCRBV07	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	5	1	6	3	3	0	18	30	-1	33	38		TCRBV07-02,TCRBV07-08												CASSLGHGNTIYF+TCRBV07-X+TCRBJ01-03	unresolved	TCRBD01-01*01	TCRBJ01-03*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GGRGGACTYSGCYGTGTATCTCTGTGCCAGCAGCCCTCATACAGGGACTGAGCAGTTCTTCGGGCCA	CASSPHTGTEQFF	In	VDJ	1	16	1.1832656653280974E-4	1.3874556664556577E-4	39	TCRBV07	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	3	3	9	6	2	22	34	46	40	48		TCRBV07-01,TCRBV07-08												CASSPHTGTEQFF+TCRBV07-X+TCRBJ02-01	unresolved	TCRBD01-01*01	TCRBJ02-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCAGTGGTTGGGGACTAGCGGGAGTGGGATACGAGCAGTACTTCGGGCCG	CASSGWGLAGVGYEQYF	In	VDJ	1	18	1.3311738734941096E-4	1.560887624762615E-4	51	TCRBV06	unresolved		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	5	0	2	4	5	5	23	35	54	40	59		TCRBV06-07,TCRBV06-08												CASSGWGLAGVGYEQYF+TCRBV06-X+TCRBJ02-07	unresolved	TCRBD02-01*02	TCRBJ02-07*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCAGTGACTCCTCGGGGAAAAATTATAGCAATCAGCCCCAGCATTTTGGTGAT	CASSDSSGKNYSNQPQHF	In	VDJ	1	20	1.4790820816601219E-4	1.734319583069572E-4	54	TCRBV06	unresolved		TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-05	01	0	8	3	0	2	8	23	40	47	42	55		TCRBV06-07,TCRBV06-08												CASSDSSGKNYSNQPQHF+TCRBV06-X+TCRBJ01-05	unresolved	TCRBD02-01*01	TCRBJ01-05*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GGGGGACTCRGCYGTGTATCTCTGTGCCAGCAGCCTCAAGGTCACAGATACGCAGTATTTTGGCCCA	CASSLKVTDTQYF	In	VDJ	1	20	1.4790820816601219E-4	1.734319583069572E-4	39	TCRBV07	unresolved					TCRBJ02	TCRBJ02-03	01	5	5	4	2	4	1	22	34	41	38	42		TCRBV07-02,TCRBV07-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLKVTDTQYF+TCRBV07-X+TCRBJ02-03	unresolved		TCRBJ02-03*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
TGTACCCTCYCAGACATCTGTGTACTTSTGTGCCAGCAGCCCCTGGGGGGGAGTAGGGGACTATGGCTACACCTTCGGTTCG	CASSPWGGVGDYGYTF	In	VDJ	1	20	1.4790820816601219E-4	1.734319583069572E-4	48	TCRBV06	unresolved		TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-02	01	6	9	0	3	5	8	28	39	51	44	59		TCRBV06-04,TCRBV06-08												CASSPWGGVGDYGYTF+TCRBV06-X+TCRBJ01-02	unresolved	TCRBD02-01*01	TCRBJ01-02*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CGACTCGGCYRTGTATCKCTGTGCCAGCAGCTTCTACGCAGGGGGCAACGGGGAGCTGTTTTTTGGAGAA	CASSFYAGGNGELFF	In	VDJ	1	24	1.774898497992146E-4	2.0811834996834865E-4	45	TCRBV07	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	3	4	0	7	5	2	18	32	45	37	47		TCRBV07-05,TCRBV07-06												CASSFYAGGNGELFF+TCRBV07-X+TCRBJ02-02	unresolved	TCRBD01-01*01	TCRBJ02-02*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCAGTTTCCTGACAGACCTGTAACTATGGCTACACCTTCGGTTCG		Out	VDJ	1	25	1.848852602075152E-4		46	TCRBV06	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	2	5	1	4	5	26	39	48	43	53		TCRBV06-07,TCRBV06-08												X+TCRBV06-X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCAGTTACCTTCAACAGGGTTCCTACGAGCAGTACTTCGGGCCG	CASSYLQQGSYEQYF	In	VDJ	1	26	1.9228067061581583E-4	2.254615457990444E-4	45	TCRBV06	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	2	3	3	1	5	1	26	41	52	46	53		TCRBV06-07,TCRBV06-08												CASSYLQQGSYEQYF+TCRBV06-X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCAGTTCCAGGACAGGGTTAAGTCAGCCCCAGCATTTTGGTGAT	CASSSRTGLSQPQHF	In	VDJ	1	26	1.9228067061581583E-4	2.254615457990444E-4	45	TCRBV06	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	4	1	3	6	3	5	26	39	50	42	55		TCRBV06-07,TCRBV06-08												CASSSRTGLSQPQHF+TCRBV06-X+TCRBJ01-05	unresolved	TCRBD01-01*01	TCRBJ01-05*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GGACTCGGCCRTGTATSTCTGTGCCAGCAGTTGGGCTAGCGGAGGGCTTTACAATGAGCAGTTCTTCGGGCCA	CASSWASGGLYNEQFF	In	VDJ	1	26	1.9228067061581583E-4	2.254615457990444E-4	48	TCRBV11	unresolved		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	6	4	5	4	5	7	19	30	42	35	49		TCRBV11-01,TCRBV11-03				01,02								CASSWASGGLYNEQFF+TCRBV11-X+TCRBJ02-01	unresolved	TCRBD02-01	TCRBJ02-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
TGYWCCCTCTCAGACWTCTGTKTACTTCTGTGCCAGCAGTGGGGAGGCCACAGATACGCAGTATTTTGGCCCA	CASSGEATDTQYF	In	VDJ	1	26	1.9228067061581583E-4	2.254615457990444E-4	39	TCRBV06	unresolved		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	4	9	1	2	0	1	28	-1	47	41	48		TCRBV06-04,TCRBV06-07												CASSGEATDTQYF+TCRBV06-X+TCRBJ02-03	unresolved	TCRBD02-01*02	TCRBJ02-03*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCAGTTACGCAGACAATGAGCAGTTCTTCGGGCCA	CASSYADNEQFF	In	VDJ	1	28	2.0707149143241705E-4	2.4280474162974012E-4	36	TCRBV06	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	2	4	5	5	1	0	23	38	-1	39	42		TCRBV06-05,TCRBV06-06,TCRBV06-08												CASSYADNEQFF+TCRBV06-X+TCRBJ02-01	unresolved	TCRBD01-01*01	TCRBJ02-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
TGTACCCTCYCAGACATCTGTGTACTTSTGTGCCAGCAGTGAACGGACTAGCGGGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSERTSGNTGELFF	In	VDJ	1	29	2.1446690184071765E-4	2.51476339545088E-4	48	TCRBV06	unresolved		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	2	1	5	1	1	0	23	38	-1	39	49		TCRBV06-01,TCRBV06-04,TCRBV06-08				01,02								CASSERTSGNTGELFF+TCRBV06-X+TCRBJ02-02	unresolved	TCRBD02-01	TCRBJ02-02*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GGACTCGGCCRTGTATSTCTGTGCCAGCAGCTTGGGGACAGGGGACTTCCACGAGCAGTACTTCGGGCCG	CASSLGTGDFHEQYF	In	VDJ	1	29	2.1446690184071765E-4	2.51476339545088E-4	45	TCRBV11	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	0	2	5	1	6	18	32	43	33	49		TCRBV11-01,TCRBV11-03												CASSLGTGDFHEQYF+TCRBV11-X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GGGGGACTCRGCYGTGTATCTCTGTGCCAGCAGCCCCGGGACTAGCGGGTATGAGCAGTTCTTCGGGCCA	CASSPGTSGYEQFF	In	VDJ	1	30	2.2186231224901825E-4	2.6014793746043585E-4	42	TCRBV07	unresolved		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	0	4	8	3	1	18	30	45	33	46		TCRBV07-02,TCRBV07-04				01,02								CASSPGTSGYEQFF+TCRBV07-X+TCRBJ02-01	unresolved	TCRBD02-01	TCRBJ02-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GGACTCGGCCRTGTATSTCTGTGCCAGCAGCTTCGGTAGCGGGAGATCGCATGAGCAGTTCTTCGGGCCA	CASSFGSGRSHEQFF	In	VDJ	1	35	2.588393642905213E-4	3.0350592703717514E-4	45	TCRBV11	unresolved		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	3	5	2	8	3	5	18	32	44	35	49		TCRBV11-01,TCRBV11-03												CASSFGSGRSHEQFF+TCRBV11-X+TCRBJ02-01	unresolved	TCRBD02-01*02	TCRBJ02-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCAGCACATTCGGGACAGCTCCGCAAGAGACCCAGTACTTCGGGCCA	CASSTFGTAPQETQYF	In	VDJ	1	36	2.662347746988219E-4	3.12177524952523E-4	48	TCRBV06	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	6	0	5	2	7	5	23	34	48	41	53		TCRBV06-07,TCRBV06-08												CASSTFGTAPQETQYF+TCRBV06-X+TCRBJ02-05	unresolved	TCRBD01-01*01	TCRBJ02-05*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GGACTCGGCCRTGTATSTCTGTGCCAGCAGCTTAACTACAGGTTACACCGGGGAGCTGTTTTTTGGAGAA	CASSLTTGYTGELFF	In	VDJ	1	37	2.736301851071225E-4	3.208491228678709E-4	45	TCRBV11	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	2	3	4	3	3	2	18	33	41	36	43		TCRBV11-01,TCRBV11-03												CASSLTTGYTGELFF+TCRBV11-X+TCRBJ02-02	unresolved	TCRBD01-01*01	TCRBJ02-02*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCTGGTATCAGGGGACAACTAACTATGGCTACACCTTCGGTTCG	CASWYQGTTNYGYTF	In	VDJ	1	39	2.884210059237237E-4	3.381923186985666E-4	45	TCRBV06	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	8	0	6	0	9	1	26	35	50	44	51		TCRBV06-07,TCRBV06-08												CASWYQGTTNYGYTF+TCRBV06-X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GGGGGACTCRGCYRTGTATCKCTGTGCCAGCAGCTTGGGGACGCGAACCTCCTACGAGCAGTACTTCGGGCCG	CASSLGTRTSYEQYF	In	VDJ	1	40	2.9581641633202437E-4	3.468639166139144E-4	45	TCRBV07	unresolved					TCRBJ02	TCRBJ02-07	01	3	0	7	0	1	6	22	36	42	37	48		TCRBV07-04,TCRBV07-06		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLGTRTSYEQYF+TCRBV07-X+TCRBJ02-07	unresolved		TCRBJ02-07*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GGGGGACTCRGCYRTGTATCKCTGTGCCAGCAGCTTAATGGCGGAGTCGGCCGGGGAGCTGTTTTTTGGAGAA	CASSLMAESAGELFF	In	VDJ	1	42	3.1060723714862557E-4	3.642071124446102E-4	45	TCRBV07	unresolved		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	2	7	5	6	3	6	22	37	44	40	50		TCRBV07-04,TCRBV07-06				01,02								CASSLMAESAGELFF+TCRBV07-X+TCRBJ02-02	unresolved	TCRBD02-01	TCRBJ02-02*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCAGTTTAACACAGGGGGCAGTGACAGATACGCAGTATTTTGGCCCA	CASSLTQGAVTDTQYF	In	VDJ	1	47	3.475842891901286E-4	4.0756510202134946E-4	48	TCRBV06	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	4	3	0	3	4	4	23	36	49	40	53		TCRBV06-07,TCRBV06-08												CASSLTQGAVTDTQYF+TCRBV06-X+TCRBJ02-03	unresolved	TCRBD01-01*01	TCRBJ02-03*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GGACTCGGCCCTSTATCTCTGTGCCAGCAGCGGAGGCTACCGGGACAGTTTTGAGACCCAGTACTTCGGGCCA	CASSGGYRDSFETQYF	In	VDJ	1	50	3.697705204150304E-4	4.3357989576739306E-4	48	TCRBV05	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	4	0	5	5	10	4	19	31	48	41	52		TCRBV05-05,TCRBV05-06,TCRBV05-07												CASSGGYRDSFETQYF+TCRBV05-X+TCRBJ02-05	unresolved	TCRBD01-01*01	TCRBJ02-05*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GGACTCRGCCRTGTATCKCTGTGCCAGCAGCTTAGTGTGGCGGGATCCAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	51	3.7716593082333106E-4		46	TCRBV07	unresolved		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	1	7	3	1	4	1	19	35	45	39	46		TCRBV07-02,TCRBV07-07												X+TCRBV07-X+TCRBJ02-05	unresolved	TCRBD02-01*02	TCRBJ02-05*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
AGGACTCSGCCGTGTATCTCTGTGCCAGCAGACCCGGTTACTCCTACGAGCAGTACTTCGGGCCG	CASRPGYSYEQYF	In	VDJ	2	57	4.215383932731347E-4	4.942810811748281E-4	39	TCRBV07	unresolved		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	6	8	5	0	3	3	18	29	35	32	38		TCRBV07-02,TCRBV07-08				01,02								CASRPGYSYEQYF+TCRBV07-X+TCRBJ02-07	unresolved	TCRBD02-01	TCRBJ02-07*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
AGGACTCSGCCGTGTATCTCTGTGCCAGCAGCTTCTACCCGGGCACTGAAGCTTTCTTTGGACAA	CASSFYPGTEAFF	In	VDJ	2	60	4.437246244980365E-4	5.202958749208717E-4	39	TCRBV07	unresolved		TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	3	8	4	4	5	0	18	32	-1	37	41		TCRBV07-02,TCRBV07-08				01,02								CASSFYPGTEAFF+TCRBV07-X+TCRBJ01-01	unresolved	TCRBD02-01	TCRBJ01-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CGACTCGGCYRTGTATCKCTGTGCTAGCAGCTCTCAGGGGACGGACAGGGGGTTCCCAGATACGCAGTATTTTGGCCCA	CASSSQGTDRGFPDTQYF	In	VDJ	2	73	5.398649598059444E-4	6.330266478203939E-4	54	TCRBV07	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	3	1	1	4	10	4	19	32	52	42	56		TCRBV07-05,TCRBV07-06												CASSSQGTDRGFPDTQYF+TCRBV07-X+TCRBJ02-03	unresolved	TCRBD01-01*01	TCRBJ02-03*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCAGTGAACCCCGGGACTAGCGGGTCTATGAGCAGTTCTTCGGGCCA	CASSEPRD*RVYEQFF	Stop	VDJ	2	78	5.768420118474474E-4		48	TCRBV06	unresolved		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	0	4	8	7	3	26	38	57	45	60		TCRBV06-01,TCRBV06-07,TCRBV06-08				01,02								CASSEPRD*RVYEQFF+TCRBV06-X+TCRBJ02-01	unresolved	TCRBD02-01	TCRBJ02-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCTSCTCCCAGACATCTGTRTATTTCTGCGCCAGCAGTGAATTCAGGCAGCTCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	10	331	0.0024478808451475014		43	TCRBV10	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	4	4	0	3	3	26	40	47	43	50		TCRBV10-01,TCRBV10-02												X+TCRBV10-X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GGGGGACTYGGCYGTGTATCTCTGTGCCAGCAGCCTAAAGAGATCCTACGAGCAGTACTTCGGGCCG	CASSLKRSYEQYF	In	VDJ	15	529	0.003912172105991022	0.0045872752972190185	39	TCRBV07	unresolved		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	5	4	9	1	0	6	22	-1	37	34	43		TCRBV07-01,TCRBV07-02				01,02								CASSLKRSYEQYF+TCRBV07-X+TCRBJ02-07	unresolved	TCRBD02-01	TCRBJ02-07*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAACTGGACACCTAATGCGGGGGAGCAGTACTTCGGGCCG	CASNWTPNAGEQYF	In	VDJ	1	17	1.2572197694111034E-4	1.4741716456091364E-4	42	TCRBV02	TCRBV02-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	7	7	3	7	14	0	23	33	-1	47	53													Vb 22	CASNWTPNAGEQYF+TCRBV02-01+TCRBJ02-07	TCRBV02-01*01	TCRBD02-01*01	TCRBJ02-07*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGTGTGATAGGGGAGGAGACCCAGTACTTCGGGCCA	CASSVIGEETQYF	In	VDJ	1	21	1.5530361857431278E-4	1.821035562223051E-4	39	TCRBV02	TCRBV02-01	01				TCRBJ02	TCRBJ02-05	01	4	5	2	5	4	2	23	36	45	40	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 22	CASSVIGEETQYF+TCRBV02-01+TCRBJ02-05	TCRBV02-01*01		TCRBJ02-05*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGCGGGGGGACAATTGGGAATGAAAAACTGTTTTTTGGCAGT	CASSGGTIGNEKLFF	In	VDJ	1	22	1.6269902898261338E-4	1.9077515413765293E-4	45	TCRBV02	TCRBV02-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-04	01	6	8	1	5	0	9	23	-1	41	34	50													Vb 22	CASSGGTIGNEKLFF+TCRBV02-01+TCRBJ01-04	TCRBV02-01*01	TCRBD02-01*01	TCRBJ01-04*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGTACAGCGAATAATGAAAAACTGTTTTTTGGCAGT	CASTANNEKLFF	In	VDJ	1	23	1.70094439390914E-4	1.994467520530008E-4	36	TCRBV02	TCRBV02-01	01				TCRBJ01	TCRBJ01-04	01	9	3	5	4	1	4	23	31	36	32	40				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 22	CASTANNEKLFF+TCRBV02-01+TCRBJ01-04	TCRBV02-01*01		TCRBJ01-04*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGCCTGGGACAGGCCACCTCCTACGAGCAGTACTTCGGGCCG	CASSLGQATSYEQYF	In	VDJ	1	25	1.848852602075152E-4	2.1678994788369653E-4	45	TCRBV02	TCRBV02-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	0	4	0	3	4	23	34	45	37	49													Vb 22	CASSLGQATSYEQYF+TCRBV02-01+TCRBJ02-07	TCRBV02-01*01	TCRBD01-01*01	TCRBJ02-07*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGGCAGGGGAGGACTGACGAGCAGTACTTCGGGCCG	CASRQGRTDEQYF	In	VDJ	1	29	2.1446690184071765E-4	2.51476339545088E-4	39	TCRBV02	TCRBV02-01	01				TCRBJ02	TCRBJ02-07	01	6	4	2	5	1	7	23	34	41	35	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 22	CASRQGRTDEQYF+TCRBV02-01+TCRBJ02-07	TCRBV02-01*01		TCRBJ02-07*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAAGGTAGCGGCACTCGGGAGCTACGAGCAGTACTTCGGGCCG	CASKVAALGSYEQYF	In	VDJ	1	35	2.588393642905213E-4	3.0350592703717514E-4	45	TCRBV02	TCRBV02-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	7	5	5	3	3	10	23	33	42	36	52						01,02							Vb 22	CASKVAALGSYEQYF+TCRBV02-01+TCRBJ02-07	TCRBV02-01*01	TCRBD02-01	TCRBJ02-07*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
TGTACCCTCTCAGACATCTGTGTACTTCTGTGCCAGCATACCGCAGTTAGTACTCTAAATAGCAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	11	8.134951449130669E-5		53	TCRBV06	TCRBV06-04					TCRBJ01	TCRBJ01-05	01	7	4	5	0	5	13	28	38	46	43	59			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV06-04+TCRBJ01-05	TCRBV06-04		TCRBJ01-05*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCAGTGGAATCGGTCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	12	8.87449248996073E-5		40	TCRBV06	TCRBV06-07	01				TCRBJ02	TCRBJ02-03	01	5	1	8	2	0	6	26	-1	41	38	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV06-07+TCRBJ02-03	TCRBV06-07*01		TCRBJ02-03*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCAGTTACTCGAGGGACAGGGGGGGCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	12	8.87449248996073E-5		47	TCRBV06	TCRBV06-07	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	0	0	1	7	2	2	26	43	56	45	58														X+TCRBV06-07+TCRBJ01-05	TCRBV06-07*01	TCRBD01-01*01	TCRBJ01-05*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCAGTGAAGAAGTAGCTAACTACAATGAGCAGTTCTTCGGGCCA	CASSEEVANYNEQFF	In	VDJ	1	13	9.614033530790792E-5	1.127307728995222E-4	45	TCRBV06	TCRBV06-07	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	5	7	3	7	3	26	38	49	45	52						01,02								CASSEEVANYNEQFF+TCRBV06-07+TCRBJ02-01	TCRBV06-07*01	TCRBD02-01	TCRBJ02-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCAGTTAACCCCCGGGACTTCGGCTATGGCTACACCTTCGGTTCG		Out	VDJ	1	13	9.614033530790792E-5		46	TCRBV06	TCRBV06-07	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	3	0	10	4	6	4	26	40	52	46	56						01,02								X+TCRBV06-07+TCRBJ01-02	TCRBV06-07*01	TCRBD02-01	TCRBJ01-02*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCACCTTGACAGGGCTCGGGGAGCTGTTTTTTGGAGAA	CASTLTGLGELFF	In	VDJ	1	14	1.0353574571620853E-4	1.2140237081487006E-4	39	TCRBV06	TCRBV06-07	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	7	2	3	7	4	2	26	36	47	40	49														CASTLTGLGELFF+TCRBV06-07+TCRBJ02-02	TCRBV06-07*01	TCRBD01-01*01	TCRBJ02-02*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCAGTACACTAGCGGGAGGGCCTCATGACGAGCAGTACTTCGGGCCG	CASSTLAGGPHDEQYF	In	VDJ	1	17	1.2572197694111034E-4	1.4741716456091364E-4	48	TCRBV06	TCRBV06-07	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	5	3	0	5	2	7	26	38	53	40	60														CASSTLAGGPHDEQYF+TCRBV06-07+TCRBJ02-07	TCRBV06-07*01	TCRBD02-01*02	TCRBJ02-07*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCAGTTCAAGAAGACGTCCCGACTGGGGCTACACCTTCGGTTCG	CASSSRRRPDWGYTF	In	VDJ	1	17	1.2572197694111034E-4	1.4741716456091364E-4	45	TCRBV06	TCRBV06-07	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	4	2	10	8	14	2	26	39	57	53	59						01,02								CASSSRRRPDWGYTF+TCRBV06-07+TCRBJ01-02	TCRBV06-07*01	TCRBD02-01	TCRBJ01-02*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCAGTCCTGCCCGGGATAGCTCCAATGAGCAGTTTTTCGGGCCA	CASSPARDSSNEQFF	In	VDJ	1	19	1.4051279775771156E-4	1.6476036039160937E-4	45	TCRBV06	TCRBV06-07	01	TCRBD02	TCRBD02-01	02	TCRBJ02			5	8	3	19	6	19	26	38	49	44	68								TCRBJ02-01,TCRBJ02-05						CASSPARDSSNEQFF+TCRBV06-07+TCRBJ02-X	TCRBV06-07*01	TCRBD02-01*02	TCRBJ02	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCAGTTACTCGGGCTCTGGAAACACCATATATTTTGGAGAG	CASSYSGSGNTIYF	In	VDJ	1	19	1.4051279775771156E-4	1.6476036039160937E-4	42	TCRBV06	TCRBV06-07	01				TCRBJ01	TCRBJ01-03	01	0	0	9	0	0	0	26	-1	-1	43	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYSGSGNTIYF+TCRBV06-07+TCRBJ01-03	TCRBV06-07*01		TCRBJ01-03*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCAGTGGCCGGGACCCTGCCGAGCCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	23	1.70094439390914E-4		47	TCRBV06	TCRBV06-07	01				TCRBJ02	TCRBJ02-02	01	5	0	7	6	4	9	26	38	47	42	56				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV06-07+TCRBJ02-02	TCRBV06-07*01		TCRBJ02-02*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCAGTTACCGCATGGGAGAGACCCAGTACTTCGGGCCA	CASSYRMGETQYF	In	VDJ	1	29	2.1446690184071765E-4	2.51476339545088E-4	39	TCRBV06	TCRBV06-07	01				TCRBJ02	TCRBJ02-05	01	2	0	9	4	5	0	26	41	-1	46	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYRMGETQYF+TCRBV06-07+TCRBJ02-05	TCRBV06-07*01		TCRBJ02-05*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCAGCCGACCGGGATCCCGCACCCAGTACTTCGGGCCA	CASSRPGSRTQYF	In	VDJ	1	32	2.3665313306561948E-4	2.7749113329113154E-4	39	TCRBV06	TCRBV06-07	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	6	8	3	8	5	6	26	37	47	42	53														CASSRPGSRTQYF+TCRBV06-07+TCRBJ02-05	TCRBV06-07*01	TCRBD02-01*02	TCRBJ02-05*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCAGTTACTCCGCCACTCTGGAAACACCATATATTTTGGAGAG		Out	VDJ	2	54	3.9935216204823286E-4		44	TCRBV06	TCRBV06-07	01				TCRBJ01	TCRBJ01-03	01	0	4	6	0	3	0	26	43	-1	46	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV06-07+TCRBJ01-03	TCRBV06-07*01		TCRBJ01-03*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCAGTTTTTCGAGATATATCTAGCCAAAAACATTCAGTACTTCGGCGCC		Out	VDJ	2	56	4.141429828648341E-4		50	TCRBV06	TCRBV06-07	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-04	01	4	11	2	0	4	8	26	39	46	43	54														X+TCRBV06-07+TCRBJ02-04	TCRBV06-07*01	TCRBD02-01*02	TCRBJ02-04*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCAGCAGGGGGCTGGCTAATGAAAAACTGTTTTTTGGCAGT	CASSRGLANEKLFF	In	VDJ	2	58	4.289338036814353E-4	5.02952679090176E-4	42	TCRBV06	TCRBV06-07	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	6	4	0	3	0	3	26	-1	45	37	48														CASSRGLANEKLFF+TCRBV06-07+TCRBJ01-04	TCRBV06-07*01	TCRBD01-01*01	TCRBJ01-04*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCAGTACAAGGACAGGGGTGAGGAGAGACCCAGTACTTCGGGCCA		Out	VDJ	7	247	0.0018266663708502503		46	TCRBV06	TCRBV06-07	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	5	1	2	4	4	5	26	38	51	42	56														X+TCRBV06-07+TCRBJ02-05	TCRBV06-07*01	TCRBD01-01*01	TCRBJ02-05*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GGACTCAGCCATGTATCGCTGTGCCAGCAGCTTATCTTTGCGGGGTAATGAAAAACTGTTTTTTGGCAGT	CASSLSLRGNEKLFF	In	VDJ	1	11	8.134951449130669E-5	9.538757706882647E-5	45	TCRBV07	TCRBV07-07	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-04	01	2	7	3	4	5	0	19	34	-1	39	45														CASSLSLRGNEKLFF+TCRBV07-07+TCRBJ01-04	TCRBV07-07*01	TCRBD02-01*01	TCRBJ01-04*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GGACTCAGCCATGTATCGCTGTGCCAGCAGCCCCCGGCAGGGCTCCTACGAGCAGTACTTCGGGCCG	CASSPRQGSYEQYF	In	VDJ	1	13	9.614033530790792E-5	1.127307728995222E-4	42	TCRBV07	TCRBV07-07	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	4	3	0	6	0	19	31	-1	37	42														CASSPRQGSYEQYF+TCRBV07-07+TCRBJ02-07	TCRBV07-07*01	TCRBD01-01*01	TCRBJ02-07*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GGACTCAGCCATGTATCGCTGTGCCAGCAGCCCGATTGGGACAGCCATGAACACTGAAGCTTTCTTTGGACAA	CASSPIGTAMNTEAFF	In	VDJ	1	13	9.614033530790792E-5	1.127307728995222E-4	48	TCRBV07	TCRBV07-07	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	0	5	0	6	3	19	31	44	37	47														CASSPIGTAMNTEAFF+TCRBV07-07+TCRBJ01-01	TCRBV07-07*01	TCRBD01-01*01	TCRBJ01-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GGACTCAGCCATGTATCGCTGTGCCAGCAGCTCCTCCTATGGGGCTAGCGGGAGGCTTAGCACAGATACGCAGTATTTTGGCCCA	CASSSSYGASGRLSTDTQYF	In	VDJ	1	15	1.1093115612450913E-4	1.3007396873021792E-4	60	TCRBV07	TCRBV07-07	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	4	4	1	0	12	3	19	32	55	44	58														CASSSSYGASGRLSTDTQYF+TCRBV07-07+TCRBJ02-03	TCRBV07-07*01	TCRBD02-01*02	TCRBJ02-03*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GGACTCAGCCATGTATCGCTGTGCCAGCAACTTCCCTGGGTGGGGACTCCTACTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	17	1.2572197694111034E-4		52	TCRBV07	TCRBV07-07	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	3	0	10	3	9	4	19	33	48	42	52						01,02								X+TCRBV07-07+TCRBJ02-01	TCRBV07-07*01	TCRBD02-01	TCRBJ02-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GGACTCAGCCATGTATCGCTGTGCCAGCAGCCCCCCCCCAGGGACTAATGAGCAGTTCTTCGGGCCA	CASSPPPGTNEQFF	In	VDJ	1	19	1.4051279775771156E-4	1.6476036039160937E-4	42	TCRBV07	TCRBV07-07	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	0	10	7	9	0	19	31	-1	40	46						01,02								CASSPPPGTNEQFF+TCRBV07-07+TCRBJ02-01	TCRBV07-07*01	TCRBD02-01	TCRBJ02-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GGACTCAGCCATGTATCGCTGTGCCAGCAGCTACTCGACAGGCAGGAAGACCCAGTACTTCGGGCCA	CASSYSTGRKTQYF	In	VDJ	1	19	1.4051279775771156E-4	1.6476036039160937E-4	42	TCRBV07	TCRBV07-07	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	4	2	4	6	4	5	19	32	42	36	47														CASSYSTGRKTQYF+TCRBV07-07+TCRBJ02-05	TCRBV07-07*01	TCRBD01-01*01	TCRBJ02-05*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CGAAGCTTGAGGATTCAGCAGTGTATTTTTGTGCCAGCAGCCCTCCGGGACAGCCTAATGAAAAACTGTTTTTTGGCAGT	CASSPPGQPNEKLFF	In	VDJ	5	187	0.001382941746352214	0.00162158881017005	45	TCRBV16	TCRBV16-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	4	0	5	3	4	1	29	42	53	46	54			01,02											CASSPPGQPNEKLFF+TCRBV16-01+TCRBJ01-04	TCRBV16-01	TCRBD01-01*01	TCRBJ01-04*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCCAAGTCACGCTCGGGGTGGACCTCTATGGCTACACCTTCGGTTCG	CASSQVTLGVDLYGYTF	In	VDJ	1	16	1.1832656653280974E-4	1.3874556664556577E-4	51	TCRBV04	TCRBV04-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-02	01	1	8	3	4	7	7	23	39	51	46	58													Vb 7.1	CASSQVTLGVDLYGYTF+TCRBV04-01+TCRBJ01-02	TCRBV04-01*01	TCRBD02-01*01	TCRBJ01-02*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCCAGTCGGGACAGGGTGACCAGTTCTTCGGGCCA	CASSQSGQGDQFF	In	VDJ	1	21	1.5530361857431278E-4	1.821035562223051E-4	39	TCRBV04	TCRBV04-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	3	0	3	13	3	4	23	37	49	40	53													Vb 7.1	CASSQSGQGDQFF+TCRBV04-01+TCRBJ02-01	TCRBV04-01*01	TCRBD01-01*01	TCRBJ02-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CRRRRGACTCAGCCSTGTATCTCTRCGCCAGCAGCCAACCCCGAGACCCGTCAGGATACGCAGTATTTTGGCCCA		Out	VDJ	1	22	1.6269902898261338E-4		46	TCRBV04	TCRBV04-01	01				TCRBJ02	TCRBJ02-03	01	2	2	7	6	6	7	22	37	46	43	53				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 7.1	X+TCRBV04-01+TCRBJ02-03	TCRBV04-01*01		TCRBJ02-03*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GAGGGACTCAGCCGTGTATCTCTACGCCAGCAGCCAAGGGGGTTCCACAGGGCTAAGGTCTGGAAACACCATATATTTTGGAGAG	YASSQGGSTGLRSGNTIYF	In	VDJ	1	23	1.70094439390914E-4	1.994467520530008E-4	57	TCRBV04	TCRBV04-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	1	3	3	1	8	6	22	38	52	46	58													Vb 7.1	YASSQGGSTGLRSGNTIYF+TCRBV04-01+TCRBJ01-03	TCRBV04-01*01	TCRBD01-01*01	TCRBJ01-03*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GAGGGACTCAGCCGTGTATCTCTACGCCAGCAGCCAAGATCCGGCCCGCGGGGACACCATATATTTTGGAGAG	YASSQDPARGDTIYF	In	VDJ	1	24	1.774898497992146E-4	2.0811834996834865E-4	45	TCRBV04	TCRBV04-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-03	01	0	7	3	8	8	0	22	39	-1	47	53													Vb 7.1	YASSQDPARGDTIYF+TCRBV04-01+TCRBJ01-03	TCRBV04-01*01	TCRBD02-01*01	TCRBJ01-03*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCCAAACTGACAGGGGCCCTGAAGCTTTCTTTGGACAA	CASSQTDRGPEAFF	In	VDJ	1	26	1.9228067061581583E-4	2.254615457990444E-4	42	TCRBV04	TCRBV04-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	2	2	6	3	2	23	38	49	41	51													Vb 7.1	CASSQTDRGPEAFF+TCRBV04-01+TCRBJ01-01	TCRBV04-01*01	TCRBD01-01*01	TCRBJ01-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GAGGGACTCAGCCGTGTATCTCTACGCCAGCAGCCAAGAGGGGCGGGAGGGCGCAGATACGCAGTATTTTGGCCCA	YASSQEGREGADTQYF	In	VDJ	1	26	1.9228067061581583E-4	2.254615457990444E-4	48	TCRBV04	TCRBV04-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	0	7	0	4	3	2	22	39	51	42	53													Vb 7.1	YASSQEGREGADTQYF+TCRBV04-01+TCRBJ02-03	TCRBV04-01*01	TCRBD02-01*02	TCRBJ02-03*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GAGGGACTCAGCCGTGTATCTCTACGCCAGCAGCCAAGATGAGGGGAGCCCACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	32	2.3665313306561948E-4		46	TCRBV04	TCRBV04-01	01				TCRBJ02	TCRBJ02-01	01	0	5	2	5	2	5	22	39	46	41	51				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 7.1	X+TCRBV04-01+TCRBJ02-01	TCRBV04-01*01		TCRBJ02-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCCTAACGGACACCTATAGCAATCAGCCCCAGCATTTTGGTGAT	CASSLTDTYSNQPQHF	In	VDJ	1	35	2.588393642905213E-4	3.0350592703717514E-4	48	TCRBV04	TCRBV04-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	4	1	6	0	4	4	23	36	45	40	49													Vb 7.1	CASSLTDTYSNQPQHF+TCRBV04-01+TCRBJ01-05	TCRBV04-01*01	TCRBD01-01*01	TCRBJ01-05*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCGAAGATGCGGCAGGGCGTTATGGCTACACCTTCGGTTCG	CASSEDAAGRYGYTF	In	VDJ	1	35	2.588393642905213E-4	3.0350592703717514E-4	45	TCRBV04	TCRBV04-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	4	3	5	5	3	23	40	50	45	53													Vb 7.1	CASSEDAAGRYGYTF+TCRBV04-01+TCRBJ01-02	TCRBV04-01*01	TCRBD01-01*01	TCRBJ01-02*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCCAAAGAGCGGGAGCGGGCACAGATACGCAGTATTTTGGCCCA	CASSQRAGAGTDTQYF	In	VDJ	1	50	3.697705204150304E-4	4.3357989576739306E-4	48	TCRBV04	TCRBV04-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	2	6	2	1	2	3	23	38	48	40	51													Vb 7.1	CASSQRAGAGTDTQYF+TCRBV04-01+TCRBJ02-03	TCRBV04-01*01	TCRBD02-01*02	TCRBJ02-03*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCCAAGGTCGGGCAGGAAGATTGAACACTGAAGCTTTCTTTGGACAA	CASSQGRAGRLNTEAFF	In	VDJ	2	53	3.9195675163993226E-4	4.5959468951343665E-4	51	TCRBV04	TCRBV04-01	01				TCRBJ01	TCRBJ01-01	01	1	4	4	0	6	5	23	39	49	45	54				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 7.1	CASSQGRAGRLNTEAFF+TCRBV04-01+TCRBJ01-01	TCRBV04-01*01		TCRBJ01-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCCAAGACTCTAGGGTAAAAACCGGGGAGCTGTTTTTTGGAGAA	CASSQDSRVKTGELFF	In	VDJ	2	59	4.363292140897359E-4	5.116242770055238E-4	48	TCRBV04	TCRBV04-01	01				TCRBJ02	TCRBJ02-02	01	0	5	3	5	4	5	23	40	48	44	53				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 7.1	CASSQDSRVKTGELFF+TCRBV04-01+TCRBJ02-02	TCRBV04-01*01		TCRBJ02-02*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCCTAGACCGGGACTACCCAGAGACCCAGTACTTCGGGCCA	CASSLDRDYPETQYF	In	VDJ	2	63	4.6591085572293835E-4	5.463106686669153E-4	45	TCRBV04	TCRBV04-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	0	0	9	4	2	3	23	40	49	42	52						01,02							Vb 7.1	CASSLDRDYPETQYF+TCRBV04-01+TCRBJ02-05	TCRBV04-01*01	TCRBD02-01	TCRBJ02-05*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCCCTGGGCTAGGGGGTATTTCCTACGAGCAGTACTTCGGGCCG	CASSPGLGGISYEQYF	In	VDJ	2	77	5.694466014391469E-4	6.677130394817853E-4	48	TCRBV04	TCRBV04-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	5	1	1	7	4	23	36	49	43	53													Vb 7.1	CASSPGLGGISYEQYF+TCRBV04-01+TCRBJ02-07	TCRBV04-01*01	TCRBD01-01*01	TCRBJ02-07*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CRRRRGACTCAGCCSTGTATCTCTRCGCCAGCAGCCAAGGGAGGCTAGCGGGAAACATTCAGTACTTCGGCGCC	XASSQGRLAGNIQYF	In	VDJ	2	82	6.064236534806499E-4	7.110710290585247E-4	45	TCRBV04	TCRBV04-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-04	01	1	4	4	6	5	0	22	38	-1	43	51						01,02							Vb 7.1	XASSQGRLAGNIQYF+TCRBV04-01+TCRBJ02-04	TCRBV04-01*01	TCRBD02-01	TCRBJ02-04*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCCTCGGGATCGCCCCTTACAATGAGCAGTTCTTCGGGCCA	CASSLGIAPYNEQFF	In	VDJ	4	151	0.001116706971653392	0.001309411285217527	45	TCRBV04	TCRBV04-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	4	8	3	4	1	8	23	36	42	37	50													Vb 7.1	CASSLGIAPYNEQFF+TCRBV04-01+TCRBJ02-01	TCRBV04-01*01	TCRBD02-01*02	TCRBJ02-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCTCCTCCCAGACATCTGTATATTTCTGCGCCAGCAGGGCTAGCCGACGAGATACGCAGTATTTTGGCCCA	CASRASRRDTQYF	In	VDJ	1	15	1.1093115612450913E-4	1.3007396873021792E-4	39	TCRBV10	TCRBV10-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	6	4	7	5	2	5	26	37	44	39	49			01,02			01,02							Vb 12	CASRASRRDTQYF+TCRBV10-01+TCRBJ02-03	TCRBV10-01	TCRBD02-01	TCRBJ02-03*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCTCCTCCCAGACATCTGTATATTTCTGCGCCAGCAGCGTCTCCGGGACAGGGCGTTCTGAAGCTTTCTTTGGACAA	CASSVSGTGRSEAFF	In	VDJ	1	16	1.1832656653280974E-4	1.3874556664556577E-4	45	TCRBV10	TCRBV10-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	0	3	6	7	4	26	37	53	44	57			01,02										Vb 12	CASSVSGTGRSEAFF+TCRBV10-01+TCRBJ01-01	TCRBV10-01	TCRBD01-01*01	TCRBJ01-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCTCCTCCCAGACATCTGTATATTTCTGCGCCAGCAGTGAGTCGTTAGGATTGGAGGGGGGAACTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	27	1.9967608102411643E-4		53	TCRBV10	TCRBV10-01					TCRBJ02	TCRBJ02-07	01	0	5	1	3	11	3	26	43	60	54	63			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 12	X+TCRBV10-01+TCRBJ02-07	TCRBV10-01		TCRBJ02-07*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCTCCTCCCAGACATCTGTATATTTCTGCGCCAGCATCGGCTAGCGGGAGTATGAGGCCGGGGAGCTGTTTTTTGGAGAA	CASIG*REYEAGELFF	Stop	VDJ	1	30	2.2186231224901825E-4		48	TCRBV10	TCRBV10-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	7	4	2	6	4	7	26	36	50	40	57			01,02										Vb 12	CASIG*REYEAGELFF+TCRBV10-01+TCRBJ02-02	TCRBV10-01	TCRBD02-01*02	TCRBJ02-02*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCTCCTCCCAGACATCTGTATATTTCTGCGCCAGCAGTGAGTCTTTGGGACAGGGTGTACATCGGGAGCTGTTTTTTGGAGAA	CASSESLGQGVHRELFF	In	VDJ	1	43	3.1800264755692617E-4	3.72878710359958E-4	51	TCRBV10	TCRBV10-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	0	0	3	9	3	8	26	43	55	46	63			01,02										Vb 12	CASSESLGQGVHRELFF+TCRBV10-01+TCRBJ02-02	TCRBV10-01	TCRBD01-01*01	TCRBJ02-02*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
AGGGGACTCAGCCCTGTATCTCTGTGCCAGCAAAAATTACCCCCCTGGCGAGCAGTACTTCGGGCCA	CASKNYPPGEQYF	In	VDJ	1	17	1.2572197694111034E-4	1.4741716456091364E-4	39	TCRBV05	TCRBV05-02	01				TCRBJ02	TCRBJ02-05	01	5	9	0	11	13	3	22	33	49	46	52				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASKNYPPGEQYF+TCRBV05-02+TCRBJ02-05	TCRBV05-02*01		TCRBJ02-05*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
AGGACTCGGCCCTGTATCTCTGTGCCAGCAGAGCCAGGGATCGCGATGGCTACACCTTCGGTTCG	CASRARDRDGYTF	In	VDJ	1	16	1.1832656653280974E-4	1.3874556664556577E-4	39	TCRBV05	TCRBV05-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	4	3	6	3	6	20	31	39	34	45														CASRARDRDGYTF+TCRBV05-08+TCRBJ01-02	TCRBV05-08*01	TCRBD01-01*01	TCRBJ01-02*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GGGGGACTTGGCTGTGTATCTCTGTGCCAGCAGCCCGCATGGGCGAGAGACCCAGTACTTCGGGCCA	CASSPHGRETQYF	In	VDJ	1	43	3.1800264755692617E-4	3.72878710359958E-4	39	TCRBV07	TCRBV07-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	5	8	0	4	6	1	22	34	44	40	45														CASSPHGRETQYF+TCRBV07-01+TCRBJ02-05	TCRBV07-01*01	TCRBD01-01*01	TCRBJ02-05*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGGACCGGGACAGTGGACTAGTTTGACAATGAGCAGTTCTTCGGGCCA	CASRTGTVD*FDNEQFF	Stop	VDJ	1	12	8.87449248996073E-5		51	TCRBV10	TCRBV10-02	01				TCRBJ02	TCRBJ02-01	01	6	0	5	5	4	12	23	34	45	38	57				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 12	CASRTGTVD*FDNEQFF+TCRBV10-02+TCRBJ02-01	TCRBV10-02*01		TCRBJ02-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTCTAGGGAACACTGAAGCTTTCTTTGGACAA	CASSLGNTEAFF	In	VDJ	1	18	1.3311738734941096E-4	1.560887624762615E-4	36	TCRBV10	TCRBV10-02	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	5	4	8	1	0	1	23	-1	39	35	40						01,02							Vb 12	CASSLGNTEAFF+TCRBV10-02+TCRBJ01-01	TCRBV10-02*01	TCRBD02-01	TCRBJ01-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTGCAAGCCGCGAAGGGACCCAGTACTTCGGGCCA	CASSASREGTQYF	In	VDJ	1	19	1.4051279775771156E-4	1.6476036039160937E-4	39	TCRBV10	TCRBV10-02	01				TCRBJ02	TCRBJ02-05	01	4	5	4	7	10	0	23	36	-1	46	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 12	CASSASREGTQYF+TCRBV10-02+TCRBJ02-05	TCRBV10-02*01		TCRBJ02-05*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGCACATCATATAGCAATCAGCCCCAGCATTTTGGTGAT	CASSTSYSNQPQHF	In	VDJ	1	20	1.4790820816601219E-4	1.734319583069572E-4	42	TCRBV10	TCRBV10-02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	6	3	6	0	1	5	23	34	38	35	43													Vb 12	CASSTSYSNQPQHF+TCRBV10-02+TCRBJ01-05	TCRBV10-02*01	TCRBD01-01*01	TCRBJ01-05*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCACTACTGTTCCAGGGGGCACAACGAGCAGTACTTCGGGCCG		Out	VDJ	1	23	1.70094439390914E-4		44	TCRBV10	TCRBV10-02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	7	4	0	5	9	3	23	33	50	42	53													Vb 12	X+TCRBV10-02+TCRBJ02-07	TCRBV10-02*01	TCRBD01-01*01	TCRBJ02-07*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGCCCAGGGGGCAGCAATCAGCCCCAGCATTTTGGTGAT	CASSPGGSNQPQHF	In	VDJ	1	25	1.848852602075152E-4	2.1678994788369653E-4	42	TCRBV10	TCRBV10-02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	6	4	0	1	2	0	23	34	-1	36	44													Vb 12	CASSPGGSNQPQHF+TCRBV10-02+TCRBJ01-05	TCRBV10-02*01	TCRBD01-01*01	TCRBJ01-05*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTGATCTCCAAAAAGGGTTTCGACGGCGAGCAGTACTTCGGGCCG		Out	VDJ	1	25	1.848852602075152E-4		49	TCRBV10	TCRBV10-02	01				TCRBJ02	TCRBJ02-07	01	3	5	3	6	9	9	23	37	50	46	59				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 12	X+TCRBV10-02+TCRBJ02-07	TCRBV10-02*01		TCRBJ02-07*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTGAGCCCTTAAACACCATATATTTTGGAGAG	CASSEPLNTIYF	In	VDJ	2	59	4.363292140897359E-4	5.116242770055238E-4	36	TCRBV10	TCRBV10-02	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-03	01	2	4	10	6	2	1	23	38	42	40	43						01,02							Vb 12	CASSEPLNTIYF+TCRBV10-02+TCRBJ01-03	TCRBV10-02*01	TCRBD02-01	TCRBJ01-03*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
AGCTCCCAGACATCTGTGTACTTCTGTGCCATCAGTGAGTCCCCTGATAGCTCCTACGAGCAGTACTTCGGGCCG	CAISESPDSSYEQYF	In	VDJ	1	13	9.614033530790792E-5	1.127307728995222E-4	45	TCRBV10	TCRBV10-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	0	5	8	0	6	0	24	41	-1	47	50						01,02							Vb 12	CAISESPDSSYEQYF+TCRBV10-03+TCRBJ02-07	TCRBV10-03*01	TCRBD02-01	TCRBJ02-07*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTGAGCCGCAGGACAGGGTTTCCTACGAGCAGTACTTCGGGCCG	CAISEPQDRVSYEQYF	In	VDJ	1	20	1.4790820816601219E-4	1.734319583069572E-4	48	TCRBV10	TCRBV10-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	2	1	3	1	5	2	23	38	51	43	53													Vb 12	CAISEPQDRVSYEQYF+TCRBV10-03+TCRBJ02-07	TCRBV10-03*01	TCRBD01-01*01	TCRBJ02-07*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
AAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATTCCCAGCCCCTTTCTGGGGACAGGGCGTTTGGCTACACCTTCGGTTCG		Out	VDJ	1	11	8.134951449130669E-5		56	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	0	3	7	16	4	25	39	64	55	68			01,02										Vb 17	X+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD01-01*01	TCRBJ01-02*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGATCCTCCGTACACTGAAGCTTTCTTTGGACAA	CASSIDPPYTEAFF	In	VDJ	1	11	8.134951449130669E-5	9.538757706882647E-5	42	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	0	4	10	3	2	4	27	44	48	46	52			01,02			01,02							Vb 17	CASSIDPPYTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD02-01	TCRBJ01-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTAGTCATCGGCAGGGTGAGCAGTTCTTCGGGCCA	CASSSHRQGEQFF	In	VDJ	1	12	8.87449248996073E-5	1.0405917498417433E-4	39	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	4	4	3	9	8	0	27	40	-1	48	53			01,02										Vb 17	CASSSHRQGEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD01-01*01	TCRBJ02-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGCAGTAGCGGAGCTCCCAATGAGCAGTTCTTCGGGCCA	CASSSGAPNEQFF	In	VDJ	1	13	9.614033530790792E-5	1.127307728995222E-4	39	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	4	7	5	6	0	6	27	-1	44	40	50			01,02			01,02							Vb 17	CASSSGAPNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01	TCRBJ02-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTACCGGGCGCCTTAGCAATCAGCCCCAGCATTTTGGTGAT	CASTGRLSNQPQHF	In	VDJ	1	13	9.614033530790792E-5	1.127307728995222E-4	42	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-05	01	7	8	0	0	2	4	27	37	43	39	47			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASTGRLSNQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01		TCRBJ01-05*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTGTGGGAAAGAATCAGCCCCAGCATTTTGGTGAT	CASSVGKNQPQHF	In	VDJ	1	13	9.614033530790792E-5	1.127307728995222E-4	39	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-05	01	5	0	8	4	2	3	27	39	45	41	48			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSVGKNQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01		TCRBJ01-05*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GCTGGCAAGCCACGTTTGGTGCCAAAAGAACCCGCAGCTTTCTATCTCTGTGCATCAACAGGGGTCGATGAGCAGTTCTTCGGGCCA	CASTGVDEQFF	In	VDJ	1	13	9.614033530790792E-5	1.127307728995222E-4	33	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	12	3	2	8	4	3	48	53	64	57	67			01,02										Vb 17	CASTGVDEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD01-01*01	TCRBJ02-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGCACAGGGACGGATCGCTACACCTTCGGTTCG	CASTGTDRYTF	In	VDJ	1	14	1.0353574571620853E-4	1.2140237081487006E-4	33	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	9	3	3	9	1	7	27	35	42	36	49			01,02										Vb 17	CASTGTDRYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD01-01*01	TCRBJ01-02*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGCCCCACCCGGCACAGGGGTAGCTCCTACGAGCAGTACTTCGGGCCG	CASSPTRHRGSSYEQYF	In	VDJ	1	14	1.0353574571620853E-4	1.2140237081487006E-4	51	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	3	2	0	11	3	27	38	56	49	59			01,02										Vb 17	CASSPTRHRGSSYEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD01-01*01	TCRBJ02-07*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GCTGGCAAGCCACGTTTGGTGCCAAAAGAACCCGACAGCTTTCTWCTCTGTGCATCAACAGGGGTCGATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	14	1.0353574571620853E-4		32	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	22	3	2	8	13	3	49	44	64	57	67			01,02										Vb 17	X+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD01-01*01	TCRBJ02-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGGCCGCACGCGGGACAGGGGGCATACGGTGAGCAGTTCTTCGGGCCA	CASRPHAGQGAYGEQFF	In	VDJ	1	15	1.1093115612450913E-4	1.3007396873021792E-4	51	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	6	0	0	9	9	6	27	38	59	47	65			01,02										Vb 17	CASRPHAGQGAYGEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD01-01*01	TCRBJ02-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTAACCGGGCGGACTATGGCTACACCTTCGGTTCG	CASSNRADYGYTF	In	VDJ	1	15	1.1093115612450913E-4	1.3007396873021792E-4	39	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-02	01	4	8	0	3	3	2	27	40	47	43	49			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSNRADYGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01		TCRBJ01-02*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGCCCTAACAGGATATGGCTACACCTTCGGTTCG	CASSIALTGYGYTF	In	VDJ	1	15	1.1093115612450913E-4	1.3007396873021792E-4	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	1	3	4	5	5	1	27	43	53	48	54			01,02										Vb 17	CASSIALTGYGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD01-01*01	TCRBJ01-02*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTTCCAGGTAGGGCGCCCCTGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	15	1.1093115612450913E-4		49	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-01	01	5	4	4	0	2	11	27	39	45	41	56			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	X+TCRBV19-01+TCRBJ01-01	TCRBV19-01		TCRBJ01-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGCGGATTAGGACTAGCCGTGGGAGAGACCCAGTACTTCGGGCCA	CASSGLGLAVGETQYF	In	VDJ	1	16	1.1832656653280974E-4	1.3874556664556577E-4	48	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	6	1	7	4	7	6	27	38	53	45	59			01,02			01,02							Vb 17	CASSGLGLAVGETQYF+TCRBV19-01+TCRBJ02-05	TCRBV19-01	TCRBD02-01	TCRBJ02-05*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTACCCAGACGGACAGGGGGGCTCTATTAAAGCAGTACTTCGGGCCG	CASSTQTDRGALLKQYF	In	VDJ	1	16	1.1832656653280974E-4	1.3874556664556577E-4	51	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	1	1	8	7	10	27	40	57	47	67			01,02										Vb 17	CASSTQTDRGALLKQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD01-01*01	TCRBJ02-07*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATCAACTACAACACCGGGGAGCTGTTTTTTGGAGAA	CASSINYNTGELFF	In	VDJ	1	17	1.2572197694111034E-4	1.4741716456091364E-4	42	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	3	3	9	2	2	1	27	41	47	43	48			01,02			01,02							Vb 17	CASSINYNTGELFF+TCRBV19-01+TCRBJ02-02	TCRBV19-01	TCRBD02-01	TCRBJ02-02*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATTATGTCCAGGTTGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSIMSRLNTGELFF	In	VDJ	1	17	1.2572197694111034E-4	1.4741716456091364E-4	48	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	3	4	4	1	6	2	27	41	51	47	53			01,02										Vb 17	CASSIMSRLNTGELFF+TCRBV19-01+TCRBJ02-02	TCRBV19-01	TCRBD01-01*01	TCRBJ02-02*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GCTGGCAAGCCACGTTTGGTGCCAAAAGAACCGACAGCTTTCTATCTCTGTGCATCAACAGGGGTCGATGAGCAGTTCTTCGGGCCA	CASTGVDEQFF	In	VDJ	1	17	1.2572197694111034E-4	1.4741716456091364E-4	33	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	12	3	2	8	4	3	48	53	64	57	67			01,02										Vb 17	CASTGVDEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD01-01*01	TCRBJ02-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAAGGGCATCCTACGAGCAGTACTTCGGGCCG	CASSIRASYEQYF	In	VDJ	1	18	1.3311738734941096E-4	1.560887624762615E-4	39	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-07	01	2	5	3	1	0	2	27	-1	46	42	48			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSIRASYEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01		TCRBJ02-07*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATTGGTGACGACGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	20	1.4790820816601219E-4		43	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-01	01	3	2	7	1	4	3	27	41	48	45	51			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	X+TCRBV19-01+TCRBJ01-01	TCRBV19-01		TCRBJ01-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCTGACTAGCGGGAGGGCCATGGATGAGCAGTTCTTCGGGCCA	CASSLTSGRAMDEQFF	In	VDJ	1	20	1.4790820816601219E-4	1.734319583069572E-4	48	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	5	2	0	8	2	6	27	39	55	41	61			01,02										Vb 17	CASSLTSGRAMDEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01*02	TCRBJ02-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTGGGGGGACAGGGGGCTTATCCACTGAAGCTTTCTTTGGACAA	CASSGGTGGLSTEAFF	In	VDJ	1	20	1.4790820816601219E-4	1.734319583069572E-4	48	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	0	0	4	3	5	27	39	54	42	59			01,02										Vb 17	CASSGGTGGLSTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTAAAACTGGGGACACTGAAGCTTTCTTTGGACAA	CASSKTGDTEAFF	In	VDJ	1	21	1.5530361857431278E-4	1.821035562223051E-4	39	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-01	01	4	6	2	3	5	0	27	40	-1	45	49			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSKTGDTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01		TCRBJ01-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATACGGAATAGCAATCAGCCCCAGCATTTTGGTGAT	CASSIRNSNQPQHF	In	VDJ	1	21	1.5530361857431278E-4	1.821035562223051E-4	42	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-05	01	2	1	8	0	1	1	27	42	46	43	47			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSIRNSNQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01		TCRBJ01-05*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
AAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCCAGGGCCGACAGGGGCCGGAACGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSPGPTGAGTNTGELFF	In	VDJ	1	23	1.70094439390914E-4	1.994467520530008E-4	57	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	5	2	2	0	8	6	24	36	52	44	58			01,02										Vb 17	CASSPGPTGAGTNTGELFF+TCRBV19-01+TCRBJ02-02	TCRBV19-01	TCRBD01-01*01	TCRBJ02-02*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTACCTCGGACAGGGGACGTACTCAGCCCCAGCATTTTGGTGAT	CASSTSDRGRTQPQHF	In	VDJ	1	23	1.70094439390914E-4	1.994467520530008E-4	48	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	4	1	2	6	4	6	27	40	53	44	59			01,02										Vb 17	CASSTSDRGRTQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD01-01*01	TCRBJ01-05*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTTCTCCAGGGGATCCCGATTCCTACGAGCAGTACTTCGGGCCG	CASSSPGDPDSYEQYF	In	VDJ	1	23	1.70094439390914E-4	1.994467520530008E-4	48	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	4	2	1	4	8	27	39	49	43	57			01,02										Vb 17	CASSSPGDPDSYEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD01-01*01	TCRBJ02-07*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCTTCGGCCTCCCCCGGGGACTGAAGCTTTCTTTGGACAA	CASSLRPPPGTEAFF	In	VDJ	1	24	1.774898497992146E-4	2.0811834996834865E-4	45	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	5	8	3	5	13	0	27	39	-1	52	57			01,02										Vb 17	CASSLRPPPGTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD02-01*01	TCRBJ01-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTGCTCGTACTGGCTACACTGAAGCTTTCTTTGGACAA	CASSARTGYTEAFF	In	VDJ	1	24	1.774898497992146E-4	2.0811834996834865E-4	42	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-01	01	5	9	0	3	9	1	27	39	51	48	52			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSARTGYTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01		TCRBJ01-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTACCTCCGGGCAAGCCTACGAGCAGTACTTCGGGCCG	CASTSGQAYEQYF	In	VDJ	1	25	1.848852602075152E-4	2.1678994788369653E-4	39	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-07	01	7	8	0	2	5	3	27	37	46	42	49			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASTSGQAYEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01		TCRBJ02-07*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAACCCCGGGGGGACTCAGCCCCAGCATTTTGGTGAT	CASNPGGTQPQHF	In	VDJ	1	26	1.9228067061581583E-4	2.254615457990444E-4	39	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-05	01	7	8	1	6	4	2	27	37	48	41	50			01,02										Vb 17	CASNPGGTQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD02-01*01	TCRBJ01-05*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATCCGGGGGGTCGGTCAGCCCCAGCATTTTGGTGAT	CASSIRGVGQPQHF	In	VDJ	1	26	1.9228067061581583E-4	2.254615457990444E-4	42	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-05	01	3	8	1	6	1	4	27	41	49	42	53			01,02										Vb 17	CASSIRGVGQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD02-01*01	TCRBJ01-05*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCCAACAGGCTCCCTAGGTGGCTACACCTTCGGTTCG	CASSPTGSLGGYTF	In	VDJ	1	27	1.9967608102411643E-4	2.3413314371439225E-4	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	3	4	7	3	9	27	39	47	42	56			01,02										Vb 17	CASSPTGSLGGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD01-01*01	TCRBJ01-02*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTACTTCCGGGACAGGGGGTGGCTATGGCTACACCTTCGGTTCG	CASTSGTGGGYGYTF	In	VDJ	1	28	2.0707149143241705E-4	2.4280474162974012E-4	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	7	0	1	4	5	3	27	37	53	42	56			01,02										Vb 17	CASTSGTGGGYGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD01-01*01	TCRBJ01-02*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATTTCCGTGGGCGGGAGAGGAAATGAGCAGTTCTTCGGGCCA	CASSISVGGRGNEQFF	In	VDJ	1	29	2.1446690184071765E-4	2.51476339545088E-4	48	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	3	7	2	7	8	4	27	41	56	49	60			01,02										Vb 17	CASSISVGGRGNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01*02	TCRBJ02-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTTGGGGGACTTATTCGCATCAGCCCCAGCATTTTGGTGAT	CASWGTYSHQPQHF	In	VDJ	1	29	2.1446690184071765E-4	2.51476339545088E-4	42	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-05	01	8	0	10	5	3	7	27	36	45	39	52			01,02			01,02							Vb 17	CASWGTYSHQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD02-01	TCRBJ01-05*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAAGGGACGGCAGCAATCAGCCCCAGCATTTTGGTGAT	CASSIRDGSNQPQHF	In	VDJ	1	30	2.2186231224901825E-4	2.6014793746043585E-4	45	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-05	01	2	0	7	1	1	3	27	42	48	43	51			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSIRDGSNQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01		TCRBJ01-05*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAACACGGGACTAGCGGGGAAAGAGACCCAGTACTTCGGGCCA	CASNTGLAGKETQYF	In	VDJ	1	31	2.2925772265731888E-4	2.688195353757837E-4	45	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	7	0	3	3	4	1	27	37	54	41	55			01,02										Vb 17	CASNTGLAGKETQYF+TCRBV19-01+TCRBJ02-05	TCRBV19-01	TCRBD02-01*01	TCRBJ02-05*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTACCGGCGGTTATACGCAGTATTTTGGCCCA	CASSTGGYTQYF	In	VDJ	1	32	2.3665313306561948E-4	2.7749113329113154E-4	36	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	4	7	5	7	3	2	27	40	47	43	49			01,02			01,02							Vb 17	CASSTGGYTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD02-01	TCRBJ02-03*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
TGTGCCAGTAGTACTGGCGGGCGCCGCTCGGGAGGTCATAAAAGGGGTGACCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	32	2.3665313306561948E-4		67	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	4	8	1	2	15	15	0	13	35	28	50			01,02										Vb 17	X+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD02-01*02	TCRBJ02-07*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGCAGGAGGGGGGAGGAATCAGCCCCAGCATTTTGGTGAT	CASSIAGGGRNQPQHF	In	VDJ	1	34	2.5144395388222067E-4	2.948343291218273E-4	48	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-05	01	1	5	1	4	4	4	27	43	53	47	57			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSIAGGGRNQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01		TCRBJ01-05*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATGAGGGGGACGGAACAAGAGACCCAGTACTTCGGGCCA	CASSMRGTEQETQYF	In	VDJ	1	35	2.588393642905213E-4	3.0350592703717514E-4	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	3	5	1	2	1	6	27	41	48	42	54			01,02										Vb 17	CASSMRGTEQETQYF+TCRBV19-01+TCRBJ02-05	TCRBV19-01	TCRBD01-01*01	TCRBJ02-05*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
AAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGTTCACCCTAGGCCCGGGGGGAGTTCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	37	2.736301851071225E-4		55	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-05	01	1	8	1	6	13	3	26	42	62	55	65			01,02										Vb 17	X+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD02-01*01	TCRBJ01-05*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTAGGGGGGGGCGGGATACGCAGTATTTTGGCCCA	CASSRGGRDTQYF	In	VDJ	1	38	2.810255955154231E-4	3.2952072078321873E-4	39	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	4	9	0	6	0	4	27	-1	47	40	51			01,02										Vb 17	CASSRGGRDTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD02-01*01	TCRBJ02-03*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATTCAGGGGGCTGTGAGTCAGCCCCAGCATTTTGGTGAT	CASSIQGAVSQPQHF	In	VDJ	1	39	2.884210059237237E-4	3.381923186985666E-4	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	3	4	0	6	1	6	27	41	50	42	56			01,02										Vb 17	CASSIQGAVSQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD01-01*01	TCRBJ01-05*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTACCCAGGGGCTAGGCAATGAGCAGTTCTTCGGGCCA	CASTQGLGNEQFF	In	VDJ	1	40	2.9581641633202437E-4	3.468639166139144E-4	39	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	7	4	2	6	2	5	27	37	45	39	50			01,02										Vb 17	CASTQGLGNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD01-01*01	TCRBJ02-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGGGGGTCCGAGGACTGAAGCTTTCTTTGGACAA	CASSIGGPRTEAFF	In	VDJ	1	41	3.0321182674032497E-4	3.555355145292623E-4	42	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-01	01	1	6	2	5	0	7	27	-1	47	43	54			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSIGGPRTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01		TCRBJ01-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GCTGGCAAGCCACGTTTGGTGCCAAAAGAACCCGACAGCTTTTATCTCTGTGCATCAACAGGGGTCGATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	42	3.1060723714862557E-4		32	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	24	3	2	8	15	3	49	42	64	57	67			01,02										Vb 17	X+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD01-01*01	TCRBJ02-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGCTTGGACGGACGATCGGAGCAGTTCTTCGGGCCA	CASSLDGRSEQFF	In	VDJ	1	43	3.1800264755692617E-4	3.72878710359958E-4	39	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-01	01	6	1	7	10	3	9	27	38	45	41	54			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSLDGRSEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01		TCRBJ02-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATCCGGGACTAGCGGGCACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	43	3.1800264755692617E-4		46	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	3	0	4	5	2	1	27	41	55	43	56			01,02			01,02							Vb 17	X+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01	TCRBJ02-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTACCCCCCGACGAGCCCCGAACACTGAAGCTTTCTTTGGACAA	CASTPRRAPNTEAFF	In	VDJ	1	44	3.2539805796522677E-4	3.8155030827530587E-4	45	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-01	01	7	2	7	1	6	7	27	37	46	43	53			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASTPRRAPNTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01		TCRBJ01-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGCGAGAAAGCGGGACAGAACACTGAAGCTTTCTTTGGACAA	CASSEKAGQNTEAFF	In	VDJ	1	45	3.3279346837352736E-4	3.9022190619065377E-4	45	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	6	6	3	1	6	2	27	38	51	44	53			01,02										Vb 17	CASSEKAGQNTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD02-01*02	TCRBJ01-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCCCGGGACAGGGTCTTACGAGCAGTACTTCGGGCCG	CASSPGTGSYEQYF	In	VDJ	1	45	3.3279346837352736E-4	3.9022190619065377E-4	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	0	3	4	3	3	27	39	51	42	54			01,02										Vb 17	CASSPGTGSYEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD01-01*01	TCRBJ02-07*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATTTATATGGGGGTAGAGACCCAGTACTTCGGGCCA	CASSIYMGVETQYF	In	VDJ	1	46	3.40188878781828E-4	3.988935041060016E-4	42	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-05	01	3	6	1	4	6	1	27	41	52	47	53			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSIYMGVETQYF+TCRBV19-01+TCRBJ02-05	TCRBV19-01		TCRBJ02-05*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATGGGGACAGGGGGCTCGTACGAGCAGTACTTCGGGCCG	CASSMGTGGSYEQYF	In	VDJ	1	47	3.475842891901286E-4	4.0756510202134946E-4	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	0	0	4	1	3	27	41	54	42	57			01,02										Vb 17	CASSMGTGGSYEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD01-01*01	TCRBJ02-07*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCTCTCTCGTGGTAGGGGGTTTCGGAACTGAAGCTTTCTTTGGACAA	CASLVVGGFGTEAFF	In	VDJ	1	47	3.475842891901286E-4	4.0756510202134946E-4	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	11	5	1	5	11	7	27	33	50	44	57			01,02										Vb 17	CASLVVGGFGTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGCCCCCTGGGGGACAGGGGGAAAGCCAAAAACATTCAGTACTTCGGCGCC	CASSPLGDRGKAKNIQYF	In	VDJ	1	48	3.549796995984292E-4	4.162366999366973E-4	54	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	6	0	1	0	8	2	27	38	57	46	59			01,02										Vb 17	CASSPLGDRGKAKNIQYF+TCRBV19-01+TCRBJ02-04	TCRBV19-01	TCRBD01-01*01	TCRBJ02-04*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAACCCGGGGAGGTAGGGAAGCTTTCTTTGGACAA	CASSITRGGREAFF	In	VDJ	1	48	3.549796995984292E-4	4.162366999366973E-4	42	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	2	9	1	8	5	4	27	42	53	47	57			01,02										Vb 17	CASSITRGGREAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD02-01*02	TCRBJ01-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATGGGACAGGGCCCACAAGAGACCCAGTACTTCGGGCCA	CASSMGQGPQETQYF	In	VDJ	1	48	3.549796995984292E-4	4.162366999366973E-4	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	3	0	3	2	0	4	27	-1	50	41	54			01,02										Vb 17	CASSMGQGPQETQYF+TCRBV19-01+TCRBJ02-05	TCRBV19-01	TCRBD01-01*01	TCRBJ02-05*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTTCACCCACAAGGGGACTTCAGCCTCAGCATTTTGGTGAT	CASSPTRGLQPQHF	In	VDJ	1	48	3.549796995984292E-4	4.162366999366973E-4	42	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-05	01	8	0	10	13	11	7	27	36	53	47	60			01,02			01,02							Vb 17	CASSPTRGLQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD02-01	TCRBJ01-05*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAAGAAAGGCGGGGCGGGAGTTGGGACCGGGGAGCTGTTTTTTGGAGAA	CASKKGGAGVGTGELFF	In	VDJ	1	50	3.697705204150304E-4	4.3357989576739306E-4	51	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	7	7	2	5	11	5	27	37	55	48	60			01,02										Vb 17	CASKKGGAGVGTGELFF+TCRBV19-01+TCRBJ02-02	TCRBV19-01	TCRBD02-01*02	TCRBJ02-02*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAAGGCCCTAGCATCTGATACGCAGTATTTTGGCCCA	CASKALASDTQYF	In	VDJ	1	50	3.697705204150304E-4	4.3357989576739306E-4	39	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	7	4	7	6	5	4	27	37	47	42	51			01,02			01,02							Vb 17	CASKALASDTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD02-01	TCRBJ02-03*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTACTGGGAGGGCAGGGGGCGCACCGCAGCCCCAGCATTTTGGTGAT	CASTGRAGGAPQPQHF	In	VDJ	1	51	3.7716593082333106E-4	4.422514936827409E-4	48	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	7	4	0	7	9	6	27	37	54	46	60			01,02										Vb 17	CASTGRAGGAPQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD01-01*01	TCRBJ01-05*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGCCCGGGACAGGGGTTTCTGGAGACCCAGTACTTCGGGCCA	CASSPGQGFLETQYF	In	VDJ	1	51	3.7716593082333106E-4	4.422514936827409E-4	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	6	0	2	5	3	6	27	38	51	41	57			01,02										Vb 17	CASSPGQGFLETQYF+TCRBV19-01+TCRBJ02-05	TCRBV19-01	TCRBD01-01*01	TCRBJ02-05*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTGGTGGGCGAGAGGCCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	51	3.7716593082333106E-4		41	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-05	01	5	8	0	7	3	7	27	39	46	42	53			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	X+TCRBV19-01+TCRBJ01-05	TCRBV19-01		TCRBJ01-05*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGCTCGACTCAAATTAGCACAGATACGCAGTATTTTGGCCCA	CASSTQISTDTQYF	In	VDJ	2	53	3.9195675163993226E-4	4.5959468951343665E-4	42	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	9	2	10	0	3	6	27	35	42	38	48			01,02			01,02							Vb 17	CASSTQISTDTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD02-01	TCRBJ02-03*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GCTGGCAAGCCACGTTTGGTGCCAAAAGAACCCGACAGYTTCTATCTCTGTGCATCAACAGGGGTCGATGAGCAGTTCTTCGGGCCA		Out	VDJ	2	53	3.9195675163993226E-4		32	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	25	3	2	8	16	3	49	41	64	57	67			01,02										Vb 17	X+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD01-01*01	TCRBJ02-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGCAGGGGGCCGTACAATGAGCAGTTCTTCGGGCCA	CASRGPYNEQFF	In	VDJ	2	54	3.9935216204823286E-4	4.682662874287845E-4	36	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	9	4	0	4	0	2	27	-1	43	35	45			01,02										Vb 17	CASRGPYNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD01-01*01	TCRBJ02-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTAATCCGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSNPNTGELFF	In	VJ	2	54	3.9935216204823286E-4	4.682662874287845E-4	39	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-02	01	4	0	0	0	0	3	27	-1	40	-1	43			01,02										Vb 17	CASSNPNTGELFF+TCRBV19-01+TCRBJ02-02	TCRBV19-01		TCRBJ02-02*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATGGGGGGGCATGGAGATACGCAGTATTTTGGCCCA	CASSMGGHGDTQYF	In	VDJ	2	55	4.0674757245653346E-4	4.7693788534413235E-4	42	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	3	9	0	5	0	5	27	-1	48	41	53			01,02										Vb 17	CASSMGGHGDTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD02-01*01	TCRBJ02-03*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCCACGGACAGGCGTTGTCTACGAGCAGTACTTCGGGCCG	CASSPRTGVVYEQYF	In	VDJ	2	55	4.0674757245653346E-4	4.7693788534413235E-4	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	1	4	3	4	6	27	39	50	43	56			01,02										Vb 17	CASSPRTGVVYEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD01-01*01	TCRBJ02-07*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCACCTCTAGTATCACTAGCGGATACACCGGGGAGCTGTTTTTTGGAGAA	CATSSITSGYTGELFF	In	VDJ	2	56	4.141429828648341E-4	4.8560948325948025E-4	48	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	10	3	5	3	11	2	27	34	53	45	55			01,02			01,02							Vb 17	CATSSITSGYTGELFF+TCRBV19-01+TCRBJ02-02	TCRBV19-01	TCRBD02-01	TCRBJ02-02*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCGGGGACAGGCCTTTATGAACACTGAAGCTTTCTTTGGACAA	CASSRGQAFMNTEAFF	In	VDJ	2	56	4.141429828648341E-4	4.8560948325948025E-4	48	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	0	4	0	2	6	27	39	49	41	55			01,02										Vb 17	CASSRGQAFMNTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCCAAGGGACAGGTTGGATACGCAGTATTTTGGCCCA	CASSPRDRLDTQYF	In	VDJ	2	61	4.511200349063371E-4	5.289674728362195E-4	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	5	0	4	6	4	3	27	39	51	43	54			01,02										Vb 17	CASSPRDRLDTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD01-01*01	TCRBJ02-03*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGCCCGGGACAGGGCAACACCGGGGAGCTGTTTTTTGGAGAA	CASSPGQGNTGELFF	In	VDJ	2	62	4.5851544531463775E-4	5.376390707515674E-4	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	6	0	3	2	3	1	27	38	50	41	51			01,02										Vb 17	CASSPGQGNTGELFF+TCRBV19-01+TCRBJ02-02	TCRBV19-01	TCRBD01-01*01	TCRBJ02-02*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTACCGTGCCGGGACAGGGGGCGAGGAACACTGAAGCTTTCTTTGGACAA	CASSTVPGQGARNTEAFF	In	VDJ	2	62	4.5851544531463775E-4	5.376390707515674E-4	54	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	0	0	1	7	3	27	40	59	47	62			01,02										Vb 17	CASSTVPGQGARNTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAATTCAGGGGGAAGGCAGCCCCAGCATTTTGGTGAT	CASNSGGRQPQHF	In	VDJ	2	63	4.6591085572293835E-4	5.463106686669153E-4	39	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	7	4	1	7	3	4	27	37	47	40	51			01,02										Vb 17	CASNSGGRQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD01-01*01	TCRBJ01-05*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATCGCGGGGTACTCCTACAATGAGCAGTTCTTCGGGCCA	CASSIAGYSYNEQFF	In	VDJ	2	66	4.8809708694784015E-4	5.723254624129589E-4	45	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	3	7	3	0	1	2	27	41	48	42	50			01,02										Vb 17	CASSIAGYSYNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01*01	TCRBJ02-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTATGGAGGGCGGGGAGACCCAGTACTTCGGGCCA	CASMEGGETQYF	In	VDJ	2	70	5.176787285810427E-4	6.070118540743503E-4	36	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	7	10	0	5	1	4	27	37	44	38	48			01,02										Vb 17	CASMEGGETQYF+TCRBV19-01+TCRBJ02-05	TCRBV19-01	TCRBD02-01*02	TCRBJ02-05*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAATATTCAGGGGGCTGTGAGTCAGCCCCAGCATTTTGGTGAT	CASNIQGAVSQPQHF	In	VDJ	2	71	5.250741389893432E-4	6.156834519896982E-4	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	3	4	0	6	1	6	27	41	50	42	56			01,02										Vb 17	CASNIQGAVSQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD01-01*01	TCRBJ01-05*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCCCAGAGACAGGGGGGGCACCGGGGAGCTGTTTTTTGGAGAA	CASSPRDRGGTGELFF	In	VDJ	2	73	5.398649598059444E-4	6.330266478203939E-4	48	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	5	2	1	4	6	2	27	39	54	45	56			01,02										Vb 17	CASSPRDRGGTGELFF+TCRBV19-01+TCRBJ02-02	TCRBV19-01	TCRBD01-01*01	TCRBJ02-02*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGGCTAGGCGATACGCAGTATTTTGGCCCA	CASRLGDTQYF	In	VDJ	2	79	5.842374222557481E-4	6.850562353124811E-4	33	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	6	4	8	6	1	2	27	38	43	39	45			01,02			01,02							Vb 17	CASRLGDTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD02-01	TCRBJ02-03*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATTACACAGCCTCCCCGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	2	82	6.064236534806499E-4		47	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	3	5	1	3	7	27	41	48	44	55			01,02										Vb 17	X+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGCCCCTCAGGGGGGGGAGAGACCCAGTACTTCGGGCCA	CASSPSGGGETQYF	In	VDJ	2	84	6.212144742972511E-4	7.284142248892203E-4	42	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-05	01	6	4	1	4	5	3	27	38	50	43	53			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSPSGGGETQYF+TCRBV19-01+TCRBJ02-05	TCRBV19-01		TCRBJ02-05*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATCGGCGGACGGGGCTTCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSIGGRGFSYNEQFF	In	VDJ	2	85	6.286098847055517E-4	7.370858228045682E-4	51	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-01	01	3	7	0	0	8	2	27	41	54	49	56			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSIGGRGFSYNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01		TCRBJ02-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTAAGGAAACGGCCGGGGAGCTGTTTTTTGGAGAA	CASSKETAGELFF	In	VDJ	2	86	6.360052951138523E-4	7.45757420719916E-4	39	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-02	01	4	1	8	6	1	5	27	40	44	41	49			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSKETAGELFF+TCRBV19-01+TCRBJ02-02	TCRBV19-01		TCRBJ02-02*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCCACTCGGGGCAGACGAGCAGTACTTCGGGCCG	CASSPLGADEQYF	In	VDJ	2	87	6.43400705522153E-4	7.544290186352639E-4	39	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-07	01	5	7	0	5	6	2	27	39	50	45	52			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSPLGADEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01		TCRBJ02-07*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGCCAGGCGGGGGCCAACGTCCTGACTTTCGGGGCC	CASQAGANVLTF	In	VDJ	3	88	6.507961159304535E-4	7.631006165506117E-4	36	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	9	4	4	4	1	2	27	35	40	36	42			01,02										Vb 17	CASQAGANVLTF+TCRBV19-01+TCRBJ02-06	TCRBV19-01	TCRBD01-01*01	TCRBJ02-06*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCCCGGGGGGACAGATACGCAGTATTTTGGCCCA	CASSPGGTDTQYF	In	VDJ	3	90	6.655869367470547E-4	7.804438123813075E-4	39	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	5	8	1	3	2	0	27	39	-1	41	48			01,02										Vb 17	CASSPGGTDTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD02-01*01	TCRBJ02-03*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTGAACAGGCGAATCAGCCCCAGCATTTTGGTGAT	CASSEQANQPQHF	In	VDJ	3	91	6.729823471553554E-4	7.891154102966553E-4	39	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	5	3	4	4	2	2	27	39	46	41	48			01,02										Vb 17	CASSEQANQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD01-01*01	TCRBJ01-05*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTAACCTCGACAGGGAGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSNLDRENTGELFF	In	VDJ	3	93	6.877731679719566E-4	8.064586061273511E-4	48	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	4	2	3	1	5	1	27	40	52	45	53			01,02										Vb 17	CASSNLDRENTGELFF+TCRBV19-01+TCRBJ02-02	TCRBV19-01	TCRBD01-01*01	TCRBJ02-02*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTACCCCCCCAGATGCAACTAATGAAAAACTGTTTTTTGGCAGT	CASSTPPDATNEKLFF	In	VDJ	3	94	6.951685783802572E-4	8.151302040426989E-4	48	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	4	4	5	0	6	3	27	40	49	46	52			01,02										Vb 17	CASSTPPDATNEKLFF+TCRBV19-01+TCRBJ01-04	TCRBV19-01	TCRBD01-01*01	TCRBJ01-04*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATCTCTCTAGCGGGAGATACGCAGTATTTTGGCCCA	CASSISLAGDTQYF	In	VDJ	3	94	6.951685783802572E-4	8.151302040426989E-4	42	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	3	4	4	5	4	0	27	41	-1	45	53			01,02			01,02							Vb 17	CASSISLAGDTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD02-01	TCRBJ02-03*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GACAGCTTTCTATCTCTGTGCCAGCTGACAGAATGGGGCAGCTAGCGGGAAATCGGGAGCCATGAGCAGTTCTTCGGGCCA		Out	VDJ	3	94	6.951685783802572E-4		59	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	9	4	3	8	17	11	16	24	50	41	61			01,02										Vb 17	X+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01*02	TCRBJ02-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGCAGGCTAGCGGGAGGTTCCTACGAGCAGTACTTCGGGCCG	CASSRLAGGSYEQYF	In	VDJ	3	99	7.321456304217603E-4	8.584881936194382E-4	45	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	6	4	1	1	4	1	27	38	53	42	54			01,02										Vb 17	CASSRLAGGSYEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD02-01*02	TCRBJ02-07*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTACCCGACAGCCTAAAAACATTCAGTACTTCGGCGCC	CASSTRQPKNIQYF	In	VDJ	3	106	7.839135032798645E-4	9.191893790268733E-4	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	4	2	5	4	3	3	27	40	48	43	51			01,02										Vb 17	CASSTRQPKNIQYF+TCRBV19-01+TCRBJ02-04	TCRBV19-01	TCRBD01-01*01	TCRBJ02-04*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
TCTCTGTGCCAGTAGTGGGAGACAGGGGGCTAGTGGGAGTGGGCCTTAACCAAAAACATTCAGTACTTCGGCGCC		Out	VDJ	3	111	8.208905553213676E-4		65	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	5	2	0	2	4	19	4	16	30	20	49			01,02										Vb 17	X+TCRBV19-01+TCRBJ02-04	TCRBV19-01	TCRBD01-01*01	TCRBJ02-04*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTAGCGGGAGGGCCTTCGATGAGCAGTTCTTCGGGCCA	CASSSGRAFDEQFF	In	VDJ	3	113	8.356813761379688E-4	9.798905644343083E-4	42	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	4	7	0	8	0	6	27	-1	49	40	55			01,02										Vb 17	CASSSGRAFDEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01*02	TCRBJ02-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTTTAGGGCCAGGCAACACCATATATTTTGGAGAG	CASLGPGNTIYF	In	VDJ	3	118	8.726584281794718E-4	0.0010232485540110476	36	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-03	01	8	4	4	7	7	1	27	36	47	43	48			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASLGPGNTIYF+TCRBV19-01+TCRBJ01-03	TCRBV19-01		TCRBJ01-03*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTTTCAACTACAATGAGCAGTTCTTCGGGCCA	CASSFNYNEQFF	In	VDJ	3	120	8.87449248996073E-4	0.0010405917498417434	36	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	4	6	3	2	1	27	39	43	41	44			01,02										Vb 17	CASSFNYNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD01-01*01	TCRBJ02-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGCTCCAGACTAGCGGGAAGTCGCAATGAGCAGTTCTTCGGGCCA	CASSSRLAGSRNEQFF	In	VDJ	3	121	8.948446594043737E-4	0.0010492633477570913	48	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	6	2	3	6	5	5	27	38	54	43	59			01,02										Vb 17	CASSSRLAGSRNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01*02	TCRBJ02-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCGGGACCACTCCTACAATGAGCAGTTCTTCGGGCCA	CASSRDHSYNEQFF	In	VDJ	3	121	8.948446594043737E-4	0.0010492633477570913	42	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-01	01	5	0	7	0	1	2	27	39	45	40	47			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSRDHSYNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01		TCRBJ02-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTACACGGGACAGGCGGAACACTGAAGCTTTCTTTGGACAA	CASTRDRRNTEAFF	In	VDJ	4	134	9.909849947122816E-4	0.0011619941206566134	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	7	0	4	1	3	2	27	37	48	40	50			01,02										Vb 17	CASTRDRRNTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTACCTACCAACGCAGGACAGGTTGGCGACAGCCCCAGCATTTTGGTGAT	CASSTYQRRTGWRQPQHF	In	VDJ	4	134	9.909849947122816E-4	0.0011619941206566134	54	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	4	1	4	7	12	7	27	40	59	52	66			01,02										Vb 17	CASSTYQRRTGWRQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD01-01*01	TCRBJ01-05*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATTAGACTAGCGGGAGTCACCGGGGAGCTGTTTTTTGGAGAA	CASSIRLAGVTGELFF	In	VDJ	4	142	0.0010501482779786864	0.0012313669039793963	48	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	3	2	2	4	2	1	27	41	55	43	56			01,02										Vb 17	CASSIRLAGVTGELFF+TCRBV19-01+TCRBJ02-02	TCRBV19-01	TCRBD02-01*02	TCRBJ02-02*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
TCTGTGCCAGTAGTATTTCCCCTTAGCCTCCGGGAGGTTCAGAACTAGCCAAAAACATTCAGTACTTCGGCGCC	CASSISP*PPGGSELAKNIQYF	Stop	VDJ	6	193	0.0014273142088020174		66	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-04	01	3	8	1	0	14	9	2	16	37	30	46			01,02										Vb 17	CASSISP*PPGGSELAKNIQYF+TCRBV19-01+TCRBJ02-04	TCRBV19-01	TCRBD02-01*02	TCRBJ02-04*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGCCCGCCGGGCCAAAGTTTCACCGGGGAGCTGTTTTTTGGAGAA	CASSPPGQSFTGELFF	In	VDJ	6	196	0.0014495004400269192	0.0016996331914081808	48	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-02	01	6	8	0	4	6	8	27	38	48	44	56			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSPPGQSFTGELFF+TCRBV19-01+TCRBJ02-02	TCRBV19-01		TCRBJ02-02*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGTAGGAGGGACCATTCAGTACTTCGGCGCC	CASSIVGGTIQYF	In	VDJ	6	203	0.0015012683128850235	0.0017603343768156157	39	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-04	01	1	10	0	9	2	2	27	43	51	45	53			01,02										Vb 17	CASSIVGGTIQYF+TCRBV19-01+TCRBJ02-04	TCRBV19-01	TCRBD02-01*02	TCRBJ02-04*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATCTCGGGCAGCTCCTACGAGCAGTACTTCGGGCCG	CASSISGSSYEQYF	In	VDJ	7	234	0.0017305260355423423	0.0020291539121913994	42	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-07	01	3	8	0	0	3	2	27	41	48	44	50			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSISGSSYEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01		TCRBJ02-07*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGAAGAGACCCAGTACTTCGGGCCA	CASSIEETQYF	In	VJ	7	255	0.0018858296541166553	0.0022112574684137044	33	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-05	01	1	0	0	3	0	0	27	-1	-1	-1	43			01,02										Vb 17	CASSIEETQYF+TCRBV19-01+TCRBJ02-05	TCRBV19-01		TCRBJ02-05*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGGCCCGACAGGCACAACGTCCTGACTTTCGGGGCC	CASRPDRHNVLTF	In	VDJ	7	256	0.0018932250645249558	0.0022199290663290523	39	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	6	2	4	9	4	2	27	38	48	42	50			01,02										Vb 17	CASRPDRHNVLTF+TCRBV19-01+TCRBJ02-06	TCRBV19-01	TCRBD01-01*01	TCRBJ02-06*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTGCCGGGACGGCCAATCAGCCCCAGCATTTTGGTGAT	CASSAGTANQPQHF	In	VDJ	9	325	0.0024035083826976977	0.002818269322488055	42	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-05	01	5	0	7	3	3	3	27	39	47	42	50			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSAGTANQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01		TCRBJ01-05*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCACCACAGGGAGGGGATACGAGCAGTACTTCGGGCCG	CATTGRGYEQYF	In	VDJ	13	466	0.0034462612502680835	0.004040964628552103	36	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	10	9	0	4	5	2	27	34	46	39	48			01,02										Vb 17	CATTGRGYEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD02-01*02	TCRBJ02-07*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCATCAACAGGGGTCGATGAGCAGTTCTTCGGGCCA	CASTGVDEQFF	In	VDJ	231	8062	0.059621798711719506	0.06991042239353445	33	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	12	3	2	8	4	3	27	32	43	36	46			01,02										Vb 17	CASTGVDEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD01-01*01	TCRBJ02-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGTGAAGACCGAGGGGATCTTCGTGAAAAACTGTTTTTTGGCAGT	CASSEDRGDLREKLFF	In	VDJ	1	13	9.614033530790792E-5	1.127307728995222E-4	48	TCRBV25	TCRBV25-01	01				TCRBJ01	TCRBJ01-04	01	2	5	2	7	5	7	23	38	48	43	55				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 11	CASSEDRGDLREKLFF+TCRBV25-01+TCRBJ01-04	TCRBV25-01*01		TCRBJ01-04*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGTGGGCAGGGGTTATACTATGGCTACACCTTCGGTTCG	CASSGQGLYYGYTF	In	VDJ	1	14	1.0353574571620853E-4	1.2140237081487006E-4	42	TCRBV25	TCRBV25-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	4	2	3	2	4	23	36	44	38	48													Vb 11	CASSGQGLYYGYTF+TCRBV25-01+TCRBJ01-02	TCRBV25-01*01	TCRBD01-01*01	TCRBJ01-02*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGTGTGGGACAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	18	1.3311738734941096E-4		35	TCRBV25	TCRBV25-01	01				TCRBJ02	TCRBJ02-05	01	4	0	7	4	1	0	23	36	-1	37	42				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 11	X+TCRBV25-01+TCRBJ02-05	TCRBV25-01*01		TCRBJ02-05*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCTCACATACCTCTCAGTACCTCTGTGCCACCTAAGACCGAGGATGGCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	22	1.6269902898261338E-4		41	TCRBV25	TCRBV25-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	10	11	1	2	9	4	23	30	43	39	47													Vb 11	X+TCRBV25-01+TCRBJ02-07	TCRBV25-01*01	TCRBD02-01*02	TCRBJ02-07*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGGGGGTATAGTTCCTACAATGAGCAGTTCTTCGGGCCA	CASRGYSSYNEQFF	In	VDJ	1	22	1.6269902898261338E-4	1.9077515413765293E-4	42	TCRBV25	TCRBV25-01	01				TCRBJ02	TCRBJ02-01	01	6	6	2	1	0	6	23	-1	38	34	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 11	CASRGYSSYNEQFF+TCRBV25-01+TCRBJ02-01	TCRBV25-01*01		TCRBJ02-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCACCGCGGACAGGGGGTGGTATGGCTACACCTTCGGTTCG	CASTADRGWYGYTF	In	VDJ	1	35	2.588393642905213E-4	3.0350592703717514E-4	42	TCRBV25	TCRBV25-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	7	1	1	5	4	3	23	33	47	37	50													Vb 11	CASTADRGWYGYTF+TCRBV25-01+TCRBJ01-02	TCRBV25-01*01	TCRBD01-01*01	TCRBJ01-02*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCACCGACAGGGGGAATGAAAAACTGTTTTTTGGCAGT	CASTDRGNEKLFF	In	VDJ	1	40	2.9581641633202437E-4	3.468639166139144E-4	39	TCRBV25	TCRBV25-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	7	2	1	5	2	0	23	33	-1	35	44													Vb 11	CASTDRGNEKLFF+TCRBV25-01+TCRBJ01-04	TCRBV25-01*01	TCRBD01-01*01	TCRBJ01-04*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGGACAGGGGGCTCCTACAATGAGCAGTTCTTCGGGCCA	CASRTGGSYNEQFF	In	VDJ	2	65	4.8070167653953955E-4	5.63653864497611E-4	42	TCRBV25	TCRBV25-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	6	2	1	0	0	0	23	-1	-1	34	43													Vb 11	CASRTGGSYNEQFF+TCRBV25-01+TCRBJ02-01	TCRBV25-01*01	TCRBD01-01*01	TCRBJ02-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGTGGGGGACTCCCTAATGAGCAGTTCTTCGGGCCA	CASSGGLPNEQFF	In	VDJ	2	72	5.324695493976438E-4	6.24355049905046E-4	39	TCRBV25	TCRBV25-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	4	0	10	7	1	4	23	36	43	37	47						01,02							Vb 11	CASSGGLPNEQFF+TCRBV25-01+TCRBJ02-01	TCRBV25-01*01	TCRBD02-01	TCRBJ02-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCCGCTGACAGGGACTGGCTACACCTTCGGTTCG		Out	VDJ	4	130	9.614033530790791E-4		35	TCRBV25	TCRBV25-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	8	2	3	7	4	2	23	32	43	36	45													Vb 11	X+TCRBV25-01+TCRBJ01-02	TCRBV25-01*01	TCRBD01-01*01	TCRBJ01-02*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGCGACAGGAGCACCTCGGTAGAAGCTTTCTTTGGACAA	CASSDRSTSVEAFF	In	VDJ	6	204	0.0015086637232933243	0.0017690059747309636	42	TCRBV25	TCRBV25-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	2	4	8	1	12	23	34	41	35	53													Vb 11	CASSDRSTSVEAFF+TCRBV25-01+TCRBJ01-01	TCRBV25-01*01	TCRBD01-01*01	TCRBJ01-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGTAAATGGGACTCGAACACTGAAGCTTTCTTTGGACAA	CASSKWDSNTEAFF	In	VDJ	6	221	0.0016343857002344346	0.0019164231392918773	42	TCRBV25	TCRBV25-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	1	0	10	1	0	1	23	-1	45	39	46						01,02							Vb 11	CASSKWDSNTEAFF+TCRBV25-01+TCRBJ01-01	TCRBV25-01*01	TCRBD02-01	TCRBJ01-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CAGGGACTTGGGCCTATATTTCTGTGCCAGCAGCTTTGGGCAGGCCGAACTATGGCTACACCTTCGGTTCG		Out	VDJ	1	16	1.1832656653280974E-4		43	TCRBV12	TCRBV12-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	1	4	4	2	2	3	22	38	44	40	47														X+TCRBV12-01+TCRBJ01-02	TCRBV12-01*01	TCRBD01-01*01	TCRBJ01-02*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CAGGGACTTGGGCCTATATTTCTGTGCCAGCAGCTTCGGAAGCGGCACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	29	2.1446690184071765E-4		41	TCRBV12	TCRBV12-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	3	6	5	5	4	1	22	36	45	40	46						01,02								X+TCRBV12-01+TCRBJ02-01	TCRBV12-01*01	TCRBD02-01	TCRBJ02-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CAGGGACTTGGGCCTATATTTCTGTGCCAGCTGACCGGGCCATAAAGACTAGCAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	50	3.697705204150304E-4		49	TCRBV12	TCRBV12-01	01				TCRBJ01	TCRBJ01-05	01	8	8	0	0	5	9	22	31	40	36	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV12-01+TCRBJ01-05	TCRBV12-01*01		TCRBJ01-05*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CAGGGACTTGGGCCTATATTTCTGTGCCAGCAGCCTGGACTTGGGGTGAAAAACTGTTTTTTGGCAGT		Out	VDJ	2	56	4.141429828648341E-4		40	TCRBV12	TCRBV12-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-04	01	5	1	10	7	2	5	22	34	41	36	46						01,02								X+TCRBV12-01+TCRBJ01-04	TCRBV12-01*01	TCRBD02-01	TCRBJ01-04*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CAGGGACTTGGGCCTATATTTCTGTGCCAGCAGCTTTCACCCCACGGGGTCCCCAGGCCTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	3	111	8.208905553213676E-4		55	TCRBV12	TCRBV12-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	2	8	3	2	7	8	22	37	49	44	57														X+TCRBV12-01+TCRBJ02-01	TCRBV12-01*01	TCRBD02-01*01	TCRBJ02-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGCCCTACCCCCAGGAGGCACTATGGCTACACCTTCGGTTCG	CATSSPTPRRHYGYTF	In	VDJ	1	12	8.87449248996073E-5	1.0405917498417433E-4	48	TCRBV15	TCRBV15-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	3	10	1	3	11	1	18	32	48	43	49														CATSSPTPRRHYGYTF+TCRBV15-01+TCRBJ01-02	TCRBV15-01*01	TCRBD02-01*02	TCRBJ01-02*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GACGCAGCCATGTACCTGTGTGCCAGCAGCTTCAACAGGGGACAGGATCGCGGCTACACCTTCGGTTCG	CASSFNRGQDRGYTF	In	VDJ	1	15	1.1093115612450913E-4	1.3007396873021792E-4	45	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	0	4	8	8	5	18	30	46	38	51														CASSFNRGQDRGYTF+TCRBV15-01+TCRBJ01-02	TCRBV15-01*01	TCRBD01-01*01	TCRBJ01-02*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GACGCAGCCATGTACCTGTGTGCCAGCAGCCATGGAACTAGCGGGAGTTACGAGCAGTACTTCGGGCCG	CASSHGTSGSYEQYF	In	VDJ	1	21	1.5530361857431278E-4	1.821035562223051E-4	45	TCRBV15	TCRBV15-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	5	3	2	4	6	1	18	30	47	36	48														CASSHGTSGSYEQYF+TCRBV15-01+TCRBJ02-07	TCRBV15-01*01	TCRBD02-01*02	TCRBJ02-07*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGGGACGGTAAACTATGGCTACACCTTCGGTTCG	CATSRGTVNYGYTF	In	VDJ	1	32	2.3665313306561948E-4	2.7749113329113154E-4	42	TCRBV15	TCRBV15-01	01				TCRBJ01	TCRBJ01-02	01	1	1	7	2	0	4	18	-1	38	34	42				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATSRGTVNYGYTF+TCRBV15-01+TCRBJ01-02	TCRBV15-01*01		TCRBJ01-02*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGGTTATTTACAGGGGGCACAAGAGACCCAGTACTTCGGGCCA	CATSRGYLQGAQETQYF	In	VDJ	1	35	2.588393642905213E-4	3.0350592703717514E-4	51	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	1	3	0	2	7	1	18	34	50	41	51														CATSRGYLQGAQETQYF+TCRBV15-01+TCRBJ02-05	TCRBV15-01*01	TCRBD01-01*01	TCRBJ02-05*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGATCTAAACAGTCTCGAGCAGTACTTCGGGCCG	CATSRDLNSLEQYF	In	VDJ	1	36	2.662347746988219E-4	3.12177524952523E-4	42	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	0	3	5	6	5	3	18	35	44	40	47														CATSRDLNSLEQYF+TCRBV15-01+TCRBJ02-07	TCRBV15-01*01	TCRBD01-01*01	TCRBJ02-07*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCATGGGAACTAGCACAGATACGCAGTATTTTGGCCCA	CATSMGTSTDTQYF	In	VDJ	3	90	6.655869367470547E-4	7.804438123813075E-4	42	TCRBV15	TCRBV15-01	01				TCRBJ02	TCRBJ02-03	01	4	0	8	0	1	3	18	31	36	32	39				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATSMGTSTDTQYF+TCRBV15-01+TCRBJ02-03	TCRBV15-01*01		TCRBJ02-03*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAAGACAGGGGGACACAGATACGCAGTATTTTGGCCCA	CATSRRQGDTDTQYF	In	VDJ	3	100	7.395410408300608E-4	8.671597915347861E-4	45	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	2	2	1	2	1	1	18	33	43	34	44														CATSRRQGDTDTQYF+TCRBV15-01+TCRBJ02-03	TCRBV15-01*01	TCRBD01-01*01	TCRBJ02-03*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCGACTCGGGACTTGCCTACGAGCAGTACTTCGGGCCG	CATSDSGLAYEQYF	In	VDJ	3	106	7.839135032798645E-4	9.191893790268733E-4	42	TCRBV15	TCRBV15-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	5	0	10	2	5	2	18	30	41	35	43						01,02								CATSDSGLAYEQYF+TCRBV15-01+TCRBJ02-07	TCRBV15-01*01	TCRBD02-01	TCRBJ02-07*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGACAGGGAAACGGTAACTATGGCTACACCTTCGGTTCG		Out	VDJ	3	107	7.913089136881652E-4		47	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	4	3	1	0	6	18	-1	40	35	46														X+TCRBV15-01+TCRBJ01-02	TCRBV15-01*01	TCRBD01-01*01	TCRBJ01-02*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGAGCGGCAGGGATTGTTATCTGGAAACACCATATATTTTGGAGAG	CATSRERQGLLSGNTIYF	In	VDJ	3	108	7.987043240964657E-4	9.36532574857569E-4	54	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	0	4	3	1	4	7	18	35	44	39	51														CATSRERQGLLSGNTIYF+TCRBV15-01+TCRBJ01-03	TCRBV15-01*01	TCRBD01-01*01	TCRBJ01-03*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGTGCACAGGGTAAAGATACGCAGTATTTTGGCCCA	CATSSAQGKDTQYF	In	VDJ	3	118	8.726584281794718E-4	0.0010232485540110476	42	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	3	3	3	5	3	3	18	32	41	35	44														CATSSAQGKDTQYF+TCRBV15-01+TCRBJ02-03	TCRBV15-01*01	TCRBD01-01*01	TCRBJ02-03*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGATAAAAGGGTGTCTGGAAACACCATATATTTTGGAGAG	CATSRDKRVSGNTIYF	In	VDJ	3	119	8.800538385877725E-4	0.0010319201519263955	48	TCRBV15	TCRBV15-01	01				TCRBJ01	TCRBJ01-03	01	0	5	3	1	4	2	18	35	43	39	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATSRDKRVSGNTIYF+TCRBV15-01+TCRBJ01-03	TCRBV15-01*01		TCRBJ01-03*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGATGCGGGGGGGTGACAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	4	133	9.835895843039808E-4		49	TCRBV15	TCRBV15-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-05	01	0	7	0	3	1	3	18	35	45	36	48														X+TCRBV15-01+TCRBJ01-05	TCRBV15-01*01	TCRBD02-01*01	TCRBJ01-05*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGATATAACGGGTAGTCAGCCCCAGCATTTTGGTGAT	CATSRDITGSQPQHF	In	VDJ	5	158	0.0011684748445114962	0.0013701124706249621	45	TCRBV15	TCRBV15-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-05	01	0	8	4	6	5	3	18	35	44	40	47						01,02								CATSRDITGSQPQHF+TCRBV15-01+TCRBJ01-05	TCRBV15-01*01	TCRBD02-01	TCRBJ01-05*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGATACAGGTTCGGGAGGCTACACCTTCGGTTCG	CATSRDTGSGGYTF	In	VDJ	5	166	0.001227638127777901	0.0014394852539477449	42	TCRBV15	TCRBV15-01	01				TCRBJ01	TCRBJ01-02	01	0	3	4	8	1	7	18	35	41	36	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATSRDTGSGGYTF+TCRBV15-01+TCRBJ01-02	TCRBV15-01*01		TCRBJ01-02*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGGGGACTAGCCCTCACAGATACGCAGTATTTTGGCCCA	CATSRGLALTDTQYF	In	VDJ	6	210	0.0015530361857431277	0.0018210355622230508	45	TCRBV15	TCRBV15-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	3	0	7	2	0	3	18	-1	41	32	44						01,02								CATSRGLALTDTQYF+TCRBV15-01+TCRBJ02-03	TCRBV15-01*01	TCRBD02-01	TCRBJ02-03*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCACCTCGGGCGCTCTCACCTACGAGCAGTACTTCGGGCCG	CATSTSGALTYEQYF	In	VDJ	6	223	0.0016491765210510357	0.001933766335122573	45	TCRBV15	TCRBV15-01	01				TCRBJ02	TCRBJ02-07	01	4	8	0	2	4	7	18	31	39	35	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATSTSGALTYEQYF+TCRBV15-01+TCRBJ02-07	TCRBV15-01*01		TCRBJ02-07*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGATAGGCTATCAATTAAAAACATTCAGTACTTCGGCGCC	CATSRDRLSIKNIQYF	In	VDJ	8	278	0.002055924093507569	0.0024107042204667053	48	TCRBV15	TCRBV15-01	01				TCRBJ02	TCRBJ02-04	01	0	5	4	4	1	9	18	35	39	36	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATSRDRLSIKNIQYF+TCRBV15-01+TCRBJ02-04	TCRBV15-01*01		TCRBJ02-04*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGATCGTGGGTTAAGGGGTCAGGTCATTCAGTACTTCGGCGCC	CATSRDRGLRGQVIQYF	In	VDJ	10	350	0.002588393642905213	0.0030350592703717516	51	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	0	5	2	9	10	6	18	35	50	45	56														CATSRDRGLRGQVIQYF+TCRBV15-01+TCRBJ02-04	TCRBV15-01*01	TCRBD01-01*01	TCRBJ02-04*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGATTCGGGGTCGGCATACGAGCAGTACTTCGGGCCG	CATSRDSGSAYEQYF	In	VDJ	12	417	0.003083886140261354	0.003616056330700058	45	TCRBV15	TCRBV15-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	0	8	3	4	2	6	18	35	42	37	48														CATSRDSGSAYEQYF+TCRBV15-01+TCRBJ02-07	TCRBV15-01*01	TCRBD02-01*01	TCRBJ02-07*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGCGTCCTAGCGGGCTACGAGCAGTACTTCGGGCCG	CATSSVLAGYEQYF	In	VDJ	18	642	0.004747853482128991	0.005567165861653327	42	TCRBV15	TCRBV15-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	3	4	4	3	4	0	18	32	-1	36	44						01,02								CATSSVLAGYEQYF+TCRBV15-01+TCRBJ02-07	TCRBV15-01*01	TCRBD02-01	TCRBJ02-07*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GACGCAGCCATGTACCTGTGTGCCACCCGGGCTTCAGGGAGGAACCAGCCCCAGCATTTTGGTGAT	CATRASGRNQPQHF	In	VDJ	22	779	0.005761024708066174	0.0067551747760559834	42	TCRBV15	TCRBV15-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-05	01	8	9	1	7	9	3	18	27	42	36	45														CATRASGRNQPQHF+TCRBV15-01+TCRBJ01-05	TCRBV15-01*01	TCRBD02-01*02	TCRBJ01-05*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GACGCAGCCATGTACCTGTGTGCCGCAACTTTGGGCGGGACCAAAGCTCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	36	1245	0.009207285958334258		47	TCRBV15	TCRBV15-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	11	7	3	0	10	6	18	24	40	34	46														X+TCRBV15-01+TCRBJ02-07	TCRBV15-01*01	TCRBD02-01*02	TCRBJ02-07*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAACACTTGGGAGTTTTGGTACAGATACGCAGTATTTTGGCCCA	CATSRTLGSFGTDTQYF	In	VDJ	113	3928	0.02904917208380479	0.0340620366114864	51	TCRBV15	TCRBV15-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	2	9	2	3	6	7	18	33	44	39	51														CATSRTLGSFGTDTQYF+TCRBV15-01+TCRBJ02-03	TCRBV15-01*01	TCRBD02-01*02	TCRBJ02-03*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GACTCGGCCGTGTATCTCTGTGCCAGCAGCCCCAGGGGGCTAACTGAAGCTTTCTTTGGACAA	CASSPRGLTEAFF	In	VDJ	1	25	1.848852602075152E-4	2.1678994788369653E-4	39	TCRBV07	TCRBV07-02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	4	0	5	2	2	18	30	40	32	42														CASSPRGLTEAFF+TCRBV07-02+TCRBJ01-01	TCRBV07-02*01	TCRBD01-01*01	TCRBJ01-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GACTCGGCCGTGTATCTCTGTGCCAGCAGCTTACCGGGACTAGTTAATAGGTTCTTCGGGCCA	CASSLPGLVNRFF	In	VDJ	1	38	2.810255955154231E-4	3.2952072078321873E-4	39	TCRBV07	TCRBV07-02	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	2	0	8	15	2	7	18	33	43	35	50						01,02								CASSLPGLVNRFF+TCRBV07-02+TCRBJ02-01	TCRBV07-02*01	TCRBD02-01	TCRBJ02-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCAAGTTCGGTCACAGGGGGCCGGAAAAAGTGACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	11	8.134951449130669E-5		61	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	5	3	0	5	11	11	18	30	50	41	61														X+TCRBV11-03+TCRBJ02-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-02*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCCGCCGGGACAGAGGCGGAAAAACTGTTTTTTGGCAGT	CASSSAGTEAEKLFF	In	VDJ	1	11	8.134951449130669E-5	9.538757706882647E-5	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	4	0	5	8	5	5	18	31	43	36	48														CASSSAGTEAEKLFF+TCRBV11-03+TCRBJ01-04	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-04*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAACCCCCGTTTACAATGAGCAGTTCTTCGGGCCA	CASSLTPVYNEQFF	In	VDJ	1	11	8.134951449130669E-5	9.538757706882647E-5	42	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-01	01	2	3	7	4	0	7	18	-1	35	33	42				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLTPVYNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01		TCRBJ02-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGGAATGGCTGGGATGGGCGGCTACACCTTCGGTTCG	CASSLGMAGMGGYTF	In	VDJ	1	11	8.134951449130669E-5	9.538757706882647E-5	45	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-02	01	1	0	8	8	8	5	18	34	46	42	51				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLGMAGMGGYTF+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01		TCRBJ01-02*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGGGTGGGAGGGGTACGAGCAGTACTTCGGGCCG	CASSLGWEGYEQYF	In	VDJ	1	11	8.134951449130669E-5	9.538757706882647E-5	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	1	9	0	4	3	1	18	34	44	37	45														CASSLGWEGYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-07*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGGTGAAGGGGGGTTCTACGAGCAGTACTTCGGGCCG	CASSLGEGGFYEQYF	In	VDJ	1	11	8.134951449130669E-5	9.538757706882647E-5	45	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-07	01	1	5	1	3	4	3	18	34	44	38	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLGEGGFYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01		TCRBJ02-07*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGGGACAGGGCTAACTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASRDRANSGANVLTF	In	VDJ	1	11	8.134951449130669E-5	9.538757706882647E-5	48	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	6	1	3	0	0	4	18	-1	37	29	41														CASRDRANSGANVLTF+TCRBV11-03+TCRBJ02-06	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-06*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GACTCGGCCGTGTATCTCTGTGCCAGCAGCTCTGGCGGCGGGAGAGGCACAGATACGCAGTATTTTGGCCCA	CASSSGGGRGTDTQYF	In	VDJ	1	12	8.87449248996073E-5	1.0405917498417433E-4	48	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	4	7	2	1	6	2	18	31	44	37	46														CASSSGGGRGTDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-03*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCGTGGACAGAGCCTCCTACGAGCAGTACTTCGGGCCR		Out	VDJ	1	12	8.87449248996073E-5		44	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	unresolved		5	1	5	0	4	3	18	30	40	34	43								TCRBJ02-05,TCRBJ02-07						X+TCRBV11-03+TCRBJ02-X	TCRBV11-03*01	TCRBD01-01*01	unresolved	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGAGCTGCGGGACACTGAAGCTTTCTTTGGACAA	CASSLELRDTEAFF	In	VDJ	1	12	8.87449248996073E-5	1.0405917498417433E-4	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	0	7	4	3	3	0	18	35	-1	38	43						01,02								CASSLELRDTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD02-01	TCRBJ01-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GACTCGGCCGTGTATSTCTGTGCTAGCAGCTTACGCTTGGACTAGCGGGAGAGGCCATCCTACAATGAGCAGTTCTTCGGGCCA	CASSLRLD*RERPSYNEQFF	Stop	VDJ	1	12	8.87449248996073E-5		60	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	2	1	2	1	5	6	18	33	51	38	57														CASSLRLD*RERPSYNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAAGGTCGAGGACAGGAAGACCGGGGAGCTGTTTTTTGGAGAA	CASKVEDRKTGELFF	In	VDJ	1	13	9.614033530790792E-5	1.127307728995222E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	7	1	4	5	7	3	18	28	42	35	45														CASKVEDRKTGELFF+TCRBV11-03+TCRBJ02-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-02*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCTCGCGCAGGGGGCTGGCGGTGAAAAACTGTTTTTTGGCAGT	CASSLAQGAGGEKLFF	In	VDJ	1	13	9.614033530790792E-5	1.127307728995222E-4	48	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	5	4	0	7	6	6	18	30	44	36	50														CASSLAQGAGGEKLFF+TCRBV11-03+TCRBJ01-04	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-04*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCCCCCGGGGCCGGCACGAGCAGTACTTCGGGCCG		Out	VDJ	1	13	9.614033530790792E-5		41	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-07	01	4	7	0	5	5	4	18	31	41	36	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01		TCRBJ02-07*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCCCGGGGACAGGGAGGGCACGAGCAGTACTTCGGGCCG	CASSSRGQGGHEQYF	In	VDJ	1	13	9.614033530790792E-5	1.127307728995222E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	0	3	5	4	5	18	31	44	35	49														CASSSRGQGGHEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-07*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGGCCGGAGCTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSLGRSSGANVLTF	In	VDJ	1	13	9.614033530790792E-5	1.127307728995222E-4	48	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-06	01	1	10	2	0	3	0	18	34	-1	37	41														CASSLGRSSGANVLTF+TCRBV11-03+TCRBJ02-06	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-06*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGCCAGGGGCACGGAGACCCAGTACTTCGGGCCA	CASSLARGTETQYF	In	VDJ	1	13	9.614033530790792E-5	1.127307728995222E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	3	4	2	5	3	4	18	32	41	35	45														CASSLARGTETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-05*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGGGACTTGAGCGGGAGTGGGAATGAGCAGTTCTTCGGGCCA	CASRDLSGSGNEQFF	In	VDJ	1	13	9.614033530790792E-5	1.127307728995222E-4	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	6	6	2	7	7	4	18	29	44	36	48														CASRDLSGSGNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGTTTAGGGGGAGGGCGAGCAGATACGCAGTATTTTGGCCCA	CASSLGGGRADTQYF	In	VDJ	1	13	9.614033530790792E-5	1.127307728995222E-4	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	1	9	0	4	1	4	18	34	42	35	46														CASSLGGGRADTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-03*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GACTCGGCCGTGTATCTCTGTGCCAGCAGTATGGCGGGACAGCTCAATCAGCCCCAGCATTTTGGTGAT	CASSMAGQLNQPQHF	In	VDJ	1	15	1.1093115612450913E-4	1.3007396873021792E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	6	0	5	3	6	2	18	29	42	35	44														CASSMAGQLNQPQHF+TCRBV11-03+TCRBJ01-05	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-05*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCACCCGGGACTAGCGGGCCCTCCGGTGAGCAGTTCTTCGGGCCA	CASSPPGTSGPSGEQFF	In	VDJ	1	15	1.1093115612450913E-4	1.3007396873021792E-4	51	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	0	4	9	6	8	18	30	48	36	56						01,02								CASSPPGTSGPSGEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01	TCRBJ02-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGATGTCAGGGGGCTTGGACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	15	1.1093115612450913E-4		49	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	0	4	0	3	3	4	18	35	46	38	50														X+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTCCGGGACTCCTACAATGAGCAGTTCTTCGGGCCA	CASSFRDSYNEQFF	In	VDJ	1	15	1.1093115612450913E-4	1.3007396873021792E-4	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	3	8	3	0	1	0	18	32	-1	33	38														CASSFRDSYNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCAAGACAGGGGAACTATGGCTACACCTTCGGTTCG	CASSPRQGNYGYTF	In	VDJ	1	16	1.1832656653280974E-4	1.3874556664556577E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	2	2	2	4	0	18	30	-1	34	42														CASSPRQGNYGYTF+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-02*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGGATGGGCGGGAGCTTCCTACGAGCAGTACTTCGGGCCG	CASSLGWAGASYEQYF	In	VDJ	1	16	1.1832656653280974E-4	1.3874556664556577E-4	48	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	1	7	2	1	5	2	18	34	46	39	48														CASSLGWAGASYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-07*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTGGGGGATGGGTAGGATAGCGGGATAATTGGAGAGCAGTTCTTCGGGCCA		Out	VDJ	1	17	1.2572197694111034E-4		56	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	4	5	3	10	15	8	18	31	54	46	62														X+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAACCCCTATCCCCTCCCTAGCGGCGCTACTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	17	1.2572197694111034E-4		58	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	2	4	5	3	15	5	18	33	55	48	60						01,02								X+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD02-01	TCRBJ02-07*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGTTCTAGGAGGGGGGCCGGGAACACTGAAGCTTTCTTTGGACAA	CASSSRRGAGNTEAFF	In	VDJ	1	17	1.2572197694111034E-4	1.4741716456091364E-4	48	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-01	01	6	5	1	1	7	5	18	29	42	36	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSSRRGAGNTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01		TCRBJ01-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GACTCGGCCGTGTATCTCTGTGCCAGCAGCGTCGGGACTACCGTCTACGAGCAGTACTTCGGGCCG	CASSVGTTVYEQYF	In	VDJ	1	18	1.3311738734941096E-4	1.560887624762615E-4	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	5	0	9	3	3	4	18	30	40	33	44						01,02								CASSVGTTVYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD02-01	TCRBJ02-07*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GACTCGGCCGTGTATGTCTGTGCCAGCACCACGCCGCCCGGGAGGGCATTAGGCGGGGAGCTGTTTTTTGGAGAA	CASTTPPGRALGGELFF	In	VDJ	1	18	1.3311738734941096E-4	1.560887624762615E-4	51	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	7	8	0	7	10	7	18	28	46	38	53														CASTTPPGRALGGELFF+TCRBV11-03+TCRBJ02-02	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-02*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGGGACTAGGAACAATGAGCAGTTCTTCGGGCCA	CASSLGTRNNEQFF	In	VDJ	1	18	1.3311738734941096E-4	1.560887624762615E-4	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	1	1	8	5	0	2	18	-1	41	34	43						01,02								CASSLGTRNNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01	TCRBJ02-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GACTCGGCCGTGTATGTCTGTGCCAGCACCCAACCTAGGGCCGGGGGGAAGAGTGAAGCTTTCTTTGGACAA	CASTQPRAGGKSEAFF	In	VDJ	1	20	1.4790820816601219E-4	1.734319583069572E-4	48	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	7	8	1	7	13	5	18	28	48	41	53														CASTQPRAGGKSEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD02-01*01	TCRBJ01-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGATCGCCGAGGGGCAGGGACAACACTGAAGCTTTCTTTGGACAA	CASRSPRGRDNTEAFF	In	VDJ	1	20	1.4790820816601219E-4	1.734319583069572E-4	48	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-01	01	6	0	7	2	14	0	18	29	-1	43	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASRSPRGRDNTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01		TCRBJ01-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCGTAAGCTAGCGGGAGGTTTGGAGGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	20	1.4790820816601219E-4		50	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	5	4	1	5	5	7	18	30	46	35	53														X+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-05*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCCACCGGGACATTCCAAGATGAGCAGTTCTTCGGGCCA	CASSSTGTFQDEQFF	In	VDJ	1	21	1.5530361857431278E-4	1.821035562223051E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	4	0	6	8	5	7	18	31	42	36	49														CASSSTGTFQDEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCCCCCCGGGACAGAAAAGAGCAGTTCTTCGGGCCA	CASSSPRDRKEQFF	In	VDJ	1	21	1.5530361857431278E-4	1.821035562223051E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	4	0	5	10	6	4	18	31	44	37	48														CASSSPRDRKEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGGACAGACCGGGACCCCCTCCGAGCAGTACTTCGGGCCG	CASSLGQTGTPSEQYF	In	VDJ	1	21	1.5530361857431278E-4	1.821035562223051E-4	48	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-07	01	1	0	7	6	8	6	18	34	47	42	53				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLGQTGTPSEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01		TCRBJ02-07*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGGAGAAGCGGGAGCGGGGGAGACCCAGTACTTCGGGCCA	CASSLGEAGAGETQYF	In	VDJ	1	22	1.6269902898261338E-4	1.9077515413765293E-4	48	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	1	6	2	5	4	5	18	34	46	38	51														CASSLGEAGAGETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-05*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCCTCAGGACGGAGCGTTACCTACGAGCAGTACTTCGGGCCG	CASSPSGRSVTYEQYF	In	VDJ	1	23	1.70094439390914E-4	1.994467520530008E-4	48	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-07	01	5	1	7	2	6	9	18	30	40	36	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPSGRSVTYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01		TCRBJ02-07*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCGGACGTCCGGCCAGATACGCAGTATTTTGGCCCA	CASSPDVRPDTQYF	In	VDJ	1	23	1.70094439390914E-4	1.994467520530008E-4	42	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-03	01	5	1	7	4	2	7	18	30	36	32	43				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPDVRPDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01		TCRBJ02-03*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCGATCGGACAGGGGGAGTTCTTGAAGCTTTCTTTGGACAA	CASSDRTGGVLEAFF	In	VDJ	1	23	1.70094439390914E-4	1.994467520530008E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	1	1	7	4	6	18	30	44	34	50														CASSDRTGGVLEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTACCACCTAGACAGGGCCATCAGCCCCAGCATTTTGGTGAT	CASSLPPRQGHQPQHF	In	VDJ	1	23	1.70094439390914E-4	1.994467520530008E-4	48	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	2	2	3	5	7	2	18	33	47	40	49														CASSLPPRQGHQPQHF+TCRBV11-03+TCRBJ01-05	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-05*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTACCCGACTAGCGGGAACAAACGACGATGCCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	23	1.70094439390914E-4		59	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	2	2	3	6	3	13	18	33	47	36	60														X+TCRBV11-03+TCRBJ02-02	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-02*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCGCGTTTGAGTGGAGCGGGAGTAGGGTCCTACAATGAGCAGTTCTTCGGGCCA	CASSPRLSGAGVGSYNEQFF	In	VDJ	1	24	1.774898497992146E-4	2.0811834996834865E-4	60	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	5	6	2	1	14	5	18	30	52	44	57														CASSPRLSGAGVGSYNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGCCAGGGGGCAAGAGACCCAGTACTTCGGGCCA	CASSLARGQETQYF	In	VDJ	1	24	1.774898497992146E-4	2.0811834996834865E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	3	4	1	2	3	0	18	32	-1	35	42														CASSLARGQETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-05*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCCGGGACAGGTATGAACACTGAAGCTTTCTTTGGACAA	CASSPGTGMNTEAFF	In	VDJ	1	25	1.848852602075152E-4	2.1678994788369653E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	0	4	0	3	2	18	30	41	33	43														CASSPGTGMNTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAACCAGGTCGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSLTRSNTGELFF	In	VDJ	1	26	1.9228067061581583E-4	2.254615457990444E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	2	4	4	0	2	1	18	33	39	35	40														CASSLTRSNTGELFF+TCRBV11-03+TCRBJ02-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-02*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTTCTCTGCGGGGCACGAACACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	26	1.9228067061581583E-4		50	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	3	7	3	0	5	2	18	32	43	37	45														X+TCRBV11-03+TCRBJ02-02	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-02*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCGGGGCAGGACCTTTGGGGCTACACCTTCGGTTCG	CASSSGQDLWGYTF	In	VDJ	1	28	2.0707149143241705E-4	2.4280474162974012E-4	42	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-02	01	4	7	0	8	1	11	18	31	37	32	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSSGQDLWGYTF+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01		TCRBJ01-02*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCCTATTATACAGGGGGCACTGAAGCTTTCTTTGGACAA	CASSSYYTGGTEAFF	In	VDJ	1	30	2.2186231224901825E-4	2.6014793746043585E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	3	1	4	8	0	18	31	-1	39	47														CASSSYYTGGTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCCGGACTAGCGGGAGTGCGAGAGCAGTTCTTCGGGCCA	CASSPGLAGVREQFF	In	VDJ	1	31	2.2925772265731888E-4	2.688195353757837E-4	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	5	1	2	10	3	5	18	30	46	33	51														CASSPGLAGVREQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCGCCCTCGGGCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSSPSGSYNEQFF	In	VDJ	1	31	2.2925772265731888E-4	2.688195353757837E-4	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	4	8	4	0	6	0	18	31	-1	37	41						01,02								CASSSPSGSYNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01	TCRBJ02-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAATAGCGGGTTCCTTCGAGCAGTACTTCGGGCCG	CASSLIAGSFEQYF	In	VDJ	1	31	2.2925772265731888E-4	2.688195353757837E-4	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	2	5	4	6	1	6	18	33	41	34	47						01,02								CASSLIAGSFEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD02-01	TCRBJ02-07*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGAGTGGGACAGCTCCAATGAGCAGTTCTTCGGGCCA	CASSLEWDSSNEQFF	In	VDJ	1	31	2.2925772265731888E-4	2.688195353757837E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	0	0	5	6	2	3	18	35	44	37	47														CASSLEWDSSNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTGGAGGTCGCACTACCGCAAGCAGTACTTCGGGCCG	CASSWRSHYRKQYF	In	VDJ	1	32	2.3665313306561948E-4	2.7749113329113154E-4	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	4	10	1	8	0	13	18	-1	36	31	49														CASSWRSHYRKQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-07*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTACCCGGGACTACGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSLPGTTNTGELFF	In	VDJ	1	32	2.3665313306561948E-4	2.7749113329113154E-4	48	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	2	0	9	0	3	0	18	33	-1	36	43						01,02								CASSLPGTTNTGELFF+TCRBV11-03+TCRBJ02-02	TCRBV11-03*01	TCRBD02-01	TCRBJ02-02*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCCCCCCGTCACGAGGGACAGGGGGCCAATGAGCAGTTCTTCGGGCCA	CASSPPRHEGQGANEQFF	In	VDJ	1	33	2.4404854347392007E-4	2.8616273120647944E-4	54	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	0	0	6	14	0	18	30	-1	44	56														CASSPPRHEGQGANEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCGGAAAGGATGGGACAGGGAGACCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	33	2.4404854347392007E-4		53	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	0	3	2	11	4	18	30	50	41	54														X+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-07*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCGGTGGGCCTGACTAGCGGAGGCACCGGGGAGCTGTTTTTTGGAGAA	CASSPVGLTSGGTGELFF	In	VDJ	1	33	2.4404854347392007E-4	2.8616273120647944E-4	54	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	5	2	5	4	11	3	18	30	50	41	53						01,02								CASSPVGLTSGGTGELFF+TCRBV11-03+TCRBJ02-02	TCRBV11-03*01	TCRBD02-01	TCRBJ02-02*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GACTCGGCCGTGTATSTCTGTGCCAGCAGCTTAAAATGTATAAGCTAGCGGGAGGGCCTGGACGAGCAGTACTTCGGGCCR	CASSLKCIS*REGLDEQYF	Stop	VDJ	1	34	2.5144395388222067E-4		57	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	unresolved		2	4	0	5	11	5	18	33	56	44	61								TCRBJ02-05,TCRBJ02-07						CASSLKCIS*REGLDEQYF+TCRBV11-03+TCRBJ02-X	TCRBV11-03*01	TCRBD02-01*02	unresolved	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGAAAGGGACCCGTATTATACGCAGTATTTTGGCCCA	CASSLERDPYYTQYF	In	VDJ	1	37	2.736301851071225E-4	3.208491228678709E-4	45	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-03	01	0	0	7	7	2	7	18	35	42	37	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLERDPYYTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01		TCRBJ02-03*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGCCTTAGCGGGAGTGGGGGAGCAGTACTTCGGGCCG	CASSLALAGVGEQYF	In	VDJ	1	40	2.9581641633202437E-4	3.468639166139144E-4	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	3	5	2	7	5	5	18	32	46	37	51														CASSLALAGVGEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-07*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTTGGGGTCGGAGGGGGTAATGAAAAACTGTTTTTTGGCAGT	CASSFGVGGGNEKLFF	In	VDJ	1	40	2.9581641633202437E-4	3.468639166139144E-4	48	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-04	01	3	5	1	4	9	0	18	32	-1	41	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSFGVGGGNEKLFF+TCRBV11-03+TCRBJ01-04	TCRBV11-03*01		TCRBJ01-04*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGTTCCCATCCGGGGGGATGGTACACCGGGGAGCTGTTTTTTGGAGAA	CASSSHPGGWYTGELFF	In	VDJ	1	40	2.9581641633202437E-4	3.468639166139144E-4	51	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	6	8	1	3	8	5	18	29	44	37	49														CASSSHPGGWYTGELFF+TCRBV11-03+TCRBJ02-02	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-02*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCCTCCCGGACTAGCTTAGGTGAGCAGTTCTTCGGGCCA	CASSPSRTSLGEQFF	In	VDJ	1	41	3.0321182674032497E-4	3.555355145292623E-4	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	1	7	9	7	5	18	30	45	37	50						01,02								CASSPSRTSLGEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01	TCRBJ02-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGGCCAGGCTACCTCCTACGAGCAGTACTTCGGGCCG	CASSLGQATSYEQYF	In	VDJ	1	42	3.1060723714862557E-4	3.642071124446102E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	1	4	4	0	2	4	18	34	40	36	44														CASSLGQATSYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-07*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGGCAGCACTCAAGATAATGAAAAACTGTTTTTTGGCAGT	CASSLGSTQDNEKLFF	In	VDJ	1	44	3.2539805796522677E-4	3.8155030827530587E-4	48	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-04	01	1	4	5	4	1	9	18	34	38	35	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLGSTQDNEKLFF+TCRBV11-03+TCRBJ01-04	TCRBV11-03*01		TCRBJ01-04*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GACTCGGCCGTGTATGTCTGTGCCAGCACCAAGGGACTAGCGGGAGAGGAACAGTTCTTCGGGCCA	CASTKGLAGEEQFF	In	VDJ	1	47	3.475842891901286E-4	4.0756510202134946E-4	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	7	0	2	13	4	5	18	28	46	32	51														CASTKGLAGEEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGTTCAGGGGTCTACACCTCGGAGTACGGCTACACCTTCGGTTCG	CASSSGVYTSEYGYTF	In	VDJ	1	51	3.7716593082333106E-4	4.422514936827409E-4	48	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	4	2	8	2	17	18	29	37	31	54														CASSSGVYTSEYGYTF+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-02*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTCTCCGGGACAGGGACTAATGAGCAGTTCTTCGGGCCA	CASSFSGTGTNEQFF	In	VDJ	1	52	3.8456134123163166E-4	4.509230915980888E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	3	0	3	7	4	3	18	32	45	36	48														CASSFSGTGTNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCGGGCAGGGGGTGTCGATCAGCCCCAGCATTTTGGTGAT	CASSRAGGVDQPQHF	In	VDJ	2	55	4.0674757245653346E-4	4.7693788534413235E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	5	4	1	5	4	5	18	30	41	34	46														CASSRAGGVDQPQHF+TCRBV11-03+TCRBJ01-05	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-05*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GACTCGGCCGTGTATGTCTGTGCCAGCACCCAGACAGGGACGGGAGGAAACACCATATATTTTGGAGAG	CASTQTGTGGNTIYF	In	VDJ	2	56	4.141429828648341E-4	4.8560948325948025E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	7	2	3	4	4	6	18	28	39	32	45														CASTQTGTGGNTIYF+TCRBV11-03+TCRBJ01-03	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-03*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGTACCGCCGGGACTAGCCCATGAGTAGTTCTTCGGGCCA	CASSLVPPGLAHE*FF	Stop	VDJ	2	58	4.289338036814353E-4		48	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	1	0	7	14	7	8	18	34	50	41	58						01,02								CASSLVPPGLAHE*FF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01	TCRBJ02-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGTTTGGGGGAAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSLFGGSSYNEQFF	In	VDJ	2	58	4.289338036814353E-4	5.02952679090176E-4	48	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-01	01	3	6	1	0	4	3	18	32	41	36	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLFGGSSYNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01		TCRBJ02-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCCTGGGGGGCGGGATCCCCAGATACGCAGTATTTTGGCCCA	CASSPWGAGSPDTQYF	In	VDJ	2	66	4.8809708694784015E-4	5.723254624129589E-4	48	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-03	01	5	6	0	4	5	8	18	30	41	35	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPWGAGSPDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01		TCRBJ02-03*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCTACAGGGCTCTAATGAAAAACTGTTTTTTGGCAGT	CASSLQGSNEKLFF	In	VDJ	2	67	4.954924973561408E-4	5.809970603283067E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	5	3	3	3	2	2	18	30	38	32	40														CASSLQGSNEKLFF+TCRBV11-03+TCRBJ01-04	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-04*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGGAGCGGGAGGGGGTTACGAGCAGTACTTCGGGCCG	CASSLGAGGGYEQYF	In	VDJ	2	68	5.028879077644413E-4	5.896686582436546E-4	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	3	6	0	4	3	3	18	32	45	35	48														CASSLGAGGGYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-07*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGGGGTTGGGAGCGGGAGGCACGAGCAGTACTTCGGGCCG	CASSLGVGSGRHEQYF	In	VDJ	2	79	5.842374222557481E-4	6.850562353124811E-4	48	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	1	6	1	5	8	1	18	34	51	42	52														CASSLGVGSGRHEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-07*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCGGGACTAGCGGGAGAGACCCAGTACTTCGGGCCA	CASSSGLAGETQYF	In	VDJ	2	81	5.990282430723493E-4	7.023994311431768E-4	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	4	0	4	4	1	0	18	31	-1	32	44						01,02								CASSSGLAGETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD02-01	TCRBJ02-05*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTATCTGGTCCGGGGGGGTCCCTTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	3	88	6.507961159304535E-4		53	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	2	8	0	4	7	5	18	33	48	40	53														X+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCATGGGACAGGGTATAATCAATGAGCAGTTCTTCGGGCCA	CASSMGQGIINEQFF	In	VDJ	3	91	6.729823471553554E-4	7.891154102966553E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	0	3	6	2	6	18	30	41	32	47														CASSMGQGIINEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCGCCCGGACGGCGGCTCCTACGAGCAGTACTTCGGGCCG	CASSRPDGGSYEQYF	In	VDJ	3	95	7.025639887885578E-4	8.238018019580468E-4	45	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-07	01	5	1	7	0	5	5	18	30	39	35	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSRPDGGSYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01		TCRBJ02-07*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCGCTGGGGCTATCCCTAGCCAAAAACATTCAGTACTTCGGCGCC	CASSPLGLSLAKNIQYF	In	VDJ	3	97	7.173548096051591E-4	8.411449977887425E-4	51	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	5	7	0	0	5	7	18	30	40	35	47														CASSPLGLSLAKNIQYF+TCRBV11-03+TCRBJ02-04	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-04*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCGGGGGCGGTAACTAATGAAAAACTGTTTTTTGGCAGT	CASSSGAVTNEKLFF	In	VDJ	3	102	7.543318616466621E-4	8.845029873654818E-4	45	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-04	01	4	6	0	1	1	3	18	31	38	32	41				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSSGAVTNEKLFF+TCRBV11-03+TCRBJ01-04	TCRBV11-03*01		TCRBJ01-04*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCAAAAAGCTACAAAGGACTAGCGGGCTTGGAATACGAGCAGTACTTCGGGCCG	CASSSKSYKGLAGLEYEQYF	In	VDJ	3	106	7.839135032798645E-4	9.191893790268733E-4	60	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	4	1	4	4	14	7	18	31	56	45	63						01,02								CASSSKSYKGLAGLEYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD02-01	TCRBJ02-07*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCCCCAGACGGGGGGAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSPPDGGSSYNEQFF	In	VDJ	3	112	8.282859657296682E-4	9.712189665189605E-4	51	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	5	8	1	0	8	2	18	30	45	38	47														CASSPPDGGSSYNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCACTCTAGCGGGAGGGATCGGAGAGCAGTACTTCGGGCCG	CASSTLAGGIGEQYF	In	VDJ	3	116	8.578676073628706E-4	0.001005905358180352	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	5	4	0	7	3	6	18	30	45	33	51														CASSTLAGGIGEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-07*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGATCCCAGCGGAGAGACCCAGTACTTCGGGCCA	CASSLDPSGETQYF	In	VDJ	3	117	8.652630177711712E-4	0.0010145769560956997	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	3	6	5	4	7	0	18	32	-1	39	44						01,02								CASSLDPSGETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD02-01	TCRBJ02-05*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCTTATCGAATGATAGCGGGAGGTAATGAGCAGTTCTTCGGGCCA	CASSPYRMIAGGNEQFF	In	VDJ	4	124	9.170308906292755E-4	0.0010752781415031348	51	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	5	5	1	7	13	1	18	30	53	43	54														CASSPYRMIAGGNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTCCAGGGGGGTAATGAAAAACTGTTTTTTGGCAGT	CASSFQGGNEKLFF	In	VDJ	4	135	9.983804051205821E-4	0.0011706657185719613	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	3	4	1	4	1	1	18	32	40	33	41														CASSFQGGNEKLFF+TCRBV11-03+TCRBJ01-04	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-04*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGGGGTTAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSLGVSSYNEQFF	In	VDJ	4	141	0.0010427528675703858	0.0012226953060640484	45	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-01	01	1	0	9	0	0	4	18	-1	37	34	41				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLGVSSYNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01		TCRBJ02-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCGCCGGGACTAAAGTCACAGATACGCAGTATTTTGGCCCA	CASSAGTKVTDTQYF	In	VDJ	4	142	0.0010501482779786864	0.0012313669039793963	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	5	0	9	2	3	4	18	30	40	33	44						01,02								CASSAGTKVTDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD02-01	TCRBJ02-03*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGAGACGGGGGCAGCCTACGAGCAGTACTTCGGGCCG	CASSLETGAAYEQYF	In	VDJ	4	142	0.0010501482779786864	0.0012313669039793963	45	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-07	01	0	6	0	2	3	2	18	35	44	38	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLETGAAYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01		TCRBJ02-07*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCAAGGAGCGGCCCCCGGGGATGAGCAGTTCTTCGGGCCA	CASSQGAAPGDEQFF	In	VDJ	4	145	0.0010723345092035882	0.0012573816977254398	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	6	5	8	5	9	18	30	40	35	49						01,02								CASSQGAAPGDEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01	TCRBJ02-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTCTCGGTTTTGGGGGCGAGTGGCTACACCTTCGGTTCG	CASSFSVLGASGYTF	In	VDJ	5	190	0.0014051279775771156	0.0016476036039160937	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	6	0	7	9	3	18	32	47	41	50														CASSFSVLGASGYTF+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-02*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTTACCAGGGTAGGAGAGACCCAGTACTTCGGGCCA	CASSFTRVGETQYF	In	VDJ	7	234	0.0017305260355423423	0.0020291539121913994	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	3	4	3	4	3	4	18	32	40	35	44														CASSFTRVGETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-05*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGATGCGGGCTCTGGAAACACCATATATTTTGGAGAG	CASSLDAGSGNTIYF	In	VDJ	7	242	0.0017896893188087473	0.0020985266955141826	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-03	01	0	7	4	0	1	0	18	35	-1	36	41						01,02								CASSLDAGSGNTIYF+TCRBV11-03+TCRBJ01-03	TCRBV11-03*01	TCRBD02-01	TCRBJ01-03*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAAGGGGTGGGCGGAGAGAGACCCAGTACTTCGGGCCA	CASSLRGGRRETQYF	In	VDJ	7	250	0.001848852602075152	0.0021678994788369653	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	2	5	2	4	0	9	18	-1	38	33	47														CASSLRGGRRETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-05*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGGCCCCTTAAAGACCGGGGAGCTGTTTTTTGGAGAA	CASSLGPLKTGELFF	In	VDJ	8	274	0.002026342451874367	0.002376017828805314	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	3	8	0	5	0	9	18	-1	36	32	45														CASSLGPLKTGELFF+TCRBV11-03+TCRBJ02-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-02*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GACTCGGCCGTGTATGTCTGTGCCAGCTCTGGGGGATGGGGATACACAGATACGCAGTATTTTGGCCCA	CASSGGWGYTDTQYF	In	VDJ	8	275	0.0020337378622826674	0.002384689426720662	45	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-03	01	8	6	1	2	3	9	18	27	35	30	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSGGWGYTDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01		TCRBJ02-03*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGTACCGGGACCTTGCAGACCCACAATGAGCAGTTCTTCGGGCCA	CASSTGTLQTHNEQFF	In	VDJ	8	285	0.0021076919663656733	0.0024714054058741406	48	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-01	01	6	0	7	5	4	11	18	29	38	33	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSTGTLQTHNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01		TCRBJ02-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCGGCCGGGGGTAACACTGAAGCTTTCTTTGGACAA	CASSSAGGNTEAFF	In	VDJ	12	414	0.0030616999090364518	0.0035900415369540147	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	4	8	2	2	4	1	18	31	41	35	42														CASSSAGGNTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD02-01*01	TCRBJ01-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGAAGGGGGCTCTGGAAACACCATATATTTTGGAGAG	CASSLEGGSGNTIYF	In	VDJ	12	415	0.0030690953194447528	0.0035987131348693626	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	0	5	1	0	0	0	18	-1	-1	35	41														CASSLEGGSGNTIYF+TCRBV11-03+TCRBJ01-03	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-03*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGCCCCTCTCAGGGGACAGGGTAATGAAAAACTGTTTTTTGGCAGT	CASSLAPLRGQGNEKLFF	In	VDJ	15	521	0.003853008822724617	0.004517902513896235	54	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	3	0	3	4	12	0	18	32	-1	44	53														CASSLAPLRGQGNEKLFF+TCRBV11-03+TCRBJ01-04	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-04*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTACGTTCGGTGAAAGAGACCCAGTACTTCGGGCCA	CASSLRSVKETQYF	In	VDJ	21	720	0.005324695493976438	0.00624355049905046	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	2	8	5	3	4	3	18	33	40	37	43						01,02								CASSLRSVKETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD02-01	TCRBJ02-05*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGTCCTCAAGGCCTACGAGCAGTACTTCGGGCCG	CASSLVLKAYEQYF	In	VDJ	21	725	0.005361672546017941	0.006286908488627199	42	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-07	01	1	5	4	2	6	0	18	34	-1	40	43				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLVLKAYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01		TCRBJ02-07*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGAGGTCGGGAGGGGAGATACGCAGTATTTTGGCCCA	CASSLEVGRGDTQYF	In	VDJ	23	808	0.005975491609906892	0.007006651115601072	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	3	8	0	5	6	1	18	32	46	38	47														CASSLEVGRGDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-03*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCCCGGGACGGAAGCACAGATACGCAGTATTTTGGCCCA	CASSPRDGSTDTQYF	In	VDJ	24	849	0.006278703436647217	0.007362186630130334	45	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-03	01	5	0	7	0	4	3	18	30	39	34	42				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPRDGSTDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01		TCRBJ02-03*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAAGACCTGGGGGGGCCAAAAACATTCAGTACTTCGGCGCC	CASSLRPGGAKNIQYF	In	VDJ	137	4790	0.03542401585575992	0.04153695401451626	48	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-04	01	2	9	1	1	6	0	18	33	-1	39	45														CASSLRPGGAKNIQYF+TCRBV11-03+TCRBJ02-04	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-04*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCCCCACGGGGCTTGGGGTGGTGGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	1	20	1.4790820816601219E-4		50	TCRBV12	TCRBV12-05	01				TCRBJ02	TCRBJ02-06	01	12	7	0	3	9	9	26	31	45	40	54				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV12-05+TCRBJ02-06	TCRBV12-05*01		TCRBJ02-06*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGTTTTAGGCCAGGGACTAATGAAAAACTGTTTTTTGGCAGT	CASGFRPGTNEKLFF	In	VDJ	1	24	1.774898497992146E-4	2.0811834996834865E-4	45	TCRBV12	TCRBV12-05	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	3	4	3	2	5	0	26	40	-1	45	50														CASGFRPGTNEKLFF+TCRBV12-05+TCRBJ01-04	TCRBV12-05*01	TCRBD01-01*01	TCRBJ01-04*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTCACGGCAGGGTTTGGGTTGGGAAAAACTGTTTTTTGGCAGT		Out	VDJ	1	24	1.774898497992146E-4		41	TCRBV12	TCRBV12-05	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	11	4	3	8	5	10	26	32	42	37	52														X+TCRBV12-05+TCRBJ01-04	TCRBV12-05*01	TCRBD01-01*01	TCRBJ01-04*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGTTGGGGGACAGGGGGCTATGGCTACACCTTCGGTTCG	CASGWGTGGYGYTF	In	VDJ	1	26	1.9228067061581583E-4	2.254615457990444E-4	42	TCRBV12	TCRBV12-05	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	0	1	4	2	0	26	39	-1	41	52														CASGWGTGGYGYTF+TCRBV12-05+TCRBJ01-02	TCRBV12-05*01	TCRBD01-01*01	TCRBJ01-02*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGCAAAGAGCCCCCTAGCCCACGAGCAGTACTTCGGGCCG		Out	VDJ	1	34	2.5144395388222067E-4		43	TCRBV12	TCRBV12-05	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	6	4	7	5	11	2	26	37	53	48	55						01,02								X+TCRBV12-05+TCRBJ02-07	TCRBV12-05*01	TCRBD02-01	TCRBJ02-07*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGTTCCCGGGAGGGGGCCAATCAGCCCCAGCATTTTGGTGAT	CASGSREGANQPQHF	In	VDJ	1	49	3.623751100067298E-4	4.249082978520452E-4	45	TCRBV12	TCRBV12-05	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-05	01	4	8	0	3	2	3	26	39	49	41	52														CASGSREGANQPQHF+TCRBV12-05+TCRBJ01-05	TCRBV12-05*01	TCRBD02-01*02	TCRBJ01-05*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGTTTGGTCTATGTGATCATAAGGCTGGAAACACCATATATTTTGGAGAG		Out	VDJ	2	62	4.5851544531463775E-4		53	TCRBV12	TCRBV12-05	01				TCRBJ01	TCRBJ01-03	01	0	5	4	2	13	0	26	43	-1	56	59				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV12-05+TCRBJ01-03	TCRBV12-05*01		TCRBJ01-03*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGTTTGCCCCGGGCGGAAATTCACACAGATACGCAGTATTTTGGCCCA	CASGLPRAEIHTDTQYF	In	VDJ	3	111	8.208905553213676E-4	9.625473686036126E-4	51	TCRBV12	TCRBV12-05	01				TCRBJ02	TCRBJ02-03	01	2	8	0	2	4	9	26	41	49	45	58				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASGLPRAEIHTDTQYF+TCRBV12-05+TCRBJ02-03	TCRBV12-05*01		TCRBJ02-03*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGTTCAGAGCTCCTACGAGCAGTACTTCGGGCCG	CASVQSSYEQYF	In	VDJ	10	353	0.0026105798741301147	0.003061074064117795	36	TCRBV12	TCRBV12-05	01				TCRBJ02	TCRBJ02-07	01	7	4	5	0	2	2	26	36	41	38	43				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASVQSSYEQYF+TCRBV12-05+TCRBJ02-07	TCRBV12-05*01		TCRBJ02-07*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGCCAATCCTGGCAGGGGGCAGGCGAGCAGTACTTCGGGCCG	CASSQSWQGAGEQYF	In	VDJ	1	12	8.87449248996073E-5	1.0405917498417433E-4	45	TCRBV23	TCRBV23-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	0	4	0	6	4	3	20	37	49	41	52														CASSQSWQGAGEQYF+TCRBV23-01+TCRBJ02-07	TCRBV23-01*01	TCRBD01-01*01	TCRBJ02-07*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGTCGATAGCGGGAACACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	12	8.87449248996073E-5		43	TCRBV23	TCRBV23-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	4	5	3	2	2	1	20	33	43	35	44														X+TCRBV23-01+TCRBJ02-03	TCRBV23-01*01	TCRBD02-01*02	TCRBJ02-03*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGCCAAGAAGCGGAGCGGGAGGTGGGAGCAGTACTTCGGGCCG		Out	VDJ	1	15	1.1093115612450913E-4		46	TCRBV23	TCRBV23-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	2	6	1	7	7	3	20	35	51	42	54														X+TCRBV23-01+TCRBJ02-07	TCRBV23-01*01	TCRBD02-01*02	TCRBJ02-07*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGCCAAGAATTACCGGGACAGGGGGACGGAAACACCATATATTTTGGAGAG	CASSQELPGQGDGNTIYF	In	VDJ	1	16	1.1832656653280974E-4	1.3874556664556577E-4	54	TCRBV23	TCRBV23-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	2	0	1	4	8	2	20	35	54	43	56														CASSQELPGQGDGNTIYF+TCRBV23-01+TCRBJ01-03	TCRBV23-01*01	TCRBD01-01*01	TCRBJ01-03*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGCTCCAGACCAAACAATGAGCAGTTCTTCGGGCCA	CASSSRPNNEQFF	In	VDJ	1	16	1.1832656653280974E-4	1.3874556664556577E-4	39	TCRBV23	TCRBV23-01	01				TCRBJ02	TCRBJ02-01	01	6	2	7	5	5	3	20	31	39	36	42				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSSRPNNEQFF+TCRBV23-01+TCRBJ02-01	TCRBV23-01*01		TCRBJ02-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGTCCACTATTCAACAGGGTCGATACTCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	18	1.3311738734941096E-4		53	TCRBV23	TCRBV23-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	3	3	0	9	6	20	33	48	42	54														X+TCRBV23-01+TCRBJ02-07	TCRBV23-01*01	TCRBD01-01*01	TCRBJ02-07*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGCCAAGATAATTTACCGGGGACCGGGGAGCTGTTTTTTGGAGAA	CASSQDNLPGTGELFF	In	VDJ	1	20	1.4790820816601219E-4	1.734319583069572E-4	48	TCRBV23	TCRBV23-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	2	8	3	5	10	0	20	35	-1	45	50														CASSQDNLPGTGELFF+TCRBV23-01+TCRBJ02-02	TCRBV23-01*01	TCRBD02-01*01	TCRBJ02-02*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGCCAGAACACGGCAGGCACACGAGAGATCCAGTACTTCGGGCCA	CASSQNTAGTREIQYF	In	VDJ	1	26	1.9228067061581583E-4	2.254615457990444E-4	48	TCRBV23	TCRBV23-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	6	4	4	10	11	12	20	31	46	42	58														CASSQNTAGTREIQYF+TCRBV23-01+TCRBJ02-05	TCRBV23-01*01	TCRBD01-01*01	TCRBJ02-05*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGTCAAAGGAAACAAATACCTTTCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	26	1.9228067061581583E-4		49	TCRBV23	TCRBV23-01	01				TCRBJ02	TCRBJ02-07	01	2	1	8	1	1	12	20	35	39	36	51				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV23-01+TCRBJ02-07	TCRBV23-01*01		TCRBJ02-07*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGTCAACCCAGCACAGGGGGCTGAGGGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	29	2.1446690184071765E-4		50	TCRBV23	TCRBV23-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	2	3	0	5	6	5	20	35	50	41	55														X+TCRBV23-01+TCRBJ02-05	TCRBV23-01*01	TCRBD01-01*01	TCRBJ02-05*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGTCAATCCGGGGACAGAGGCACAGATACGCAGTATTTTGGCCCA	CASSQSGDRGTDTQYF	In	VDJ	1	29	2.1446690184071765E-4	2.51476339545088E-4	48	TCRBV23	TCRBV23-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	0	0	5	1	2	2	20	37	46	39	48														CASSQSGDRGTDTQYF+TCRBV23-01+TCRBJ02-03	TCRBV23-01*01	TCRBD01-01*01	TCRBJ02-03*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGTCAATCTGTGAGGGGGCGCTAACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	47	3.475842891901286E-4		49	TCRBV23	TCRBV23-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	0	5	0	5	4	4	20	37	48	41	52														X+TCRBV23-01+TCRBJ02-01	TCRBV23-01*01	TCRBD01-01*01	TCRBJ02-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGTCAATCTTGTCAGGGGGTGGCCCAAAAACATTCAGTACTTCGGCGCC		Out	VDJ	1	48	3.549796995984292E-4		52	TCRBV23	TCRBV23-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	0	4	1	2	4	4	20	37	48	41	52														X+TCRBV23-01+TCRBJ02-04	TCRBV23-01*01	TCRBD01-01*01	TCRBJ02-04*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGCCGAACGACTTCAGGGGAAGCTCTGGAAACACCATATATTTTGGAGAG		Out	VDJ	2	58	4.289338036814353E-4		53	TCRBV23	TCRBV23-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	6	4	2	0	11	3	20	31	48	42	51														X+TCRBV23-01+TCRBJ01-03	TCRBV23-01*01	TCRBD01-01*01	TCRBJ01-03*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGTCAACCGTCCGGGACAGGGGCGTATAAGCAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	2	67	4.954924973561408E-4		58	TCRBV23	TCRBV23-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	2	0	2	1	6	6	20	35	51	41	57														X+TCRBV23-01+TCRBJ01-05	TCRBV23-01*01	TCRBD01-01*01	TCRBJ01-05*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGTCAAGATCAGGGAAAGGCCTAATTGAACACTGAAGCTTTCTTTGGACAA	CASSQDQGKA*LNTEAFF	Stop	VDJ	3	105	7.765180928715639E-4		54	TCRBV23	TCRBV23-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	4	3	0	3	11	20	35	43	38	54														CASSQDQGKA*LNTEAFF+TCRBV23-01+TCRBJ01-01	TCRBV23-01*01	TCRBD01-01*01	TCRBJ01-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGTCAATCTAGGAGACAGAACAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	5	182	0.0013459646943107108		47	TCRBV23	TCRBV23-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	0	2	5	2	5	2	20	37	47	42	49														X+TCRBV23-01+TCRBJ02-05	TCRBV23-01*01	TCRBD01-01*01	TCRBJ02-05*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGTTTTGGACAGGGGCGTGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	5	183	0.0013533601047190113		46	TCRBV23	TCRBV23-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	1	2	0	3	2	20	32	44	35	46														X+TCRBV23-01+TCRBJ01-01	TCRBV23-01*01	TCRBD01-01*01	TCRBJ01-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGCCAAGATTCGGCCGGCGGGGCCGGGGAGCTGTTTTTTGGAGAA	CASSQDSAGGAGELFF	In	VDJ	6	196	0.0014495004400269192	0.0016996331914081808	48	TCRBV23	TCRBV23-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	2	7	3	6	10	0	20	35	-1	45	51														CASSQDSAGGAGELFF+TCRBV23-01+TCRBJ02-02	TCRBV23-01*01	TCRBD02-01*01	TCRBJ02-02*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGTCCTTAAAATGACAGGGGGTCTATGGCTACACCTTCGGTTCG		Out	VDJ	6	211	0.0015604315961514285		47	TCRBV23	TCRBV23-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	2	1	4	8	1	20	33	50	41	51														X+TCRBV23-01+TCRBJ01-02	TCRBV23-01*01	TCRBD01-01*01	TCRBJ01-02*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
ARCYYRGKGACTCWGCTGTGTATTTYTGTGCCAGCAGCCAAAGGGGGGACGGTGAGACCCAGTACTTCGGGCCA	CASSQRGDGETQYF	In	VDJ	1	11	8.134951449130669E-5	9.538757706882647E-5	42	unresolved						TCRBJ02	TCRBJ02-05	01	6	5	1	5	4	6	26	37	47	41	53	TCRBV03,TCRBV12			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQRGDGETQYF+X+TCRBJ02-05	unresolved		TCRBJ02-05*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTGGACCGTTATACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	11	8.134951449130669E-5		41	TCRBV12						TCRBJ02	TCRBJ02-01	01	3	1	7	4	0	5	26	-1	44	40	49		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV12-X+TCRBJ02-01	TCRBV12		TCRBJ02-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
AGCTCCCAGACATCTGTGTACTTCTGTGCCAGCAGCCGGACAGGGGAAGGAGATACGCAGTATTTTGGCCCA	CASSRTGEGDTQYF	In	VDJ	1	11	8.134951449130669E-5	9.538757706882647E-5	42				TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	6	1	2	5	2	4	24	35	46	37	50	TCRBV06,TCRBV10	TCRBV06-01,TCRBV06-05,TCRBV06-06,TCRBV10-03												CASSRTGEGDTQYF+X+TCRBJ02-03		TCRBD01-01*01	TCRBJ02-03*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGAGGCAGGGAGATTCACCGGGGAGCTGTTTTTTGGAGAA	CSAREAGRFTGELFF	In	VDJ	1	11	8.134951449130669E-5	9.538757706882647E-5	45	TCRBV20						TCRBJ02	TCRBJ02-02	01	0	4	3	4	2	5	26	40	47	42	52		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSAREAGRFTGELFF+TCRBV20-X+TCRBJ02-02	TCRBV20		TCRBJ02-02*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGATCTAGCGGGCTCAACACAGATACGCAGTATTTTGGCCCA	CSARSSGLNTDTQYF	In	VDJ	1	11	8.134951449130669E-5	9.538757706882647E-5	45	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	2	4	4	2	1	5	26	38	47	39	52		TCRBV20-01,TCRBV20-or09_02				01,02								CSARSSGLNTDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01	TCRBJ02-03*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATTGCCGGACAGGGGTACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	11	8.134951449130669E-5		46	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	1	2	3	3	1	24	40	52	43	53		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ01-01	TCRBV24	TCRBD01-01*01	TCRBJ01-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATTTTGTAGGGCGTTGGCACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	11	8.134951449130669E-5		46	TCRBV24						TCRBJ01	TCRBJ01-01	01	1	5	3	4	3	6	24	41	48	44	54		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV24-X+TCRBJ01-01	TCRBV24		TCRBJ01-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CTGTGTATTTCTGTGCCAGCAGCCAAGTATACCGGGACAGGAGGACTCCTGGGCCAAAAACATTCAGTACTTCGGCGCC		Out	VDJ	1	11	8.134951449130669E-5		62	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	1	0	4	1	6	11	11	27	41	33	52		TCRBV03-01,TCRBV03-02												X+TCRBV03-X+TCRBJ02-04	TCRBV03	TCRBD01-01*01	TCRBJ02-04*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCAGCCCCTACTCCCGACAGGGGACTAGGAATGAGCAGTTCTTCGGGCCA	CASSPYSRQGTRNEQFF	In	VDJ	1	11	8.134951449130669E-5	9.538757706882647E-5	51	unresolved						TCRBJ02	TCRBJ02-01	01	5	2	2	7	10	6	18	30	48	40	54	TCRBV05,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPYSRQGTRNEQFF+X+TCRBJ02-01	unresolved		TCRBJ02-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGCGGGTTACTCCTACAATGAGCAGTTCTTCGGGCCA	CASSLAGYSYNEQFF	In	VDJ	1	11	8.134951449130669E-5	9.538757706882647E-5	45							TCRBJ02	TCRBJ02-01	01	0	0	9	0	0	3	18	-1	38	35	41	TCRBV07,TCRBV11	TCRBV07-02,TCRBV11-03		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLAGYSYNEQFF+X+TCRBJ02-01			TCRBJ02-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
AAYCMRGRGACWCAGCWSKGTATTTYTGTGCCAGCAGTTGGGCGGACAGGGTCGCAGATACGCAGTATTTTGGCCCA	CASSWADRVADTQYF	In	VDJ	1	12	8.87449248996073E-5	1.0405917498417433E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	4	1	3	4	4	3	26	39	51	43	54	TCRBV12,TCRBV21													CASSWADRVADTQYF+X+TCRBJ02-03	unresolved	TCRBD01-01*01	TCRBJ02-03*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTTGGTAGCGCAATCACCGGGGAGCTGTTTTTTGGAGAA	CASSFGSAITGELFF	In	VDJ	1	12	8.87449248996073E-5	1.0405917498417433E-4	45	TCRBV12			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	3	5	6	4	3	4	26	40	48	43	52		TCRBV12-03,TCRBV12-04				01,02								CASSFGSAITGELFF+TCRBV12-X+TCRBJ02-02	TCRBV12	TCRBD02-01	TCRBJ02-02*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
AAGRAGACWCRGCWSYGTATCTCTGCGCCAGCAGCCAGAACCGGGACAGGGGGACAGATACGCAGTATTTTGGCCCA	CASSQNRDRGTDTQYF	In	VDJ	1	12	8.87449248996073E-5	1.0405917498417433E-4	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	3	0	1	3	5	0	23	37	-1	42	53	TCRBV01,TCRBV23													CASSQNRDRGTDTQYF+X+TCRBJ02-03	unresolved	TCRBD01-01*01	TCRBJ02-03*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCACCCCCTGGGGTCGGGCTGAAGCTTTCTTTGGACAA	CASTPWGRAEAFF	In	VDJ	1	12	8.87449248996073E-5	1.0405917498417433E-4	39	TCRBV03						TCRBJ01	TCRBJ01-01	01	7	6	2	6	6	5	26	36	46	42	51		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASTPWGRAEAFF+TCRBV03-X+TCRBJ01-01	TCRBV03		TCRBJ01-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCACGCCCTCAGTTCCCCCCTAGCAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	12	8.87449248996073E-5		49	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	7	4	5	0	6	8	26	36	45	42	53		TCRBV03-01,TCRBV03-02												X+TCRBV03-X+TCRBJ01-05	TCRBV03	TCRBD01-01*01	TCRBJ01-05*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
AGCTKGGKGACTCWGCTKTGTATTTCTGTGCCAGCAGCATCGGGGCGCGGGGCTACACCTTCGGTTCG	CASSIGARGYTF	In	VDJ	1	12	8.87449248996073E-5	1.0405917498417433E-4	36	unresolved						TCRBJ01	TCRBJ01-02	01	5	7	0	8	3	4	26	38	46	41	50	TCRBV03,TCRBV09			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSIGARGYTF+X+TCRBJ01-02	unresolved		TCRBJ01-02*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGAGGGGGCCGACAATCAGCCCCAGCATTTTGGTGAT	CASSQEGADNQPQHF	In	VDJ	1	12	8.87449248996073E-5	1.0405917498417433E-4	45	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	0	6	0	3	0	3	26	-1	49	43	52		TCRBV03-01,TCRBV03-02												CASSQEGADNQPQHF+TCRBV03-X+TCRBJ01-05	TCRBV03	TCRBD01-01*01	TCRBJ01-05*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGATACAACTGAAGCTTTCTTTGGACAA	CASSQDTTEAFF	In	VDJ	1	12	8.87449248996073E-5	1.0405917498417433E-4	36	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	0	3	6	5	1	0	26	43	-1	44	47		TCRBV03-01,TCRBV03-02												CASSQDTTEAFF+TCRBV03-X+TCRBJ01-01	TCRBV03	TCRBD01-01*01	TCRBJ01-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCACAGGGTTCCCTACGAGCAGTACTTCGGGCCG	CASSHRVPYEQYF	In	VDJ	1	12	8.87449248996073E-5	1.0405917498417433E-4	39	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	4	3	2	0	3	26	-1	45	40	48		TCRBV03-01,TCRBV03-02												CASSHRVPYEQYF+TCRBV03-X+TCRBJ02-07	TCRBV03	TCRBD01-01*01	TCRBJ02-07*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGCAGGGGGCGCATGGGAGACCCAGTACTTCGGGCCA	CSARAGGAWETQYF	In	VDJ	1	12	8.87449248996073E-5	1.0405917498417433E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	1	4	0	5	0	6	26	-1	47	39	53		TCRBV20-01,TCRBV20-or09_02												CSARAGGAWETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD01-01*01	TCRBJ02-05*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCAGACCAGGGTTGAGCAGCCCCAGCATTTTGGTGAT	CSAQTRVEQPQHF	In	VDJ	1	12	8.87449248996073E-5	1.0405917498417433E-4	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	5	4	3	7	5	5	26	35	45	40	50		TCRBV20-01,TCRBV20-or09_02												CSAQTRVEQPQHF+TCRBV20-X+TCRBJ01-05	TCRBV20	TCRBD01-01*01	TCRBJ01-05*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCAGTAACAGGAGGAACACTGAAGCTTTCTTTGGACAA	CASSNRRNTEAFF	In	VDJ	1	12	8.87449248996073E-5	1.0405917498417433E-4	39	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	3	4	1	1	2	22	34	40	35	42		TCRBV12-03,TCRBV12-04												CASSNRRNTEAFF+TCRBV12-X+TCRBJ01-01	TCRBV12	TCRBD01-01*01	TCRBJ01-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATCCTTCTGGAAACACCATATATTTTGGAGAG	CATSDPSGNTIYF	In	VDJ	1	12	8.87449248996073E-5	1.0405917498417433E-4	39	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-03	01	3	4	10	1	1	0	24	39	-1	40	42		TCRBV24-01,TCRBV24-or09_02				01,02								CATSDPSGNTIYF+TCRBV24-X+TCRBJ01-03	TCRBV24	TCRBD02-01	TCRBJ01-03*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGGGCAGGCGATCAATCAGCCCCAGCATTTTGGTGAT	CATSGQAINQPQHF	In	VDJ	1	12	8.87449248996073E-5	1.0405917498417433E-4	42	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	5	4	4	3	2	4	24	37	43	39	47		TCRBV24-01,TCRBV24-or09_02												CATSGQAINQPQHF+TCRBV24-X+TCRBJ01-05	TCRBV24	TCRBD01-01*01	TCRBJ01-05*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTCACGTACCGGGACTAGCGGGATCTTCGCGCAGTTCTTCGGGCCA	CASSSRTGTSGIFAQFF	In	VDJ	1	12	8.87449248996073E-5	1.0405917498417433E-4	51	TCRBV24			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	6	0	3	12	9	7	24	36	58	45	65		TCRBV24-01,TCRBV24-or09_02												CASSSRTGTSGIFAQFF+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD02-01*02	TCRBJ02-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GGACTCRGCCRTGTATSKCTGTGCCAGCAGCCCCCTCCGGATAGCTAACTATGGCTACACCTTCGGTTCG	CASSPLRIANYGYTF	In	VDJ	1	12	8.87449248996073E-5	1.0405917498417433E-4	45	unresolved						TCRBJ01	TCRBJ01-02	01	5	1	8	0	7	3	18	30	40	37	43	TCRBV07,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPLRIANYGYTF+X+TCRBJ01-02	unresolved		TCRBJ01-02*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCTCACAGGGATGGGACACAGATACGCAGTATTTTGGCCCA	CASSSQGWDTDTQYF	In	VDJ	1	12	8.87449248996073E-5	1.0405917498417433E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	4	3	3	2	1	6	18	31	38	32	44	TCRBV07,TCRBV11													CASSSQGWDTDTQYF+X+TCRBJ02-03	unresolved	TCRBD01-01*01	TCRBJ02-03*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCTCTCCGGGACACCTCCGGGCCCCAGCATTTTGGTGAT		Out	VDJ	1	12	8.87449248996073E-5		43	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	4	0	6	9	4	7	18	31	41	35	48	TCRBV07,TCRBV11													X+X+TCRBJ01-05	unresolved	TCRBD01-01*01	TCRBJ01-05*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
ARRRRGACTCAGCYGYGTATCTCTRCGCCAGCAGTGAGCAAGAGGAGGGACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	12	8.87449248996073E-5		41	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	11	10	0	5	17	0	22	25	-1	42	48	TCRBV01,TCRBV17													X+X+TCRBJ01-01	unresolved	TCRBD02-01*02	TCRBJ01-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
TGGGGGACTCRGCYWTGTATYTCTGTGCCAGCAGCCCCCAGGTGGGGGTTTGGAACACTGAAGCTTTCTTTGGACAA	CASSPQVGVWNTEAFF	In	VDJ	1	12	8.87449248996073E-5	1.0405917498417433E-4	48	unresolved						TCRBJ01	TCRBJ01-01	01	5	6	1	1	8	4	19	31	44	39	48	TCRBV09,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPQVGVWNTEAFF+X+TCRBJ01-01	unresolved		TCRBJ01-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
AGCTKGGKGACTCWGCTGTGTATYTCTGTGCCAGCAGCCTCAAGAAGGGCATTGGCTACACCTTCGGTTCG	CASSLKKGIGYTF	In	VDJ	1	12	8.87449248996073E-5	1.0405917498417433E-4	39	unresolved						TCRBJ01	TCRBJ01-02	01	5	5	3	7	7	3	22	34	45	41	48	TCRBV03,TCRBV07			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLKKGIGYTF+X+TCRBJ01-02	unresolved		TCRBJ01-02*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
TACCTCTGTGCCAGCAGTGAATATTATTCTAGTAACAGAGATAGGACTAGCGGGAGGGCCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSEYYSSNRDRTSGRASYNEQFF	In	VDJ	1	12	8.87449248996073E-5	1.0405917498417433E-4	75	TCRBV25			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	0	1	0	0	20	1	6	23	58	43	59		TCRBV25-01,TCRBV25-or09_02												CASSEYYSSNRDRTSGRASYNEQFF+TCRBV25-X+TCRBJ02-01	TCRBV25	TCRBD02-01*02	TCRBJ02-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
AAYCMRGRGACWCAGCWSKGTATTTYTGTGCCAGCAGTGCCCTATCGTCCCAGGGCCTTAACTATGGCTACACCTTCGGTTCG	CASSALSSQGLNYGYTF	In	VDJ	1	12	8.87449248996073E-5	1.0405917498417433E-4	51	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	4	3	1	13	3	24	35	53	48	56	TCRBV12,TCRBV21													CASSALSSQGLNYGYTF+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCGTAGACGGGAGGGCTGCAGGTGAGCAGTTCTTCGGGCCA	CASSVDGRAAGEQFF	In	VDJ	1	13	9.614033530790792E-5	1.127307728995222E-4	45	TCRBV12			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	6	8	0	9	6	7	26	37	51	43	58		TCRBV12-03,TCRBV12-04,TCRBV12-05												CASSVDGRAAGEQFF+TCRBV12-X+TCRBJ02-01	TCRBV12	TCRBD02-01*02	TCRBJ02-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCTGGGACGTCACTGAAGCTTTCTTTGGACAA	CASSWDVTEAFF	In	VDJ	1	13	9.614033530790792E-5	1.127307728995222E-4	36	TCRBV12						TCRBJ01	TCRBJ01-01	01	6	0	7	4	2	2	26	37	44	39	46		TCRBV12-03,TCRBV12-04,TCRBV12-05		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSWDVTEAFF+TCRBV12-X+TCRBJ01-01	TCRBV12		TCRBJ01-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTCTAGGACAGGCAAGATACGGCTACACCTTCGGTTCG	CASSLGQARYGYTF	In	VDJ	1	13	9.614033530790792E-5	1.127307728995222E-4	42	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	1	2	4	8	0	8	26	-1	48	42	56		TCRBV12-03,TCRBV12-04												CASSLGQARYGYTF+TCRBV12-X+TCRBJ01-02	TCRBV12	TCRBD01-01*01	TCRBJ01-02*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTATTAGGGACCAACCCCTACGAGCAGTACTTCGGGCCG	CASSLLGTNPYEQYF	In	VDJ	1	13	9.614033530790792E-5	1.127307728995222E-4	45	TCRBV12						TCRBJ02	TCRBJ02-07	01	2	0	7	2	3	5	26	41	49	44	54		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLLGTNPYEQYF+TCRBV12-X+TCRBJ02-07	TCRBV12		TCRBJ02-07*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCAGCTCAGGAGGAGCCACTGAAGCTTTCTTTGGACAA	CASSSGGATEAFF	In	VDJ	1	13	9.614033530790792E-5	1.127307728995222E-4	39	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	6	10	1	4	4	3	24	35	44	39	47	TCRBV06,TCRBV10													CASSSGGATEAFF+X+TCRBJ01-01	unresolved	TCRBD02-01*02	TCRBJ01-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGATCTAACGGGACAGGGACCGAACACTGAAGCTTTCTTTGGACAA	CASSQDLTGQGPNTEAFF	In	VDJ	1	13	9.614033530790792E-5	1.127307728995222E-4	54	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	0	0	3	1	6	3	26	43	58	49	61		TCRBV03-01,TCRBV03-02												CASSQDLTGQGPNTEAFF+TCRBV03-X+TCRBJ01-01	TCRBV03	TCRBD01-01*01	TCRBJ01-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGGTCCCCCGACAGGGGGATACGAGCAGTACTTCGGGCCG	CASSQGPPTGGYEQYF	In	VDJ	1	13	9.614033530790792E-5	1.127307728995222E-4	48	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	1	2	1	4	7	1	26	42	58	49	59		TCRBV03-01,TCRBV03-02												CASSQGPPTGGYEQYF+TCRBV03-X+TCRBJ02-07	TCRBV03	TCRBD01-01*01	TCRBJ02-07*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGTTGGGGCAGTAAAATTCTACGAGCAGTACTTCGGGCCG	CASSQVGAVKFYEQYF	In	VDJ	1	13	9.614033530790792E-5	1.127307728995222E-4	48	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	1	7	0	3	2	9	26	42	49	44	58		TCRBV03-01,TCRBV03-02												CASSQVGAVKFYEQYF+TCRBV03-X+TCRBJ02-07	TCRBV03	TCRBD01-01*01	TCRBJ02-07*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCCCCCCCCAAGACTAGCGGGAGATCGAGGACGGTTCTTCGGGCCA	CASSPPPRLAGDRGRFF	In	VDJ	1	13	9.614033530790792E-5	1.127307728995222E-4	51	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	4	2	2	15	9	10	26	39	60	48	70		TCRBV03-01,TCRBV03-02												CASSPPPRLAGDRGRFF+TCRBV03-X+TCRBJ02-01	TCRBV03	TCRBD02-01*02	TCRBJ02-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCTTAGATCGAACGGGACATTGAGACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	13	9.614033530790792E-5		52	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	5	0	6	5	11	5	26	38	55	49	60		TCRBV03-01,TCRBV03-02												X+TCRBV03-X+TCRBJ02-02	TCRBV03	TCRBD01-01*01	TCRBJ02-02*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCTTGAGGAGTCCTGGGGCCAACGTCCTGACTTTCGGGGCC	CSALRSPGANVLTF	In	VDJ	1	13	9.614033530790792E-5	1.127307728995222E-4	42	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-06	01	6	10	2	2	5	2	26	34	43	39	45		TCRBV20-01,TCRBV20-or09_02												CSALRSPGANVLTF+TCRBV20-X+TCRBJ02-06	TCRBV20	TCRBD02-01*02	TCRBJ02-06*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCAGTTTCCGGGACAGGGGAGAGACCCAGTACTTCGGGCCA	CASSFRDRGETQYF	In	VDJ	1	13	9.614033530790792E-5	1.127307728995222E-4	42	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	3	0	2	4	2	0	22	36	-1	38	48		TCRBV12-03,TCRBV12-04												CASSFRDRGETQYF+TCRBV12-X+TCRBJ02-05	TCRBV12	TCRBD01-01*01	TCRBJ02-05*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATAACCGGGACACCCCAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	13	9.614033530790792E-5		46	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	3	0	6	1	4	2	24	39	49	43	51		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ02-05	TCRBV24	TCRBD01-01*01	TCRBJ02-05*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GACTCGGCCGTGTATGTCTGTGCCAGAAGCTTCGGCGGGAGGGCCATTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	13	9.614033530790792E-5		44				TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	2	7	0	4	2	4	18	32	43	34	47	TCRBV05,TCRBV11	TCRBV05-03,TCRBV11-03												X+X+TCRBJ02-07		TCRBD02-01*02	TCRBJ02-07*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGCCTCCGGCTTATCCAGTCAGCCCCAGCATTTTGGTGAT	CASSLASGLSSQPQHF	In	VDJ	1	13	9.614033530790792E-5	1.127307728995222E-4	48							TCRBJ01	TCRBJ01-05	01	0	4	5	6	12	0	18	35	-1	47	50	TCRBV07,TCRBV11	TCRBV07-02,TCRBV11-03		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLASGLSSQPQHF+X+TCRBJ01-05			TCRBJ01-05*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GGACTCRGCCRTGTATSKCTGTGCCAGCAGTTCACCGGGGGCGGGAAACACCATATATTTTGGAGAG	CASSSPGAGNTIYF	In	VDJ	1	13	9.614033530790792E-5	1.127307728995222E-4	42	unresolved						TCRBJ01	TCRBJ01-03	01	6	6	0	4	6	1	18	29	41	35	42	TCRBV07,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSSPGAGNTIYF+X+TCRBJ01-03	unresolved		TCRBJ01-03*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GGACTCRGCCRTGTATSKCTGTGCCAGCAGCTTAGACTTTCAGGGAGTACATGAAAAACTGTTTTTTGGCAGT	CASSLDFQGVHEKLFF	In	VDJ	1	13	9.614033530790792E-5	1.127307728995222E-4	48	unresolved						TCRBJ01	TCRBJ01-04	01	1	4	3	6	5	5	19	35	45	40	50	TCRBV07,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLDFQGVHEKLFF+X+TCRBJ01-04	unresolved		TCRBJ01-04*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GGACTCGGCCCTCTATCTCTGTGCCAGCAGCCCGGTTGACGTGGGAATTTTGGACAATGAGCAGTTCTTCGGGCCA	CASSPVDVGILDNEQFF	In	VDJ	1	13	9.614033530790792E-5	1.127307728995222E-4	51	TCRBV05						TCRBJ02	TCRBJ02-01	01	4	0	8	5	11	7	19	31	46	42	53		TCRBV05-06,TCRBV05-07		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPVDVGILDNEQFF+TCRBV05-X+TCRBJ02-01	TCRBV05		TCRBJ02-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCCACGGGACAGGGGGAAATGAGCAGTTCTTCGGGCCA	CASSHGTGGNEQFF	In	VDJ	1	14	1.0353574571620853E-4	1.2140237081487006E-4	42	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	6	0	1	7	4	1	26	37	52	41	53		TCRBV12-03,TCRBV12-04,TCRBV12-05												CASSHGTGGNEQFF+TCRBV12-X+TCRBJ02-01	TCRBV12	TCRBD01-01*01	TCRBJ02-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGGCAGCTATGGCTACACCTTCGGTTCG	CASSQGSYGYTF	In	VDJ	1	14	1.0353574571620853E-4	1.2140237081487006E-4	36	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	1	4	5	4	1	0	26	42	-1	43	46		TCRBV03-01,TCRBV03-02												CASSQGSYGYTF+TCRBV03-X+TCRBJ01-02	TCRBV03	TCRBD01-01*01	TCRBJ01-02*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
AGCTTGGYGACTCKGCTGTGTATYTCTGTGCCAGCAGCTTCTTCGTACAGGGAAGAAACTATGGCTACACCTTCGGTTCG	CASSFFVQGRNYGYTF	In	VDJ	1	14	1.0353574571620853E-4	1.2140237081487006E-4	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	3	3	2	8	4	26	38	52	46	56	TCRBV03,TCRBV07													CASSFFVQGRNYGYTF+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATCTGTATCAGAGGCGGGAAAGCACAGATACGCAGTATTTTGGCCCA	CSARDLYQRRESTDTQYF	In	VDJ	1	14	1.0353574571620853E-4	1.2140237081487006E-4	54	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	0	7	3	0	12	1	26	40	58	52	59		TCRBV20-01,TCRBV20-or09_02												CSARDLYQRRESTDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01*02	TCRBJ02-03*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTGGAGGGGCCAGGGGGGGTTAGGCAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	14	1.0353574571620853E-4		50	TCRBV20						TCRBJ01	TCRBJ01-05	01	1	4	1	2	4	6	26	39	50	43	56		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV20-X+TCRBJ01-05	TCRBV20		TCRBJ01-05*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTTTGGACCTACCGAGCTCCTACGAGCAGTACTTCGGGCCG	CSALDLPSSYEQYF	In	VDJ	1	14	1.0353574571620853E-4	1.2140237081487006E-4	42	TCRBV20						TCRBJ02	TCRBJ02-07	01	5	1	7	0	2	8	26	35	41	37	49		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSALDLPSSYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20		TCRBJ02-07*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
SRGGGACTCAGCTGTGTAYYTCTGTGCCAGCAGCTTAAATCAGGGCTAGCGGGGAGCTCCTRCGAGCAGTACTTCGGGCCG		Out	VDJ	1	14	1.0353574571620853E-4		53	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	2	4	3	6	8	8	22	37	54	45	62	TCRBV07,TCRBV12													X+X+TCRBJ02-07	unresolved	TCRBD02-01*01	TCRBJ02-07*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
TSRRGGACTCAGCYRTGTACTTCTGTGCCAGCTATGACCCTACACAGAACACCGGGGAGCTGTTTTTTGGAGAA	CASYDPTQNTGELFF	In	VDJ	1	14	1.0353574571620853E-4	1.2140237081487006E-4	45	unresolved						TCRBJ02	TCRBJ02-02	01	8	2	7	1	3	8	22	31	37	34	45	TCRBV02,TCRBV12			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASYDPTQNTGELFF+X+TCRBJ02-02	unresolved		TCRBJ02-02*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTATCGATTGGGGATACTGAAGCTTTCTTTGGACAA	CASSLSIGDTEAFF	In	VDJ	1	14	1.0353574571620853E-4	1.2140237081487006E-4	42							TCRBJ01	TCRBJ01-01	01	6	0	8	5	10	1	24	36	50	46	51	TCRBV24,TCRBV27	TCRBV24-01,TCRBV24-or09_02,TCRBV27-01		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLSIGDTEAFF+X+TCRBJ01-01			TCRBJ01-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTATCGCCAGGGCCACTCCATCGGGAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	14	1.0353574571620853E-4		53				TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	6	4	3	4	7	13	24	36	48	43	61	TCRBV24,TCRBV27	TCRBV24-01,TCRBV24-or09_02,TCRBV27-01												X+X+TCRBJ02-05		TCRBD01-01*01	TCRBJ02-05*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CACCWMMCAKACMTCTMWGTACCTCTGTGCCAGCAAGATTTCGCCGTCGGAAAAACTGTTTTTTGGCAGT	CASKISPSEKLFF	In	VDJ	1	14	1.0353574571620853E-4	1.2140237081487006E-4	39	unresolved						TCRBJ01	TCRBJ01-04	01	7	2	8	8	1	11	23	33	36	34	47	TCRBV25,TCRBV28			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASKISPSEKLFF+X+TCRBJ01-04	unresolved		TCRBJ01-04*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GGACTCGGCCMTSTATCKCTGTGCCAGCAGCAGTAGAGGTTTGGGCTCCGAGGTAGGTCTATGGCTACACCTTCGGTTCG		Out	VDJ	1	14	1.0353574571620853E-4		55	unresolved						TCRBJ01	TCRBJ01-02	01	5	8	0	4	11	12	18	30	45	41	57	TCRBV05,TCRBV07			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+X+TCRBJ01-02	unresolved		TCRBJ01-02*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GGACTCGGCCMTSTATCTCTGTGCCAGCAGCTTAGACAGTCTGATCGAGACCCAGTACTTCGGGCCA	CASSLDSLIETQYF	In	VDJ	1	14	1.0353574571620853E-4	1.2140237081487006E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	2	2	5	5	1	7	19	33	39	34	46	TCRBV05,TCRBV11													CASSLDSLIETQYF+X+TCRBJ02-05	unresolved	TCRBD01-01*01	TCRBJ02-05*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
TCAGGAGACWCRGCMSKGTATKTCTGTGCCAGCAGCTCCTTTCGGGACTAGAGTACCAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	14	1.0353574571620853E-4		50	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	5	0	8	0	7	3	24	36	51	43	54	TCRBV11,TCRBV21					01,02								X+X+TCRBJ02-05	unresolved	TCRBD02-01	TCRBJ02-05*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
TCGGCCRTGTATCKCTGTGCAAGTCGCTTTGGATGGGGGGCGCGGATCGATTATCGAATAAACACCGGGGAGCTGTTTTTTGGAGAA	CASRFGWGARIDYRINTGELFF	In	VDJ	1	14	1.0353574571620853E-4	1.2140237081487006E-4	66	unresolved						TCRBJ02	TCRBJ02-02	01	3	6	0	2	6	19	15	29	41	35	60	TCRBV07,TCRBV12			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASRFGWGARIDYRINTGELFF+X+TCRBJ02-02	unresolved		TCRBJ02-02*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
AAGCCACGTTTGGTGCCAGCCAGACCTCTGTACCTCTGTGCCAGCAGTTTAATTAGGACAGGTGACACTGAAGCTTTCTTTGGACAA	CASSLIRTGDTEAFF	In	VDJ	1	15	1.1093115612450913E-4	1.3007396873021792E-4	45				TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	1	4	3	4	2	36	51	62	55	64	TCRBV27,TCRBV28	TCRBV27-01,TCRBV28-01												CASSLIRTGDTEAFF+X+TCRBJ01-01		TCRBD01-01*01	TCRBJ01-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
ARCYYRGKGACTCWGCTGTGTATTTYTGTGCCAGCAGCCATGGACCAGCGGGAGGGGAACACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	15	1.1093115612450913E-4		52	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	3	6	0	1	6	0	26	40	-1	46	56	TCRBV03,TCRBV12													X+X+TCRBJ02-02	unresolved	TCRBD02-01*02	TCRBJ02-02*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCCCCTGGGACGGGGTAGATACGCAGTATTTTGGCCCA	CSAPWDGVDTQYF	In	VDJ	1	15	1.1093115612450913E-4	1.3007396873021792E-4	39	TCRBV20						TCRBJ02	TCRBJ02-03	01	6	0	7	5	5	5	26	34	44	39	49		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSAPWDGVDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20		TCRBJ02-03*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAATAGCGAGGGTGGCGGGTGAGCAGTTCTTCGGGCCA	CSARIARVAGEQFF	In	VDJ	1	15	1.1093115612450913E-4	1.3007396873021792E-4	42	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	2	5	6	9	1	11	26	38	44	39	55		TCRBV20-01,TCRBV20-or09_02				01,02								CSARIARVAGEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01	TCRBJ02-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGACCGACTAGCGGGAGAGTCTATGAGCAGTTCTTCGGGCCA	CSARPTSGRVYEQFF	In	VDJ	1	15	1.1093115612450913E-4	1.3007396873021792E-4	45	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	2	2	2	8	2	5	26	38	52	40	57		TCRBV20-01,TCRBV20-or09_02												CSARPTSGRVYEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*02	TCRBJ02-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATATAGGGCGCAGTCAGTACTTCGGGCCG	CSARDIGRSQYF	In	VDJ	1	15	1.1093115612450913E-4	1.3007396873021792E-4	36	TCRBV20						TCRBJ02	TCRBJ02-07	01	0	5	3	10	3	6	26	40	47	43	53		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARDIGRSQYF+TCRBV20-X+TCRBJ02-07	TCRBV20		TCRBJ02-07*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATCTTGGTGGAGGCAATCAGCCCCAGCATTTTGGTGAT	CSARDLGGGNQPQHF	In	VDJ	1	15	1.1093115612450913E-4	1.3007396873021792E-4	45	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-05	01	0	10	2	2	7	0	26	40	-1	47	51		TCRBV20-01,TCRBV20-or09_02												CSARDLGGGNQPQHF+TCRBV20-X+TCRBJ01-05	TCRBV20	TCRBD02-01*02	TCRBJ01-05*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGGACTAGCGGGACGCTCCTACAATGAGCAGTTCTTCGGGCCA	CSARGLAGRSYNEQFF	In	VDJ	1	15	1.1093115612450913E-4	1.3007396873021792E-4	48	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	1	2	3	0	0	2	26	-1	50	39	52		TCRBV20-01,TCRBV20-or09_02												CSARGLAGRSYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*02	TCRBJ02-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCCAACCAGACMKCTCTKTACTTCTGTGCCAGCAGTTCCGGGCTGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSSGLNTGELFF	In	VDJ	1	15	1.1093115612450913E-4	1.3007396873021792E-4	42	unresolved						TCRBJ02	TCRBJ02-02	01	4	8	0	1	2	1	23	36	42	38	43	TCRBV24,TCRBV27			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSSGLNTGELFF+X+TCRBJ02-02	unresolved		TCRBJ02-02*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTCCGACAGGTCCTAACGAGCAGTACTTCGGGCCG	CASSPTGPNEQYF	In	VDJ	1	15	1.1093115612450913E-4	1.3007396873021792E-4	39	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	2	4	5	2	5	24	36	44	38	49		TCRBV24-01,TCRBV24-or09_02												CASSPTGPNEQYF+TCRBV24-X+TCRBJ02-07	TCRBV24	TCRBD01-01*01	TCRBJ02-07*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCAGCTCAAGCGGGAGGGCCTGGGAGCAGTACTTCGGGCCG	CASSSSGRAWEQYF	In	VDJ	1	15	1.1093115612450913E-4	1.3007396873021792E-4	42	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	3	6	0	7	2	5	19	32	44	34	49	TCRBV05,TCRBV11													CASSSSGRAWEQYF+X+TCRBJ02-07	unresolved	TCRBD02-01*02	TCRBJ02-07*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GGACTCGGCCCTCTATCTCTGTGCCAGCAGCTTAGCGGGCAGGGGGACCACTGAAGCTTTCTTTGGACAA	CASSLAGRGTTEAFF	In	VDJ	1	15	1.1093115612450913E-4	1.3007396873021792E-4	45	TCRBV05			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	4	1	4	6	2	19	33	46	39	48		TCRBV05-06,TCRBV05-07												CASSLAGRGTTEAFF+TCRBV05-X+TCRBJ01-01	TCRBV05	TCRBD01-01*01	TCRBJ01-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGTTGGACTAGCGGCGACAATGAGCAGTTCTTCGGGCCA	CASSWTSGDNEQFF	In	VDJ	1	16	1.1832656653280974E-4	1.3874556664556577E-4	42	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	6	1	5	5	2	2	26	37	49	39	51		TCRBV03-01,TCRBV03-02				01,02								CASSWTSGDNEQFF+TCRBV03-X+TCRBJ02-01	TCRBV03	TCRBD02-01	TCRBJ02-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
AGGACTCSGCCSTGTATCTCTGTGCCAGCAGCCCTCGGGCAGGGGGCGGGGGGCGGCGGGGCTACACCTTCGGTTCG	CASSPRAGGGGRRGYTF	In	VDJ	1	16	1.1832656653280974E-4	1.3874556664556577E-4	51	unresolved						TCRBJ01	TCRBJ01-02	01	4	4	0	8	7	12	20	32	47	39	59	TCRBV05,TCRBV07			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPRAGGGGRRGYTF+X+TCRBJ01-02	unresolved		TCRBJ01-02*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCGCCGGCTAGCGGCCGAAACCACTACGAGCAGTACTTCGGGCCG	CSAPASGRNHYEQYF	In	VDJ	1	16	1.1832656653280974E-4	1.3874556664556577E-4	45	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	6	4	5	3	5	9	26	34	46	39	55		TCRBV20-01,TCRBV20-or09_02				01,02								CSAPASGRNHYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01	TCRBJ02-07*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATACTAGCGGTACCGGGGAGCTGTTTTTTGGAGAA	CSARDTSGTGELFF	In	VDJ	1	16	1.1832656653280974E-4	1.3874556664556577E-4	42	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	0	3	5	5	1	1	26	40	49	41	50		TCRBV20-01,TCRBV20-or09_02				01,02								CSARDTSGTGELFF+TCRBV20-X+TCRBJ02-02	TCRBV20	TCRBD02-01	TCRBJ02-02*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGCAGGGTTCCGGGACACCTTAACACTGAAGCTTTCTTTGGACAA	CSASRVPGHLNTEAFF	In	VDJ	1	16	1.1832656653280974E-4	1.3874556664556577E-4	48	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	0	6	2	9	4	26	37	52	46	56		TCRBV20-01,TCRBV20-or09_02												CSASRVPGHLNTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTAGACTCCCAACTCCAGCAGTACTTCGGGCCG	CASSLDSQLQQYF	In	VDJ	1	16	1.1832656653280974E-4	1.3874556664556577E-4	39	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	6	2	10	8	3	9	24	36	43	39	52		TCRBV24-01,TCRBV24-or09_02				01,02								CASSLDSQLQQYF+TCRBV24-X+TCRBJ02-07	TCRBV24	TCRBD02-01	TCRBJ02-07*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTTATTGGGGGGGCCTACGGCTACACCTTCGGTTCG	CASSFIGGAYGYTF	In	VDJ	1	16	1.1832656653280974E-4	1.3874556664556577E-4	42	TCRBV24			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-02	01	6	9	0	8	6	5	24	36	49	42	54		TCRBV24-01,TCRBV24-or09_02												CASSFIGGAYGYTF+TCRBV24-X+TCRBJ01-02	TCRBV24	TCRBD02-01*01	TCRBJ01-02*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCAGTCCACCCAGGAGGGGTAGAAATGAAAAACTGTTTTTTGGCAGT	CASSPPRRGRNEKLFF	In	VDJ	1	16	1.1832656653280974E-4	1.3874556664556577E-4	48	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-04	01	5	10	0	5	7	5	23	35	48	42	53	TCRBV06,TCRBV10													CASSPPRRGRNEKLFF+X+TCRBJ01-04	unresolved	TCRBD02-01*02	TCRBJ01-04*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCAGTGACGCCACGGTGGTCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	16	1.1832656653280974E-4		41	unresolved			unresolved			TCRBJ01	TCRBJ01-05	01	5	2	7	6	0	10	23	-1	38	35	48	TCRBV06,TCRBV10			TCRBD01,TCRBD02										X+X+TCRBJ01-05	unresolved	unresolved	TCRBJ01-05*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CGACTCGGCYGTGTATCTCTGTGCCAGCAGCTCCCAAGGGGGGGACAATCAGCCCCAGCATTTTGGTGAT	CASSSQGGDNQPQHF	In	VDJ	1	16	1.1832656653280974E-4	1.3874556664556577E-4	45	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-05	01	4	9	0	3	5	1	18	31	43	36	44	TCRBV07,TCRBV11													CASSSQGGDNQPQHF+X+TCRBJ01-05	unresolved	TCRBD02-01*01	TCRBJ01-05*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CGACTCGGCYGTGTATSTCTGTGCCAGCAGCTTAGAGTCCAGACCTGGAAACACCATATATTTTGGAGAG	CASSLESRPGNTIYF	In	VDJ	1	16	1.1832656653280974E-4	1.3874556664556577E-4	45	unresolved						TCRBJ01	TCRBJ01-03	01	0	2	7	2	5	0	18	35	-1	40	43	TCRBV07,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLESRPGNTIYF+X+TCRBJ01-03	unresolved		TCRBJ01-03*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GGACTCGGCCMTGTATCTCTGTGCCAGCAGCGTAAGCGGGCTACAAGAGACCCAGTACTTCGGGCCA	CASSVSGLQETQYF	In	VDJ	1	16	1.1832656653280974E-4	1.3874556664556577E-4	42	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	4	6	4	2	3	3	19	31	40	34	43	TCRBV05,TCRBV11					01,02								CASSVSGLQETQYF+X+TCRBJ02-05	unresolved	TCRBD02-01	TCRBJ02-05*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCCATCGCGGTGTTACTGAAGCTTTCTTTGGACAA	CASSHRGVTEAFF	In	VDJ	1	17	1.2572197694111034E-4	1.4741716456091364E-4	39	TCRBV12			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	6	7	5	5	5	4	26	37	46	42	50		TCRBV12-03,TCRBV12-04,TCRBV12-05				01,02								CASSHRGVTEAFF+TCRBV12-X+TCRBJ01-01	TCRBV12	TCRBD02-01	TCRBJ01-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTCCCTGGGTAGCGGGAGGGTGGTTGAGCAGTTCTTCGGGCCA	CASSSLGSGRVVEQFF	In	VDJ	1	17	1.2572197694111034E-4	1.4741716456091364E-4	48	TCRBV12			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	4	5	0	9	7	4	26	39	57	46	61		TCRBV12-03,TCRBV12-04												CASSSLGSGRVVEQFF+TCRBV12-X+TCRBJ02-01	TCRBV12	TCRBD02-01*02	TCRBJ02-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
ARRRRGACTCAGCYGYGTATCTCTRCGCCAGCAGCCACGGGACGCCAACAGATACGCAGTATTTTGGCCCA	XASSHGTPTDTQYF	In	VDJ	1	17	1.2572197694111034E-4	1.4741716456091364E-4	42	unresolved						TCRBJ02	TCRBJ02-03	01	3	0	7	3	1	4	23	37	43	38	47	TCRBV01,TCRBV04,TCRBV07,TCRBV17			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									XASSHGTPTDTQYF+X+TCRBJ02-03	unresolved		TCRBJ02-03*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGATTGGTCGGGGGCACGAGAGACCCAGTACTTCGGGCCA	CASSQDWSGARETQYF	In	VDJ	1	17	1.2572197694111034E-4	1.4741716456091364E-4	48	TCRBV03						TCRBJ02	TCRBJ02-05	01	0	6	0	4	6	3	26	43	55	49	58		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQDWSGARETQYF+TCRBV03-X+TCRBJ02-05	TCRBV03		TCRBJ02-05*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCGGACTAGTGCGGAGCTGTTTTTTGGAGAA	CASSRTSAELFF	In	VDJ	1	17	1.2572197694111034E-4	1.4741716456091364E-4	36	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	4	1	8	10	0	3	26	-1	46	39	49		TCRBV03-01,TCRBV03-02				01,02								CASSRTSAELFF+TCRBV03-X+TCRBJ02-02	TCRBV03	TCRBD02-01	TCRBJ02-02*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCCGAGCGGGAGGGGGCACAGATACGCAGTATTTTGGCCCA	CSARAGGGTDTQYF	In	VDJ	1	17	1.2572197694111034E-4	1.4741716456091364E-4	42	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	6	6	0	1	3	1	26	34	47	37	48		TCRBV20-01,TCRBV20-or09_02												CSARAGGGTDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01*02	TCRBJ02-03*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTCGCGGACTGAACACTGAAGCTTTCTTTGGACAA	CATSRGLNTEAFF	In	VDJ	1	17	1.2572197694111034E-4	1.4741716456091364E-4	39	TCRBV24						TCRBJ01	TCRBJ01-01	01	6	1	7	0	3	0	24	36	-1	39	43		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATSRGLNTEAFF+TCRBV24-X+TCRBJ01-01	TCRBV24		TCRBJ01-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATGCCGGCAGGGGATTCGGTCAGCCCCAGCATTTTGGTGAT	CATSDAGRGFGQPQHF	In	VDJ	1	17	1.2572197694111034E-4	1.4741716456091364E-4	48	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	3	4	2	6	5	6	24	39	50	44	56		TCRBV24-01,TCRBV24-or09_02												CATSDAGRGFGQPQHF+TCRBV24-X+TCRBJ01-05	TCRBV24	TCRBD01-01*01	TCRBJ01-05*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCTTAATTCAAGGGGCCACAGATACGCAGTATTTTGGCCCA	CASSLIQGATDTQYF	In	VDJ	1	17	1.2572197694111034E-4	1.4741716456091364E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	2	5	2	2	5	1	18	33	43	38	44	TCRBV07,TCRBV11													CASSLIQGATDTQYF+X+TCRBJ02-03	unresolved	TCRBD01-01*01	TCRBJ02-03*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
TGGTGACTCTGCTGTGTATTTCTGTGCCGGCCGGAGACACTAGGGGCAGGGCCCCCAAGAAACGCTCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	17	1.2572197694111034E-4		59	TCRBV03						TCRBJ01	TCRBJ01-05	01	11	4	3	6	18	14	22	28	51	46	65		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV03-X+TCRBJ01-05	TCRBV03		TCRBJ01-05*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
AACYSRGGGACTCAGCTKTGTATTTYTGTGCCAGCAGCGTTGGCATAAGGAAGACCGGGGAGCTGTTTTTTGGAGAA	CASSVGIRKTGELFF	In	VDJ	1	18	1.3311738734941096E-4	1.560887624762615E-4	45	unresolved						TCRBJ02	TCRBJ02-02	01	6	1	8	5	11	2	26	37	51	48	53	TCRBV09,TCRBV12			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSVGIRKTGELFF+X+TCRBJ02-02	unresolved		TCRBJ02-02*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTCTCCACAGGAACACTGAAGCTTTCTTTGGACAA	CASSLHRNTEAFF	In	VDJ	1	18	1.3311738734941096E-4	1.560887624762615E-4	39	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	3	5	1	4	0	26	38	-1	42	46		TCRBV12-03,TCRBV12-04												CASSLHRNTEAFF+TCRBV12-X+TCRBJ01-01	TCRBV12	TCRBD01-01*01	TCRBJ01-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTGGGACAGGGAGCCTACGAGCAGTACTTCGGGCCG	CASSLGQGAYEQYF	In	VDJ	1	18	1.3311738734941096E-4	1.560887624762615E-4	42	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	0	3	2	0	2	26	-1	49	40	51		TCRBV12-03,TCRBV12-04												CASSLGQGAYEQYF+TCRBV12-X+TCRBJ02-07	TCRBV12	TCRBD01-01*01	TCRBJ02-07*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGGCTTTCGGGCGGGAGGCCAAACGAGCAGTACTTCGGGCCG	CRLSGGRPNEQYF	In	VDJ	1	18	1.3311738734941096E-4	1.560887624762615E-4	39	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	9	7	1	5	8	4	26	31	47	39	51		TCRBV20-01,TCRBV20-or09_02												CRLSGGRPNEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01*02	TCRBJ02-07*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGACCGACTAGCGGGAGGTCCTACGAGCAGTACTTCGGGCCG	CSARPTSGRSYEQYF	In	VDJ	1	18	1.3311738734941096E-4	1.560887624762615E-4	45	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	2	2	1	1	2	0	26	38	-1	40	53		TCRBV20-01,TCRBV20-or09_02												CSARPTSGRSYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01*02	TCRBJ02-07*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGCCGGTATCAGCAATCAGCCCCAGCATTTTGGTGAT	CATSAGISNQPQHF	In	VDJ	1	18	1.3311738734941096E-4	1.560887624762615E-4	42	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-05	01	5	8	5	1	1	4	24	37	41	38	45		TCRBV24-01,TCRBV24-or09_02				01,02								CATSAGISNQPQHF+TCRBV24-X+TCRBJ01-05	TCRBV24	TCRBD02-01	TCRBJ01-05*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGACCCTACAGCACGAACTACGAGCAGTACTTCGGGCCG	CASRPYSTNYEQYF	In	VDJ	1	18	1.3311738734941096E-4	1.560887624762615E-4	42	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	7	3	5	3	5	6	24	35	44	40	50		TCRBV24-01,TCRBV24-or09_02												CASRPYSTNYEQYF+TCRBV24-X+TCRBJ02-07	TCRBV24	TCRBD01-01*01	TCRBJ02-07*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCAGTCTCCCGCTCCGGCAGGGCTTCTTTGGACAA	CASSLPLRQGFF	In	VDJ	1	18	1.3311738734941096E-4	1.560887624762615E-4	36	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	4	3	14	12	1	23	35	52	47	53	TCRBV06,TCRBV10													CASSLPLRQGFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CGACTCGGCYGTGTATSTCTGTGCCAGCAGGCCCGGAAAAGCGGGAGTAAGAGCCCCCTACGAGCAGTACTTCGGGCCG	CASRPGKAGVRAPYEQYF	In	VDJ	1	18	1.3311738734941096E-4	1.560887624762615E-4	54	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	8	6	2	2	12	9	19	27	47	39	56	TCRBV07,TCRBV11													CASRPGKAGVRAPYEQYF+X+TCRBJ02-07	unresolved	TCRBD02-01*02	TCRBJ02-07*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
AGGACTCSGCCRTGTATCTCTGTGCCAGCAGCTCCACCGGGACCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSSTGTSYNEQFF	In	VDJ	1	18	1.3311738734941096E-4	1.560887624762615E-4	45	unresolved						TCRBJ02	TCRBJ02-01	01	4	0	7	0	5	0	19	32	-1	37	42	TCRBV07,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSSTGTSYNEQFF+X+TCRBJ02-01	unresolved		TCRBJ02-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
TGGRGGACTCAGCYWTGTAYTTCTGTGCCAGCAGCTTAGGCCTACAGGGAAACACCATATATTTTGGAGAG	CASSLGLQGNTIYF	In	VDJ	1	18	1.3311738734941096E-4	1.560887624762615E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	0	3	5	4	4	0	23	39	-1	43	47	TCRBV09,TCRBV13													CASSLGLQGNTIYF+X+TCRBJ01-03	unresolved	TCRBD01-01*01	TCRBJ01-03*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCTTCCGACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	19	1.4051279775771156E-4		34	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	8	6	5	3	0	26	38	-1	41	43		TCRBV03-01,TCRBV03-02				01,02								X+TCRBV03-X+TCRBJ02-01	TCRBV03	TCRBD02-01	TCRBJ02-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATAACAGGGGGCCTCTAAGGGAGACCCAGTACTTCGGGCCA	CSARDNRGPLRETQYF	In	VDJ	1	19	1.4051279775771156E-4	1.6476036039160937E-4	48	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	0	3	0	5	2	8	26	40	51	42	59		TCRBV20-01,TCRBV20-or09_02												CSARDNRGPLRETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD01-01*01	TCRBJ02-05*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATCTCGTCTCGGGACTTACCGGGGAGCTGTTTTTTGGAGAA	CSARDLVSGLTGELFF	In	VDJ	1	19	1.4051279775771156E-4	1.6476036039160937E-4	48	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	0	0	10	5	9	1	26	40	55	49	56		TCRBV20-01,TCRBV20-or09_02				01,02								CSARDLVSGLTGELFF+TCRBV20-X+TCRBJ02-02	TCRBV20	TCRBD02-01	TCRBJ02-02*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGGGGATGGGAGCGGGGCAAGAAACCCAGTACTTCGGGCCA	CSARGMGAGQETQYF	In	VDJ	1	19	1.4051279775771156E-4	1.6476036039160937E-4	45	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	3	6	3	8	9	6	26	37	53	46	59		TCRBV20-01,TCRBV20-or09_02												CSARGMGAGQETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD02-01*01	TCRBJ02-05*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTGATCGGCTCTATGGCTACACCTTCGGTTCG	CSASDRLYGYTF	In	VDJ	1	19	1.4051279775771156E-4	1.6476036039160937E-4	36	TCRBV20						TCRBJ01	TCRBJ01-02	01	3	9	0	4	5	1	26	37	45	42	46		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSASDRLYGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20		TCRBJ01-02*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCAGCGTAGTCGGGAGCAATGAGCAGTTCTTCGGGCCA	CASSVVGSNEQFF	In	VDJ	1	19	1.4051279775771156E-4	1.6476036039160937E-4	39	TCRBV12			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	6	8	2	6	6	0	22	33	-1	39	45		TCRBV12-03,TCRBV12-04												CASSVVGSNEQFF+TCRBV12-X+TCRBJ02-01	TCRBV12	TCRBD02-01*02	TCRBJ02-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGTGGGAGGAGGGGCCGGGGAGCTGTTTTTTGGAGAA	CATSVGGGAGELFF	In	VDJ	1	19	1.4051279775771156E-4	1.6476036039160937E-4	42	TCRBV24			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	5	9	1	6	1	5	24	37	44	38	49		TCRBV24-01,TCRBV24-or09_02												CATSVGGGAGELFF+TCRBV24-X+TCRBJ02-02	TCRBV24	TCRBD02-01*02	TCRBJ02-02*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGCGCCCACTTGCGGTGAATAGTACGAGCAGTACTTCGGGCCG	CASSLAPTCGE*YEQYF	Stop	VDJ	1	19	1.4051279775771156E-4		51				TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	0	7	5	4	8	7	18	35	47	43	54	TCRBV07,TCRBV11	TCRBV07-02,TCRBV11-03				01,02								CASSLAPTCGE*YEQYF+X+TCRBJ02-07		TCRBD02-01	TCRBJ02-07*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GGACTCGGCCCTCTATCTCTGTGCCAGCAGCCCAAGGACAAGGGGGACATCCCGTCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	19	1.4051279775771156E-4		52	TCRBV05			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	0	6	3	12	6	19	31	49	43	55		TCRBV05-06,TCRBV05-07												X+TCRBV05-X+TCRBJ02-07	TCRBV05	TCRBD01-01*01	TCRBJ02-07*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
AACYSRGGGACTCAGCTKTGTATTTYTGTGCCAGCAGCCCCCGGTGGGACAAACCAACTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSPRWDKPTGANVLTF	In	VDJ	1	19	1.4051279775771156E-4	1.6476036039160937E-4	54	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	4	0	6	2	7	6	23	35	48	42	54	TCRBV09,TCRBV12													CASSPRWDKPTGANVLTF+X+TCRBJ02-06	unresolved	TCRBD01-01*01	TCRBJ02-06*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
AACCCAGGGACTCAGCTGTGTAYTTYTGTGCCAGCAGCCCAGGGGGCTGGGACACTGAAGCTTTCTTTGGACAA	CASSPGGWDTEAFF	In	VDJ	1	20	1.4790820816601219E-4	1.734319583069572E-4	42	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	4	0	3	2	4	26	37	47	39	51		TCRBV12-03,TCRBV12-04,TCRBV12-05												CASSPGGWDTEAFF+TCRBV12-X+TCRBJ01-01	TCRBV12	TCRBD01-01*01	TCRBJ01-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGCACTAGCGCTGGGTACGCAGTATTTTGGCCCA	CASSQALALGTQYF	In	VDJ	1	20	1.4790820816601219E-4	1.734319583069572E-4	42	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	1	3	6	8	1	5	26	42	50	43	55		TCRBV03-01,TCRBV03-02				01,02								CASSQALALGTQYF+TCRBV03-X+TCRBJ02-03	TCRBV03	TCRBD02-01	TCRBJ02-03*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGCGGACAGGGTTCCAACTATGGCTACACCTTCGGTTCG	CSGQGSNYGYTF	In	VDJ	1	20	1.4790820816601219E-4	1.734319583069572E-4	36	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	9	1	3	2	1	4	26	31	40	32	44		TCRBV20-01,TCRBV20-or09_02												CSGQGSNYGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGGCGGACAATTCAGATACGCAGTATTTTGGCCCA	CSARADNSDTQYF	In	VDJ	1	20	1.4790820816601219E-4	1.734319583069572E-4	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	3	1	6	4	3	3	26	37	45	40	48		TCRBV20-01,TCRBV20-or09_02												CSARADNSDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD01-01*01	TCRBJ02-03*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGTTCCGTCCGGGCGAGATACGCAGTATTTTGGCCCA	CSVPSGRDTQYF	In	VDJ	1	20	1.4790820816601219E-4	1.734319583069572E-4	36	TCRBV20						TCRBJ02	TCRBJ02-03	01	7	8	0	5	8	1	26	33	45	41	46		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSVPSGRDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20		TCRBJ02-03*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCCWMCCAGACAKCTSTKTACTTSTGTGCCAGCAGTGCCCGGGGGGGCCAGGGACTAGTGCTCCAGGATACGCAGTATTTTGGCCCA	CASSARGGQGLVLQDTQYF	In	VDJ	1	20	1.4790820816601219E-4	1.734319583069572E-4	57	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	5	0	8	6	13	8	24	37	58	50	66	TCRBV06,TCRBV24					01,02								CASSARGGQGLVLQDTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01	TCRBJ02-03*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTACGGACAGGTTATGGCTACACCTTCGGTTCG	CASSLRTGYGYTF	In	VDJ	1	20	1.4790820816601219E-4	1.734319583069572E-4	39	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	1	4	5	4	1	24	36	47	40	48		TCRBV24-01,TCRBV24-or09_02												CASSLRTGYGYTF+TCRBV24-X+TCRBJ01-02	TCRBV24	TCRBD01-01*01	TCRBJ01-02*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTTAGTACTCTGGAAACACCATATATTTTGGAGAG		Out	VDJ	1	20	1.4790820816601219E-4		41	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-03	01	6	5	8	0	2	2	24	36	41	38	43		TCRBV24-01,TCRBV24-or09_02				01,02								X+TCRBV24-X+TCRBJ01-03	TCRBV24	TCRBD02-01	TCRBJ01-03*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GACTCGGCCRTGTATSTCTGTGCCAGCAGCCCTAGGAGGGGGCCTTTGACTAGCGGGGCAAGGGTTGAGACCCAGTACTTCGGGCCA	CASSPRRGPLTSGARVETQYF	In	VDJ	1	20	1.4790820816601219E-4	1.734319583069572E-4	63				TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	5	2	3	5	17	8	18	30	58	47	66	TCRBV07,TCRBV11	TCRBV07-02,TCRBV11-02,TCRBV11-03												CASSPRRGPLTSGARVETQYF+X+TCRBJ02-05		TCRBD02-01*01	TCRBJ02-05*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCTTCCCACTAGCGGGAGGGGCAGATACGCAGTATTTTGGCCCA	CASSFPLAGGADTQYF	In	VDJ	1	20	1.4790820816601219E-4	1.734319583069572E-4	48	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	3	3	0	4	3	1	18	32	48	35	49	TCRBV07,TCRBV11													CASSFPLAGGADTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01*02	TCRBJ02-03*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCAGCTTAGGAGCAGGGATGTACGAGCAGTACTTCGGGCCG	CASSLGAGMYEQYF	In	VDJ	1	20	1.4790820816601219E-4	1.734319583069572E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	2	4	3	4	5	3	19	33	43	38	46	TCRBV05,TCRBV11													CASSLGAGMYEQYF+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTATGCAGGGGGCAGGACTGAAGCTTTCTTTGGACAA	CASSYAGGRTEAFF	In	VDJ	1	21	1.5530361857431278E-4	1.821035562223051E-4	42	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	4	0	5	3	3	26	39	50	42	53		TCRBV12-03,TCRBV12-04												CASSYAGGRTEAFF+TCRBV12-X+TCRBJ01-01	TCRBV12	TCRBD01-01*01	TCRBJ01-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTGGGGGACAGGGGGCAGTTGGCTACACCTTCGGTTCG	CSAGGQGAVGYTF	In	VDJ	1	21	1.5530361857431278E-4	1.821035562223051E-4	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	0	0	7	2	3	26	35	49	37	52		TCRBV20-01,TCRBV20-or09_02												CSAGGQGAVGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
AACCCAGGGACTCAGCTGTGTAYTTYTGTGCCAGCAGTTTGGGAATTTCTAGGGGTACACAAGAGACCCAGTACTTCGGGCCA	CASSLGISRGTQETQYF	In	VDJ	1	21	1.5530361857431278E-4	1.821035562223051E-4	51	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	3	5	2	2	10	4	22	36	51	46	55		TCRBV12-03,TCRBV12-04												CASSLGISRGTQETQYF+TCRBV12-X+TCRBJ02-05	TCRBV12	TCRBD01-01*01	TCRBJ02-05*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCGGGGGTGACCTCAGCACAGATACGCAGTATTTTGGCCCA	CATGGDLSTDTQYF	In	VDJ	1	21	1.5530361857431278E-4	1.821035562223051E-4	42	TCRBV24						TCRBJ02	TCRBJ02-03	01	9	6	1	0	0	7	24	-1	38	33	45		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATGGDLSTDTQYF+TCRBV24-X+TCRBJ02-03	TCRBV24		TCRBJ02-03*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GGACTCRGCCRTGTATSKCTGTGCCAGCAGAAGGGACAGCCAAAACACCGGGGAGCTGTTTTTTGGAGAA	CASRRDSQNTGELFF	In	VDJ	1	21	1.5530361857431278E-4	1.821035562223051E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	6	0	5	2	2	4	18	29	38	31	42	TCRBV07,TCRBV11													CASRRDSQNTGELFF+X+TCRBJ02-02	unresolved	TCRBD01-01*01	TCRBJ02-02*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCAGGGCAACACAGGGGGAAGGAAACACTGAAGCTTTCTTTGGACAA	CASRATQGEGNTEAFF	In	VDJ	1	22	1.6269902898261338E-4	1.9077515413765293E-4	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	3	1	2	6	5	24	35	49	41	54	TCRBV06,TCRBV10													CASRATQGEGNTEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
SRGGGACTTGGSYSTRTATYTCTGTGCCAGCAGCTTAGTCGGAGGGGCGAAGGCTGGCTACACCTTCGGTTCG	CASSLVGGAKAGYTF	In	VDJ	1	22	1.6269902898261338E-4	1.9077515413765293E-4	45	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	3	10	0	7	4	8	22	36	46	40	54	TCRBV07,TCRBV12													CASSLVGGAKAGYTF+X+TCRBJ01-02	unresolved	TCRBD02-01*02	TCRBJ01-02*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCCAACCAGACMKCTCTKTACTTCTGTGCCAGCAGTCCACTGTGGACGGTAAACACTGAAGCTTTCTTTGGACAA	CASSPLWTVNTEAFF	In	VDJ	1	22	1.6269902898261338E-4	1.9077515413765293E-4	45	unresolved						TCRBJ01	TCRBJ01-01	01	5	1	7	2	7	4	23	35	46	42	50	TCRBV24,TCRBV27			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPLWTVNTEAFF+X+TCRBJ01-01	unresolved		TCRBJ01-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCCAACCAGACMKCTCTKTACTTCTGTGCCAGCAGTTTAAGTCGGCAGAAACAAGAGACCCAGTACTTCGGGCCA	CASSLSRQKQETQYF	In	VDJ	1	22	1.6269902898261338E-4	1.9077515413765293E-4	45	unresolved						TCRBJ02	TCRBJ02-05	01	2	4	5	2	6	3	23	38	47	44	50	TCRBV24,TCRBV27			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLSRQKQETQYF+X+TCRBJ02-05	unresolved		TCRBJ02-05*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CGACTCGGCYGTGTATSTCTGTGCCAGCAGCTTAGAAGCGGGAGGGGCCAATGAGCAGTTCTTCGGGCCA	CASSLEAGGANEQFF	In	VDJ	1	22	1.6269902898261338E-4	1.9077515413765293E-4	45	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	0	6	0	6	0	2	18	-1	45	35	47	TCRBV07,TCRBV11													CASSLEAGGANEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01*02	TCRBJ02-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGCGCCCGGCGCGGTGCTAGCACCCACAATGAGCAGTTCTTCGGGCCA	CASSARRGASTHNEQFF	In	VDJ	1	22	1.6269902898261338E-4	1.9077515413765293E-4	51	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	3	4	7	5	12	4	23	36	53	48	57	TCRBV09,TCRBV21					01,02								CASSARRGASTHNEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01	TCRBJ02-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCCTAGGCGGGACAGGGGCAGATACGCAGTATTTTGGCCCA	CASSLGGTGADTQYF	In	VDJ	1	23	1.70094439390914E-4	1.994467520530008E-4	45	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	6	0	2	4	7	0	26	37	-1	44	54		TCRBV12-03,TCRBV12-04,TCRBV12-05												CASSLGGTGADTQYF+TCRBV12-X+TCRBJ02-03	TCRBV12	TCRBD01-01*01	TCRBJ02-03*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGACGGGCGGGTGAACACTGAAGCTTTCTTTGGACAA	CSARDGRVNTEAFF	In	VDJ	1	23	1.70094439390914E-4	1.994467520530008E-4	42	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	0	7	4	0	3	0	26	40	-1	43	48		TCRBV20-01,TCRBV20-or09_02				01,02								CSARDGRVNTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD02-01	TCRBJ01-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATCGATGGGGCATCCGCTCCTACGAGCAGTACTTCGGGCCG	CSARDRWGIRSYEQYF	In	VDJ	1	23	1.70094439390914E-4	1.994467520530008E-4	48	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	0	7	0	0	5	5	26	40	50	45	55		TCRBV20-01,TCRBV20-or09_02												CSARDRWGIRSYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD01-01*01	TCRBJ02-07*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGGCCAAGCCTACGGGGAGCAGTACTTCGGGCCG	CSARGQAYGEQYF	In	VDJ	1	23	1.70094439390914E-4	1.994467520530008E-4	39	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	1	8	4	7	10	0	26	39	-1	49	53		TCRBV20-01,TCRBV20-or09_02				01,02								CSARGQAYGEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01	TCRBJ02-07*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTGGACTAGCGGGAGGGCCCGGGAGCACAGATACGCAGTATTTTGGCCCA	CSAGLAGGPGSTDTQYF	In	VDJ	1	23	1.70094439390914E-4	1.994467520530008E-4	51	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	5	1	0	0	0	6	26	-1	50	35	56		TCRBV20-01,TCRBV20-or09_02												CSAGLAGGPGSTDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01*02	TCRBJ02-03*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCAGGCTCCGGGCCACTAATGAAAAACTGTTTTTTGGCAGT	CASRLRATNEKLFF	In	VDJ	1	23	1.70094439390914E-4	1.994467520530008E-4	42	TCRBV12						TCRBJ01	TCRBJ01-04	01	6	8	0	2	5	1	22	33	42	38	43		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASRLRATNEKLFF+TCRBV12-X+TCRBJ01-04	TCRBV12		TCRBJ01-04*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATTTACGGACTAGCTCAGATACGCAGTATTTTGGCCCA	CATSDLRTSSDTQYF	In	VDJ	1	23	1.70094439390914E-4	1.994467520530008E-4	45	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	1	1	7	4	2	1	24	41	51	43	52		TCRBV24-01,TCRBV24-or09_02				01,02								CATSDLRTSSDTQYF+TCRBV24-X+TCRBJ02-03	TCRBV24	TCRBD02-01	TCRBJ02-03*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGCCTCGGACAGATCACCGGGGAGCTGTTTTTTGGAGAA	CASSLGQITGELFF	In	VDJ	1	23	1.70094439390914E-4	1.994467520530008E-4	42	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	7	1	5	4	4	2	24	35	45	39	47		TCRBV24-01,TCRBV24-or09_02												CASSLGQITGELFF+TCRBV24-X+TCRBJ02-02	TCRBV24	TCRBD01-01*01	TCRBJ02-02*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CGACTCGGCYGTGTATSTCTGTGCCAGCAGCCCAGTAGGGACTAGTAATATAGGGCAGTTCTTCGGGCCA	CASSPVGTSNIGQFF	In	VDJ	1	23	1.70094439390914E-4	1.994467520530008E-4	45	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	0	8	12	6	9	18	30	44	36	53	TCRBV07,TCRBV11					01,02								CASSPVGTSNIGQFF+X+TCRBJ02-01	unresolved	TCRBD02-01	TCRBJ02-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
AACYSRGGGACTCAGCTKTGTATTTYTGTGCCAGCAGCGTCGTCGGGACTAGCGCCGCCGACGAGCAGTACTTCGGGCCG	CASSVVGTSAADEQYF	In	VDJ	1	24	1.774898497992146E-4	2.0811834996834865E-4	48	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	6	0	6	5	7	6	26	37	54	44	60	TCRBV09,TCRBV12					01,02								CASSVVGTSAADEQYF+X+TCRBJ02-07	unresolved	TCRBD02-01	TCRBJ02-07*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTGAAGTGGCGGGGAGCAACTAATGAAAAACTGTTTTTTGGCAGT	CASSLKWRGATNEKLFF	In	VDJ	1	24	1.774898497992146E-4	2.0811834996834865E-4	51	TCRBV12			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-04	01	3	7	3	0	6	2	26	40	52	46	54		TCRBV12-03,TCRBV12-04												CASSLKWRGATNEKLFF+TCRBV12-X+TCRBJ01-04	TCRBV12	TCRBD02-01*01	TCRBJ01-04*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGCCTCGGGGGACCTCTTTACGAGCAGTACTTCGGGCCG	CSLGGPLYEQYF	In	VDJ	1	24	1.774898497992146E-4	2.0811834996834865E-4	36	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	9	8	2	4	3	7	26	31	40	34	47		TCRBV20-01,TCRBV20-or09_02												CSLGGPLYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01*01	TCRBJ02-07*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTACAACTAGCGGGAGATTTTCAGATACGCAGTATTTTGGCCCA	CSTTSGRFSDTQYF	In	VDJ	1	24	1.774898497992146E-4	2.0811834996834865E-4	42	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	8	3	2	4	3	5	26	32	46	35	51		TCRBV20-01,TCRBV20-or09_02												CSTTSGRFSDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01*02	TCRBJ02-03*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATACGGAGAGCTCCTACGAGCAGTACTTCGGGCCG	CSARDTESSYEQYF	In	VDJ	1	24	1.774898497992146E-4	2.0811834996834865E-4	42	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	0	10	2	0	3	2	26	40	47	43	49		TCRBV20-01,TCRBV20-or09_02												CSARDTESSYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01*02	TCRBJ02-07*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CAGCTTCTACATCTGCAGTGGGGACAGGAGTCCTCATCTAGCTAGGACCCCAAAGCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	24	1.774898497992146E-4		61	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	7	0	4	0	0	25	13	-1	28	20	53		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD01-01*01	TCRBJ02-03*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
TSRGGGACTCAGCTKTGTAYTTCTGTGCCAGCAGCGGAGGGGAGAGCAATCAGCCCCAGCATTTTGGTGAT	CASSGGESNQPQHF	In	VDJ	1	24	1.774898497992146E-4	2.0811834996834865E-4	42	unresolved			unresolved			TCRBJ01	TCRBJ01-05	01	6	10	0	1	1	3	22	33	40	34	43	TCRBV09,TCRBV12			TCRBD01,TCRBD02										CASSGGESNQPQHF+X+TCRBJ01-05	unresolved	unresolved	TCRBJ01-05*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGACTCTCCCGGGACAGGGCCCTACGAGCAGTACTTCGGGCCG	CATSDSPGTGPYEQYF	In	VDJ	1	24	1.774898497992146E-4	2.0811834996834865E-4	48	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	0	3	2	7	1	24	38	54	45	55		TCRBV24-01,TCRBV24-or09_02												CATSDSPGTGPYEQYF+TCRBV24-X+TCRBJ02-07	TCRBV24	TCRBD01-01*01	TCRBJ02-07*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTGAACCGGGACAGGGATCCTACAAGCAGTACTTCGGGCCG	CAISEPGQGSYKQYF	In	VDJ	1	24	1.774898497992146E-4	2.0811834996834865E-4	45				TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	2	0	3	8	2	8	23	38	49	40	57	TCRBV06,TCRBV10	TCRBV06-01,TCRBV06-08,TCRBV10-03												CAISEPGQGSYKQYF+X+TCRBJ02-07		TCRBD01-01*01	TCRBJ02-07*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CGACTCGGCYGTGTATSTCTGTGCCAGCAGCTTAGGATTTCCGGGGGATGAGCAGTTCTTCGGGCCA	CASSLGFPGDEQFF	In	VDJ	1	24	1.774898497992146E-4	2.0811834996834865E-4	42	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	0	8	2	8	6	0	19	35	-1	41	47	TCRBV07,TCRBV11													CASSLGFPGDEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01*01	TCRBJ02-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GGACTCGGCCCTCTATCTCTGTGCCAGCAGCTTAAAGGACGGATTGCGCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	24	1.774898497992146E-4		46	TCRBV05						TCRBJ02	TCRBJ02-07	01	2	1	7	2	3	8	19	33	40	36	48		TCRBV05-06,TCRBV05-07		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV05-X+TCRBJ02-07	TCRBV05		TCRBJ02-07*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
TGGTGGCACCAACCAGACATCTAGTACCTCTGTGCCAGCAGTCCTAGCGGGAGGGCCTCACGGAACAATGAGCAGTTCTTCGGGCCA	CASSPSGRASRNNEQFF	In	VDJ	1	24	1.774898497992146E-4	2.0811834996834865E-4	51	TCRBV25			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	5	4	0	5	1	9	30	42	55	43	64		TCRBV25-01,TCRBV25-or09_02												CASSPSGRASRNNEQFF+TCRBV25-X+TCRBJ02-01	TCRBV25	TCRBD02-01*02	TCRBJ02-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAATGGCAGGGGAACTATGGCTACACCTTCGGTTCG	CASSQWQGNYGYTF	In	VDJ	1	25	1.848852602075152E-4	2.1678994788369653E-4	42	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	2	4	2	2	3	0	26	41	-1	44	50		TCRBV03-01,TCRBV03-02												CASSQWQGNYGYTF+TCRBV03-X+TCRBJ01-02	TCRBV03	TCRBD01-01*01	TCRBJ01-02*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCCTACAGGGGGCACTGAAGCTTTCTTTGGACAA	CSAPTGGTEAFF	In	VDJ	1	25	1.848852602075152E-4	2.1678994788369653E-4	36	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	3	1	4	3	0	26	35	-1	38	46		TCRBV20-01,TCRBV20-or09_02												CSAPTGGTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTCCACAGGGGGGAATGAACACTGAAGCTTTCTTTGGACAA	CASSPQGGMNTEAFF	In	VDJ	1	25	1.848852602075152E-4	2.1678994788369653E-4	45	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	3	1	0	2	3	24	36	46	38	49		TCRBV24-01,TCRBV24-or09_02												CASSPQGGMNTEAFF+TCRBV24-X+TCRBJ01-01	TCRBV24	TCRBD01-01*01	TCRBJ01-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTCTACACGACAAGTCAGATACGCAGTATTTTGGCCCA	CASSLHDKSDTQYF	In	VDJ	1	25	1.848852602075152E-4	2.1678994788369653E-4	42	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	6	2	6	4	6	3	24	36	46	42	49		TCRBV24-01,TCRBV24-or09_02												CASSLHDKSDTQYF+TCRBV24-X+TCRBJ02-03	TCRBV24	TCRBD01-01*01	TCRBJ02-03*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCAGTGGAGGGACATACCGAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	25	1.848852602075152E-4		43	unresolved			unresolved			TCRBJ02	TCRBJ02-05	01	5	0	6	3	3	5	23	35	44	38	49	TCRBV06,TCRBV10			TCRBD01,TCRBD02										X+X+TCRBJ02-05	unresolved	unresolved	TCRBJ02-05*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GGACTCGGCCMTSTATCKCTGTGCCAGCAGCCGGAGTACTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSRSTGANVLTF	In	VDJ	1	25	1.848852602075152E-4	2.1678994788369653E-4	42	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-06	01	4	10	2	2	1	2	19	31	36	32	38	TCRBV05,TCRBV07													CASSRSTGANVLTF+X+TCRBJ02-06	unresolved	TCRBD02-01*02	TCRBJ02-06*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GGACTCGGCCCTCTATCTCTGTGCCAGCAGCCGGGACAGGGCTAACACTGAAGCTTTCTTTGGACAA	CASSRDRANTEAFF	In	VDJ	1	25	1.848852602075152E-4	2.1678994788369653E-4	42	TCRBV05			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	0	3	2	1	2	19	31	41	32	43		TCRBV05-06,TCRBV05-07												CASSRDRANTEAFF+TCRBV05-X+TCRBJ01-01	TCRBV05	TCRBD01-01*01	TCRBJ01-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
AACCCAGGGACTCAGCTGTGTAYTTYTGTGCCAGCAGACGGCGGGAGGATAACACTGAAGCTTTCTTTGGACAA	CASRRREDNTEAFF	In	VDJ	1	26	1.9228067061581583E-4	2.254615457990444E-4	42	TCRBV12			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	6	7	1	2	3	2	26	37	48	40	50		TCRBV12-03,TCRBV12-04,TCRBV12-05												CASRRREDNTEAFF+TCRBV12-X+TCRBJ01-01	TCRBV12	TCRBD02-01*02	TCRBJ01-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTCTCCGGGACAGGGGTGAGACCCAGTACTTCGGGCCA	CASSLRDRGETQYF	In	VDJ	1	26	1.9228067061581583E-4	2.254615457990444E-4	42	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	5	0	2	5	4	1	26	38	52	42	53		TCRBV12-03,TCRBV12-04												CASSLRDRGETQYF+TCRBV12-X+TCRBJ02-05	TCRBV12	TCRBD01-01*01	TCRBJ02-05*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
ACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATTGCCAGGAGGCCCTTAGATAGTCCGAACACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	26	1.9228067061581583E-4		61	TCRBV24			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	2	10	1	0	4	13	20	36	45	40	58		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ02-02	TCRBV24	TCRBD02-01*02	TCRBJ02-02*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTCGGTCCGCGGGCCTCTCCTACGAGCAGTACTTCGGGCCG	CASSRSAGLSYEQYF	In	VDJ	1	26	1.9228067061581583E-4	2.254615457990444E-4	45	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	6	7	4	0	6	3	24	36	47	42	50		TCRBV24-01,TCRBV24-or09_02				01,02								CASSRSAGLSYEQYF+TCRBV24-X+TCRBJ02-07	TCRBV24	TCRBD02-01	TCRBJ02-07*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GGACTCGGCCMTGTATCTCTGTGCCAGCAGCCTTACAGGGGTGGGCACTGAAGCTTTCTTTGGACAA	CASSLTGVGTEAFF	In	VDJ	1	26	1.9228067061581583E-4	2.254615457990444E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	3	2	4	3	4	19	31	41	34	45	TCRBV05,TCRBV11													CASSLTGVGTEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CAGARGACTCRGCCCTKTATCTYTGCACCAGCAGCCAGCGAACAGGGAGGTGAAAAACTGTTTTTTGGCAGT		Out	VDJ	1	26	1.9228067061581583E-4		43	unresolved						TCRBJ01	TCRBJ01-04	01	4	3	3	7	6	3	19	31	43	37	46	TCRBV04,TCRBV05			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+X+TCRBJ01-04	unresolved		TCRBJ01-04*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
AGCTCCCAGACATCTGTGTACTTCTGTGCCAGCAGTCTACAGGGGGACAACTATGGCTACACCTTCGGTTCG	CASSLQGDNYGYTF	In	VDJ	1	27	1.9967608102411643E-4	2.3413314371439225E-4	42				TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	3	1	2	2	2	24	36	46	38	48	TCRBV06,TCRBV10	TCRBV06-01,TCRBV06-05,TCRBV06-06,TCRBV10-03												CASSLQGDNYGYTF+X+TCRBJ01-02		TCRBD01-01*01	TCRBJ01-02*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGAGGCTAGCGGGCATTTTCAAGAGACCCAGTACTTCGGGCCA	CSAREASGHFQETQYF	In	VDJ	1	27	1.9967608102411643E-4	2.3413314371439225E-4	48	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	0	4	4	2	2	6	26	40	50	42	56		TCRBV20-01,TCRBV20-or09_02				01,02								CSAREASGHFQETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD02-01	TCRBJ02-05*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGCTGGCTAGCGGGAACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	27	1.9967608102411643E-4		43	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	1	4	3	5	4	0	26	39	-1	43	52		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*02	TCRBJ02-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAACTCCGGGGCTTGAACTATGGCTACACCTTCGGTTCG		Out	VDJ	1	27	1.9967608102411643E-4		38	TCRBV24						TCRBJ01	TCRBJ01-02	01	11	7	0	2	5	3	24	31	41	36	44		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV24-X+TCRBJ01-02	TCRBV24		TCRBJ01-02*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGCCGGGACAGTTACAATGAGCAGTTCTTCGGGCCA	CATSRDSYNEQFF	In	VDJ	1	27	1.9967608102411643E-4	2.3413314371439225E-4	39	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	7	0	5	4	2	1	24	35	44	37	45		TCRBV24-01,TCRBV24-or09_02												CATSRDSYNEQFF+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD01-01*01	TCRBJ02-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCCCGGGATGGGGCTGGGAGGTGGTACGCAGTATTTTGGCCCA		Out	VDJ	1	27	1.9967608102411643E-4		41	TCRBV24			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	12	9	1	8	13	3	24	30	49	43	52		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ02-03	TCRBV24	TCRBD02-01*02	TCRBJ02-03*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCACGACAGGGTCCCCCTACAATGAGCAGTTCTTCGGGCCA	CASSTTGSPYNEQFF	In	VDJ	1	28	2.0707149143241705E-4	2.4280474162974012E-4	45	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	6	2	3	2	3	4	26	37	47	40	51		TCRBV12-03,TCRBV12-04,TCRBV12-05												CASSTTGSPYNEQFF+TCRBV12-X+TCRBJ02-01	TCRBV12	TCRBD01-01*01	TCRBJ02-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
AGCTCCCAGACATCTGTGTACTTCTGTGCCAGCAGTTTCCTCGACAGAACCACCGGGGAGCTGTTTTTTGGAGAA	CASSFLDRTTGELFF	In	VDJ	1	28	2.0707149143241705E-4	2.4280474162974012E-4	45	TCRBV06			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	4	2	5	4	5	3	24	37	47	42	50		TCRBV06-05,TCRBV06-06												CASSFLDRTTGELFF+TCRBV06-X+TCRBJ02-02	TCRBV06	TCRBD01-01*01	TCRBJ02-02*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGACGACAACAGGGGCTACACCTTCGGTTCG	CASSQDDNRGYTF	In	VDJ	1	28	2.0707149143241705E-4	2.4280474162974012E-4	39	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	3	4	8	5	0	26	43	-1	48	53		TCRBV03-01,TCRBV03-02												CASSQDDNRGYTF+TCRBV03-X+TCRBJ01-02	TCRBV03	TCRBD01-01*01	TCRBJ01-02*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCGCAGTCTACAGGGGAGGGACAGCCCCAGCATTTTGGTGAT	CSAQSTGEGQPQHF	In	VDJ	1	28	2.0707149143241705E-4	2.4280474162974012E-4	42	TCRBV20						TCRBJ01	TCRBJ01-05	01	6	3	2	7	7	5	26	34	48	41	53		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSAQSTGEGQPQHF+TCRBV20-X+TCRBJ01-05	TCRBV20		TCRBJ01-05*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATCTAGTAGGTTCCTACGAGCAGTACTTCGGGCCG	CSARDLVGSYEQYF	In	VDJ	1	28	2.0707149143241705E-4	2.4280474162974012E-4	42	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	0	4	8	1	1	5	26	40	45	41	50		TCRBV20-01,TCRBV20-or09_02				01,02								CSARDLVGSYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01	TCRBJ02-07*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGGCTCGGGCGGGGACAAAATTAATAGTCCTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	28	2.0707149143241705E-4		59	TCRBV24						TCRBJ02	TCRBJ02-01	01	5	0	6	1	9	10	22	35	50	44	60		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV24-X+TCRBJ02-01	TCRBV24		TCRBJ02-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCATCACCGCGTCAGGCTTCGCCGAATGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	28	2.0707149143241705E-4		50	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	11	4	4	0	9	10	24	31	44	40	54		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ01-01	TCRBV24	TCRBD01-01*01	TCRBJ01-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GACTCGGCCGTGTATSTCTGTGCCAGCAGCTTAGGTCTGCCTGGCAATGAGCAGTTCTTCGGGCCA	CASSLGLPGNEQFF	In	VDJ	1	28	2.0707149143241705E-4	2.4280474162974012E-4	42	unresolved						TCRBJ02	TCRBJ02-01	01	1	0	10	6	8	0	18	34	-1	42	44	TCRBV07,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLGLPGNEQFF+X+TCRBJ02-01	unresolved		TCRBJ02-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
AGCTTGGTGACTCKGCYGTGTATKTCTGTGCCAGCAGCTTGGGTCTTGGTGGGGAGTTTGAGCAGTTCTTCGGGCCA	CASSLGLGGEFEQFF	In	VDJ	1	28	2.0707149143241705E-4	2.4280474162974012E-4	45	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	3	9	2	9	11	2	18	32	48	43	50	TCRBV03,TCRBV11													CASSLGLGGEFEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01*02	TCRBJ02-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
AAGARGACTCRGCYSYKTATCTYTGCGCCAGCAGCCTAGGACAGGGAGGGACTGAAGCTTTCTTTGGACAA	CASSLGQGGTEAFF	In	VDJ	1	28	2.0707149143241705E-4	2.4280474162974012E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	1	3	5	3	4	19	31	42	34	46	TCRBV01,TCRBV05													CASSLGQGGTEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGGGTTCCTTCGTAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	29	2.1446690184071765E-4		43	TCRBV03						TCRBJ02	TCRBJ02-05	01	1	0	10	4	0	9	26	-1	44	42	53		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV03-X+TCRBJ02-05	TCRBV03		TCRBJ02-05*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGGGGGACAGCTCTCTAACTATGGCTACACCTTCGGTTCG	CSARGGQLSNYGYTF	In	VDJ	1	29	2.1446690184071765E-4	2.51476339545088E-4	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	1	0	5	0	1	4	26	39	47	40	51		TCRBV20-01,TCRBV20-or09_02												CSARGGQLSNYGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGATCGGGACTAGCGTCAGAGACCCAGTACTTCGGGCCA	CSARSGLASETQYF	In	VDJ	1	29	2.1446690184071765E-4	2.51476339545088E-4	42	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	2	0	6	4	2	2	26	38	50	40	52		TCRBV20-01,TCRBV20-or09_02				01,02								CSARSGLASETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD02-01	TCRBJ02-05*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGCGGAGACACAGGGCCGAACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	29	2.1446690184071765E-4		43	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	7	3	3	5	7	4	24	35	48	42	52		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ01-01	TCRBV24	TCRBD01-01*01	TCRBJ01-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCAGTATTCAAAAGTGGGTGCTGAAAGACCTATGGCTACACCTTCGGTTCG		Out	VDJ	1	29	2.1446690184071765E-4		52	unresolved						TCRBJ01	TCRBJ01-02	01	5	0	9	4	10	11	23	35	48	45	59	TCRBV06,TCRBV10			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+X+TCRBJ01-02	unresolved		TCRBJ01-02*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CACCWMCCAGACATCTRTGTACYTSTGTGCCATCAGCGATGACAGGGACTATGGCTACACCTTCGGTTCG	CAISDDRDYGYTF	In	VDJ	1	29	2.1446690184071765E-4	2.51476339545088E-4	39	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	2	3	3	4	0	23	34	-1	38	45	TCRBV06,TCRBV28													CAISDDRDYGYTF+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
AGCTCCCAGACATCTGTGTACTTCTGTGCCAGCAGTCTACGCTCCGACAGGGTTTCAGATACGCAGTATTTTGGCCCA	CASSLRSDRVSDTQYF	In	VDJ	1	30	2.2186231224901825E-4	2.6014793746043585E-4	48				TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	5	2	3	4	9	3	24	36	52	45	55	TCRBV06,TCRBV10	TCRBV06-01,TCRBV06-05,TCRBV06-06,TCRBV10-03												CASSLRSDRVSDTQYF+X+TCRBJ02-03		TCRBD01-01*01	TCRBJ02-03*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAAGGGAGGGGTATAGAGACCCAGTACTTCGGGCCA	CASSQGRGIETQYF	In	VDJ	1	30	2.2186231224901825E-4	2.6014793746043585E-4	42	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	1	10	0	4	0	4	23	-1	45	39	49	TCRBV01,TCRBV04													CASSQGRGIETQYF+X+TCRBJ02-05	unresolved	TCRBD02-01*02	TCRBJ02-05*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGGCGGACAGGGTCTTCCTCCTACGAGCAGTACTTCGGGCCG	CASRRTGSSSYEQYF	In	VDJ	1	30	2.2186231224901825E-4	2.6014793746043585E-4	45	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	7	1	3	0	2	5	24	35	45	37	50		TCRBV24-01,TCRBV24-or09_02												CASRRTGSSSYEQYF+TCRBV24-X+TCRBJ02-07	TCRBV24	TCRBD01-01*01	TCRBJ02-07*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GACTCGGCCGTGTATGTCTGTGCCAGAAGCACGGACTAGCGGGAGGAAGGTCAACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	30	2.2186231224901825E-4		53				TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	4	1	1	5	2	7	18	30	46	32	53	TCRBV05,TCRBV11	TCRBV05-03,TCRBV11-03												X+X+TCRBJ02-02		TCRBD02-01*02	TCRBJ02-02*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCGTAAATGACAACTATGGCTACACCTTCGGTTCG	CASSVNDNYGYTF	In	VDJ	1	31	2.2925772265731888E-4	2.688195353757837E-4	39	TCRBV12						TCRBJ01	TCRBJ01-02	01	6	2	7	2	7	0	26	37	-1	44	47		TCRBV12-03,TCRBV12-04,TCRBV12-05		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSVNDNYGYTF+TCRBV12-X+TCRBJ01-02	TCRBV12		TCRBJ01-02*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTCTAGCGGGAGAAAAACATTCAGTACTTCGGCGCC	CASSF*REKNIQYF	Stop	VDJ	1	31	2.2925772265731888E-4		42	TCRBV12			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-04	01	3	4	2	4	0	0	26	-1	-1	40	50		TCRBV12-03,TCRBV12-04												CASSF*REKNIQYF+TCRBV12-X+TCRBJ02-04	TCRBV12	TCRBD02-01*02	TCRBJ02-04*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGAAGTGGATCCTAACTATGGCTACACCTTCGGTTCG	CASSQEVDPNYGYTF	In	VDJ	1	31	2.2925772265731888E-4	2.688195353757837E-4	45	TCRBV03						TCRBJ01	TCRBJ01-02	01	0	1	8	0	3	2	26	43	49	46	51		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQEVDPNYGYTF+TCRBV03-X+TCRBJ01-02	TCRBV03		TCRBJ01-02*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGTAAATGATAGAGAAGCTTTCTTTGGACAA	CASSQVNDREAFF	In	VDJ	1	31	2.2925772265731888E-4	2.688195353757837E-4	39	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	1	5	8	8	7	1	26	42	52	49	53		TCRBV03-01,TCRBV03-02				01,02								CASSQVNDREAFF+TCRBV03-X+TCRBJ01-01	TCRBV03	TCRBD02-01	TCRBJ01-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCATCTCACTAGCGGGAGCCCCAAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	31	2.2925772265731888E-4		50	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	3	3	2	5	4	5	26	40	55	44	60		TCRBV03-01,TCRBV03-02												X+TCRBV03-X+TCRBJ02-03	TCRBV03	TCRBD02-01*02	TCRBJ02-03*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCAGGGGAGCGGGAGTGGATACGCAGTATTTTGGCCCA	CSARGAGVDTQYF	In	VDJ	1	31	2.2925772265731888E-4	2.688195353757837E-4	39	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	6	6	2	6	6	2	26	34	48	40	50		TCRBV20-01,TCRBV20-or09_02												CSARGAGVDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01*02	TCRBJ02-03*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGGAAACCTAGCGGGAGGGCCCCACGAGCAGTACTTCGGGCCG	CSARGNLAGGPHEQYF	In	VDJ	1	31	2.2925772265731888E-4	2.688195353757837E-4	48	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	1	4	0	5	5	4	26	39	56	44	60		TCRBV20-01,TCRBV20-or09_02												CSARGNLAGGPHEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01*02	TCRBJ02-07*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTGGAGGGACAGAACTCTGGAAACACCATATATTTTGGAGAG		Out	VDJ	1	31	2.2925772265731888E-4		43	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	1	1	5	0	0	2	26	-1	45	39	47		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ01-03	TCRBV20	TCRBD01-01*01	TCRBJ01-03*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTATCGATGCTCCTATCCTCCTACGAGCAGTACTTCGGGCCG	CASSLSMLLSSYEQYF	In	VDJ	1	31	2.2925772265731888E-4	2.688195353757837E-4	48				TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	6	4	9	0	12	2	24	36	51	48	53	TCRBV24,TCRBV27	TCRBV24-01,TCRBV24-or09_02,TCRBV27-01				01,02								CASSLSMLLSSYEQYF+X+TCRBJ02-07		TCRBD02-01	TCRBJ02-07*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CGACTCGGCYGTGTATSTCTGTGCCAGCAGCCCAACAGCAGGGTCCCCGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSPTAGSPNTGELFF	In	VDJ	1	31	2.2925772265731888E-4	2.688195353757837E-4	51	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	5	4	3	0	7	4	18	30	42	37	46	TCRBV07,TCRBV11													CASSPTAGSPNTGELFF+X+TCRBJ02-02	unresolved	TCRBD01-01*01	TCRBJ02-02*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CGACTCGGCYGTGTATSTCTGTGCCAGCAGCCGCGAAGGGACAGGGGGCTACGAGCAGTACTTCGGGCCG	CASSREGTGGYEQYF	In	VDJ	1	31	2.2925772265731888E-4	2.688195353757837E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	0	1	3	6	0	18	30	-1	36	47	TCRBV07,TCRBV11													CASSREGTGGYEQYF+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
SGACTCGGCYSTSTATCTCTGTGCCAGCAGCTTGGCAGGCGGGCGTCAGCCCCAGCATTTTGGTGAT	CASSLAGGRQPQHF	In	VDJ	1	31	2.2925772265731888E-4	2.688195353757837E-4	42	unresolved			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-05	01	0	7	4	6	3	2	19	35	43	38	45	TCRBV05,TCRBV07					01,02								CASSLAGGRQPQHF+X+TCRBJ01-05	unresolved	TCRBD02-01	TCRBJ01-05*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGCACCTGGATTCACAGATACGCAGTATTTTGGCCCA	CASSQAPGFTDTQYF	In	VDJ	1	32	2.3665313306561948E-4	2.7749113329113154E-4	45	TCRBV03						TCRBJ02	TCRBJ02-03	01	1	1	8	2	5	2	26	42	50	47	52		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQAPGFTDTQYF+TCRBV03-X+TCRBJ02-03	TCRBV03		TCRBJ02-03*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGAAGGAGGGAGGTCCTTTTACGAGCAGTACTTCGGGCCG	CSAREGGRSFYEQYF	In	VDJ	1	32	2.3665313306561948E-4	2.7749113329113154E-4	45	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	0	9	1	4	4	6	26	40	50	44	56		TCRBV20-01,TCRBV20-or09_02												CSAREGGRSFYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01*02	TCRBJ02-07*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATCGGGGAATCACGGAAGGCCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	32	2.3665313306561948E-4		49	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	0	8	3	6	1	12	26	40	46	41	58		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ02-02	TCRBV20	TCRBD02-01*01	TCRBJ02-02*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGCCGACAGGGGGACTAGCGGGACTAAAGAGCAGTACTTCGGGCCG	CSARADRGTSGTKEQYF	In	VDJ	1	32	2.3665313306561948E-4	2.7749113329113154E-4	51	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	1	0	3	7	8	5	26	39	60	47	65		TCRBV20-01,TCRBV20-or09_02												CSARADRGTSGTKEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01*02	TCRBJ02-07*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTTATACTAAAGCTAACTATGGCTACACCTTCGGTTCG	CSAYTKANYGYTF	In	VDJ	1	32	2.3665313306561948E-4	2.7749113329113154E-4	39	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	5	3	9	0	3	3	26	35	42	38	45		TCRBV20-01,TCRBV20-or09_02				01,02								CSAYTKANYGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD02-01	TCRBJ01-02*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTTGGTCTCGGGACCCACGTAGCACAGATACGCAGTATTTTGGCCCA	CSAWSRDPRSTDTQYF	In	VDJ	1	32	2.3665313306561948E-4	2.7749113329113154E-4	48	TCRBV20						TCRBJ02	TCRBJ02-03	01	5	0	7	0	7	6	26	35	47	42	53		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSAWSRDPRSTDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20		TCRBJ02-03*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTTTATTTTTGCCGGGACTAGCGGGAGGTGGAGAGACCCAGTACTTCGGGCCA	CSALFLPGLAGGGETQYF	In	VDJ	1	32	2.3665313306561948E-4	2.7749113329113154E-4	54	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	5	0	1	4	11	3	26	35	61	46	64		TCRBV20-01,TCRBV20-or09_02												CSALFLPGLAGGGETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD02-01*02	TCRBJ02-05*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CAYSRGSSAMWCAGCTTTGTAYTTCTGTGCCAGCTCGTCACTAGCGGGAACCACCGGGGAGCTGTTTTTTGGAGAA	CASSSLAGTTGELFF	In	VDJ	1	32	2.3665313306561948E-4	2.7749113329113154E-4	45	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	13	3	3	4	11	2	25	28	49	39	51	TCRBV09,TCRBV22													CASSSLAGTTGELFF+X+TCRBJ02-02	unresolved	TCRBD02-01*02	TCRBJ02-02*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCAGTTTAGTACGAAACACTGAAGCTTTCTTTGGACAA	CASSLVRNTEAFF	In	VDJ	1	32	2.3665313306561948E-4	2.7749113329113154E-4	39	TCRBV12						TCRBJ01	TCRBJ01-01	01	1	2	8	2	3	0	22	38	-1	41	43		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLVRNTEAFF+TCRBV12-X+TCRBJ01-01	TCRBV12		TCRBJ01-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGCGTGGGTCTCCGGGGCTACACCTTCGGTTCG	CASSVGLRGYTF	In	VDJ	1	32	2.3665313306561948E-4	2.7749113329113154E-4	36	unresolved						TCRBJ01	TCRBJ01-02	01	2	0	9	8	0	7	23	-1	40	37	47	TCRBV09,TCRBV21			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSVGLRGYTF+X+TCRBJ01-02	unresolved		TCRBJ01-02*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTCCACGTCCTACAATGAGCAGTTCTTCGGGCCA	CASSSTSYNEQFF	In	VDJ	1	33	2.4404854347392007E-4	2.8616273120647944E-4	39	TCRBV12						TCRBJ02	TCRBJ02-01	01	4	3	7	1	2	1	26	39	43	41	44		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSSTSYNEQFF+TCRBV12-X+TCRBJ02-01	TCRBV12		TCRBJ02-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTGCGGGGGCTCAATAGCAATCAGCCCCAGCATTTTGGTGAT	CASSLRGLNSNQPQHF	In	VDJ	1	33	2.4404854347392007E-4	2.8616273120647944E-4	48	TCRBV12			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-05	01	3	7	2	0	0	5	26	-1	47	40	52		TCRBV12-03,TCRBV12-04												CASSLRGLNSNQPQHF+TCRBV12-X+TCRBJ01-05	TCRBV12	TCRBD02-01*01	TCRBJ01-05*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCTTAGGCGCGAGCAGTACTTCGGGCCG	CASSLRREQYF	In	VDJ	1	33	2.4404854347392007E-4	2.8616273120647944E-4	33	TCRBV03						TCRBJ02	TCRBJ02-07	01	4	5	4	6	2	2	26	39	44	41	46		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLRREQYF+TCRBV03-X+TCRBJ02-07	TCRBV03		TCRBJ02-07*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCAGCGCGGGGGGGGCCGGCACGCAGTATTTTGGCCCA	CASSAGGAGTQYF	In	VDJ	1	33	2.4404854347392007E-4	2.8616273120647944E-4	39	TCRBV12			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	6	7	0	9	1	6	22	33	43	34	49		TCRBV12-03,TCRBV12-04												CASSAGGAGTQYF+TCRBV12-X+TCRBJ02-03	TCRBV12	TCRBD02-01*01	TCRBJ02-03*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCCAACCAGACMKCTCTKTACTTCTGTGCCAGCAAGGGGGGTTATGCGGGAGGAATCTACAATGAGCAGTTCTTCGGGCCA	CASKGGYAGGIYNEQFF	In	VDJ	1	33	2.4404854347392007E-4	2.8616273120647944E-4	51	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	7	7	1	3	11	3	23	33	52	44	55	TCRBV24,TCRBV27													CASKGGYAGGIYNEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01*02	TCRBJ02-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGAGGGCAATCAGCCCCAGCATTTTGGTGAT	CATSEGNQPQHF	In	VDJ	1	33	2.4404854347392007E-4	2.8616273120647944E-4	36	TCRBV24						TCRBJ01	TCRBJ01-05	01	4	0	10	2	0	0	24	-1	-1	38	40		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATSEGNQPQHF+TCRBV24-X+TCRBJ01-05	TCRBV24		TCRBJ01-05*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCAGGGGTGGGCTAGCGGGGATCCCCTACAATGAGCAGTTCTTCGGGCCA	CASRGGLAGIPYNEQFF	In	VDJ	1	33	2.4404854347392007E-4	2.8616273120647944E-4	51	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	5	4	3	2	7	4	19	30	46	37	50	TCRBV05,TCRBV11													CASRGGLAGIPYNEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01*01	TCRBJ02-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCGACTCGGACGCCGCCGAGCAGTACTTCGGGCCG	CSADSDAAEQYF	In	VDJ	1	34	2.5144395388222067E-4	2.948343291218273E-4	36	TCRBV20						TCRBJ02	TCRBJ02-07	01	6	1	7	6	6	5	26	34	44	40	49		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSADSDAAEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20		TCRBJ02-07*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGGTCGGGTTCTGGAGACCCAGTACTTCGGGCCA	CSARGRVLETQYF	In	VDJ	1	34	2.5144395388222067E-4	2.948343291218273E-4	39	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	1	8	4	5	2	5	26	39	45	41	50		TCRBV20-01,TCRBV20-or09_02				01,02								CSARGRVLETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD02-01	TCRBJ02-05*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
TSRGGGACTCAGCTKTGTAYTTCTGTGCCAGCAGCCTGACAGGCCAGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSLTGQNTGELFF	In	VDJ	1	34	2.5144395388222067E-4	2.948343291218273E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	6	2	4	1	3	3	22	33	42	36	45	TCRBV09,TCRBV12													CASSLTGQNTGELFF+X+TCRBJ02-02	unresolved	TCRBD01-01*01	TCRBJ02-02*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATTCTTGGGTGGAGCAGCCCCAGCATTTTGGTGAT	CATSDSWVEQPQHF	In	VDJ	1	34	2.5144395388222067E-4	2.948343291218273E-4	42	TCRBV24			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-05	01	2	10	2	7	7	0	24	40	-1	47	51		TCRBV24-01,TCRBV24-or09_02												CATSDSWVEQPQHF+TCRBV24-X+TCRBJ01-05	TCRBV24	TCRBD02-01*02	TCRBJ01-05*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTCTCAGACAGGGATCTATGGCTACACCTTCGGTTCG	CASSSQTGIYGYTF	In	VDJ	1	34	2.5144395388222067E-4	2.948343291218273E-4	42	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	2	3	4	5	2	24	36	48	41	50		TCRBV24-01,TCRBV24-or09_02												CASSSQTGIYGYTF+TCRBV24-X+TCRBJ01-02	TCRBV24	TCRBD01-01*01	TCRBJ01-02*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
TCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGGACCTTCGGGGACTAGCGGCGAAGATTGGATACGCAGTATTTTGGCCCA		Out	VDJ	1	34	2.5144395388222067E-4		56	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	1	0	5	6	8	9	25	38	57	46	66		TCRBV20-01,TCRBV20-or09_02				01,02								X+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01	TCRBJ02-03*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAAGACCGAAGGGGAACTAATGAAAAACTGTTTTTTGGCAGT	CASSQDRRGTNEKLFF	In	VDJ	1	35	2.588393642905213E-4	3.0350592703717514E-4	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	0	5	2	1	4	0	23	40	-1	44	49	TCRBV01,TCRBV04													CASSQDRRGTNEKLFF+X+TCRBJ01-04	unresolved	TCRBD01-01*01	TCRBJ01-04*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCACAACGGGGAGGTTTTGAACCCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	35	2.588393642905213E-4		50	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	3	9	1	6	5	8	26	40	51	45	59		TCRBV03-01,TCRBV03-02												X+TCRBV03-X+TCRBJ02-02	TCRBV03	TCRBD02-01*02	TCRBJ02-02*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCCCCGCAGCAGGGGTATCGACGAGCAGTACTTCGGGCCG	CASSPRSRGIDEQYF	In	VDJ	1	35	2.588393642905213E-4	3.0350592703717514E-4	45	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	4	2	5	7	5	26	39	52	46	57		TCRBV03-01,TCRBV03-02												CASSPRSRGIDEQYF+TCRBV03-X+TCRBJ02-07	TCRBV03	TCRBD01-01*01	TCRBJ02-07*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATGGTGGACAGCGAGGCGAAAAACTGTTTTTTGGCAGT	CSARDGGQRGEKLFF	In	VDJ	1	35	2.588393642905213E-4	3.0350592703717514E-4	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	0	1	5	8	4	6	26	40	50	44	56		TCRBV20-01,TCRBV20-or09_02												CSARDGGQRGEKLFF+TCRBV20-X+TCRBJ01-04	TCRBV20	TCRBD01-01*01	TCRBJ01-04*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTCGATACGGCATCACAGATACGCAGTATTTTGGCCCA	CATSRYGITDTQYF	In	VDJ	1	35	2.588393642905213E-4	3.0350592703717514E-4	42	TCRBV24						TCRBJ02	TCRBJ02-03	01	6	9	0	2	6	2	24	36	45	42	47		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATSRYGITDTQYF+TCRBV24-X+TCRBJ02-03	TCRBV24		TCRBJ02-03*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGAGCGTGGCCCCTACAATGAGCAGTTCTTCGGGCCA	CATSERGPYNEQFF	In	VDJ	1	35	2.588393642905213E-4	3.0350592703717514E-4	42	TCRBV24						TCRBJ02	TCRBJ02-01	01	4	9	0	2	4	1	24	38	45	42	46		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATSERGPYNEQFF+TCRBV24-X+TCRBJ02-01	TCRBV24		TCRBJ02-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTAAAGGCTGCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	35	2.588393642905213E-4		38	TCRBV24						TCRBJ02	TCRBJ02-07	01	6	5	4	3	4	3	24	36	43	40	46		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV24-X+TCRBJ02-07	TCRBV24		TCRBJ02-07*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTATACGGGGCCGGTACAGGGTTTCGCACCGGGGAGCTGTTTTTTGGAGAA	CASSLYGAGTGFRTGELFF	In	VDJ	1	35	2.588393642905213E-4	3.0350592703717514E-4	57	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	6	3	3	4	15	5	24	36	57	51	62		TCRBV24-01,TCRBV24-or09_02												CASSLYGAGTGFRTGELFF+TCRBV24-X+TCRBJ02-02	TCRBV24	TCRBD01-01*01	TCRBJ02-02*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCAGCCAGGACACAGAATACAATGAGCAGTTCTTCGGGCCA	CASSQDTEYNEQFF	In	VDJ	1	35	2.588393642905213E-4	3.0350592703717514E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	6	1	6	4	3	5	23	34	42	37	47	TCRBV06,TCRBV10													CASSQDTEYNEQFF+X+TCRBJ02-01	unresolved	TCRBD01-01*01	TCRBJ02-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GRGACWCGGCMCTSTATCTCTGYGCCAGCACCGGAAGGGGGTACAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CASTGRGYSSYNEQFF	In	VDJ	1	35	2.588393642905213E-4	3.0350592703717514E-4	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	7	5	1	0	5	5	20	30	41	35	46	TCRBV05,TCRBV23													CASTGRGYSSYNEQFF+X+TCRBJ02-01	unresolved	TCRBD01-01*01	TCRBJ02-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTCCCGGGGGGGGACTAGCGGGGAGCACAGATACGCAGTATTTTGGCCCA	CASSPGGGLAGSTDTQYF	In	VDJ	1	36	2.662347746988219E-4	3.12177524952523E-4	54	TCRBV12			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	5	0	3	0	8	0	26	38	-1	46	59		TCRBV12-03,TCRBV12-04												CASSPGGGLAGSTDTQYF+TCRBV12-X+TCRBJ02-03	TCRBV12	TCRBD02-01*01	TCRBJ02-03*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAACAGTGACAGGGGATCCTACAATGAGCAGTTCTTCGGGCCA	CANSDRGSYNEQFF	In	VDJ	1	36	2.662347746988219E-4	3.12177524952523E-4	42	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	4	4	2	1	0	1	24	-1	44	38	45		TCRBV24-01,TCRBV24-or09_02												CANSDRGSYNEQFF+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD01-01*01	TCRBJ02-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGACCTCGACAGATTCTATGGCTACACCTTCGGTTCG	CATSDLDRFYGYTF	In	VDJ	1	36	2.662347746988219E-4	3.12177524952523E-4	42	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	2	5	4	4	3	24	38	47	42	50		TCRBV24-01,TCRBV24-or09_02												CATSDLDRFYGYTF+TCRBV24-X+TCRBJ01-02	TCRBV24	TCRBD01-01*01	TCRBJ01-02*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
TCAGGAGACWCRGCMMKGTATYKCTGTRCCAGCAGCTTTGGCCAGGGTGGAGAGACCCAGTACTTCGGGCCA	CXSSFGQGGETQYF	In	VDJ	1	36	2.662347746988219E-4	3.12177524952523E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	3	4	3	4	4	3	18	32	41	36	44	TCRBV07,TCRBV21													CXSSFGQGGETQYF+X+TCRBJ02-05	unresolved	TCRBD01-01*01	TCRBJ02-05*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GACTCGGCCRTGTATCKCTGTGCCAGCAGCTTGGTTGGACAGGGGCCCACTGAAGCTTTCTTTGGACAA	CASSLVGQGPTEAFF	In	VDJ	1	36	2.662347746988219E-4	3.12177524952523E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	1	2	4	4	2	18	32	45	36	47	TCRBV07,TCRBV11													CASSLVGQGPTEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
SGACTCGGCYSTSTATCTCTGTGCCAGCAGCGACATCCAGGGAGGTGGTGGGACTGAAGCTTTCTTTGGACAA	CASSDIQGGGGTEAFF	In	VDJ	1	36	2.662347746988219E-4	3.12177524952523E-4	48	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	4	9	1	5	8	7	19	31	45	39	52	TCRBV05,TCRBV07													CASSDIQGGGGTEAFF+X+TCRBJ01-01	unresolved	TCRBD02-01*02	TCRBJ01-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCTCCACCGGGACAGGGGTCTGCGCCAAGAGACCCAGTACTTCGGGCCA	CASSLHRDRGLRQETQYF	In	VDJ	1	37	2.736301851071225E-4	3.208491228678709E-4	54	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	4	0	2	1	6	6	26	39	55	45	61		TCRBV03-01,TCRBV03-02												CASSLHRDRGLRQETQYF+TCRBV03-X+TCRBJ02-05	TCRBV03	TCRBD01-01*01	TCRBJ02-05*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTACCGGGGACTATGGCTACACCTTCGGTTCG	CSATGDYGYTF	In	VDJ	1	37	2.736301851071225E-4	3.208491228678709E-4	33	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-02	01	4	8	3	3	1	0	26	36	-1	37	42		TCRBV20-01,TCRBV20-or09_02												CSATGDYGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD02-01*01	TCRBJ01-02*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCATTAGGGACTTTTCGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSIRDFSNTGELFF	In	VDJ	1	37	2.736301851071225E-4	3.208491228678709E-4	48	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	5	0	10	0	4	3	18	30	40	34	43	TCRBV07,TCRBV11					01,02								CASSIRDFSNTGELFF+X+TCRBJ02-02	unresolved	TCRBD02-01	TCRBJ02-02*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GRGACWCKGCMSTGTATCTCTGYGCCAGCAGCCAAGAGGTCTCCCGGGCCGGGGGATCCTACGAGCAGTACTTCGGGCCG	CASSQEVSRAGGSYEQYF	In	VDJ	1	37	2.736301851071225E-4	3.208491228678709E-4	54	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	5	8	2	1	17	1	19	31	54	48	55	TCRBV11,TCRBV23													CASSQEVSRAGGSYEQYF+X+TCRBJ02-07	unresolved	TCRBD02-01*01	TCRBJ02-07*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
TYRGRRGACWCAGCMMKGTAYTTCTGTGCCAGCAGTGGGGACTAGCGGAACTTTTCCTACGAGCAGTACTTCGGGCCG	CASSGD*RNFSYEQYF	Stop	VDJ	1	37	2.736301851071225E-4		48	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	4	0	5	1	0	6	23	-1	47	36	53	TCRBV02,TCRBV21					01,02								CASSGD*RNFSYEQYF+X+TCRBJ02-07	unresolved	TCRBD02-01	TCRBJ02-07*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCACGACCAAGACAGGGCCTGGCGTGGCTACACCTTCGGTTCG		Out	VDJ	1	38	2.810255955154231E-4		44	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	2	3	7	9	7	26	34	50	43	57		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCAGTCAATCCCACTAGCGTTCTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	38	2.810255955154231E-4		47	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	6	3	6	3	11	2	26	34	52	45	54		TCRBV20-01,TCRBV20-or09_02				01,02								X+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01	TCRBJ02-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCCTCTGGGGAGCGGGAGGGGGGTCCTACGAGCAGTACTTCGGGCCG	CSALWGAGGGSYEQYF	In	VDJ	1	38	2.810255955154231E-4	3.2952072078321873E-4	48	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	6	6	0	1	9	3	26	34	53	43	56		TCRBV20-01,TCRBV20-or09_02												CSALWGAGGGSYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01*02	TCRBJ02-07*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCWSSSASWCAKCTGTGTACTTSTGTGCCAGCCGCCGGGAACCAGCAACTAATGAAAAACTGTTTTTTGGCAGT	CASRREPATNEKLFF	In	VDJ	1	38	2.810255955154231E-4	3.2952072078321873E-4	45	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-04	01	8	8	3	0	3	5	22	31	39	34	44	TCRBV06,TCRBV12													CASRREPATNEKLFF+X+TCRBJ01-04	unresolved	TCRBD02-01*02	TCRBJ01-04*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGAGCACCGACAGGGTACCTCCTACAATGAGCAGTTCTTCGGGCCA	CATSEHRQGTSYNEQFF	In	VDJ	1	38	2.810255955154231E-4	3.2952072078321873E-4	51	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	4	2	3	0	5	3	24	38	50	43	53		TCRBV24-01,TCRBV24-or09_02												CATSEHRQGTSYNEQFF+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD01-01*01	TCRBJ02-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAACTAGGGGTCTACAATGAGCAGTTCTTCGGGCCA	CASSELGVYNEQFF	In	VDJ	1	38	2.810255955154231E-4	3.2952072078321873E-4	42	TCRBV06			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	2	5	2	3	2	1	23	38	45	40	46		TCRBV06-01,TCRBV06-08												CASSELGVYNEQFF+TCRBV06-X+TCRBJ02-01	TCRBV06	TCRBD01-01*01	TCRBJ02-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GGACTCGGCCCTCTATCTCTGTGCCAGCAGCTTTGGGTACGGGAGAGGGGGGTACGAGCAGTACTTCGGGCCG	CASSFGYGRGGYEQYF	In	VDJ	1	38	2.810255955154231E-4	3.2952072078321873E-4	48	TCRBV05						TCRBJ02	TCRBJ02-07	01	2	5	1	4	12	1	19	33	51	45	52		TCRBV05-06,TCRBV05-07		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSFGYGRGGYEQYF+TCRBV05-X+TCRBJ02-07	TCRBV05		TCRBJ02-07*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GTATTTCTGTGCCAGCAGCGTAGTCCTCGTCGAGGCCCTGGGAGGCTGTGCTCTGGAAACACCATATATTTTGGAGAG		Out	VDJ	1	38	2.810255955154231E-4		65	TCRBV21			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-03	01	5	9	1	0	20	5	7	19	45	39	50		TCRBV21-or09_02,TCRBV21-01												X+TCRBV21-X+TCRBJ01-03	TCRBV21	TCRBD02-01*02	TCRBJ01-03*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCTGGCAATCTGCCATTTCGTGTTAGACGAGCAGTACTTCGGGCCG		Out	VDJ	1	39	2.884210059237237E-4		50	TCRBV03						TCRBJ02	TCRBJ02-07	01	5	9	0	5	1	20	26	38	42	39	62		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV03-X+TCRBJ02-07	TCRBV03		TCRBJ02-07*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGTCATAAGCGGGGGACACTACGAGCAGTACTTCGGGCCG	CSVISGGHYEQYF	In	VDJ	1	39	2.884210059237237E-4	3.381923186985666E-4	39	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	7	6	2	3	5	3	26	33	46	38	49		TCRBV20-01,TCRBV20-or09_02												CSVISGGHYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01*01	TCRBJ02-07*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
TSRGGGACTCAGCTKTGTAYTTCTGTGCCAGCAGTGAAAATGTCGTCGGAGGCGTAGGGTTAGCTATGCGGTACACCTTCGGTTCG	CASSENVVGGVGLAMRYTF	In	VDJ	1	39	2.884210059237237E-4	3.381923186985666E-4	57	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	5	10	1	11	12	19	22	34	51	46	70	TCRBV09,TCRBV12													CASSENVVGGVGLAMRYTF+X+TCRBJ01-02	unresolved	TCRBD02-01*02	TCRBJ01-02*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GACTCGGCCGTGTATGTCTGTGCTAGCAGCTTAGCGTCGTCCCTGGCCGAAGGGGAGCTGTTTTTTGGAGAA	CASSLASSLAEGELFF	In	VDJ	1	39	2.884210059237237E-4	3.381923186985666E-4	48				TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	0	9	0	8	9	4	18	35	47	44	51	TCRBV07,TCRBV11	TCRBV07-02,TCRBV11-03												CASSLASSLAEGELFF+X+TCRBJ02-02		TCRBD01-01*01	TCRBJ02-02*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GGGGGACTYGGCYGTGTATCTCTGTGCCAGCAGCTTAGACTCTTACAATGAGCAGTTCTTCGGGCCA	CASSLDSYNEQFF	In	VDJ	1	39	2.884210059237237E-4	3.381923186985666E-4	39	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	4	2	10	4	2	2	22	35	41	37	43	TCRBV07,TCRBV11					01,02								CASSLDSYNEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01	TCRBJ02-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGCGGGAGGGATTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	40	2.9581641633202437E-4		41	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	1	8	0	4	0	2	26	-1	47	39	49		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*02	TCRBJ02-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGTCCCGACCAAAGGGGATACAATGAGCAGTTCTTCGGGCCA	CASSPDQRGYNEQFF	In	VDJ	1	40	2.9581641633202437E-4	3.468639166139144E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	6	5	2	4	10	1	18	29	44	39	45	TCRBV07,TCRBV11													CASSPDQRGYNEQFF+X+TCRBJ02-01	unresolved	TCRBD01-01*01	TCRBJ02-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCGGGGGGCGGAGAGGGCCGAGTACGCAGTATTTTGGCCCA	CSAGGRRGPSTQYF	In	VDJ	1	41	3.0321182674032497E-4	3.555355145292623E-4	42	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	6	8	1	8	0	14	26	-1	41	34	55		TCRBV20-01,TCRBV20-or09_02												CSAGGRRGPSTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01*01	TCRBJ02-03*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCGGGCCCTCTAGCACAGATACGCAGTATTTTGGCCCA	CATGPSSTDTQYF	In	VDJ	1	41	3.0321182674032497E-4	3.555355145292623E-4	39	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	9	8	0	0	0	5	24	-1	37	33	42		TCRBV24-01,TCRBV24-or09_02												CATGPSSTDTQYF+TCRBV24-X+TCRBJ02-03	TCRBV24	TCRBD01-01*01	TCRBJ02-03*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCATAGAGTTTGCCGGGGCGCTTGAAGCTTTCTTTGGACAA	CASIEFAGALEAFF	In	VDJ	1	41	3.0321182674032497E-4	3.555355145292623E-4	42	TCRBV24						TCRBJ01	TCRBJ01-01	01	11	7	0	7	14	3	24	31	50	45	53		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASIEFAGALEAFF+TCRBV24-X+TCRBJ01-01	TCRBV24		TCRBJ01-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
AACCCAGGGACTCAGCTGTGTAYTTYTGTGCCAGCAGTTTAGGGTTCGGGGGGAGGACTGAAGCTTTCTTTGGACAA	CASSLGFGGRTEAFF	In	VDJ	1	42	3.1060723714862557E-4	3.642071124446102E-4	45	TCRBV12			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	1	8	1	5	4	3	26	42	53	46	56		TCRBV12-03,TCRBV12-04												CASSLGFGGRTEAFF+TCRBV12-X+TCRBJ01-01	TCRBV12	TCRBD02-01*01	TCRBJ01-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GGACTCGGCCCTCTATCTCTGTGCCAGCAGCCCGGACGGGACAGGGAGCTGGAAACACCATATATTTTGGAGAG		Out	VDJ	1	42	3.1060723714862557E-4		49	TCRBV05			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	4	0	3	2	6	2	19	31	46	37	48		TCRBV05-06,TCRBV05-07												X+TCRBV05-X+TCRBJ01-03	TCRBV05	TCRBD01-01*01	TCRBJ01-03*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCGGGCGGGGGACTAGCGGGATATGAGCAGTTCTTCGGGCCA	CSAGGGLAGYEQFF	In	VDJ	1	43	3.1800264755692617E-4	3.72878710359958E-4	42	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	6	0	3	8	6	1	26	34	53	40	54		TCRBV20-01,TCRBV20-or09_02												CSAGGGLAGYEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*02	TCRBJ02-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
TSRRGGACTCAGCYRTGTACTTCTGTGCCAGCAGTTTTGGGACAGTGGGGGAAAAACTGTTTTTTGGCAGT	CASSFGTVGEKLFF	In	VDJ	1	43	3.1800264755692617E-4	3.72878710359958E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	3	0	5	8	1	5	22	36	44	37	49	TCRBV02,TCRBV12													CASSFGTVGEKLFF+X+TCRBJ01-04	unresolved	TCRBD01-01*01	TCRBJ01-04*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAATGAGACTAGCGGGAGCCGCGAGCAGTACTTCGGGCCG	CATNETSGSREQYF	In	VDJ	1	43	3.1800264755692617E-4	3.72878710359958E-4	42	TCRBV24			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	4	2	2	6	0	3	24	-1	50	38	53		TCRBV24-01,TCRBV24-or09_02												CATNETSGSREQYF+TCRBV24-X+TCRBJ02-07	TCRBV24	TCRBD02-01*02	TCRBJ02-07*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGAGAGGGACCCGTTCCCCGGCCCCAGCATTTTGGTGAT		Out	VDJ	1	44	3.2539805796522677E-4		47	TCRBV03						TCRBJ01	TCRBJ01-05	01	0	0	7	9	2	10	26	43	50	45	60		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV03-X+TCRBJ01-05	TCRBV03		TCRBJ01-05*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAATTAGCGGACGACCCACAGATACGCAGTATTTTGGCCCA	CSARISGRPTDTQYF	In	VDJ	1	44	3.2539805796522677E-4	3.8155030827530587E-4	45	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	2	5	5	2	2	6	26	38	46	40	52		TCRBV20-01,TCRBV20-or09_02				01,02								CSARISGRPTDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01	TCRBJ02-03*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAAAGTTGCACACCATATATTTTGGAGAG	CASSQKLHTIYF	In	VDJ	1	45	3.3279346837352736E-4	3.9022190619065377E-4	36	TCRBV03						TCRBJ01	TCRBJ01-03	01	2	5	5	8	1	4	26	41	44	42	48		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQKLHTIYF+TCRBV03-X+TCRBJ01-03	TCRBV03		TCRBJ01-03*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAAGGGGGCGCTGGAATGAGCAGTTCTTCGGGCCA	CSARRGRWNEQFF	In	VDJ	1	45	3.3279346837352736E-4	3.9022190619065377E-4	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	2	5	0	7	0	5	26	-1	45	38	50		TCRBV20-01,TCRBV20-or09_02												CSARRGRWNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD01-01*01	TCRBJ02-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGACCCCCCCGGGGCCCACACCGGGGAGCTGTTTTTTGGAGAA	CATSDPPGAHTGELFF	In	VDJ	1	45	3.3279346837352736E-4	3.9022190619065377E-4	48	TCRBV24						TCRBJ02	TCRBJ02-02	01	4	7	0	3	7	2	24	38	50	45	52		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATSDPPGAHTGELFF+TCRBV24-X+TCRBJ02-02	TCRBV24		TCRBJ02-02*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGACCCGACTAGCGGGAACTACAATGAGCAGTTCTTCGGGCCA	CATSDPTSGNYNEQFF	In	VDJ	1	45	3.3279346837352736E-4	3.9022190619065377E-4	48	TCRBV24			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	4	2	3	3	3	1	24	38	52	41	53		TCRBV24-01,TCRBV24-or09_02												CATSDPTSGNYNEQFF+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD02-01*02	TCRBJ02-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGCCCCAACCCCCTGGGACTAGCGATTCGCGAGCAGTACTTCGGGCCG	CASSPNPLGLAIREQYF	In	VDJ	1	45	3.3279346837352736E-4	3.9022190619065377E-4	51	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	7	0	6	6	12	5	24	35	57	47	62		TCRBV24-01,TCRBV24-or09_02				01,02								CASSPNPLGLAIREQYF+TCRBV24-X+TCRBJ02-07	TCRBV24	TCRBD02-01	TCRBJ02-07*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CTMSCTCYCAGACWTCTGTKTACTTCTGTGCCAGTCGGGACAGGGGGCGAGAGACCCAGTACTTCGGGCCA	CASRDRGRETQYF	In	VDJ	1	45	3.3279346837352736E-4	3.9022190619065377E-4	39	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	9	0	0	4	2	1	26	34	48	36	49	TCRBV06,TCRBV10													CASRDRGRETQYF+X+TCRBJ02-05	unresolved	TCRBD01-01*01	TCRBJ02-05*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCTCTCTCCTGGCGGGACGGGAGGGGGTCTGAGCAGTTCTTCGGGCCA		Out	VDJ	1	45	3.3279346837352736E-4		52	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	4	8	0	9	14	4	18	31	53	45	57	TCRBV07,TCRBV11													X+X+TCRBJ02-01	unresolved	TCRBD02-01*02	TCRBJ02-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
AAGRAGACWCRGCWSYGTATCTCTGCGCCAGCAGCCAAGAGGCCAAGGTGGGGGAGCAGTTCTTCGGGCCA	CASSQEAKVGEQFF	In	VDJ	1	46	3.40188878781828E-4	3.988935041060016E-4	42	unresolved						TCRBJ02	TCRBJ02-01	01	0	6	2	10	9	0	23	40	-1	49	53	TCRBV01,TCRBV23			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQEAKVGEQFF+X+TCRBJ02-01	unresolved		TCRBJ02-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGAGGTATCAGGGGGCTTCTACAATGAGCAGTTCTTCGGGCCA	CSAREVSGGFYNEQFF	In	VDJ	1	46	3.40188878781828E-4	3.988935041060016E-4	48	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	0	4	0	3	5	2	26	40	53	45	55		TCRBV20-01,TCRBV20-or09_02												CSAREVSGGFYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD01-01*01	TCRBJ02-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTCCCTTTGTGGCCGGCGATCTGACAGATACGCAGTATTTTGGCCCA	CSASPFVAGDLTDTQYF	In	VDJ	1	46	3.40188878781828E-4	3.988935041060016E-4	51	TCRBV20						TCRBJ02	TCRBJ02-03	01	3	9	0	3	9	10	26	37	49	46	59		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSASPFVAGDLTDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20		TCRBJ02-03*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAATGGGGGGGTTACGCGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSQWGGYANTGELFF	In	VDJ	1	47	3.475842891901286E-4	4.0756510202134946E-4	51	TCRBV03			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	2	9	0	0	1	5	26	41	49	42	54		TCRBV03-01,TCRBV03-02												CASSQWGGYANTGELFF+TCRBV03-X+TCRBJ02-02	TCRBV03	TCRBD02-01*01	TCRBJ02-02*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCTTTGTGGTCCATTTCGTGTTAGACGAGCAGTACTTCGGGCCG		Out	VDJ	1	47	3.475842891901286E-4		49	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	4	5	8	5	19	0	26	39	-1	58	61		TCRBV03-01,TCRBV03-02				01,02								X+TCRBV03-X+TCRBJ02-07	TCRBV03	TCRBD02-01	TCRBJ02-07*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATCTCTGGCGGCCTAGCACAGATACGCAGTATTTTGGCCCA	CSARDLWRPSTDTQYF	In	VDJ	1	47	3.475842891901286E-4	4.0756510202134946E-4	48	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	0	7	5	0	6	3	26	40	50	46	53		TCRBV20-01,TCRBV20-or09_02				01,02								CSARDLWRPSTDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01	TCRBJ02-03*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATTTGCCCGGGACTAGCGGGGATACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	47	3.475842891901286E-4		53	TCRBV24			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	0	0	3	4	3	1	24	42	58	45	59		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD02-01*01	TCRBJ02-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCGCCGGGGTAGCAGATACGCAGTATTTTGGCCCA	CATAGVADTQYF	In	VDJ	1	47	3.475842891901286E-4	4.0756510202134946E-4	36	TCRBV24			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	9	8	3	4	2	3	24	33	40	35	43		TCRBV24-01,TCRBV24-or09_02												CATAGVADTQYF+TCRBV24-X+TCRBJ02-03	TCRBV24	TCRBD02-01*01	TCRBJ02-03*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCTTAACGACAGGGCCTAGCTATGGCTACACCTTCGGTTCG	CASSLTTGPSYGYTF	In	VDJ	1	48	3.549796995984292E-4	4.162366999366973E-4	45	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	2	3	4	5	5	26	38	50	43	55		TCRBV03-01,TCRBV03-02												CASSLTTGPSYGYTF+TCRBV03-X+TCRBJ01-02	TCRBV03	TCRBD01-01*01	TCRBJ01-02*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCAGCGTAGGGGGGAGGGGACCACGAGGACGAGCAGTACTTCGGGCCG		Out	VDJ	1	48	3.549796995984292E-4		49	TCRBV12			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	6	9	0	5	7	10	22	33	47	40	57		TCRBV12-03,TCRBV12-04												X+TCRBV12-X+TCRBJ02-07	TCRBV12	TCRBD02-01*02	TCRBJ02-07*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGGGTAGGCTTACCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	48	3.549796995984292E-4		40	TCRBV24						TCRBJ02	TCRBJ02-07	01	5	5	4	2	3	4	24	37	43	40	47		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV24-X+TCRBJ02-07	TCRBV24		TCRBJ02-07*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTCCCATCGCGTACCAAGAGACCCAGTACTTCGGGCCA	CASSPIAYQETQYF	In	VDJ	1	48	3.549796995984292E-4	4.162366999366973E-4	42	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	6	7	6	0	6	1	24	36	45	42	46		TCRBV24-01,TCRBV24-or09_02				01,02								CASSPIAYQETQYF+TCRBV24-X+TCRBJ02-05	TCRBV24	TCRBD02-01	TCRBJ02-05*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GGACTCGGCCMTSTATCTCTGTGCCAGCTCGAGAACAGGGTCGACAGATACGCAGTATTTTGGCCCA	CASSRTGSTDTQYF	In	VDJ	1	48	3.549796995984292E-4	4.162366999366973E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	7	3	3	3	6	3	19	28	40	34	43	TCRBV05,TCRBV11													CASSRTGSTDTQYF+X+TCRBJ02-03	unresolved	TCRBD01-01*01	TCRBJ02-03*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGCGTGACAGGGTTCGATGAGCAGTTCTTCGGGCCA	CASSVTGFDEQFF	In	VDJ	1	48	3.549796995984292E-4	4.162366999366973E-4	39	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	2	2	3	8	0	4	23	-1	44	37	48	TCRBV09,TCRBV21													CASSVTGFDEQFF+X+TCRBJ02-01	unresolved	TCRBD01-01*01	TCRBJ02-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCGTAGCTGGGGTGGTGGATGAGCAGTTCTTCGGGCCA	CASSVAGVVDEQFF	In	VDJ	1	49	3.623751100067298E-4	4.249082978520452E-4	42	TCRBV12						TCRBJ02	TCRBJ02-01	01	6	6	2	8	7	6	26	37	48	44	54		TCRBV12-03,TCRBV12-04,TCRBV12-05		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSVAGVVDEQFF+TCRBV12-X+TCRBJ02-01	TCRBV12		TCRBJ02-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGTCGGGGACGGATATCTGGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	1	49	3.623751100067298E-4		53	TCRBV03						TCRBJ02	TCRBJ02-06	01	1	0	7	1	3	5	26	42	50	45	55		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV03-X+TCRBJ02-06	TCRBV03		TCRBJ02-06*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCACTCGGACCGGGACAGGGGCCCATCAGCCCCAGCATTTTGGTGAT	CASTRTGTGAHQPQHF	In	VDJ	1	49	3.623751100067298E-4	4.249082978520452E-4	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	7	0	2	5	8	3	23	33	51	41	54	TCRBV06,TCRBV10													CASTRTGTGAHQPQHF+X+TCRBJ01-05	unresolved	TCRBD01-01*01	TCRBJ01-05*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTCACCACAGAGGGAGGAACACTGAAGCTTTCTTTGGACAA	CASSHHRGRNTEAFF	In	VDJ	1	50	3.697705204150304E-4	4.3357989576739306E-4	45	TCRBV12			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	5	9	2	1	9	0	26	38	-1	47	52		TCRBV12-03,TCRBV12-04												CASSHHRGRNTEAFF+TCRBV12-X+TCRBJ01-01	TCRBV12	TCRBD02-01*02	TCRBJ01-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATTTGCGCAGGGCCGGTGAGCTGTTTTTTGGAGAA	CATSDLRRAGELFF	In	VDJ	1	50	3.697705204150304E-4	4.3357989576739306E-4	42	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	0	4	3	11	2	5	24	42	49	44	54		TCRBV24-01,TCRBV24-or09_02												CATSDLRRAGELFF+TCRBV24-X+TCRBJ02-02	TCRBV24	TCRBD01-01*01	TCRBJ02-02*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
AGGACTCSGCCGTGTATSTCTGTGCCAGCAGCTTAGTGATAGGGGGAGGCCCTTACAATGAGCAGTTCTTCGGGCCA	CASSLVIGGGPYNEQFF	In	VDJ	1	50	3.697705204150304E-4	4.3357989576739306E-4	51	unresolved						TCRBJ02	TCRBJ02-01	01	1	5	1	4	4	7	18	34	44	38	51	TCRBV07,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLVIGGGPYNEQFF+X+TCRBJ02-01	unresolved		TCRBJ02-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GAGACWCGGCMSTGTATCTCTGYGCCAGCAGGGGCACCGGGAGGATCTATGGCTACACCTTCGGTTCG	CASRGTGRIYGYTF	In	VDJ	1	50	3.697705204150304E-4	4.3357989576739306E-4	42	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	6	8	1	4	6	2	20	31	44	37	46	TCRBV07,TCRBV23													CASRGTGRIYGYTF+X+TCRBJ01-02	unresolved	TCRBD02-01*02	TCRBJ01-02*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGATTGGGGGGACAGGGTATACGAGCAGTACTTCGGGCCG	CASSQDWGDRVYEQYF	In	VDJ	1	52	3.8456134123163166E-4	4.509230915980888E-4	48	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	0	0	3	4	5	2	26	43	57	48	59		TCRBV03-01,TCRBV03-02												CASSQDWGDRVYEQYF+TCRBV03-X+TCRBJ02-07	TCRBV03	TCRBD01-01*01	TCRBJ02-07*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAACGCCCCCCCTAGGGGGAATCCGCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	52	3.8456134123163166E-4		49	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	5	1	3	11	6	26	36	53	47	59		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD01-01*01	TCRBJ02-07*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCCAACCAGACMKCTCTKTACTTCTGTGCCAGCAGTTTAGGGGGAGCAGATACGCAGTATTTTGGCCCA	CASSLGGADTQYF	In	VDJ	1	52	3.8456134123163166E-4	4.509230915980888E-4	39	unresolved			unresolved			TCRBJ02	TCRBJ02-03	01	2	6	1	4	0	2	23	-1	43	38	45	TCRBV24,TCRBV27			TCRBD01,TCRBD02										CASSLGGADTQYF+X+TCRBJ02-03	unresolved	unresolved	TCRBJ02-03*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCACCGGGACAGGGAACGGGGAGCTGTTTTTTGGAGAA	CATTGTGNGELFF	In	VDJ	1	52	3.8456134123163166E-4	4.509230915980888E-4	39	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	8	0	3	7	2	2	24	34	45	36	47		TCRBV24-01,TCRBV24-or09_02												CATTGTGNGELFF+TCRBV24-X+TCRBJ02-02	TCRBV24	TCRBD01-01*01	TCRBJ02-02*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCCWMCCAGACAKCTSTKTACTTSTGTGCCAGCAGTCCATCGGGGAGCAGGAGTATCTACGAGCAGTACTTCGGGCCG	CASSPSGSRSIYEQYF	In	VDJ	1	52	3.8456134123163166E-4	4.509230915980888E-4	48	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	6	8	3	3	4	11	24	36	45	40	56	TCRBV06,TCRBV24					01,02								CASSPSGSRSIYEQYF+X+TCRBJ02-07	unresolved	TCRBD02-01	TCRBJ02-07*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCCAACCAGACMKCTCTKTACTTCTGTGCCAGCGGGACCGGGACAGGGACCTTCTATGGCTACACCTTCGGTTCG	CASGTGTGTFYGYTF	In	VDJ	1	52	3.8456134123163166E-4	4.509230915980888E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	11	0	3	4	8	5	24	31	48	39	53	TCRBV24,TCRBV27													CASGTGTGTFYGYTF+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCAAAACGGGACAGGGGAATTGGAACTGTTTTTTGGCAGT		Out	VDJ	2	53	3.9195675163993226E-4		44	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	5	0	2	12	5	6	26	38	53	43	59		TCRBV03-01,TCRBV03-02												X+TCRBV03-X+TCRBJ01-04	TCRBV03	TCRBD01-01*01	TCRBJ01-04*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCAGGCCACAGGGTTTTAATGAAAAACTGTTTTTTGGCAGT	CSARPQGFNEKLFF	In	VDJ	2	53	3.9195675163993226E-4	4.5959468951343665E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	6	3	3	4	6	3	26	34	46	40	49		TCRBV20-01,TCRBV20-or09_02												CSARPQGFNEKLFF+TCRBV20-X+TCRBJ01-04	TCRBV20	TCRBD01-01*01	TCRBJ01-04*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATCGGCGCGGCTCCTACAATGAGCAGTTCTTCGGGCCA	CSARDRRGSYNEQFF	In	VDJ	2	53	3.9195675163993226E-4	4.5959468951343665E-4	45	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	0	7	5	0	5	0	26	40	-1	45	49		TCRBV20-01,TCRBV20-or09_02				01,02								CSARDRRGSYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01	TCRBJ02-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATGTACAGGGGGCGAACTACGAGCAGTACTTCGGGCCG	CSARDVQGANYEQYF	In	VDJ	2	53	3.9195675163993226E-4	4.5959468951343665E-4	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	0	3	0	3	3	3	26	40	52	43	55		TCRBV20-01,TCRBV20-or09_02												CSARDVQGANYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD01-01*01	TCRBJ02-07*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGTGGCGTTATGAGTATACGCAAGAGACCCAGTACTTCGGGCCA	CSARWRYEYTQETQYF	In	VDJ	2	53	3.9195675163993226E-4	4.5959468951343665E-4	48	TCRBV20						TCRBJ02	TCRBJ02-05	01	3	9	0	2	2	14	26	37	42	39	56		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARWRYEYTQETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20		TCRBJ02-05*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGCCGATCGCAGGGGGCGCGAGACCCAGTACTTCGGGCCA	CATSADRRGRETQYF	In	VDJ	2	53	3.9195675163993226E-4	4.5959468951343665E-4	45	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	5	4	0	5	7	2	24	37	52	44	54		TCRBV24-01,TCRBV24-or09_02												CATSADRRGRETQYF+TCRBV24-X+TCRBJ02-05	TCRBV24	TCRBD01-01*01	TCRBJ02-05*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
AGGACTCGGCCSTGTATCTCTGTGCCAGCGAGGACAGGGGGCGAGATACGCAGTATTTTGGCCCA	CASEDRGRDTQYF	In	VDJ	2	53	3.9195675163993226E-4	4.5959468951343665E-4	39	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	8	1	0	5	2	1	18	27	40	29	41	TCRBV05,TCRBV07													CASEDRGRDTQYF+X+TCRBJ02-03	unresolved	TCRBD01-01*01	TCRBJ02-03*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCAGTGACGGGAGAAAGACCGGGGAGCTGTTTTTTGGAGAA	CASSDGRKTGELFF	In	VDJ	2	54	3.9935216204823286E-4	4.682662874287845E-4	42	TCRBV12			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	5	8	2	5	2	4	22	34	42	36	46		TCRBV12-03,TCRBV12-04												CASSDGRKTGELFF+TCRBV12-X+TCRBJ02-02	TCRBV12	TCRBD02-01*02	TCRBJ02-02*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGGACAGGGTCGGGAGATCAGCCCCAGCATTTTGGTGAT	CASRTGSGDQPQHF	In	VDJ	2	55	4.0674757245653346E-4	4.7693788534413235E-4	42	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	7	2	3	5	0	7	24	-1	42	35	49		TCRBV24-01,TCRBV24-or09_02												CASRTGSGDQPQHF+TCRBV24-X+TCRBJ01-05	TCRBV24	TCRBD01-01*01	TCRBJ01-05*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTGGGAGGGGCCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSLGGASYNEQFF	In	VDJ	2	55	4.0674757245653346E-4	4.7693788534413235E-4	45	TCRBV24			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	6	9	0	0	2	2	24	36	45	38	47		TCRBV24-01,TCRBV24-or09_02												CASSLGGASYNEQFF+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD02-01*02	TCRBJ02-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CGACTCGGCYGTGTATSTCTGTGCCAGCAGCTCGAGGGCGGGAGGGTTGGAGACCCAGTACTTCGGGCCA	CASSSRAGGLETQYF	In	VDJ	2	55	4.0674757245653346E-4	4.7693788534413235E-4	45	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	4	7	0	5	5	3	18	31	45	36	48	TCRBV07,TCRBV11													CASSSRAGGLETQYF+X+TCRBJ02-05	unresolved	TCRBD02-01*02	TCRBJ02-05*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
TGGRGGACTCAGCYWTGTAYTTCTGTGCCAGCAGTGGGGGACTAGTCGACCAAGAGACCCAGTACTTCGGGCCA	CASSGGLVDQETQYF	In	VDJ	2	55	4.0674757245653346E-4	4.7693788534413235E-4	45	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	5	0	8	0	3	3	23	34	45	37	48	TCRBV02,TCRBV09					01,02								CASSGGLVDQETQYF+X+TCRBJ02-05	unresolved	TCRBD02-01	TCRBJ02-05*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCCTTTAGGACAGAAGAATAACTATGGCTACACCTTCGGTTCG	CASSPLGQKNNYGYTF	In	VDJ	2	56	4.141429828648341E-4	4.8560948325948025E-4	48	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	1	5	1	5	5	26	39	50	44	55		TCRBV03-01,TCRBV03-02												CASSPLGQKNNYGYTF+TCRBV03-X+TCRBJ01-02	TCRBV03	TCRBD01-01*01	TCRBJ01-02*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGGAGTCCGGGACAGGAACCTTTACGAGCAGTACTTCGGGCCG	CSARGVRDRNLYEQYF	In	VDJ	2	56	4.141429828648341E-4	4.8560948325948025E-4	48	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	1	0	4	4	6	6	26	39	53	45	59		TCRBV20-01,TCRBV20-or09_02												CSARGVRDRNLYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD01-01*01	TCRBJ02-07*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GGACTCGGCCMTSTATCKCTGTGCCAGCAGCCAACGATCGAGGGGACTAGCGGGAGTTGAGCAGTTCTTCGGGCCA	CASSQRSRGLAGVEQFF	In	VDJ	2	56	4.141429828648341E-4	4.8560948325948025E-4	51	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	5	0	2	9	11	1	18	30	55	41	56	TCRBV05,TCRBV07													CASSQRSRGLAGVEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01*02	TCRBJ02-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GGACTCGGCCMTSTATCKCTGTGCCAGCAGCTTAGTTCGGCTAGCGGGAGGTGACGAGCAGTTCTTCGGGCCA	CASSLVRLAGGDEQFF	In	VDJ	2	56	4.141429828648341E-4	4.8560948325948025E-4	48	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	2	4	1	10	7	4	19	33	51	40	55	TCRBV05,TCRBV07													CASSLVRLAGGDEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01*02	TCRBJ02-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCAGGCGTAGTCCATTTCCATTCCGACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	2	57	4.215383932731347E-4		52	TCRBV03						TCRBJ02	TCRBJ02-01	01	5	5	4	5	0	20	26	-1	41	38	61		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV03-X+TCRBJ02-01	TCRBV03		TCRBJ02-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGGGCTAGCGTTTAACAATGAGTAGTTCTTCGGGCCA	CSARGLAFNNE*FF	Stop	VDJ	2	57	4.215383932731347E-4		42	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	1	4	6	14	2	13	26	39	47	41	60		TCRBV20-01,TCRBV20-or09_02				01,02								CSARGLAFNNE*FF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01	TCRBJ02-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTGGTGGAGGGACAGGGGATGGCTACACCTTCGGTTCG	CSAGGGTGDGYTF	In	VDJ	2	57	4.215383932731347E-4	4.942810811748281E-4	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	0	2	6	6	0	26	35	-1	41	51		TCRBV20-01,TCRBV20-or09_02												CSAGGGTGDGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CAGRAGACWCRGCMCTGTATCTCTGCGCCAGCAGCCAGGCAAACGACAGTTGCGTCCCACACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	2	57	4.215383932731347E-4		55	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	3	2	5	3	7	9	23	37	49	44	58	TCRBV04,TCRBV23													X+X+TCRBJ02-02	unresolved	TCRBD01-01*01	TCRBJ02-02*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
AAYCMRGRGACWCAGCWSKGTATTTYTGTGCCAGCAGTTTCTTGGTAAGATGGGAGAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSFLVRWESSYNEQFF	In	VDJ	2	58	4.289338036814353E-4	5.02952679090176E-4	54	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	3	9	2	0	11	2	26	40	56	51	58	TCRBV12,TCRBV21													CASSFLVRWESSYNEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01*02	TCRBJ02-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCCTGGGGTAAACGCAGTATTTTGGCCCA		Out	VDJ	2	58	4.289338036814353E-4		34	TCRBV03						TCRBJ02	TCRBJ02-03	01	4	6	2	9	2	3	26	39	45	41	48		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV03-X+TCRBJ02-03	TCRBV03		TCRBJ02-03*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGTCCGGACGACGAGCTCCTACGAGCAGTACTTCGGGCCG	CSVRTTSSYEQYF	In	VDJ	2	58	4.289338036814353E-4	5.02952679090176E-4	39	TCRBV20						TCRBJ02	TCRBJ02-07	01	7	1	7	0	3	6	26	33	40	36	46		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSVRTTSSYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20		TCRBJ02-07*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CGACTCGGCYGTGTATSTCTGTGCCAGCAGCTTAGTGCAGGGCGCCTCCTACGAGCAGTACTTCGGGCCG	CASSLVQGASYEQYF	In	VDJ	2	59	4.363292140897359E-4	5.116242770055238E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	1	4	3	0	2	3	18	34	41	36	44	TCRBV07,TCRBV11													CASSLVQGASYEQYF+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGCACTACAGGGTTCGGACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	2	60	4.437246244980365E-4		46	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	5	3	3	5	4	5	24	37	47	41	52		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ02-02	TCRBV24	TCRBD01-01*01	TCRBJ02-02*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
AACYSRGGGACTCAGCTKTGTATTTYTGTGCCAGCAGCGTAGAGGCGGGAGGGCCCGCCGGGGAGCTGTTTTTTGGAGAA	CASSVEAGGPAGELFF	In	VDJ	2	60	4.437246244980365E-4	5.202958749208717E-4	48	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	0	7	0	6	2	4	23	39	50	41	54	TCRBV09,TCRBV12													CASSVEAGGPAGELFF+X+TCRBJ02-02	unresolved	TCRBD02-01*02	TCRBJ02-02*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTTGGGGGACTAGCGGGGTTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	2	61	4.511200349063371E-4		49	TCRBV12			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	3	0	3	4	3	1	26	40	56	43	57		TCRBV12-03,TCRBV12-04												X+TCRBV12-X+TCRBJ02-01	TCRBV12	TCRBD02-01*01	TCRBJ02-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGGGGCCCTACTCACCTACGAGCAGTACTTCGGGCCG	CSARGALLTYEQYF	In	VDJ	2	61	4.511200349063371E-4	5.289674728362195E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	1	8	0	2	0	8	26	-1	43	39	51		TCRBV20-01,TCRBV20-or09_02												CSARGALLTYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD01-01*01	TCRBJ02-07*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGCCGGACTAGCGGCTACGAGCAGTACTTCGGGCCG	CSASRTSGYEQYF	In	VDJ	2	61	4.511200349063371E-4	5.289674728362195E-4	39	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	3	1	5	3	2	0	26	37	-1	39	49		TCRBV20-01,TCRBV20-or09_02				01,02								CSASRTSGYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01	TCRBJ02-07*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGGGGGCAATAGATGTGGGAGATACGCAGTATTTTGGCCCA	CSARGAIDVGDTQYF	In	VDJ	2	61	4.511200349063371E-4	5.289674728362195E-4	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	3	6	0	5	0	12	26	-1	43	37	55		TCRBV20-01,TCRBV20-or09_02												CSARGAIDVGDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD01-01*01	TCRBJ02-03*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGCGTTTGGGGACAGAAAGAGACCCAGTACTTCGGGCCA	CASSVWGQKETQYF	In	VDJ	2	61	4.511200349063371E-4	5.289674728362195E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	2	0	5	3	3	1	23	37	47	40	48	TCRBV09,TCRBV21													CASSVWGQKETQYF+X+TCRBJ02-05	unresolved	TCRBD01-01*01	TCRBJ02-05*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCGGGGTAGCGGGAAGTGGGGAGCAGTTCTTCGGGCCA	CASSGVAGSGEQFF	In	VDJ	2	62	4.5851544531463775E-4	5.376390707515674E-4	42	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	5	5	3	10	4	6	26	38	50	42	56		TCRBV03-01,TCRBV03-02												CASSGVAGSGEQFF+TCRBV03-X+TCRBJ02-01	TCRBV03	TCRBD02-01*02	TCRBJ02-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAAAAATCCTTAGTTGAGCATGAAGCACAGATACGCAGTATTTTGGCCCA	CASSQKILS*A*STDTQYF	Stop	VDJ	2	62	4.5851544531463775E-4		57	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	2	5	8	0	8	10	24	39	50	47	60		TCRBV03-01,TCRBV03-02				01,02								CASSQKILS*A*STDTQYF+TCRBV03-X+TCRBJ02-03	TCRBV03	TCRBD02-01	TCRBJ02-03*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGGCCCCGGGAGGGCTATACCGGGGAGCTGTTTTTTGGAGAA	CASRPREGYTGELFF	In	VDJ	2	63	4.6591085572293835E-4	5.463106686669153E-4	45	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	6	8	0	5	4	4	26	37	49	41	53		TCRBV03-01,TCRBV03-02												CASRPREGYTGELFF+TCRBV03-X+TCRBJ02-02	TCRBV03	TCRBD02-01*02	TCRBJ02-02*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTGATGACTAGCGGGGGAAACTCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	2	63	4.6591085572293835E-4		49	TCRBV24			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	3	2	2	0	0	3	24	-1	51	39	54		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ02-07	TCRBV24	TCRBD02-01*01	TCRBJ02-07*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
TSRGGGACTCAGCTKTGTAYTTCTGTGCCAGCGGACCTGGGGGGGCTTCGAGCAGTACTTCGGGCCG		Out	VDJ	2	64	4.7330626613123895E-4		38	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	7	9	0	6	6	3	23	32	45	38	48	TCRBV09,TCRBV12													X+X+TCRBJ02-07	unresolved	TCRBD02-01*01	TCRBJ02-07*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTACCCTGGACATAGGAACCTACAATGAGCAGTTCTTCGGGCCA	CSATLDIGTYNEQFF	In	VDJ	2	65	4.8070167653953955E-4	5.63653864497611E-4	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	4	1	6	2	4	6	26	36	45	40	51		TCRBV20-01,TCRBV20-or09_02												CSATLDIGTYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD01-01*01	TCRBJ02-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCTCTAATCCCCGAACAGATACGCAGTATTTTGGCCCA	CATSNPRTDTQYF	In	VDJ	2	65	4.8070167653953955E-4	5.63653864497611E-4	39	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	9	4	9	3	1	8	24	33	37	34	45		TCRBV24-01,TCRBV24-or09_02				01,02								CATSNPRTDTQYF+TCRBV24-X+TCRBJ02-03	TCRBV24	TCRBD02-01	TCRBJ02-03*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTCAGGTGGGACCGGAACCTACGAGCAGTACTTCGGGCCG	CASSSGGTGTYEQYF	In	VDJ	2	65	4.8070167653953955E-4	5.63653864497611E-4	45	TCRBV24						TCRBJ02	TCRBJ02-07	01	6	0	7	2	6	5	24	36	47	42	52		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSSGGTGTYEQYF+TCRBV24-X+TCRBJ02-07	TCRBV24		TCRBJ02-07*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGGTCTAGCGTTAGAGACCCAGTACTTCGGGCCA	CSARGLALETQYF	In	VDJ	2	67	4.954924973561408E-4	5.809970603283067E-4	39	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	1	4	6	4	2	2	26	39	47	41	49		TCRBV20-01,TCRBV20-or09_02				01,02								CSARGLALETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD02-01	TCRBJ02-05*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGCGGAAAGGAACTAGCGGGAGTTGCTAACGAGCAGTACTTCGGGCCG	CASSGKELAGVANEQYF	In	VDJ	2	68	5.028879077644413E-4	5.896686582436546E-4	51	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	5	3	2	5	8	6	24	36	55	44	61	TCRBV09,TCRBV21													CASSGKELAGVANEQYF+X+TCRBJ02-07	unresolved	TCRBD02-01*02	TCRBJ02-07*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTAATCCGGCCACAGGGGGACACGAGCAGTACTTCGGGCCG	CSASNPATGGHEQYF	In	VDJ	2	70	5.176787285810427E-4	6.070118540743503E-4	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	3	1	5	10	2	26	37	55	47	57		TCRBV20-01,TCRBV20-or09_02												CSASNPATGGHEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD01-01*01	TCRBJ02-07*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTCGCCAGGGGCCTGGCTACACCTTCGGTTCG		Out	VDJ	2	71	5.250741389893432E-4		37	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	4	2	7	3	2	26	39	48	42	50		TCRBV12-03,TCRBV12-04												X+TCRBV12-X+TCRBJ01-02	TCRBV12	TCRBD01-01*01	TCRBJ01-02*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCCCCGGGGGCCAGGCGACGTTCAGCCCCAGCATTTTGGTGAT	CASSPRGPGDVQPQHF	In	VDJ	2	71	5.250741389893432E-4	6.156834519896982E-4	48	TCRBV03						TCRBJ01	TCRBJ01-05	01	4	6	0	6	3	10	26	39	48	42	58		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPRGPGDVQPQHF+TCRBV03-X+TCRBJ01-05	TCRBV03		TCRBJ01-05*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTGAGCGGGAGGCCGTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	2	71	5.250741389893432E-4		40	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	5	6	1	4	1	3	26	35	45	36	48		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*02	TCRBJ02-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCAGCCTTAGGGGGATCTCCCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	2	71	5.250741389893432E-4		44	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	5	1	2	3	6	19	31	40	34	46	TCRBV05,TCRBV11													X+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
TGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGACCGCCGGGACTAAAGACCGCGTTCGGAGAATACGAGCAGTACTTCGGGCCG		Out	VDJ	2	71	5.250741389893432E-4		59	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	0	0	9	4	5	18	22	36	48	41	66		TCRBV20-01,TCRBV20-or09_02				01,02								X+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01	TCRBJ02-07*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCAGTTCATCCGGGACAGCAGGAAAACTGTTTTTTGGCAGT	CASSSSGTAGKLFF	In	VDJ	2	72	5.324695493976438E-4	6.24355049905046E-4	42	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	4	0	5	10	5	4	22	35	47	40	51		TCRBV12-03,TCRBV12-04												CASSSSGTAGKLFF+TCRBV12-X+TCRBJ01-04	TCRBV12	TCRBD01-01*01	TCRBJ01-04*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCATCAACCCAGGACGAGAGGACGCTGAAGCTTTCTTTGGACAA	CAINPGREDAEAFF	In	VDJ	2	72	5.324695493976438E-4	6.24355049905046E-4	42	unresolved						TCRBJ01	TCRBJ01-01	01	10	1	7	6	8	9	23	30	42	38	51	TCRBV06,TCRBV10			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CAINPGREDAEAFF+X+TCRBJ01-01	unresolved		TCRBJ01-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCGGTTAGGTTCCATTTCATACATCATAATTCACCCCTCCACTTTGGGAAC		Out	VDJ	2	73	5.398649598059444E-4		55	TCRBV03						TCRBJ01	TCRBJ01-06	01	5	3	6	5	18	2	26	38	59	56	61		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV03-X+TCRBJ01-06	TCRBV03		TCRBJ01-06*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCGAGACCAAGTCAACTTAACGAGCAGTACTTCGGGCCG	CSARPSQLNEQYF	In	VDJ	2	73	5.398649598059444E-4	6.330266478203939E-4	39	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	2	3	10	5	8	2	26	38	49	46	51		TCRBV20-01,TCRBV20-or09_02				01,02								CSARPSQLNEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01	TCRBJ02-07*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATCACGACTAGCCAATTATTACGAGCAGTACTTCGGGCCG		Out	VDJ	2	73	5.398649598059444E-4		47	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	0	2	7	4	4	7	26	40	51	44	58		TCRBV20-01,TCRBV20-or09_02				01,02								X+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01	TCRBJ02-07*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
AACCCAGGGACTCAGCTGTGTAYTTYTGTGCCAGCAGTCCCGAAAGCTTTAGCACAGATACGCAGTATTTTGGCCCA	CASSPESFSTDTQYF	In	VDJ	2	73	5.398649598059444E-4	6.330266478203939E-4	45	TCRBV12			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	5	6	7	0	6	3	22	34	43	40	46		TCRBV12-03,TCRBV12-04				01,02								CASSPESFSTDTQYF+TCRBV12-X+TCRBJ02-03	TCRBV12	TCRBD02-01	TCRBJ02-03*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCTAGCAGCCCAGCGGGAGTCTCAGATACGCAGTATTTTGGCCCA	CASSPAGVSDTQYF	In	VDJ	2	75	5.546557806225457E-4	6.503698436510896E-4	42	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	4	6	2	4	1	3	23	36	45	37	48	TCRBV01,TCRBV04													CASSPAGVSDTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01*02	TCRBJ02-03*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAAGCGGACGGCAATCAGCCCCAGCATTTTGGTGAT	CASSQADGNQPQHF	In	VDJ	2	75	5.546557806225457E-4	6.503698436510896E-4	42	unresolved						TCRBJ01	TCRBJ01-05	01	1	1	7	2	1	1	23	39	44	40	45	TCRBV01,TCRBV04			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQADGNQPQHF+X+TCRBJ01-05	unresolved		TCRBJ01-05*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GACTCGGCCRTGTATSKCTGTGTCAGCAGCTATTCCCCCAGGCCAGATACGCAGTATTTTGGCCCA	CVSSYSPRPDTQYF	In	VDJ	2	76	5.620511910308462E-4	6.590414415664375E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	4	4	4	4	7	1	18	31	42	38	43	TCRBV07,TCRBV11													CVSSYSPRPDTQYF+X+TCRBJ02-03	unresolved	TCRBD01-01*01	TCRBJ02-03*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCAAGCAGACACAGGGGGAGAAACTATGGCTACACCTTCGGTTCG	CSASRHRGRNYGYTF	In	VDJ	2	77	5.694466014391469E-4	6.677130394817853E-4	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	3	1	2	8	3	26	34	50	42	53		TCRBV20-01,TCRBV20-or09_02												CSASRHRGRNYGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTCCTACAGGGGAGCAAGAGACCCAGTACTTCGGGCCA	CATSPTGEQETQYF	In	VDJ	2	78	5.768420118474474E-4	6.763846373971332E-4	42	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	6	3	2	2	3	2	24	36	46	39	48		TCRBV24-01,TCRBV24-or09_02												CATSPTGEQETQYF+TCRBV24-X+TCRBJ02-05	TCRBV24	TCRBD01-01*01	TCRBJ02-05*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATTCGTTCCCCCTGGGACAGGGAACAGATACGCAGTATTTTGGCCCA	CATSDSFPLGQGTDTQYF	In	VDJ	2	78	5.768420118474474E-4	6.763846373971332E-4	54	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	2	0	3	3	10	1	24	40	59	50	60		TCRBV24-01,TCRBV24-or09_02												CATSDSFPLGQGTDTQYF+TCRBV24-X+TCRBJ02-03	TCRBV24	TCRBD01-01*01	TCRBJ02-03*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGTTAGCCGACTAGCGGAATCTAGGCGAGCAGTACTTCGGGCCG		Out	VDJ	2	79	5.842374222557481E-4		43	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	3	2	5	6	2	8	26	37	48	39	56		TCRBV20-01,TCRBV20-or09_02				01,02								X+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01	TCRBJ02-07*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATTCCATAGACAGGGACTACTCTAGGGCTACACCTTCGGTTCG		Out	VDJ	2	80	5.916328326640487E-4		50	TCRBV24						TCRBJ01	TCRBJ01-02	01	2	2	3	8	5	10	24	40	52	45	62		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV24-X+TCRBJ01-02	TCRBV24		TCRBJ01-02*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCAGGGCGAGGCGGGAGGGGGAATGAGCAGTTCTTCGGGCCA	CSAGRGGRGNEQFF	In	VDJ	2	82	6.064236534806499E-4	7.110710290585247E-4	42	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	6	7	0	7	8	2	26	34	51	42	53		TCRBV20-01,TCRBV20-or09_02												CSAGRGGRGNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*02	TCRBJ02-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTCGGGCCCCTTATAAAGACAATGAGCAGTTCTTCGGGCCA	CSASRAPYKDNEQFF	In	VDJ	2	82	6.064236534806499E-4	7.110710290585247E-4	45	TCRBV20						TCRBJ02	TCRBJ02-01	01	3	8	0	5	2	11	26	37	43	39	54		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSASRAPYKDNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20		TCRBJ02-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTTATAGCGGGAGAGGCGACAATGAGCAGTTCTTCGGGCCA	CSAYSGRGDNEQFF	In	VDJ	2	82	6.064236534806499E-4	7.110710290585247E-4	42	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	5	5	2	5	2	5	26	35	46	37	51		TCRBV20-01,TCRBV20-or09_02												CSAYSGRGDNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*02	TCRBJ02-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCGTAGCTGGTAGCGGGGTCTACGAGCAGTACTTCGGGCCG	CASSVAGSGVYEQYF	In	VDJ	2	84	6.212144742972511E-4	7.284142248892203E-4	45	TCRBV12			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	6	5	3	3	9	1	26	37	54	46	55		TCRBV12-03,TCRBV12-04,TCRBV12-05												CASSVAGSGVYEQYF+TCRBV12-X+TCRBJ02-07	TCRBV12	TCRBD02-01*01	TCRBJ02-07*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCTAAAACGGAACCAGGGTGGACTAGAAACTGAAGCTTTCTTTGGACAA		Out	VDJ	2	86	6.360052951138523E-4		50	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	9	1	8	5	17	2	24	33	57	50	59		TCRBV24-01,TCRBV24-or09_02				01,02								X+TCRBV24-X+TCRBJ01-01	TCRBV24	TCRBD02-01	TCRBJ01-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CGACTCGGCYGTGTATSTCTGTGCCAGCAGCTTTGGGTCAGGGTCCTCCTATGGCTACACCTTCGGTTCG	CASSFGSGSSYGYTF	In	VDJ	2	86	6.360052951138523E-4	7.45757420719916E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	4	3	4	5	5	18	32	42	37	47	TCRBV07,TCRBV11													CASSFGSGSSYGYTF+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GAGACWCGGCMSTGTATCTCTGYGCCAGCAGCTCTTTGGGGGGCTCCGGCTACACCTTCGGTTCG	CASSSLGGSGYTF	In	VDJ	2	86	6.360052951138523E-4	7.45757420719916E-4	39	unresolved						TCRBJ01	TCRBJ01-02	01	6	6	0	8	7	3	20	31	44	38	47	TCRBV07,TCRBV23			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSSLGGSGYTF+X+TCRBJ01-02	unresolved		TCRBJ01-02*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCAACGGGGCGGCCCGAAACTATGGCTACACCTTCGGTTCG	CASSNGAARNYGYTF	In	VDJ	2	87	6.43400705522153E-4	7.544290186352639E-4	45	TCRBV03						TCRBJ01	TCRBJ01-02	01	5	7	0	2	3	7	26	38	46	41	53		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSNGAARNYGYTF+TCRBV03-X+TCRBJ01-02	TCRBV03		TCRBJ01-02*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCAGTCTCGGGACTAACTATGGCTACACCTTCGGTTCG	CASSLGTNYGYTF	In	VDJ	3	89	6.581915263387542E-4	7.717722144659596E-4	39	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	5	8	3	0	2	0	23	35	-1	37	42	TCRBV06,TCRBV10													CASSLGTNYGYTF+X+TCRBJ01-02	unresolved	TCRBD02-01*02	TCRBJ01-02*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCCCAAAGGGCTAGCGGGAAAGAATGAGCAGTTCTTCGGGCCA	CASSPKGLAGKNEQFF	In	VDJ	3	90	6.655869367470547E-4	7.804438123813075E-4	48	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	4	4	3	7	8	3	26	39	56	47	59		TCRBV03-01,TCRBV03-02												CASSPKGLAGKNEQFF+TCRBV03-X+TCRBJ02-01	TCRBV03	TCRBD02-01*02	TCRBJ02-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTGGGGGGGCTGCCACTGAAGCTTTCTTTGGACAA	CSAGGAATEAFF	In	VDJ	3	90	6.655869367470547E-4	7.804438123813075E-4	36	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	5	9	0	4	0	4	26	-1	42	35	46		TCRBV20-01,TCRBV20-or09_02												CSAGGAATEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD02-01*01	TCRBJ01-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
ARRRRGACTCAGCYGYGTATCTCTRCGCCAGCAGCCCAGGAATTGCGGAGACCCAGTACTTCGGGCCA	XASSPGIAETQYF	In	VDJ	3	90	6.655869367470547E-4	7.804438123813075E-4	39	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	5	4	4	5	1	7	22	34	39	35	46	TCRBV01,TCRBV07,TCRBV17													XASSPGIAETQYF+X+TCRBJ02-05	unresolved	TCRBD01-01*01	TCRBJ02-05*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTACCCACTTAACAGAAAACATTCAGTACTTCGGCGCC	CSATHLTENIQYF	In	VDJ	3	91	6.729823471553554E-4	7.891154102966553E-4	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	4	3	5	5	8	0	26	36	-1	44	48		TCRBV20-01,TCRBV20-or09_02												CSATHLTENIQYF+TCRBV20-X+TCRBJ02-04	TCRBV20	TCRBD01-01*01	TCRBJ02-04*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTGGGCCGGGACCCCAAGAGACCCAGTACTTCGGGCCA	CSAGPGPQETQYF	In	VDJ	3	91	6.729823471553554E-4	7.891154102966553E-4	39	TCRBV20						TCRBJ02	TCRBJ02-05	01	5	0	7	1	5	1	26	35	45	40	46		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSAGPGPQETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20		TCRBJ02-05*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTAGAAAGGCCTTCTTGGGGCTACGAGCAGTACTTCGGGCCG	CASSLERPSWGYEQYF	In	VDJ	3	92	6.80377757563656E-4	7.977870082120032E-4	48	TCRBV12						TCRBJ02	TCRBJ02-07	01	1	6	2	3	12	0	26	42	-1	54	58		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLERPSWGYEQYF+TCRBV12-X+TCRBJ02-07	TCRBV12		TCRBJ02-07*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGCGTAGGCGGCCTAGCGGGAAACACAGATACGCAGTATTTTGGCCCA	CASSVGGLAGNTDTQYF	In	VDJ	3	93	6.877731679719566E-4	8.064586061273511E-4	51	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	0	4	3	2	5	2	23	39	53	44	55	TCRBV09,TCRBV21													CASSVGGLAGNTDTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01*02	TCRBJ02-03*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCGAGGGCAGTCCCATTTAGGTGCTAATGAAAAACTGTTTTTTGGCAGT		Out	VDJ	3	96	7.099593991968584E-4		53	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-04	01	5	11	0	3	0	16	26	-1	43	38	59		TCRBV03-01,TCRBV03-02												X+TCRBV03-X+TCRBJ01-04	TCRBV03	TCRBD02-01*02	TCRBJ01-04*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCATTCACCTACAGGGTTGTTGGAGCAATGAGCAGTTCTTCGGGCCA		Out	VDJ	3	98	7.247502200134596E-4		52	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	3	3	3	6	7	9	26	40	53	47	62		TCRBV03-01,TCRBV03-02												X+TCRBV03-X+TCRBJ02-01	TCRBV03	TCRBD01-01*01	TCRBJ02-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
AAGRAGACWCRGCWSYGTATCTCTGCGCCAGCAGCCTCGGACAGGGYTACCACACTGAAGCTTTCTTTGGACAA	CASSLGQGYHTEAFF	In	VDJ	3	99	7.321456304217603E-4	8.584881936194382E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	1	3	3	4	5	20	31	43	35	48	TCRBV01,TCRBV23													CASSLGQGYHTEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCGCGACGACAGATACGCAGTATTTTGGCCCA	CSAATTDTQYF	In	VDJ	3	102	7.543318616466621E-4	8.845029873654818E-4	33	TCRBV20						TCRBJ02	TCRBJ02-03	01	6	2	7	3	3	1	26	34	40	37	41		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSAATTDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20		TCRBJ02-03*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCTCAGACCACTGGACCTAATTTCCATGAGCAGTTCTTCGGGCCA		Out	VDJ	3	103	7.617272720549627E-4		43	TCRBV24						TCRBJ02	TCRBJ02-01	01	12	1	7	8	10	9	24	30	44	40	53		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV24-X+TCRBJ02-01	TCRBV24		TCRBJ02-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTTCATATATGGATGAGCAGTTCTTCGGGCCA	CSASYMDEQFF	In	VDJ	3	105	7.765180928715639E-4	9.105177811115254E-4	33	TCRBV20						TCRBJ02	TCRBJ02-01	01	5	0	10	8	8	0	26	35	-1	43	45		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSASYMDEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20		TCRBJ02-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCAAGACGCGGGAACAAAGTCAGATACGCAGTATTTTGGCCCA	CASSQDAGTKSDTQYF	In	VDJ	3	105	7.765180928715639E-4	9.105177811115254E-4	48				TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	0	7	3	4	1	7	18	35	42	36	49	TCRBV04,TCRBV11	TCRBV04-02,TCRBV11-03												CASSQDAGTKSDTQYF+X+TCRBJ02-03		TCRBD02-01*02	TCRBJ02-03*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
TGGRGGACTCAGCYWTGTAYTTCTGTGCCAGCAGTGGCGAACTAGGGACTAGCGGGAGTTTGGATGAGCAGTTCTTCGGGCCA	CASSGELGTSGSLDEQFF	In	VDJ	3	107	7.913089136881652E-4	9.278609769422211E-4	54	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	5	0	2	8	10	5	23	34	58	44	63	TCRBV02,TCRBV09													CASSGELGTSGSLDEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01*02	TCRBJ02-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCTCTGGACAGGGGGCTAGCACTGAAGCTTTCTTTGGACAA	CASSSGQGASTEAFF	In	VDJ	3	108	7.987043240964657E-4	9.36532574857569E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	1	0	4	2	3	18	31	44	33	47	TCRBV07,TCRBV11													CASSSGQGASTEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
AAYCMRGRGACWCAGCWSKGTATTTYTGTGCCAGCAGCACTGTTCAGCAAGAGACCCAGTACTTCGGGCCA	CASSTVQQETQYF	In	VDJ	3	110	8.134951449130669E-4	9.538757706882647E-4	39	unresolved			unresolved			TCRBJ02	TCRBJ02-05	01	4	4	5	2	5	0	24	37	-1	42	45	TCRBV12,TCRBV21			TCRBD01,TCRBD02										CASSTVQQETQYF+X+TCRBJ02-05	unresolved	unresolved	TCRBJ02-05*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATTTGCTCGGGGCTAGCACAGATACGCAGTATTTTGGCCCA	CATSDLLGASTDTQYF	In	VDJ	3	111	8.208905553213676E-4	9.625473686036126E-4	48	TCRBV24						TCRBJ02	TCRBJ02-03	01	0	7	0	0	3	1	24	42	50	45	51		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATSDLLGASTDTQYF+TCRBV24-X+TCRBJ02-03	TCRBV24		TCRBJ02-03*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGTCCCTCTCTCCGCGGGAGTTTCGATGAGCAGTTCTTCGGGCCA	CASSPSLRGSFDEQFF	In	VDJ	3	111	8.208905553213676E-4	9.625473686036126E-4	48	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	6	7	2	8	11	5	18	29	47	40	52	TCRBV07,TCRBV11													CASSPSLRGSFDEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01*02	TCRBJ02-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGGAAGAAACAGATACGCAGTATTTTGGCCCA		Out	VDJ	3	115	8.5047219695457E-4		35	TCRBV03						TCRBJ02	TCRBJ02-03	01	6	2	8	3	0	4	26	-1	39	37	43		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV03-X+TCRBJ02-03	TCRBV03		TCRBJ02-03*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTCAGACTAGCGGGGGCCACTACGAGCAGTACTTCGGGCCG	CASSQTSGGHYEQYF	In	VDJ	3	118	8.726584281794718E-4	0.0010232485540110476	45	TCRBV12			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	5	2	2	3	2	3	26	38	52	40	55		TCRBV12-03,TCRBV12-04												CASSQTSGGHYEQYF+TCRBV12-X+TCRBJ02-07	TCRBV12	TCRBD02-01*01	TCRBJ02-07*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTCCCTACTCGACAGGGGGCGGCACCGGGGAGCTGTTTTTTGGAGAA	CASSPYSTGGGTGELFF	In	VDJ	3	118	8.726584281794718E-4	0.0010232485540110476	51	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	6	2	0	4	8	2	24	36	54	44	56		TCRBV24-01,TCRBV24-or09_02												CASSPYSTGGGTGELFF+TCRBV24-X+TCRBJ02-02	TCRBV24	TCRBD01-01*01	TCRBJ02-02*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
ARRRRGACTCAGCYGYGTATCTCTRCGCCAGCAGCCATGACCCGAGGGGGGACTGTCTCGTGCATTGAGCAGTTCTTCGGGCCA		Out	VDJ	4	124	9.170308906292755E-4		55	unresolved						TCRBJ02	TCRBJ02-01	01	3	5	1	9	7	15	23	37	50	44	65	TCRBV01,TCRBV04,TCRBV07,TCRBV17			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+X+TCRBJ02-01	unresolved		TCRBJ02-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCTCTCTCGGGGACTACCATTCACAGGGGGAGTTCTTCGGGCCA	CASSSLGDYHSQGEFF	In	VDJ	4	129	9.540079426707786E-4	0.001118636131079874	48	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	3	1	14	20	0	26	38	-1	58	66		TCRBV03-01,TCRBV03-02												CASSSLGDYHSQGEFF+TCRBV03-X+TCRBJ02-01	TCRBV03	TCRBD01-01*01	TCRBJ02-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTGGGATGGGATATTATCAGCCCCAGCATTTTGGTGAT	CASSGMGYYQPQHF	In	VDJ	4	130	9.614033530790791E-4	0.001127307728995222	42	TCRBV12						TCRBJ01	TCRBJ01-05	01	5	0	8	5	0	9	26	-1	42	38	51		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSGMGYYQPQHF+TCRBV12-X+TCRBJ01-05	TCRBV12		TCRBJ01-05*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GGACTCRGCCRTGTATSKCTGTGCCGGACAGGCGGACTAGCGGAAATACTAAAACACGAATCAGTACTTCGGCGCC	CAGQAD*RKY*NTNQYF	Stop	VDJ	4	130	9.614033530790791E-4		51	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-04	01	12	1	5	12	9	17	18	23	42	32	59	TCRBV07,TCRBV12					01,02								CAGQAD*RKY*NTNQYF+X+TCRBJ02-04	unresolved	TCRBD02-01	TCRBJ02-04*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGACCCTGGACAGTCTATTCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	4	131	9.687987634873798E-4		49	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	4	1	5	2	4	6	24	38	48	42	54		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ02-03	TCRBV24	TCRBD01-01*01	TCRBJ02-03*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTAGTTGGCTAGAGGGGAATGAGCAGTTCTTCGGGCCA	CSASSWLEGNEQFF	In	VDJ	4	142	0.0010501482779786864	0.0012313669039793963	42	TCRBV20						TCRBJ02	TCRBJ02-01	01	3	5	2	7	11	0	26	37	-1	48	53		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSASSWLEGNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20		TCRBJ02-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAATCGGGACTAGCGGAGCAATGAGCAGTTCTTCGGGCCA		Out	VDJ	4	145	0.0010723345092035882		47	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	2	0	5	6	3	2	26	41	55	44	57		TCRBV03-01,TCRBV03-02				01,02								X+TCRBV03-X+TCRBJ02-01	TCRBV03	TCRBD02-01	TCRBJ02-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATTACCGGACAGGGTCCGATGAGCAGTTCTTCGGGCCA	CSARDYRTGSDEQFF	In	VDJ	4	145	0.0010723345092035882	0.0012573816977254398	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	0	1	3	8	5	4	26	40	53	45	57		TCRBV20-01,TCRBV20-or09_02												CSARDYRTGSDEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD01-01*01	TCRBJ02-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCTCCGGATGGGGGGTCACCGGGGAGCTGTTTTTTGGAGAA	CASSSGWGVTGELFF	In	VDJ	4	147	0.0010871253300201895	0.0012747248935561356	45	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	4	9	1	4	6	1	18	31	43	37	44	TCRBV07,TCRBV11													CASSSGWGVTGELFF+X+TCRBJ02-02	unresolved	TCRBD02-01*01	TCRBJ02-02*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GGACTCRGCCRTGTATSKCTGTGCCAGCAGCGCCCAACTAGCGGGAGGGGGAGAGACCCAGTACTTCGGGCCA	CASSAQLAGGGETQYF	In	VDJ	4	147	0.0010871253300201895	0.0012747248935561356	48	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	5	3	0	4	5	2	19	31	49	36	51	TCRBV07,TCRBV11													CASSAQLAGGGETQYF+X+TCRBJ02-05	unresolved	TCRBD02-01*02	TCRBJ02-05*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTGAGGTGGACAGGGGGCTTAGAGACCCAGTACTTCGGGCCA	CASSLRWTGGLETQYF	In	VDJ	4	148	0.00109452074042849	0.0012833964914714835	48	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	6	1	0	4	7	2	24	36	54	43	56		TCRBV24-01,TCRBV24-or09_02												CASSLRWTGGLETQYF+TCRBV24-X+TCRBJ02-05	TCRBV24	TCRBD01-01*01	TCRBJ02-05*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGCCCTGACACGGCGGAATGAGCAGTTCTTCGGGCCA	CSARALTRRNEQFF	In	VDJ	4	149	0.0011019161508367906	0.0012920680893868312	42	TCRBV20						TCRBJ02	TCRBJ02-01	01	1	2	6	7	4	6	26	39	47	43	53		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARALTRRNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20		TCRBJ02-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
TTTCTGTGCCAGCAGCCCGATTAGGGGAACCGGGACTAGCGGGATATAGATACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	4	149	0.0011019161508367906		64	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	4	0	3	4	14	6	4	17	44	31	50		TCRBV03-01,TCRBV03-02												X+TCRBV03-X+TCRBJ02-01	TCRBV03	TCRBD02-01*02	TCRBJ02-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTAAAAAGCGGGAACACAGATACGCAGTATTTTGGCCCA	CASSLKSGNTDTQYF	In	VDJ	4	150	0.0011093115612450914	0.0013007396873021791	45	TCRBV12			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	2	6	3	2	3	1	26	41	51	44	52		TCRBV12-03,TCRBV12-04												CASSLKSGNTDTQYF+TCRBV12-X+TCRBJ02-03	TCRBV12	TCRBD02-01*02	TCRBJ02-03*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTATGGTTCTGCCGGATAGACCCAGTACTTCGGGCCA		Out	VDJ	4	155	0.0011462886132865943		38	TCRBV20						TCRBJ02	TCRBJ02-05	01	4	1	8	6	10	1	26	36	49	46	50		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV20-X+TCRBJ02-05	TCRBV20		TCRBJ02-05*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCCAACCAGACMKCTCTKTACTTCTGTGCCAGCAGTCCGATAATGGACGTCCTGGCGGGCGAGCAGTACTTCGGGCCG	CASSPIMDVLAGEQYF	In	VDJ	4	155	0.0011462886132865943	0.0013440976768789184	48	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	6	7	4	6	18	0	24	36	-1	54	59	TCRBV24,TCRBV27					01,02								CASSPIMDVLAGEQYF+X+TCRBJ02-07	unresolved	TCRBD02-01	TCRBJ02-07*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGACAGGGGCGGGCTCTATACCTACAATGAGCAGTTCTTCGGGCCA	CASSQDRGGLYTYNEQFF	In	VDJ	5	159	0.0011758702549197967	0.00137878406854031	54	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	0	4	2	2	0	11	26	-1	49	43	60		TCRBV03-01,TCRBV03-02												CASSQDRGGLYTYNEQFF+TCRBV03-X+TCRBJ02-01	TCRBV03	TCRBD01-01*01	TCRBJ02-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
ARRRRGACTCAGCYGYGTATCTCTRCGCCAGCAGCCAAGCGGACAGCGGATTTCACTACGAGCAGTACTTCGGGCCG	XASSQADSGFHYEQYF	In	VDJ	5	162	0.0011980564861446986	0.0014047988622863535	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	1	1	5	3	1	9	23	39	46	40	55	TCRBV01,TCRBV04													XASSQADSGFHYEQYF+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GGACTCRGCCRTGTATSKCTGTGCCAGCAGCTTAGGAGGACTAGCGGCCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	5	165	0.0012202427173696004		46	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	1	1	5	2	2	1	18	34	46	36	47	TCRBV07,TCRBV11					01,02								X+X+TCRBJ02-07	unresolved	TCRBD02-01	TCRBJ02-07*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCGGGGAGGCAGACGGGACTAGCGGGAGCCGAGCCCTTCGGGCCG		Out	VDJ	5	167	0.0012350335381862017		43	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	11	0	2	15	12	7	23	29	55	41	62	TCRBV01,TCRBV04													X+X+TCRBJ02-07	unresolved	TCRBD02-01*02	TCRBJ02-07*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
TGGRGGACTCAGCYWTGTAYTTCTGTGCCAGCAGAGGGGCCTATCACCACGAGCAGTACTTCGGGCCG	CASRGAYHHEQYF	In	VDJ	5	170	0.0012572197694111034	0.0014741716456091365	39	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	5	2	5	0	9	23	-1	39	34	48	TCRBV02,TCRBV09													CASRGAYHHEQYF+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTGGTGACGGGAACACTGAAGCTTTCTTTGGACAA	CSASGDGNTEAFF	In	VDJ	5	172	0.0012720105902277047	0.001491514841439832	39	TCRBV20						TCRBJ01	TCRBJ01-01	01	3	2	7	1	4	2	26	37	44	41	46		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSASGDGNTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20		TCRBJ01-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
TGGRGGACTCAGCYWTGTAYTTCTGTGCCAGCAGAACCGGGCTCAATGAGCAGTTCTTCGGGCCA	CASRTGLNEQFF	In	VDJ	5	173	0.0012794060006360052	0.00150018643935518	36	unresolved						TCRBJ02	TCRBJ02-01	01	6	8	0	6	4	1	23	34	42	38	43	TCRBV02,TCRBV09			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASRTGLNEQFF+X+TCRBJ02-01	unresolved		TCRBJ02-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAATGGACAGGGCGCGCAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	5	175	0.0012941968214526065		47	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	2	1	3	2	1	3	26	41	50	42	53		TCRBV03-01,TCRBV03-02												X+TCRBV03-X+TCRBJ01-05	TCRBV03	TCRBD01-01*01	TCRBJ01-05*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGAGGGCCGACACAGATACGCAGTATTTTGGCCCA	CSARRADTDTQYF	In	VDJ	5	178	0.0013163830526775084	0.0015435444289319193	39	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	3	11	0	2	0	4	26	-1	42	37	46		TCRBV20-01,TCRBV20-or09_02												CSARRADTDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01*02	TCRBJ02-03*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCCCTATTCCGGAGGACTTCTTTTAGACCCAGTACTTCGGGCCA		Out	VDJ	5	178	0.0013163830526775084		46	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	5	1	10	6	12	6	26	35	52	47	58		TCRBV20-01,TCRBV20-or09_02				01,02								X+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD02-01	TCRBJ02-05*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CGTTTGGTGCCAGCCAGACCTCTGTACCTCTGTGCCAGCAGTCCTAGCGGGAGGGCCTCACGGAACAATGAGCAGTTCTTCGGGCCA	CASSPSGRASRNNEQFF	In	VDJ	5	188	0.0013903371567605145	0.0016302604080853979	51				TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	5	4	0	5	1	9	30	42	55	43	64	TCRBV25,TCRBV27,TCRBV28	TCRBV25-01,TCRBV25-or09_02,TCRBV27-01,TCRBV28-01												CASSPSGRASRNNEQFF+X+TCRBJ02-01		TCRBD02-01*02	TCRBJ02-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCGGATCCGGGAGCTCGGATACGCAGTATTTTGGCCCA	CASGSGSSDTQYF	In	VDJ	6	192	0.0014199187983937169	0.0016649467997467892	39	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	8	8	2	6	5	4	26	35	46	40	50		TCRBV03-01,TCRBV03-02												CASGSGSSDTQYF+TCRBV03-X+TCRBJ02-03	TCRBV03	TCRBD02-01*02	TCRBJ02-03*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCAAGACAGGTTATGAGGGTGAAAAACTGTTTTTTGGCAGT	CASSKTGYEGEKLFF	In	VDJ	6	199	0.001471686671251821	0.0017256479851542243	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	5	2	4	7	2	9	23	35	43	37	52	TCRBV01,TCRBV04													CASSKTGYEGEKLFF+X+TCRBJ01-04	unresolved	TCRBD01-01*01	TCRBJ01-04*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GACTCGGCCGTGTATGTCTGTGCCAGAAGCTTTGGGGCCAAGCGGAGGCGATCCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	6	207	0.0015308499545182259		52							TCRBJ02	TCRBJ02-07	01	2	7	0	2	1	15	18	32	38	33	53	TCRBV05,TCRBV11	TCRBV05-03,TCRBV11-03		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+X+TCRBJ02-07			TCRBJ02-07*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCTCCRTTGGGACTAGTTGGTTCCAGTACTTCGGGCCA	CASSSXGTSWFQYF	In	VDJ	6	220	0.0016269902898261338	0.0019077515413765294	42	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	5	0	8	10	6	6	26	38	52	44	58		TCRBV03-01,TCRBV03-02				01,02								CASSSXGTSWFQYF+TCRBV03-X+TCRBJ02-05	TCRBV03	TCRBD02-01	TCRBJ02-05*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CGACTCGGCYGTGTATSTCTGTGCCAGCAGCCCTAGGGGGTTTCCAGGGATGGAGACTGAAGCTTTCTTTGGACAA	CASSPRGFPGMETEAFF	In	VDJ	6	220	0.0016269902898261338	0.0019077515413765294	51	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	5	1	5	3	15	18	30	39	33	54	TCRBV07,TCRBV11													CASSPRGFPGMETEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCACCTCCCCCCTGGCGCCGACTCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	6	221	0.0016343857002344346		47	TCRBV24						TCRBJ02	TCRBJ02-07	01	11	9	0	0	13	5	24	31	47	44	52		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV24-X+TCRBJ02-07	TCRBV24		TCRBJ02-07*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTATTAGCGAATCCCTACAATGAGCAGTTCTTCGGGCCA	CASSLLANPYNEQFF	In	VDJ	6	223	0.0016491765210510357	0.001933766335122573	45	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	6	5	6	2	4	4	24	36	45	40	49		TCRBV24-01,TCRBV24-or09_02				01,02								CASSLLANPYNEQFF+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD02-01	TCRBJ02-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCGGGGAGGGGTCCGCCTCGTGAGCAGTTCTTCGGGCCA		Out	VDJ	7	227	0.001678758162684238		40	TCRBV24			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	9	9	0	9	1	10	24	33	41	34	51		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD02-01*02	TCRBJ02-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATTCCACTCCCCAAAGGGCCCCAGATACGCAGTATTTTGGCCCA	CATSDSTPQRAPDTQYF	In	VDJ	7	229	0.0016935489835008394	0.0019857959226146603	51	TCRBV24						TCRBJ02	TCRBJ02-03	01	2	5	3	4	11	3	24	40	55	51	58		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATSDSTPQRAPDTQYF+TCRBV24-X+TCRBJ02-03	TCRBV24		TCRBJ02-03*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGTACACCTATTAAACACCGGGGAGCTGTTTTTTGGAGAA	CASSQVHLLNTGELFF	In	VDJ	7	237	0.0017527122667672442	0.002055168705937443	48	TCRBV03						TCRBJ02	TCRBJ02-02	01	1	3	6	2	1	7	26	42	46	43	53		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQVHLLNTGELFF+TCRBV03-X+TCRBJ02-02	TCRBV03		TCRBJ02-02*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGGTCTAGCCTAGGAGTTTGGACTGAAGCTTTCTTTGGACAA	CASRSSLGVWTEAFF	In	VDJ	7	260	0.0019228067061581582	0.002254615457990444	45	unresolved			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	6	4	7	5	2	12	23	34	41	36	53	TCRBV01,TCRBV04					01,02								CASRSSLGVWTEAFF+X+TCRBJ01-01	unresolved	TCRBD02-01	TCRBJ01-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTCGACTGGTGAGATGGCAGGGGATACGCAGTATTTTGGCCCA	CASSSTGEMAGDTQYF	In	VDJ	8	263	0.00194499293738306	0.0022806302517364876	48	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	4	4	3	6	15	0	26	39	-1	54	59		TCRBV12-03,TCRBV12-04												CASSSTGEMAGDTQYF+TCRBV12-X+TCRBJ02-03	TCRBV12	TCRBD01-01*01	TCRBJ02-03*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
TTTACTTCTGTGCCAGCAGTCCCGGGGCCACAGGGAGCCTCCTATACTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSPGATGSLLYSGANVLTF	In	VDJ	8	264	0.0019523883477913606	0.0022893018496518355	63	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	6	3	3	0	9	11	8	20	35	29	46		TCRBV24-01,TCRBV24-or09_02												CASSPGATGSLLYSGANVLTF+TCRBV24-X+TCRBJ02-06	TCRBV24	TCRBD01-01*01	TCRBJ02-06*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCAGGGCCGGCGGGAGCGCAGATACGCAGTATTTTGGCCCA	CSARAGGSADTQYF	In	VDJ	8	267	0.0019745745790162627	0.002315316643397879	42	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	6	7	2	4	8	2	26	34	49	42	51		TCRBV20-01,TCRBV20-or09_02												CSARAGGSADTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01*02	TCRBJ02-03*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCTTCGGACAGGGGGCGGCAGATACGCAGTATTTTGGCCCA	CASSFGQGAADTQYF	In	VDJ	8	288	0.0021298781975905754	0.002497420199620184	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	3	1	0	4	1	2	18	32	44	33	46	TCRBV07,TCRBV11													CASSFGQGAADTQYF+X+TCRBJ02-03	unresolved	TCRBD01-01*01	TCRBJ02-03*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCCCAGCCGTGAACACTGAAGCTTTCTTTGGACAA	CASSPAVNTEAFF	In	VDJ	9	301	0.0022260185328984833	0.002610150972519706	39	TCRBV12						TCRBJ01	TCRBJ01-01	01	6	4	5	0	2	3	26	37	42	39	45		TCRBV12-03,TCRBV12-04,TCRBV12-05		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPAVNTEAFF+TCRBV12-X+TCRBJ01-01	TCRBV12		TCRBJ01-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
TSRRGGACTCAGCYRTGTACTTCTGTGCCAGCAGTGAATTTTCGGCTAGCCGTCTCGTAAGGCAGTTCTTCGGGCCA	CASSEFSASRLVRQFF	In	VDJ	9	316	0.0023369496890229924	0.0027402249412499242	48	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	2	4	7	12	7	11	23	38	50	45	61	TCRBV02,TCRBV12					01,02								CASSEFSASRLVRQFF+X+TCRBJ02-01	unresolved	TCRBD02-01	TCRBJ02-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTAATTAGGACAGGTGACACTGAAGCTTTCTTTGGACAA	CASSLIRTGDTEAFF	In	VDJ	9	325	0.0024035083826976977	0.002818269322488055	45	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	1	4	3	7	2	24	36	50	43	52		TCRBV24-01,TCRBV24-or09_02												CASSLIRTGDTEAFF+TCRBV24-X+TCRBJ01-01	TCRBV24	TCRBD01-01*01	TCRBJ01-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
AAGRAGACWCRGCWSYGTATCTCTGCGCCAGCAGCCCCGGGACAGGGGGCCGATTGAACACTGAAGCTTTCTTTGGACAA	CASSPGTGGRLNTEAFF	In	VDJ	10	363	0.002684533978213121	0.0031477900432712734	51	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	0	0	0	4	4	20	31	47	35	51	TCRBV01,TCRBV23													CASSPGTGGRLNTEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGAGATCGGGAGAGGGTGGGACAATGAGCAGTTCTTCGGGCCA	CSAREIGRGWDNEQFF	In	VDJ	11	369	0.0027289064406629247	0.003199819630763361	48	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	0	8	2	5	3	8	26	40	49	43	57		TCRBV20-01,TCRBV20-or09_02												CSAREIGRGWDNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*02	TCRBJ02-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATTTGCGGGCAGACCGGGGGACCCAGTACTTCGGGCCA	CATSDLRADRGTQYF	In	VDJ	11	370	0.0027363018510712252	0.0032084912286787087	45	TCRBV24			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	0	8	3	7	9	0	24	42	-1	51	56		TCRBV24-01,TCRBV24-or09_02												CATSDLRADRGTQYF+TCRBV24-X+TCRBJ02-05	TCRBV24	TCRBD02-01*01	TCRBJ02-05*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCGGACGGGGCTAGCGGGACCAGATACGCAGTATTTTGGCCCA		Out	VDJ	11	371	0.0027436972614795258		41	TCRBV24			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	12	4	3	4	8	1	24	30	47	38	48		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ02-03	TCRBV24	TCRBD02-01*02	TCRBJ02-03*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCATCATGGGGTCCCCGAGCAGTACTTCGGGCCG	CASSHHGVPEQYF	In	VDJ	11	373	0.002758488082296127	0.003234506022424752	39	unresolved						TCRBJ02	TCRBJ02-07	01	3	6	2	6	4	4	23	37	45	41	49	TCRBV01,TCRBV04			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSHHGVPEQYF+X+TCRBJ02-07	unresolved		TCRBJ02-07*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATGGGACTACCCGAGGGCGGCAGTACTTCGGGCCG	CATSDGTTRGRQYF	In	VDJ	11	391	0.002891605469645538	0.003390594784901014	42	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	3	0	9	9	0	10	24	-1	46	39	56		TCRBV24-01,TCRBV24-or09_02				01,02								CATSDGTTRGRQYF+TCRBV24-X+TCRBJ02-07	TCRBV24	TCRBD02-01	TCRBJ02-07*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGCATCGACAGGGGTTCGTCGTGGAGCTTTCTTTGGACAA	CASSQASTGVRRGAFF	In	VDJ	12	404	0.002987745804953446	0.003503325557800536	48	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	1	2	2	10	4	10	26	42	54	46	64		TCRBV03-01,TCRBV03-02												CASSQASTGVRRGAFF+TCRBV03-X+TCRBJ01-01	TCRBV03	TCRBD01-01*01	TCRBJ01-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGAGGCCCAGCGGCAATGAGCAGTTCTTCGGGCCA		Out	VDJ	12	420	0.0031060723714862555		40	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	0	6	5	6	5	0	26	40	-1	45	50		TCRBV20-01,TCRBV20-or09_02				01,02								X+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01	TCRBJ02-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAAGATCTTTCCAGGCAGCACTACAATGAGCAGTTCTTCGGGCCA	CASSQDLSRQHYNEQFF	In	VDJ	12	435	0.003217003527610765	0.0037721450931763197	51	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	0	4	4	3	6	5	23	40	50	46	55	TCRBV01,TCRBV04													CASSQDLSRQHYNEQFF+X+TCRBJ02-01	unresolved	TCRBD01-01*01	TCRBJ02-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
TSRRGGACTCAGCYRTGTACTTCTGTGCCAGGCGGACACAGTACCAAGAGACCCAGTACTTCGGGCCA	CARRTQYQETQYF	In	VDJ	13	438	0.0032391897588356666	0.003798159886922363	39	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	9	1	6	0	2	4	22	30	37	32	41	TCRBV02,TCRBV12													CARRTQYQETQYF+X+TCRBJ02-05	unresolved	TCRBD01-01*01	TCRBJ02-05*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
AAGRAGACWCRGCWSYGTATCTCTGCGCCAGCAGCCTCAGCTCCAGCTCCTACGAGCAGTACTTCGGGCCG	CASSLSSSSYEQYF	In	VDJ	17	583	0.004311524268039255	0.0050555415846478035	42	unresolved						TCRBJ02	TCRBJ02-07	01	4	4	5	0	1	6	23	36	40	37	46	TCRBV01,TCRBV23			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLSSSSYEQYF+X+TCRBJ02-07	unresolved		TCRBJ02-07*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCGGACTAGCGGGAGCAGATACGCAGTATTTTGGCCCA	CATGLAGADTQYF	In	VDJ	18	641	0.0047404580717206905	0.005558494263737979	39	TCRBV24			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	9	1	2	4	0	0	24	-1	-1	33	46		TCRBV24-01,TCRBV24-or09_02												CATGLAGADTQYF+TCRBV24-X+TCRBJ02-03	TCRBV24	TCRBD02-01*02	TCRBJ02-03*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GGGGGACTCRGCYGTGTATSTCTGTGCCAGCAGACACAGGACTAGCGGGGCTACACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	22	756	0.00559093026867526		50	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	6	1	3	3	5	2	22	33	50	38	52	TCRBV07,TCRBV11													X+X+TCRBJ02-02	unresolved	TCRBD02-01*01	TCRBJ02-02*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGCGTATTGAGCTCAAATGAAAAACTGTTTTTTGGCAGT	CASSVLSSNEKLFF	In	VDJ	27	949	0.007018244477477277	0.00822934642166512	42	unresolved			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-04	01	1	6	7	5	3	3	23	38	44	41	47	TCRBV09,TCRBV21					01,02								CASSVLSSNEKLFF+X+TCRBJ01-04	unresolved	TCRBD02-01	TCRBJ01-04*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCCCGACAGTTTCCTCACAGATACGCAGTATTTTGGCCCA	CSAPDSFLTDTQYF	In	VDJ	28	982	0.007262293020951198	0.0085155091528716	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	5	2	5	2	3	6	26	35	43	38	49		TCRBV20-01,TCRBV20-or09_02												CSAPDSFLTDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD01-01*01	TCRBJ02-03*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAAGGGACTAGCGAATACTACGAGCAGTACTTCGGGCCG	CASSQGTSEYYEQYF	In	VDJ	42	1480	0.010945207404284901	0.012833964914714835	45	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	1	1	6	3	0	4	23	-1	48	39	52	TCRBV01,TCRBV04					01,02								CASSQGTSEYYEQYF+X+TCRBJ02-07	unresolved	TCRBD02-01	TCRBJ02-07*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTCCTTTCCGGGGAGCTGTTTTTTGGAGAA	CASSFLSGELFF	In	VDJ	47	1623	0.012002751092671888	0.014074003416609578	36	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	6	4	10	6	3	2	24	36	41	39	43		TCRBV24-01,TCRBV24-or09_02				01,02								CASSFLSGELFF+TCRBV24-X+TCRBJ02-02	TCRBV24	TCRBD02-01	TCRBJ02-02*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAAATCGGGTGACTATGGCTACACCTTCGGTTCG	CASKSGDYGYTF	In	VDJ	1	11	8.134951449130669E-5	9.538757706882647E-5	36	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	7	8	4	3	3	2	23	33	40	36	42						01,02								CASKSGDYGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD02-01	TCRBJ01-02*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGCTAGGGAGGGGGCCTACGAGCAGTACTTCGGGCCG	CASSAREGAYEQYF	In	VDJ	1	11	8.134951449130669E-5	9.538757706882647E-5	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	5	9	0	2	4	2	23	35	46	39	48														CASSAREGAYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-07*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCCAGTGGAAGGGTGGATACGCAGTATTTTGGCCCA	CASSYSSGRVDTQYF	In	VDJ	1	11	8.134951449130669E-5	9.538757706882647E-5	45	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-03	01	0	5	3	6	7	2	23	40	51	47	53				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYSSGRVDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01		TCRBJ02-03*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTCTACAGCTGGGAGGGATACGCAGTATTTTGGCCCA	CASSSTAGRDTQYF	In	VDJ	1	11	8.134951449130669E-5	9.538757706882647E-5	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	4	9	1	6	8	0	23	36	-1	44	50														CASSSTAGRDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-03*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCTCAGCAAGGCAGGGGAACCAGCCCCAGCATTTTGGTGAT	CASSARQGNQPQHF	In	VDJ	1	11	8.134951449130669E-5	9.538757706882647E-5	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	8	4	2	7	9	3	23	32	47	41	50														CASSARQGNQPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-05*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGGACTGACAGGGTAAAGCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	13	9.614033530790792E-5		46	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	6	2	3	0	4	3	23	34	45	38	48														X+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-03*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTTCCCGGGACAGGGGGCCTATGGCTACACCTTCGGTTCG	CASSFPGQGAYGYTF	In	VDJ	1	13	9.614033530790792E-5	1.127307728995222E-4	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	0	0	4	4	0	23	36	-1	40	52														CASSFPGQGAYGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-02*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCGGGCTAGCGGGCACAGATACGCAGTATTTTGGCCCA	CASGLAGTDTQYF	In	VDJ	1	13	9.614033530790792E-5	1.127307728995222E-4	39	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	8	4	5	1	3	0	23	32	-1	35	42						01,02								CASGLAGTDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01	TCRBJ02-03*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
TCTGTGTACTTGTGTGCCAGCAGTGGATCGACGAGAGCAGCGCGACTGGGGAGAAAGACCTATGGCTACACCTTCGGTTCG	CASSGSTRAARLGRKTYGYTF	In	VDJ	1	13	9.614033530790792E-5	1.127307728995222E-4	63	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	5	9	2	4	24	6	12	24	53	48	59														CASSGSTRAARLGRKTYGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD02-01*02	TCRBJ01-02*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAACGACAGGGGGAACACTGAAGCTTTCTTTGGACAA	CASNDRGNTEAFF	In	VDJ	1	14	1.0353574571620853E-4	1.2140237081487006E-4	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	7	2	2	1	2	0	23	33	-1	35	43														CASNDRGNTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGATACCTGGGGGGGGACAGCGGGGACGAGCAGTACTTCGGGCCG	CASRYLGGDSGDEQYF	In	VDJ	1	14	1.0353574571620853E-4	1.2140237081487006E-4	48	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-07	01	2	0	5	5	7	5	23	38	52	45	57				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASRYLGGDSGDEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01		TCRBJ02-07*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCCTGGCAATCAGGGATGATGAGCAGTTCTTCGGGCCA	CASSLAIRDDEQFF	In	VDJ	1	14	1.0353574571620853E-4	1.2140237081487006E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	6	4	3	8	9	3	23	34	48	43	51														CASSLAIRDDEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGGATGACTAGCGGGAGGCAAGAGACCCAGTACTTCGGGCCA	CASRMTSGRQETQYF	In	VDJ	1	15	1.1093115612450913E-4	1.3007396873021792E-4	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	6	2	1	2	3	0	23	34	-1	37	50														CASRMTSGRQETQYF+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-05*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGTTTCAGGGCCAGAGGGCTACACCTTCGGTTCG	CASSVSGPEGYTF	In	VDJ	1	15	1.1093115612450913E-4	1.3007396873021792E-4	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	4	3	8	4	6	23	35	44	39	50														CASSVSGPEGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-02*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACGGCCACCCAAACACCGGGGAGCTGTTTTTTGGAGAA	CASSYGHPNTGELFF	In	VDJ	1	15	1.1093115612450913E-4	1.3007396873021792E-4	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	2	9	0	2	0	6	23	-1	41	38	47														CASSYGHPNTGELFF+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-02*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTACCGGTCGTTTGAACACTGAAGCTTTCTTTGGACAA	CAISTGRLNTEAFF	In	VDJ	1	15	1.1093115612450913E-4	1.3007396873021792E-4	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	5	8	5	0	2	5	23	35	40	37	45						01,02								CAISTGRLNTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD02-01	TCRBJ01-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCGGCGGGACTCAAGATAACTATGGCTACACCTTCGGTTCG	CAIGGTQDNYGYTF	In	VDJ	1	15	1.1093115612450913E-4	1.3007396873021792E-4	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	10	0	10	1	5	5	23	30	41	35	46						01,02								CAIGGTQDNYGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD02-01	TCRBJ01-02*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCCCGGGACTGACTTCCTCTACGAGCAGTACTTCGGGCCG	CASSPGTDFLYEQYF	In	VDJ	1	16	1.1832656653280974E-4	1.3874556664556577E-4	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	5	0	10	3	3	8	23	35	44	38	52						01,02								CASSPGTDFLYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD02-01	TCRBJ02-07*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCCGAACAGGGTATGAGTGAAGCTTTCTTTGGACAA	CASSYSEQGMSEAFF	In	VDJ	1	16	1.1832656653280974E-4	1.3874556664556577E-4	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	0	3	3	7	3	6	23	40	49	43	55														CASSYSEQGMSEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTGGACTAGCGGGGGGATAGACAATGAGCAGTTCTTCGGGCCA	CASSWTSGGIDNEQFF	In	VDJ	1	16	1.1832656653280974E-4	1.3874556664556577E-4	48	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	4	1	1	5	0	4	23	-1	50	36	54														CASSWTSGGIDNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGACGCCAGGGTGGTGAAGCTTTCTTTGGACAA	CASRRQGGEAFF	In	VDJ	1	17	1.2572197694111034E-4	1.4741716456091364E-4	36	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	4	3	7	4	3	23	34	43	38	46														CASRRQGGEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGATTGGACAAAAGAGACCCAGTACTTCGGGCCA	CASSDWTKETQYF	In	VDJ	1	17	1.2572197694111034E-4	1.4741716456091364E-4	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	5	1	6	3	4	1	23	35	44	39	45														CASSDWTKETQYF+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-05*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCGGACGGGGGCTACGAGCAGTACTTCGGGCCG	CASSYSDGGYEQYF	In	VDJ	1	17	1.2572197694111034E-4	1.4741716456091364E-4	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	0	8	2	3	3	0	23	40	-1	43	49														CASSYSDGGYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-07*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCAGACCCAGTCCAGGGGCTGGCTACACCTTCGGTTCG	CASSRPSPGAGYTF	In	VDJ	1	18	1.3311738734941096E-4	1.560887624762615E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	4	2	7	11	1	23	34	51	45	52														CASSRPSPGAGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-02*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTCGGACCGGAGAGGCCGGCCAAGAGACCCAGTACTTCGGGCCA	CAISRTGEAGQETQYF	In	VDJ	1	18	1.3311738734941096E-4	1.560887624762615E-4	48	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-05	01	5	1	7	1	1	12	23	35	40	36	52				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CAISRTGEAGQETQYF+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01		TCRBJ02-05*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGAGGACAGGGGGATCAGGAGACCCAGTACTTCGGGCCA	CAIRGQGDQETQYF	In	VDJ	1	19	1.4051279775771156E-4	1.6476036039160937E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	6	1	1	5	1	5	23	34	45	35	50														CAIRGQGDQETQYF+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-05*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAAGCCACAGGGGGCGAGGGAGACCCAGTACTTCGGGCCA	CASKPQGARETQYF	In	VDJ	1	20	1.4790820816601219E-4	1.734319583069572E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	7	3	0	5	4	4	23	33	46	37	50														CASKPQGARETQYF+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-05*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGGACCATACGCTCGAACACCGGGGAGCTGTTTTTTGGAGAA	CASRTIRSNTGELFF	In	VDJ	1	20	1.4790820816601219E-4	1.734319583069572E-4	45	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-02	01	6	2	7	0	0	8	23	-1	37	34	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASRTIRSNTGELFF+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01		TCRBJ02-02*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCACCCGGACTAGCGGGAGAACAGATACGCAGTATTTTGGCCCA	CASTRTSGRTDTQYF	In	VDJ	1	21	1.5530361857431278E-4	1.821035562223051E-4	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	7	1	2	3	3	1	23	33	49	36	50														CASTRTSGRTDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-03*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCCATTTCTTCGACAGGGGGAGCAGTACTTCGGGCCG	CASSPFLRQGEQYF	In	VDJ	1	22	1.6269902898261338E-4	1.9077515413765293E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	2	2	7	10	0	23	35	-1	45	53														CASSPFLRQGEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-07*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTTACGGAGACAGGGGGTAATCTACGAGCAGTACTTCGGGCCG	CASSLRRQGVIYEQYF	In	VDJ	1	22	1.6269902898261338E-4	1.9077515413765293E-4	48	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	2	1	3	6	4	23	36	51	42	55														CASSLRRQGVIYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-07*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGCTCCTTCGACTAGCGGGAGTGGTGAGCAGTTCTTCGGGCCA	CASSAPSTSGSGEQFF	In	VDJ	1	23	1.70094439390914E-4	1.994467520530008E-4	48	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	5	2	2	9	8	3	23	35	55	43	58														CASSAPSTSGSGEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTTCACTCGACAGGGGGCCTATGAGCAGTTCTTCGGGCCA	CASSFTRQGAYEQFF	In	VDJ	1	23	1.70094439390914E-4	1.994467520530008E-4	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	4	2	0	8	6	2	23	36	52	42	54														CASSFTRQGAYEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGTGTGACGGTTCCCGGATAGACGGCTACACCTTCGGTTCG		Out	VDJ	1	23	1.70094439390914E-4		41	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-02	01	9	1	8	8	13	5	23	31	47	44	52				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01		TCRBJ01-02*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCACTCCCCGTTGGGGGAACTTCGAGGCTTTCTTTGGACAA	CASTPRWGNFEAFF	In	VDJ	1	24	1.774898497992146E-4	2.0811834996834865E-4	42	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-01	01	7	6	1	11	9	9	23	33	47	42	56				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASTPRWGNFEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01		TCRBJ01-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCCAGATCCTACGAGCAGTACTTCGGGCCG	CASSYSRSYEQYF	In	VDJ	1	24	1.774898497992146E-4	2.0811834996834865E-4	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	0	4	5	1	0	1	23	-1	43	40	44														CASSYSRSYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-07*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCGGGGCAAGTGGGAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CASGASGSSYNEQFF	In	VDJ	1	24	1.774898497992146E-4	2.0811834996834865E-4	45	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-01	01	8	7	0	0	0	9	23	-1	37	32	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASGASGSSYNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01		TCRBJ02-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCCGTAATGTCAATGAGCAGTTCTTCGGGCCA	CASSRNVNEQFF	In	VDJ	1	25	1.848852602075152E-4	2.1678994788369653E-4	36	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	6	5	9	6	3	4	23	34	39	37	43						01,02								CASSRNVNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01	TCRBJ02-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTGGGGGACTAGCACAGATACGCAGTATTTTGGCCCA	CASSWGTSTDTQYF	In	VDJ	1	25	1.848852602075152E-4	2.1678994788369653E-4	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	4	0	10	0	2	0	23	36	-1	38	44						01,02								CASSWGTSTDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01	TCRBJ02-03*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCGGTGACAGTAATCAGCCCCAGCATTTTGGTGAT	CASGDSNQPQHF	In	VDJ	1	25	1.848852602075152E-4	2.1678994788369653E-4	36	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	8	2	5	4	3	1	23	32	40	35	41														CASGDSNQPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-05*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTCCTACAGGGACCGGCGGAAACACCATATATTTTGGAGAG	CAISPTGTGGNTIYF	In	VDJ	1	25	1.848852602075152E-4	2.1678994788369653E-4	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	5	3	3	4	3	6	23	35	44	38	50														CAISPTGTGGNTIYF+TCRBV06-08+TCRBJ01-03	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-03*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCGTCGGCAGGGCAATCAGCCCCAGCATTTTGGTGAT	CASSRRQGNQPQHF	In	VDJ	1	26	1.9228067061581583E-4	2.254615457990444E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	5	4	4	2	6	0	23	35	-1	41	45														CASSRRQGNQPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-05*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCGGCGACTAGCGGAGCACAGATACGCAGTATTTTGGCCCA	CAGD*RSTDTQYF	Stop	VDJ	1	26	1.9228067061581583E-4		39	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	11	2	5	0	3	0	23	29	-1	32	41						01,02								CAGD*RSTDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01	TCRBJ02-03*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGAGAGAAGCGGGACCGCCCAGATACGCAGTATTTTGGCCCA	CASREKRDRPDTQYF	In	VDJ	1	27	1.9967608102411643E-4	2.3413314371439225E-4	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	6	6	3	4	5	5	23	34	46	39	51														CASREKRDRPDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-03*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACGAGGCTTCCAATCCAAGGGGGACAGATACGCAGTATTTTGGCCCA	CASSYEASNPRGTDTQYF	In	VDJ	1	27	1.9967608102411643E-4	2.3413314371439225E-4	54	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	2	5	1	3	15	0	23	38	-1	53	59														CASSYEASNPRGTDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-03*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTATCCCTTTAGGCAGGGGAAAAATGAGCAGTTCTTCGGGCCA	CASSYYPFRQGKNEQFF	In	VDJ	1	27	1.9967608102411643E-4	2.3413314371439225E-4	51	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	1	4	2	7	11	3	23	39	56	50	59														CASSYYPFRQGKNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCGAGTGATCCTTTGGATTTTAACACCGGGGAGCTGTTTTTTGGAGAA	CASSYSSDPLDFNTGELFF	In	VDJ	1	27	1.9967608102411643E-4	2.3413314371439225E-4	57	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-02	01	0	1	8	2	12	4	23	40	55	52	59				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYSSDPLDFNTGELFF+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01		TCRBJ02-02*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCACTGGGCGGCGAGAAGAGACCCAGTACTTCGGGCCA	CASTGRREETQYF	In	VDJ	1	28	2.0707149143241705E-4	2.4280474162974012E-4	39	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-05	01	7	8	0	3	2	6	23	33	39	35	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASTGRREETQYF+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01		TCRBJ02-05*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCTACTGTCGGAGGGTCGCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	28	2.0707149143241705E-4		47	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	1	10	0	1	3	2	23	39	48	42	50														X+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-03*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCTACAGGGAGTTACAATAATGAGCAGTTCTTCGGGCCA	CASSYSTGSYNNEQFF	In	VDJ	1	28	2.0707149143241705E-4	2.4280474162974012E-4	48	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	0	3	3	7	1	9	23	40	47	41	56														CASSYSTGSYNNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTCCGCTGGGCGGGAGGGGTCAAGAGACCCAGTACTTCGGGCCA	CAISPLGGRGQETQYF	In	VDJ	1	28	2.0707149143241705E-4	2.4280474162974012E-4	48	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	5	7	0	2	7	2	23	35	51	42	53														CAISPLGGRGQETQYF+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-05*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCCCCGCGGGATAGCGCCAAGGAATACGCAGTATTTTGGCCCA	CASSPRGIAPRNTQYF	In	VDJ	1	29	2.1446690184071765E-4	2.51476339545088E-4	48	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	5	7	3	7	4	12	23	35	45	39	57														CASSPRGIAPRNTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-03*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACCCACAGATGGCGCAGTATTTTGGCCCA	CASSYPQMAQYF	In	VDJ	1	29	2.1446690184071765E-4	2.51476339545088E-4	36	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	2	3	5	10	2	4	23	38	44	40	48														CASSYPQMAQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-03*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCGGGGCAGGCCCGAGGGGATGGCTACACCTTCGGTTCG	CASSYSGQARGDGYTF	In	VDJ	1	29	2.1446690184071765E-4	2.51476339545088E-4	48	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-02	01	0	5	2	6	12	0	23	40	-1	52	57				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYSGQARGDGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01		TCRBJ01-02*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGGAGCCATCTTAGCGGGACGTACAACGAGCAGTACTTCGGGCCG	CASRSHLSGTYNEQYF	In	VDJ	1	30	2.2186231224901825E-4	2.6014793746043585E-4	48	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	6	5	3	5	9	6	23	34	51	43	57														CASRSHLSGTYNEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-07*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGGCCACAAAGCTCTGGAAACACCATATATTTTGGAGAG	CASRPQSSGNTIYF	In	VDJ	1	30	2.2186231224901825E-4	2.6014793746043585E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	6	3	6	0	3	3	23	34	40	37	43														CASRPQSSGNTIYF+TCRBV06-08+TCRBJ01-03	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-03*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACCGTCTAGCGGGAGGTATACGAGCAGTACTTCGGGCCG		Out	VDJ	1	31	2.2925772265731888E-4		46	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	2	4	1	4	3	2	23	38	52	41	54														X+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-07*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGACCGGGACAGACCCTCTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASRPGQTLSGANVLTF	In	VDJ	1	32	2.3665313306561948E-4	2.7749113329113154E-4	51	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	6	0	5	0	3	5	23	34	44	37	49														CASRPGQTLSGANVLTF+TCRBV06-08+TCRBJ02-06	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-06*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCATGGTGAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CASMVSSYNEQFF	In	VDJ	1	32	2.3665313306561948E-4	2.7749113329113154E-4	39	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	7	11	2	0	4	0	23	33	-1	37	40														CASMVSSYNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGACTCGGGGGGGAGAGATACGCAGTATTTTGGCCCA	CASSDSGGRDTQYF	In	VDJ	1	34	2.5144395388222067E-4	2.948343291218273E-4	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	0	9	0	5	0	2	23	-1	47	40	49														CASSDSGGRDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-03*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTTTTACTAGCGGGAGGGCCCGTAATGAGCAGTTCTTCGGGCCA	CAISFTSGRARNEQFF	In	VDJ	1	34	2.5144395388222067E-4	2.948343291218273E-4	48	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	4	3	0	7	2	5	23	36	51	38	56														CAISFTSGRARNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCGGCGATGGAAACTATGGCTACACCTTCGGTTCG	CAIGDGNYGYTF	In	VDJ	1	34	2.5144395388222067E-4	2.948343291218273E-4	36	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-02	01	10	1	8	2	8	0	23	30	-1	38	41				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CAIGDGNYGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01		TCRBJ01-02*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTATCCCTCCTACGAGCAGTACTTCGGGCCG	CASSYPSYEQYF	In	VJ	1	35	2.588393642905213E-4	3.0350592703717514E-4	36	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-07	01	3	0	0	0	0	3	23	-1	37	-1	40														CASSYPSYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01		TCRBJ02-07*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCCCCTTGTTGTACAGGGGGAAATACGAGCAGTACTTCGGGCCG	CASSPLLYRGKYEQYF	In	VDJ	1	36	2.662347746988219E-4	3.12177524952523E-4	48	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	3	1	4	11	3	23	34	53	45	56														CASSPLLYRGKYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-07*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGGGTACGAGGACAGATAAATCAGCCCCAGCATTTTGGTGAT	CASRVRGQINQPQHF	In	VDJ	1	36	2.662347746988219E-4	3.12177524952523E-4	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	6	1	5	4	7	3	23	34	47	41	50														CASRVRGQINQPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-05*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCGGGGGTGGAGCAGTTCTTCGGGCCA	CASSYSGVEQFF	In	VDJ	1	36	2.662347746988219E-4	3.12177524952523E-4	36	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-01	01	0	6	1	10	0	2	23	-1	45	40	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYSGVEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01		TCRBJ02-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCATCAGGGACGCCGCCGAACCTTTCTTTGGACAA	CASIRDAAEPFF	In	VDJ	1	36	2.662347746988219E-4	3.12177524952523E-4	36	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-01	01	7	0	7	12	3	10	23	33	41	36	51				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASIRDAAEPFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01		TCRBJ01-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCCCGCGCTTTACATAGGGATGAACACTGAAGCTTTCTTTGGACAA	CASSPALYIGMNTEAFF	In	VDJ	1	38	2.810255955154231E-4	3.2952072078321873E-4	51	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-01	01	5	0	8	0	15	0	23	35	-1	50	54				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPALYIGMNTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01		TCRBJ01-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTCCTTACGGGTAGGTGAGCAGTTCTTCGGGCCA	CASSSLRVGEQFF	In	VDJ	1	40	2.9581641633202437E-4	3.468639166139144E-4	39	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	4	8	4	9	5	4	23	36	45	41	49						01,02								CASSSLRVGEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01	TCRBJ02-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCATATTAGGAGGGTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASILGGSGANVLTF	In	VDJ	1	40	2.9581641633202437E-4	3.468639166139144E-4	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-06	01	7	10	0	1	5	0	23	33	-1	38	44														CASILGGSGANVLTF+TCRBV06-08+TCRBJ02-06	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-06*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGGGACTAGCGGGAGAGAGGGGCTTCCTACGAGCAGTACTTCGGGCCG	CASRD*RERGASYEQYF	Stop	VDJ	1	41	3.0321182674032497E-4		51	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	6	1	2	1	0	9	23	-1	47	34	56														CASRD*RERGASYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-07*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACCCGAACACTGAAGCTTTCTTTGGACAA	CASSYPNTEAFF	In	VJ	1	41	3.0321182674032497E-4	3.555355145292623E-4	36	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-01	01	2	0	0	1	0	2	23	-1	38	-1	40														CASSYPNTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01		TCRBJ01-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCGGGTTTGGGGGCACTGAAGCTTTCTTTGGACAA	CASGFGGTEAFF	In	VDJ	1	41	3.0321182674032497E-4	3.555355145292623E-4	36	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-01	01	8	6	1	4	6	0	23	32	-1	38	43				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASGFGGTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01		TCRBJ01-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGACATCGCTAGTAACAATGAGCAGTTCTTCGGGCCA	CASSDIASNNEQFF	In	VDJ	1	43	3.1800264755692617E-4	3.72878710359958E-4	42	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-01	01	5	2	6	5	0	9	23	-1	39	35	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSDIASNNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01		TCRBJ02-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTTGGGCGGGAGCTCTGGAAACACCATATATTTTGGAGAG	CASSLGGSSGNTIYF	In	VDJ	1	43	3.1800264755692617E-4	3.72878710359958E-4	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-03	01	4	7	2	0	3	0	23	36	-1	39	46														CASSLGGSSGNTIYF+TCRBV06-08+TCRBJ01-03	TCRBV06-08*01	TCRBD02-01*02	TCRBJ01-03*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTCAGGGGACTAGCGGTTACAATGAGCAGTTCTTCGGGCCA	CAISQGTSGYNEQFF	In	VDJ	1	43	3.1800264755692617E-4	3.72878710359958E-4	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	0	5	4	3	1	23	35	49	38	50						01,02								CAISQGTSGYNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01	TCRBJ02-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAAGCCAACTTTTACAGGGGGAAATCAGCCCCAGCATTTTGGTGAT	CASKPTFTGGNQPQHF	In	VDJ	1	46	3.40188878781828E-4	3.988935041060016E-4	48	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	7	3	1	4	11	1	23	33	52	44	53														CASKPTFTGGNQPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-05*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCCCGTCGGGAGGGGGATACAATGAGCAGTTCTTCGGGCCA	CASSPSGGGYNEQFF	In	VDJ	1	46	3.40188878781828E-4	3.988935041060016E-4	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	6	8	0	4	5	3	23	34	47	39	50														CASSPSGGGYNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCTCTCCCCAGGGACGGAATCAGCCCCAGCATTTTGGTGAT	CASSSPQGRNQPQHF	In	VDJ	1	47	3.475842891901286E-4	4.0756510202134946E-4	45	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-05	01	6	0	7	4	9	2	23	34	48	43	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSSPQGRNQPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01		TCRBJ01-05*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGGGTGACAGGGAGGGACACTGAAGCTTTCTTTGGACAA	CASRVTGRDTEAFF	In	VDJ	1	48	3.549796995984292E-4	4.162366999366973E-4	42	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-01	01	6	2	3	3	3	4	23	34	44	37	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASRVTGRDTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01		TCRBJ01-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTAAGGGGACAGGGAAAAGGGAAAGAAACACCATATATTTTGGAGAG	CASSKGTGKRERNTIYF	In	VDJ	1	48	3.549796995984292E-4	4.162366999366973E-4	51	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	5	0	3	5	3	10	23	35	47	38	57														CASSKGTGKRERNTIYF+TCRBV06-08+TCRBJ01-03	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-03*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCACAACAGGTCGCCCCACAGATACGCAGTATTTTGGCCCA	CATTGRPTDTQYF	In	VDJ	1	52	3.8456134123163166E-4	4.509230915980888E-4	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	10	3	4	2	2	6	23	30	37	32	43														CATTGRPTDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-03*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACGGACCCTACGAGCAGTACTTCGGGCCG	CASSYGPYEQYF	In	VDJ	2	53	3.9195675163993226E-4	4.5959468951343665E-4	36	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-07	01	2	1	7	2	0	0	23	-1	-1	38	42				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYGPYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01		TCRBJ02-07*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGTTCCCGTAGGACTTTCTCAAGAGACCCAGTACTTCGGGCCA	CASSVPVGLSQETQYF	In	VDJ	2	55	4.0674757245653346E-4	4.7693788534413235E-4	48	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	5	1	10	2	9	4	23	35	49	44	53						01,02								CASSVPVGLSQETQYF+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01	TCRBD02-01	TCRBJ02-05*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCATCTGGACTCCCGGTTACAATCAGCCCCAGCATTTTGGTGAT	CASIWTPGYNQPQHF	In	VDJ	2	56	4.141429828648341E-4	4.8560948325948025E-4	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-05	01	7	1	10	3	3	8	23	33	41	36	49						01,02								CASIWTPGYNQPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01	TCRBD02-01	TCRBJ01-05*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCCACGACAGGGAAAAGGGAGACCCAGTACTTCGGGCCA	CASSYSTTGKRETQYF	In	VDJ	2	59	4.363292140897359E-4	5.116242770055238E-4	48	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	0	2	3	5	3	6	23	40	50	43	56														CASSYSTTGKRETQYF+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-05*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAAAGCTCGGTTCGCAGGACACTCATCCTACAATGAGCAGTTCTTCGGGCCA	CASKARFAGHSSYNEQFF	In	VDJ	2	62	4.5851544531463775E-4	5.376390707515674E-4	54	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	7	1	6	1	14	4	23	33	52	47	56														CASKARFAGHSSYNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCCGGGACAAAACTATGGCTACACCTTCGGTTCG	CASSPGQNYGYTF	In	VDJ	2	64	4.7330626613123895E-4	5.549822665822631E-4	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	0	6	2	2	1	23	35	43	37	44														CASSPGQNYGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-02*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTCCCTYGGGGGGAGTGGTGCCTACAATGAGCAGTTCTTCGGGCCA	CASSSLGGSGAYNEQFF	In	VDJ	2	65	4.8070167653953955E-4	5.63653864497611E-4	51	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	4	9	1	2	5	7	23	36	47	41	54														CASSSLGGSGAYNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGCCCGGTCCCCCGAAGGTCGACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	2	68	5.028879077644413E-4		47	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-01	01	6	5	4	5	13	3	23	34	50	47	53				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01		TCRBJ02-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTATAACGAGGGCCGGGGGAATGAGCAGTTCTTCGGGCCA	CASSYNEGRGNEQFF	In	VDJ	2	72	5.324695493976438E-4	6.24355049905046E-4	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	3	8	2	7	10	0	23	37	-1	47	53														CASSYNEGRGNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTATCGGCCCTACAATGAGCAGTTCTTCGGGCCA	CASSYRPYNEQFF	In	VDJ	2	72	5.324695493976438E-4	6.24355049905046E-4	39	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-01	01	3	9	0	2	2	0	23	37	-1	39	42				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYRPYNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01		TCRBJ02-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCACGGGCGGGTGGCCAGGTGGGACTGAAGCTTTCTTTGGACAA	CATGGWPGGTEAFF	In	VDJ	2	77	5.694466014391469E-4	6.677130394817853E-4	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	10	7	4	5	3	12	23	30	38	33	50						01,02								CATGGWPGGTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD02-01	TCRBJ01-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACAGGATGACGGAGACCCAGTACTTCGGGCCA	CASSYRMTETQYF	In	VDJ	2	77	5.694466014391469E-4	6.677130394817853E-4	39	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-05	01	2	1	8	5	1	5	23	38	42	39	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYRMTETQYF+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01		TCRBJ02-05*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTCCAGGAAGGGGGCCGAAGCTTTCTTTGGACAA	CASSSRKGAEAFF	In	VDJ	2	83	6.138190638889505E-4	7.197426269738724E-4	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	5	0	8	6	1	23	36	49	42	50														CASSSRKGAEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGCCCCGGACAGGGGTCAGACTGAAGCTTTCTTTGGACAA	CASSAPDRGQTEAFF	In	VDJ	2	84	6.212144742972511E-4	7.284142248892203E-4	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	1	2	5	5	4	23	35	49	40	53														CASSAPDRGQTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCCAAAGGGACCGCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSQRDRSYNEQFF	In	VDJ	2	87	6.43400705522153E-4	7.544290186352639E-4	45	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-01	01	6	0	7	0	5	2	23	34	44	39	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQRDRSYNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01		TCRBJ02-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCGTTTCCGACAGGGGAATCAGCCCCAGCATTTTGGTGAT	CASSRFRQGNQPQHF	In	VDJ	3	88	6.507961159304535E-4	7.631006165506117E-4	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	5	2	2	4	7	0	23	35	-1	42	50														CASSRFRQGNQPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-05*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCATTCCGCACCTTCAGCCTCAACTAATGAAAAACTGTTTTTTGGCAGT	CASSHSAPSASTNEKLFF	In	VDJ	3	94	6.951685783802572E-4	8.151302040426989E-4	54	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-04	01	5	4	5	0	13	3	23	35	51	48	54				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSHSAPSASTNEKLFF+TCRBV06-08+TCRBJ01-04	TCRBV06-08*01		TCRBJ01-04*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTTCCGACCAGTGAGCGGGAGGATTCACAATGAGCAGTTCTTCGGGCCA	CASSFRPVSGRIHNEQFF	In	VDJ	3	110	8.134951449130669E-4	9.538757706882647E-4	54	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	4	6	1	5	11	4	23	36	56	47	60														CASSFRPVSGRIHNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGGCCCCAGGGATCTTACGAGCAGTACTTCGGGCCG	CASRPQGSYEQYF	In	VDJ	3	111	8.208905553213676E-4	9.625473686036126E-4	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	4	3	4	4	4	23	34	43	38	47														CASRPQGSYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-07*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTCCAGGGAGAGGGGCACTGAAGCTTTCTTTGGACAA	CASSSRERGTEAFF	In	VDJ	4	123	9.096354802209749E-4	0.0010666065435877869	42	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-01	01	4	4	3	4	1	7	23	36	42	37	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSSRERGTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01		TCRBJ01-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGAACAGCGAACACTGAAGCTTTCTTTGGACAA	CASRTANTEAFF	In	VDJ	4	128	9.466125322624779E-4	0.0011099645331645262	36	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	3	5	1	1	1	23	34	39	35	40														CASRTANTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCGGGACAGGCGAAGCGTACTGAGCAGTTCTTCGGGCCA	CASSYSGQAKRTEQFF	In	VDJ	4	141	0.0010427528675703858	0.0012226953060640484	48	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	0	0	4	9	0	10	23	-1	48	40	58														CASSYSGQAKRTEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTTTGCCATTGAGAAAGCACCCTACGAGCAGTACTTCGGGCCG	CASSFAIEKAPYEQYF	In	VDJ	5	190	0.0014051279775771156	0.0016476036039160937	48	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	4	6	7	2	13	2	23	36	52	49	54						01,02								CASSFAIEKAPYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD02-01	TCRBJ02-07*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCGCCGTTAGCGGGAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CASAVSGSSYNEQFF	In	VDJ	6	192	0.0014199187983937169	0.0016649467997467892	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	8	5	2	0	5	0	23	32	-1	37	46														CASAVSGSSYNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTCGACAGGAAGTTTGTCCTACGAGCAGTACTTCGGGCCG	CASSSTGSLSYEQYF	In	VDJ	6	204	0.0015086637232933243	0.0017690059747309636	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	2	4	1	1	7	23	36	43	37	50														CASSSTGSLSYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-07*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTCCCCACAGGGGGTCCTCTACGAGCAGTACTTCGGGCCG	CASSSPQGVLYEQYF	In	VDJ	7	260	0.0019228067061581582	0.002254615457990444	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	3	1	3	4	4	23	36	48	40	52														CASSSPQGVLYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-07*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGATCGGGGACGCCTGCAACTAATGAAAAACTGTTTTTTGGCAGT		Out	VDJ	8	265	0.001959783758199661		50	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-04	01	5	0	7	0	5	5	23	35	45	40	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV06-08+TCRBJ01-04	TCRBV06-08*01		TCRBJ01-04*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCCGCGGGGGAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSPRGSSYNEQFF	In	VDJ	8	272	0.0020115516310577654	0.0023586746329746183	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	5	7	2	0	2	2	23	35	44	37	46														CASSPRGSSYNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCACTCTCTCACTAGCGGGAGAAGCAGATACGCAGTATTTTGGCCCA	CASTLSLAGEADTQYF	In	VDJ	10	361	0.00266974315739652	0.003130446847440578	48	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	7	3	2	4	7	3	23	33	51	40	54														CASTLSLAGEADTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-03*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCCATCGTCGGGACAACCGGAAACACCATATATTTTGGAGAG		Out	VDJ	11	378	0.00279546513433763		46	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	6	0	6	4	8	3	23	34	48	42	51														X+TCRBV06-08+TCRBJ01-03	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-03*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAAACATCCAGACAGGGCCCCCTACGAGCAGTACTTCGGGCCG	CAIKHPDRAPYEQYF	In	VDJ	14	471	0.0034832383023095867	0.004084322618128843	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	10	2	3	2	11	3	23	30	48	41	51														CAIKHPDRAPYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-07*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCACCCCGGAGGGCGGGAGGGCCTCCGGGGCCAACGTCCTGACTTTCGGGGCC	CAITPEGGRASGANVLTF	In	VDJ	15	524	0.003875195053949519	0.0045439173076422795	54	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-06	01	10	7	0	4	12	5	23	30	51	42	56														CAITPEGGRASGANVLTF+TCRBV06-08+TCRBJ02-06	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-06*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGACGACCGGGACAGGGAGGAGGCTACACCTTCGGTTCG	CASRRPGQGGGYTF	In	VDJ	25	863	0.006382239182363425	0.0074835890009452045	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	0	3	8	6	4	23	34	49	40	53														CASRRPGQGGGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-02*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCCTGCCCGGGACAGCTCCAATGAGCAGTTCTTCGGGCCA	CASSPARDSSNEQFF	In	VDJ	89	3113	0.023021912601039796	0.02699468431047789	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	0	5	6	7	3	23	35	49	42	52														CASSPARDSSNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCACCGAACAGCGGTGAAAACATTCAGTACTTCGGCGCC	CASSPPNSGENIQYF	In	VDJ	1	12	8.87449248996073E-5	1.0405917498417433E-4	45	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-04	01	0	6	5	5	4	2	24	41	50	45	52						01,02							Vb 18	CASSPPNSGENIQYF+TCRBV18-01+TCRBJ02-04	TCRBV18-01*01	TCRBD02-01	TCRBJ02-04*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCACGAGTCTTGGGGGATGGGGGTCTGCACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	12	8.87449248996073E-5		58	TCRBV18	TCRBV18-01	01				TCRBJ02	TCRBJ02-02	01	1	6	1	4	7	11	23	39	51	46	62				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	X+TCRBV18-01+TCRBJ02-02	TCRBV18-01*01		TCRBJ02-02*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCTCTTCAAGCAGCGTGGGGTAATGAGCAGTTCTTCGGGCCA	CASSPLQAAWGNEQFF	In	VDJ	1	13	9.614033530790792E-5	1.127307728995222E-4	48	TCRBV18	TCRBV18-01	01				TCRBJ02	TCRBJ02-01	01	3	6	2	7	14	1	24	38	56	52	57				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSPLQAAWGNEQFF+TCRBV18-01+TCRBJ02-01	TCRBV18-01*01		TCRBJ02-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CGTTTGGTGGCGAGGAGATTCGGCGCTTATTTCTGTGCCAGCTCACCAAGGGAACAGTCCAGCAATCAGCCCCAGCATTTTGGTGAT	CASSPREQSSNQPQHF	In	VDJ	1	14	1.0353574571620853E-4	1.2140237081487006E-4	48	TCRBV18	TCRBV18-01	01				TCRBJ01	TCRBJ01-05	01	2	0	8	1	1	7	33	48	53	49	60				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSPREQSSNQPQHF+TCRBV18-01+TCRBJ01-05	TCRBV18-01*01		TCRBJ01-05*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCAAAGGTTAAAGGGACCGGAGGGACCCAGTACTTCGGGCCA	CASSPKVKGTGGTQYF	In	VDJ	1	15	1.1093115612450913E-4	1.3007396873021792E-4	48	TCRBV18	TCRBV18-01	01				TCRBJ02	TCRBJ02-05	01	2	0	7	7	9	6	24	39	53	48	59				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSPKVKGTGGTQYF+TCRBV18-01+TCRBJ02-05	TCRBV18-01*01		TCRBJ02-05*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CGTTTGGTGGCGAGGAGATTCGGCAGCTATTTCTGTGCCAGCTCACCAAGGGAACAGTCCAGCAATCAGCCCCAGCATTTTGGTGAT	CASSPREQSSNQPQHF	In	VDJ	1	15	1.1093115612450913E-4	1.3007396873021792E-4	48	TCRBV18	TCRBV18-01	01				TCRBJ01	TCRBJ01-05	01	2	0	8	1	1	7	33	48	53	49	60				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSPREQSSNQPQHF+TCRBV18-01+TCRBJ01-05	TCRBV18-01*01		TCRBJ01-05*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CGTTTGGTGGCGAGGAGATTCGGCAGCTTATTCTGTGCCAGCTCACCAAGGGAACAGTCCAGCAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	15	1.1093115612450913E-4		47	TCRBV18	TCRBV18-01	01				TCRBJ01	TCRBJ01-05	01	19	0	8	1	17	7	34	32	53	49	60				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	X+TCRBV18-01+TCRBJ01-05	TCRBV18-01*01		TCRBJ01-05*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCACGGGGAGGCGCAATTGGAACTGAAGCTTTCTTTGGACAA	CASSPRGGAIGTEAFF	In	VDJ	1	16	1.1832656653280974E-4	1.3874556664556577E-4	48	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	1	9	1	5	1	10	24	40	47	41	57													Vb 18	CASSPRGGAIGTEAFF+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01	TCRBD02-01*02	TCRBJ01-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCAGAACCGGAGGGGGGGGAGCAGGGATCGAGCAGTACTTCGGGCCG	CASRTGGGGAGIEQYF	In	VDJ	1	18	1.3311738734941096E-4	1.560887624762615E-4	48	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	8	9	0	6	9	10	24	33	49	42	59													Vb 18	CASRTGGGGAGIEQYF+TCRBV18-01+TCRBJ02-07	TCRBV18-01*01	TCRBD02-01*01	TCRBJ02-07*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACTAGACAAGGGAACCTACGAGCAGTACTTCGGGCCG	CASSLDKGTYEQYF	In	VDJ	1	18	1.3311738734941096E-4	1.560887624762615E-4	42	TCRBV18	TCRBV18-01	01				TCRBJ02	TCRBJ02-07	01	4	0	8	2	7	1	24	37	48	44	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSLDKGTYEQYF+TCRBV18-01+TCRBJ02-07	TCRBV18-01*01		TCRBJ02-07*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CGTTTGGTGGCGAGGAGATCGGCAGCTTATTTCTGTGCCAGCTCACCAAGGGAACAGTCCAGCAATCAGCCCCAGCATTTTGGTGAT	CASSPREQSSNQPQHF	In	VDJ	1	18	1.3311738734941096E-4	1.560887624762615E-4	48	TCRBV18	TCRBV18-01	01				TCRBJ01	TCRBJ01-05	01	2	0	8	1	1	7	33	48	53	49	60				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSPREQSSNQPQHF+TCRBV18-01+TCRBJ01-05	TCRBV18-01*01		TCRBJ01-05*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
TGTGCCAGCTCACCAGTTTATGGTCAGCAGATAACTAGCGGGGCCGATGCTCCGGATACGCAGTATTTTGGCCCA	CASSPVYGQQITSGADAPDTQYF	In	VDJ	1	18	1.3311738734941096E-4	1.560887624762615E-4	69	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	2	3	3	6	18	11	0	15	43	33	54													Vb 18	CASSPVYGQQITSGADAPDTQYF+TCRBV18-01+TCRBJ02-03	TCRBV18-01*01	TCRBD02-01*01	TCRBJ02-03*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
TTCTGTGCCAGCTCCCTCCTTCCCCTGGGGCTGTGGCCGAACAGGGAGGAGGACACTGAAGCTTTCTTTGGACAA	CASSLLPLGLWPNREEDTEAFF	In	VDJ	1	18	1.3311738734941096E-4	1.560887624762615E-4	66	TCRBV18	TCRBV18-01	01				TCRBJ01	TCRBJ01-01	01	6	3	3	3	26	6	3	14	46	40	52				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSLLPLGLWPNREEDTEAFF+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01		TCRBJ01-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACGACGACTAGCGGTCACAGATACGCAGTATTTTGGCCCA	CASSRRLAVTDTQYF	In	VDJ	1	21	1.5530361857431278E-4	1.821035562223051E-4	45	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	4	2	5	2	3	1	24	37	49	40	50						01,02							Vb 18	CASSRRLAVTDTQYF+TCRBV18-01+TCRBJ02-03	TCRBV18-01*01	TCRBD02-01	TCRBJ02-03*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCAGTAGCAGGGGGGCTAAACAATGAGCAGTTCTTCGGGCCA	CASSPVAGGLNNEQFF	In	VDJ	1	22	1.6269902898261338E-4	1.9077515413765293E-4	48	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	2	4	1	5	4	5	24	39	50	43	55													Vb 18	CASSPVAGGLNNEQFF+TCRBV18-01+TCRBJ02-01	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACGACCCGGGACCGCTGGAAACACCATATATTTTGGAGAG	CASSRPGTAGNTIYF	In	VDJ	1	27	1.9967608102411643E-4	2.3413314371439225E-4	45	TCRBV18	TCRBV18-01	01				TCRBJ01	TCRBJ01-03	01	0	0	7	2	1	2	24	41	47	42	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSRPGTAGNTIYF+TCRBV18-01+TCRBJ01-03	TCRBV18-01*01		TCRBJ01-03*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCACCGAAAGACAGGGAAAGGCTAATGAAAAACTGTTTTTTGGCAGT		Out	VDJ	1	29	2.1446690184071765E-4		53	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	0	2	3	3	4	5	24	41	52	45	57													Vb 18	X+TCRBV18-01+TCRBJ01-04	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-04*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCAGGGTCGGGGTAGAATGAAAAACTGTTTTTTGGCAGT	CASSPGSG*NEKLFF	Stop	VDJ	1	29	2.1446690184071765E-4		45	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-04	01	2	8	3	5	4	3	24	39	48	43	51													Vb 18	CASSPGSG*NEKLFF+TCRBV18-01+TCRBJ01-04	TCRBV18-01*01	TCRBD02-01*01	TCRBJ01-04*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCCCTCATGGGTTCGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSPLMGSNTGELFF	In	VDJ	1	29	2.1446690184071765E-4	2.51476339545088E-4	48	TCRBV18	TCRBV18-01	01				TCRBJ02	TCRBJ02-02	01	3	0	9	0	6	2	24	38	47	44	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSPLMGSNTGELFF+TCRBV18-01+TCRBJ02-02	TCRBV18-01*01		TCRBJ02-02*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCGATGAAGGGGTCGGCGGATCAGCCCCAGCATTTTGGTGAT	CASSPMKGSADQPQHF	In	VDJ	1	31	2.2925772265731888E-4	2.688195353757837E-4	48	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	3	5	2	5	5	7	24	38	48	43	55													Vb 18	CASSPMKGSADQPQHF+TCRBV18-01+TCRBJ01-05	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-05*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCGCCAACTCGAATGAACACTGAAGCTTTCTTTGGACAA	CASSPTRMNTEAFF	In	VDJ	1	31	2.2925772265731888E-4	2.688195353757837E-4	42	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	2	3	10	0	0	4	24	-1	42	39	46						01,02							Vb 18	CASSPTRMNTEAFF+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01	TCRBD02-01	TCRBJ01-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACTGGGGACTATTAATGGGGCCAACGTCCTGACTTTCGGGGCC	CASSLGTINGANVLTF	In	VDJ	1	33	2.4404854347392007E-4	2.8616273120647944E-4	48	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-06	01	4	0	9	3	2	4	24	37	46	39	50						01,02							Vb 18	CASSLGTINGANVLTF+TCRBV18-01+TCRBJ02-06	TCRBV18-01*01	TCRBD02-01	TCRBJ02-06*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCCGGGACGGGGGCTCTGGAAACACCATATATTTTGGAGAG	CASRDGGSGNTIYF	In	VDJ	1	42	3.1060723714862557E-4	3.642071124446102E-4	42	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-03	01	8	8	2	0	5	0	24	33	-1	38	44													Vb 18	CASRDGGSGNTIYF+TCRBV18-01+TCRBJ01-03	TCRBV18-01*01	TCRBD02-01*01	TCRBJ01-03*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCATATTCCGGGACAGGGAATTTCTACGAGCAGTACTTCGGGCCG	CASSPYSGTGNFYEQYF	In	VDJ	1	42	3.1060723714862557E-4	3.642071124446102E-4	51	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	2	0	3	3	6	5	24	39	54	45	59													Vb 18	CASSPYSGTGNFYEQYF+TCRBV18-01+TCRBJ02-07	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-07*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCGGGGCAAGAGACCCAGTACTTCGGGCCA	CASSPGQETQYF	In	VDJ	1	47	3.475842891901286E-4	4.0756510202134946E-4	36	TCRBV18	TCRBV18-01	01				TCRBJ02	TCRBJ02-05	01	3	6	2	2	0	0	24	-1	-1	38	42				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSPGQETQYF+TCRBV18-01+TCRBJ02-05	TCRBV18-01*01		TCRBJ02-05*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCAGGGAGACCAAATGAAAAACTGTTTTTTGGCAGT	CASSGRPNEKLFF	In	VDJ	1	48	3.549796995984292E-4	4.162366999366973E-4	39	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-04	01	5	9	2	5	0	4	24	-1	41	36	45													Vb 18	CASSGRPNEKLFF+TCRBV18-01+TCRBJ01-04	TCRBV18-01*01	TCRBD02-01*02	TCRBJ01-04*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCCCCCCAGGGAGAGTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	50	3.697705204150304E-4		37	TCRBV18	TCRBV18-01	01				TCRBJ02	TCRBJ02-07	01	8	4	3	4	4	4	24	33	42	37	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	X+TCRBV18-01+TCRBJ02-07	TCRBV18-01*01		TCRBJ02-07*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCCGCAGGACAAACCTACAATGAGCAGTTCTTCGGGCCA	CASSPAGQTYNEQFF	In	VDJ	2	53	3.9195675163993226E-4	4.5959468951343665E-4	45	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	3	1	6	2	4	2	24	38	47	42	49													Vb 18	CASSPAGQTYNEQFF+TCRBV18-01+TCRBJ02-01	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCCAAGGGGAAGGGGGACACTGAAGCTTTCTTTGGACAA	CASSPKGKGDTEAFF	In	VDJ	2	57	4.215383932731347E-4	4.942810811748281E-4	45	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	5	1	3	8	0	24	38	-1	46	52													Vb 18	CASSPKGKGDTEAFF+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCGTCGGGACGGAGCCAGAGCTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSPSGRSQSSGANVLTF	In	VDJ	2	58	4.289338036814353E-4	5.02952679090176E-4	57	TCRBV18	TCRBV18-01	01				TCRBJ02	TCRBJ02-06	01	3	0	7	0	3	10	24	38	46	41	56				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSPSGRSQSSGANVLTF+TCRBV18-01+TCRBJ02-06	TCRBV18-01*01		TCRBJ02-06*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCACAAAGACTAGCGGGAGTTAAGACCCAGTACTTCGGGCCA	CASSPQRLAGVKTQYF	In	VDJ	2	63	4.6591085572293835E-4	5.463106686669153E-4	48	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	1	2	2	6	3	3	24	40	55	43	58													Vb 18	CASSPQRLAGVKTQYF+TCRBV18-01+TCRBJ02-05	TCRBV18-01*01	TCRBD02-01*02	TCRBJ02-05*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCACCGGAGATACGCAGTATTTTGGCCCA		Out	VDJ	2	63	4.6591085572293835E-4		35	TCRBV18	TCRBV18-01	01				TCRBJ02	TCRBJ02-03	01	0	0	10	5	0	0	24	-1	-1	41	43				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	X+TCRBV18-01+TCRBJ02-03	TCRBV18-01*01		TCRBJ02-03*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCGGGACAGGCAATGACTGAAGCTTTCTTTGGACAA	CASSPGQAMTEAFF	In	VDJ	2	65	4.8070167653953955E-4	5.63653864497611E-4	42	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	0	4	5	0	5	24	-1	46	38	51													Vb 18	CASSPGQAMTEAFF+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACTCGTTCCGGGACAGGGACACGAGCAGTACTTCGGGCCG	CASSLVPGQGHEQYF	In	VDJ	2	66	4.8809708694784015E-4	5.723254624129589E-4	45	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	0	3	5	7	2	24	37	53	44	55													Vb 18	CASSLVPGQGHEQYF+TCRBV18-01+TCRBJ02-07	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-07*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCCAGGGGGCCGGACTACGAGCAGTACTTCGGGCCG	CASSRGPDYEQYF	In	VDJ	2	73	5.398649598059444E-4	6.330266478203939E-4	39	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	4	0	3	0	4	24	-1	43	35	47													Vb 18	CASSRGPDYEQYF+TCRBV18-01+TCRBJ02-07	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-07*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCGTGACCTGGCGGAACCAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	2	87	6.43400705522153E-4		47	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	3	7	5	0	8	1	24	38	50	46	51						01,02							Vb 18	X+TCRBV18-01+TCRBJ02-05	TCRBV18-01*01	TCRBD02-01	TCRBJ02-05*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
TTCTGTGCCAGCTCAAGCTACACCGGGACTAGCGGTGATTGGGGAATCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSSYTGTSGDWGISYNEQFF	In	VDJ	3	92	6.80377757563656E-4	7.977870082120032E-4	66	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	0	5	0	9	12	3	15	35	24	47						01,02							Vb 18	CASSSYTGTSGDWGISYNEQFF+TCRBV18-01+TCRBJ02-01	TCRBV18-01*01	TCRBD02-01	TCRBJ02-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACAAGAGTTTTCCGAGCAGTACTTCGGGCCG	CASSQEFSEQYF	In	VDJ	3	93	6.877731679719566E-4	8.064586061273511E-4	36	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	4	11	2	6	2	5	24	37	42	39	47													Vb 18	CASSQEFSEQYF+TCRBV18-01+TCRBJ02-07	TCRBV18-01*01	TCRBD02-01*02	TCRBJ02-07*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCAGGCGGGACAGGCGGAAACACCATATATTTTGGAGAG	CASSPGGTGGNTIYF	In	VDJ	3	104	7.691226824632633E-4	9.018461831961776E-4	45	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	2	0	4	4	3	1	24	39	50	42	51													Vb 18	CASSPGGTGGNTIYF+TCRBV18-01+TCRBJ01-03	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-03*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
GGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCAGGTTATGAGAATGGGACTAGCGGAGGCCTTTGAGAGCAGTACTTCGGGCCG	CASSPGYENGTSGGL*EQYF	Stop	VDJ	3	104	7.691226824632633E-4		60	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	2	0	5	7	12	10	21	36	59	48	69						01,02							Vb 18	CASSPGYENGTSGGL*EQYF+TCRBV18-01+TCRBJ02-07	TCRBV18-01*01	TCRBD02-01	TCRBJ02-07*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCGCGGACTAGCGGGAGTTCCAAAAACATTCAGTACTTCGGCGCC	CASSPRTSGSSKNIQYF	In	VDJ	3	106	7.839135032798645E-4	9.191893790268733E-4	51	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-04	01	3	1	2	2	2	2	24	38	53	40	55													Vb 18	CASSPRTSGSSKNIQYF+TCRBV18-01+TCRBJ02-04	TCRBV18-01*01	TCRBD02-01*02	TCRBJ02-04*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCGGGACTAGAAGGGACCCAGTACTTCGGGCCA	CASSPGLEGTQYF	In	VDJ	3	110	8.134951449130669E-4	9.538757706882647E-4	39	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	3	0	8	7	0	4	24	-1	46	38	50						01,02							Vb 18	CASSPGLEGTQYF+TCRBV18-01+TCRBJ02-05	TCRBV18-01*01	TCRBD02-01	TCRBJ02-05*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCCGAGCAGGGACAGGGGTCCTACGAGCAGTACTTCGGGCCG	CASSPEQGQGSYEQYF	In	VDJ	4	130	9.614033530790791E-4	0.001127307728995222	48	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	0	2	1	6	0	24	38	-1	44	54													Vb 18	CASSPEQGQGSYEQYF+TCRBV18-01+TCRBJ02-07	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-07*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCAGCGAAGGGACACTGAAGCTTTCTTTGGACAA		Out	VDJ	4	134	9.909849947122816E-4		40	TCRBV18	TCRBV18-01	01				TCRBJ01	TCRBJ01-01	01	2	5	3	3	4	0	24	39	-1	43	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	X+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01		TCRBJ01-01*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACGGGACAGCACAGATACGCAGTATTTTGGCCCA	CASSRDSTDTQYF	In	VDJ	4	139	0.0010279620467537845	0.0012053521102333526	39	TCRBV18	TCRBV18-01	01				TCRBJ02	TCRBJ02-03	01	4	0	7	0	0	0	24	-1	-1	37	42				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSRDSTDTQYF+TCRBV18-01+TCRBJ02-03	TCRBV18-01*01		TCRBJ02-03*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCTTTACCAGTCAGCGTTAATGAAAAACTGTTTTTTGGCAGT	CASSPLPVSVNEKLFF	In	VDJ	4	155	0.0011462886132865943	0.0013440976768789184	48	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-04	01	3	6	6	4	10	1	24	38	52	48	53						01,02							Vb 18	CASSPLPVSVNEKLFF+TCRBV18-01+TCRBJ01-04	TCRBV18-01*01	TCRBD02-01	TCRBJ01-04*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCACTTAGAACGGACAGGGGATATGGCTACACCTTCGGTTCG	CASSPLRTDRGYGYTF	In	VDJ	5	173	0.0012794060006360052	0.00150018643935518	48	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	1	1	2	5	7	1	24	40	56	47	57													Vb 18	CASSPLRTDRGYGYTF+TCRBV18-01+TCRBJ01-02	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-02*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCCGCGCGGGGCCTAGGTGGAAACACCATATATTTTGGAGAG	CASSPARGLGGNTIYF	In	VDJ	6	196	0.0014495004400269192	0.0016996331914081808	48	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-03	01	3	7	3	3	3	6	24	38	47	41	53													Vb 18	CASSPARGLGGNTIYF+TCRBV18-01+TCRBJ01-03	TCRBV18-01*01	TCRBD02-01*01	TCRBJ01-03*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCAGCACATGGGACCGCTCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	6	223	0.0016491765210510357		44	TCRBV18	TCRBV18-01	01				TCRBJ02	TCRBJ02-07	01	1	0	7	0	2	2	24	40	47	42	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	X+TCRBV18-01+TCRBJ02-07	TCRBV18-01*01		TCRBJ02-07*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACGAACAGCTCGGGATGAAAAACTGTTTTTTGGCAGT	CASSRTARDEKLFF	In	VDJ	8	265	0.001959783758199661	0.002297973447567183	42	TCRBV18	TCRBV18-01	01				TCRBJ01	TCRBJ01-04	01	4	3	5	6	2	6	24	37	43	39	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSRTARDEKLFF+TCRBV18-01+TCRBJ01-04	TCRBV18-01*01		TCRBJ01-04*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACGCCTGGGACCACATGCGGGACAGGGGAATCACGAGCAGTACTTCGGGCCG	CASSRLGPHAGQGNHEQYF	In	VDJ	8	266	0.0019671791686079617	0.002306645045482531	57	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	0	2	5	16	4	24	37	63	53	67													Vb 18	CASSRLGPHAGQGNHEQYF+TCRBV18-01+TCRBJ02-07	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-07*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCATTTGGGACAAGCTCCTACGAGCAGTACTTCGGGCCG	CASSPFGTSSYEQYF	In	VDJ	9	324	0.002396112972289397	0.002809597724572707	45	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	2	0	6	0	3	2	24	39	48	42	50													Vb 18	CASSPFGTSSYEQYF+TCRBV18-01+TCRBJ02-07	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-07*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCAAGGGAACAGTCCAGCAATCAGCCCCAGCATTTTGGTGAT	CASSPREQSSNQPQHF	In	VDJ	128	4475	0.033094461577145226	0.038805400671181677	48	TCRBV18	TCRBV18-01	01				TCRBJ01	TCRBJ01-05	01	2	0	8	1	1	7	24	39	44	40	51				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSPREQSSNQPQHF+TCRBV18-01+TCRBJ01-05	TCRBV18-01*01		TCRBJ01-05*01	4240A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4156	3544	570	41	0	1375	1119	231	25	0	135219	115319	18557	1343	0	0.207479179	8.02664661	0.187245682	8.47313881				68422	0.050053928	0.0718095005	0.061241392	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:20	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1035,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 262,treatment:nact,type of chemo:carbo/taxol	0.8527429988939466	MSKCC- Snyder- P01-01		3425.0	
